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MOTIVATION OF THIS WORK
Efficient therapy planning for oncology patients requires an accurate and cost-
effective diagnosis and follow-up of the neoplastic disease. The standard diagnostic
imaging technique in clinical oncology is Computed Tomography (CT). In recent
years, however, functional imaging using Positron Emission Tomography (PET) has
been recognized as an important imaging modality and adjunct to CT that provides
complementary metabolic information in many oncology applications. While a
limited number of combined PET and CT imaging studies have been performed,
combined functional and anatomical imaging is expected to increase both accuracy
and sensitivity of clinical diagnosis in oncology.
PET and CT images have previously been acquired on different scanners, leading
to variety of image registration confounds when imaging the extra-cranial regions
due to patient repositioning in different scanners, and curvature of the patient bed. To
address these issues and obtain accurately aligned functional and anatomical images,
we have constructed a prototype dual-modality PET/CT tomograph for use in clinical
oncology in collaboration with the University of Pittsburgh Medical Center, CTI
PET Systems Inc. and the National Cancer Institute (Grant support CA 65856).
This thesis describes the design, construction and validation of the combined
PET/CT tomograph. The dual-modality tomograph combines two diagnostic imaging
techniques that are presented in chapter 1 and 2. The combined scanner is described
in chapter 4. We show that CT and PET components perform equally well compared
to their operation in dedicated CT and PET systems. Part of the thesis work was
dedicated to improve the performance of the PET components (ECAT ART) of the
combined system in count-limited whole-body imaging situations (chapter 3). As a
result the countrate performance of the ECAT ART was increased substantially and
the final image quality was improved by modifying the detection acquisition
electronics and optimizing standard acquisition parameters. These findings were
applied to standard ART scanners and the prototype PET/CT tomograph.
In extension to the work by others we propose a hybrid segmentation/scaling
algorithm to calculate attenuation correction factors for the available PET emission
data (chapter 5). For use in clinical PET/CT scanning, however, certain limitations of
CT-based attenuation correction must be considered (chapter 6).
The prototype PET/CT tomograph was installed at the University of Pittsburgh
PET Facility in June 1998. The applicability of combined PET/CT imaging in
clinical oncology (chapter 7 and 8) is evaluated in a series of 70 patients covering a
range of different cancers, including lung, esophageal, head and neck, and pancreas.
Finally, a few promising areas of future applications of this prototype tomographs or
dual-modality PET/CT imaging in general are discussed in chapter 9.
© Thomas Beyer, 1999
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1. ANATOMICAL IMAGING: COMPUTED TOMOGRAPHY
X-ray Computed Tomography (CT) was invented in the late 1960s by Godfrey
Hounsfield [Hounsfield, 1977] who was working at that time on pattern recognition
and reconstruction techniques using a computer. The first prototype CT developed by
Hounsfield working at EMI Ltd. in the UK was based on an americium gamma
source and a scintillation crystal. It took nine days to scan a head-size object and
more than two hours to process the data from 28,000 measurements [Webster, 1995].
In 1971, the first clinical prototype CT scanner was installed in the Atkinson-Morley
hospital and the first patient was scanned with this device in 1972 [Ambrose, 1973;
Hounsfield, 1973]. As it became clear that this scanner was able to distinguish
normal from diseased brain tissue more patients were studied, and CT scanners were
ultimately to become standard diagnostic imaging devices, not just for the brain as
with the early prototype developed by Hounsfield but increasingly for whole-body
imaging [Ledley, 1974].
1.1	 CT SCANNERS
1.1.1 CT SCANNER GENERATIONS
During the ten years following its introduction, CT technology underwent major
technical advances in both scanner design and data acquisition. From the first CT
scanner, the EMI scanner (derived from the Electric and Musical Industries
company) introduced by Hounsfield, subsequent scanner designs can be classified
into four generations [Maravilla, 1978]. These generations differ mainly in the
acquisition geometry (fig. 1.1), although also in detector technology and computation
power.
While the first two generations acquired data in translate-rotate mode, CT
scanners of the third and fourth generation use a rotate acquisition scheme only. First
generation scanners used a thin, focused X-ray beam (pencil beam) that is detected
by a single detector after traversing the patient. While the tube/detector assembly
translates stepwise tangential to the orbit around the patient, a series of
measurements called projections is collected. After a complete translation the
assembly is rotated by 10 and another translation process commences. To acquire a
full set of data from which to reconstruct an image, a series of translate-rotate
procedures has to be performed in order to cover an arc of 180° around the stationary
patient, thus allowing to acquire a complete set of transmission measurements,
covering the entire cross-section of the patient
Second and higher generation scanners incorporate X-ray tubes that produce fan
beams. Although the tube/detector assembly in second generation CT scanners still
translated across the patient, the number of rotational steps is significantly reduced
owing to the replacement of single detector elements with one dimensional detector
arrays. In third and fourth generation scanners the translation step is eliminated by
introducing curved detector arrays that extend over either a partial or full ring. The
tube
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Figure 1.1 CT scanner
generations. (1') translate-
rotate, parallel beam, (2nd)
translate-rotate, fan beam,
linear detector array, (3rd)
continuously rotating fan
beam, curved detector
array, (4'h) rotating fan
beam, stationary detector
ring.
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X-ray tube and detectors are rotated continuously around the patient in contrast to the
first two generations (step-and-shoot mode).
The major difference between third and fourth generation CT scanners is the pulse
mode operation of the X-ray tube. Since in third generation scanners the same
detectors are exposed to the transmitted X-ray fan beam, significant dead-time losses
are avoided by pulsing the X-ray beam. In contrast, X-ray tubes in fourth generation
scanners may be operated continuously because the continuous rotation of the tube
results in different arcs of the full ring of detectors being exposed to X-rays, and thus
detector dead-time effects between measurements are no longer an issue. The
continuous X-ray tube operation, on the other hand, causes the radiation exposure to
the patient to be higher than in third generation scanners.
The development from pencil beam geometry and single detectors to fan beam
geometries and curved detector arrays has led to a significant reduction in the total
scan time, and to an overall improvement in image quality and spatial resolution of
CT images. Today, only third and fourth generation CT scanners are available
commercially. Fifth generation CT scanners, introduced in the early 1980s, are high-
speed tomographs for sub-second CT acquisitions that avoid or limit motion artifacts.
The Imatron Ultrafast CT scanner uses electron beam technology that eliminates the
X-ray tube and rotary motion of gantry components [McCollough, 19944 An
electron beam is scanned over four stationary tungsten rings to generate fan beam X-
rays. The combination of the target rings with two solid state detector arrays allows
eight independent transaxial images to be acquired without incrementing the patient
table [McCollough, 19944 A different design, the Dynamic Spatial Reconstructor
(DSR) at the Mayo Clinic, employs 14 X-ray tubes arranged in a partial ring around
the patient opposite to an arc of detectors. Unlike the Ultrafast scanner, the DSR
assembly rotates around the patient. Although the total scan time in fifth generation
CT scanners is reduced to milliseconds, the dose delivered to the patient
[McCollough, 1994b] far exceeds that from standard radiographic procedures. Fifth
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generation CT scanners are used in the assessment of the myocardium for bypass
operations or for 3D coronary angiograms where excellent temporal resolution is
essential for the visualization of internal structures that are involved in involuntary
patient motion.
1.1.2 THE X-RAY SYSTEM
The core of every CT scanner is the X-ray system, which is common to all
generations of CT scanners and shown schematically in fig. 1.2. The production of
X-rays is facilitated by an X-ray tube powered by a generator. Since X-ray tubes are
operated at high voltages, typically in the range of 20keV to 150keV, high voltage
transformation is one of the many functions of the X-ray generator [Seibert, 199'7].
This allows the operator to select the X-ray energy (maximum tube voltage [kV]),
the intensity (tube current [mA]), the focal spot size, and the exposure time.
Side view	 Front view
Figure 1.2 Schematic X-ray system that is common to all CT scanners. The collimation scheme is
shown in both, the side view (left) and frontal view (right). The isotropically produced X-rays are
shaped into a fan beam (right) of an angle not larger than 50° and some constant axial beam width
using pre-patient collimation. Additional bow-tie filtering is provided to equalize beam hardening
across the transverse sections.
A number of designs of X-ray generators are currently in use: single and three
phase generators, constant potential generators, and high frequency generators. These
generators all incorporate the same basic components such as a high voltage
transformer, a filament transformer (to control the filament and tube currents), and
other stabilizing and rectifying circuitries. The high frequency inverter generator is
the most common type for all but a few applications, such as there were very high
voltages or very fast switching times needed [Seibert, 1997]. The generated high
frequency, high voltage output waveform is affected by voltage ripples (a descriptor
of the kV-linearity) similar to the ripples created by the three-phase, 12 pulse
4generators. However, the high frequency generators are more efficient, more
compact and less costly to manufacture.
The X-ray generator powers the X-ray tube that is used to produce X-rays. The
tube is described in detail in section 1.2.1. Electrons are released from a cathode
filament in a process called thermionic emission and accelerated in an electric field
towards an anode opposite to the cathode. The electric field strength is adjusted by
changing the generator power. Heterogeneous X-ray spectra are produced when the
accelerated electrons hit the surface of the rotating anode disk (typically made out of
an alloy of tungsten, molybdenum and rhenium) with a focal spot size optimized for
high spatial resolution. The anode disk rotates to prevent excessive heat from
building up at any single location of the target region. The disk is also tilted with
respect to the incoming electron beam to limit self absorption of the emitted
Bremsstrahlung near the surface of the anode. The generated X-ray spectra leaving
the X-ray tube cover an energy range from about 20keV up to 140keV depending on
the maximum tube acceleration voltage. X-ray tubes are oil-cooled and mounted on
the rotating CT gantry.
The X-ray tube assembly should be designed to minimize the exposure to the
patient. Since X-rays are emitted from the focal spot on the anode isotropically the
X-ray tube is opaque except for a small window that allows X-rays to escape in the
direction of the patient. The tube window itself consists of a filter, that restricts the
passage of low-energy X-rays that do not contribute to useful CT transmission
information but do increase the dose delivered to the patient. As a result of the
filtering, the beam becomes harder as the lower energy part of the X-ray spectrum is
eliminated. Typical filters comprise aluminum or equivalent low-Z materials with
thicknesses in the range of a few mm. A second function of the filtering is to render
the energy distribution of the beam more uniform over the detector array. Since the
transmitted X-ray beam is more attenuated (hardened) along the lines through the
centre of the imaged object and less outside or at the edge of the object, a shaping
filter (bow-tie filter) is placed in the beam path (fig. 1-2) to shift the spectrum
towards higher energies at the edge of the X-ray beam distribution. The beam
hardening of X-rays traversing the central part of the object is thus balanced by the
artificial hardening of the beam along only those the paths that tangentially traverse
the object, i.e. where the bow-tie filter is widest (fig. 1-2, right).
Final beam shaping takes place at the collimators before the X-rays enter the
patient. The purpose of the collimators in CT imaging is to limit the radiation
exposure to the patient. The X-rays are emitted uniformly from the X-ray tube and
collimated into a fan beam of a given axial beam width (i.e. slice width) and fan
angle. The collimators are typically of lead [Krestel, 1990, p 441]. The fan beam
angle of modern CT tomographs is adjusted to allow for whole-body imaging and
generally does not exceed 50° [Zeman, 1995].
Detector collimation is used in conjunction with the source collimation to provide
better definition of the axial slice width. The distance between the detector
collimators is adjustable to allow for a variety of slice widths to be defined for each
CT scan, typically in a range of 1-10mm. Detector collimators also serve to restrict
5unwanted scattered X-rays from entering the detector assembly from arbitrary angles
and thus help to improve the overall image quality.
There are two basic categories of CT detectors: gas ionization and scintillators. In
order to be sensitive to the detection of X-rays these detectors should possess high
efficiency for photon capture, absorption and energy conversion. The photon capture
efficiency is high when the size of the active detector area facing the transmitted
beam is large and the distance between individual detector elements is small. This is
the case for xenon gas detectors that consist of thin, vertical, and electrically charged
plates arranged in a row. The plates are separated from each other by narrow
chambers filled with pressured gas, which leaves essentially no space between
adjacent detector chambers. Capture efficiency for gas ionization detectors is
approximately 90-95% compared to 50% for scintillation crystal detectors that are
spaced at equidistant intervals. Only a fraction of the captured photons is actually
absorbed and converted into a useful signal. Scintillation detectors, however, have a
much higher photon conversion efficiency (close to 100%) than the less-dense Xe-
filled ionization chambers, which convert only about 60% of the incoming photons
[Maravilla, 19'78]. The total detection efficiency is given by the product of the
photon absorption and the conversion factor and is thus about the same for both the
scintillation and ionization detectors used in CT (about 60%).
Gas detectors are characterized by excellent stability and fast response times. Gas
detectors also do not suffer from afterglow as can be the case for scintillation
detectors. The relative insensitivity of Xe gas detectors to X-rays striking the
detector from multiple angles prohibits their use in fourth generation scanners where
a given detector element is not aligned with the X-ray tube at all times (fig. 1-1).
However, in state-of-the-art third generation CT scanners, ionization chamber
detectors are replaced by solid state detectors coupled to photodiodes for reasons of
higher efficiency. Solid state detectors are only applicable at certain CT energies
because of the band gap restrictions. The band gap in solid state detectors is much
smaller than in scintillation crystals. Hence more electrons are liberated per incoming
X-ray photon, which decreases the amount of noise on the outgoing signal and
improves the signal-to-noise ratio.
Although the detection of single X-ray photons would be possible with
scintillation detectors (for example, a 100keV photon creates 3,000 scintillation light
quanta that are converted into 500 electrons in the photomultiplier), single events are
not recorded in CT. Instead signals in CT are formed by integrals of counts
(integrated counts) due to the high influx of photons per detector element. An
integration of the current at the output of each detector element allows the detector to
remain active throughout the exposure, and deadtime is thus limited. Unlike emission
tomography where single events are recorded and processed to determine the energy
that is deposited by a single photon in the detector, energy discrimination is not
required in CT. While photons are scattered both in emission and transmission
computed tomography, scatter in CT is adequately rejected by the collimators
positioned at the source and the detectors (fig. 1-2).
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1 .1 .3 CONVENTIONAL CT
In conventional CT, the X-ray system (section 1.1.2) rotates around the patient to
collect projection data for a single axial slice of tissue. The table is then moved by a
pre-defined increment before projection data of the adjacent slice is acquired. The
data acquisition is a step-and-shoot process that consists of four steps (fig. 1-3). First,
the X-ray system is accelerated to a constant speed of rotation. During this rotation,
X-rays are produced that are collected by the detectors after traversing the patient. At
this point (step 2) the patient is required to stop breathing for the time of the
acquisition of that particular slice. Following this acquisition the patient resumes
breathing and the X-ray system is decelerated to a full stop (step 3). In the last step
the table is indexed to the next axial position and the power cable to the tube is
unwound to allow for the next acquisition. This process has to be repeated as many
times as there are slices to be scanned to cover the axial volume of interest. The time
for steps 1, 2, and 4 in conventional CT is often referred to as interscan delay, and
typically takes as long as the acquisition itself, thus limiting the duty-cycle of step-
and-shoot CT to 50% at the most [Hu, 1999].
Conventional CT
•-
Slice position	 Time
Helical CT
Slice position
Figure 1.3 Acquisition scheme of conventional CT (top) and helical CT (bottom). Conventional CT
data are acquired in a four step process indicated by the small box. The patient is required to stop
breathing for the duration of the single slice acquisition before the table is indexed to the next slice
position. Helical CT allows the same axial volume to be acquired in a single bre,athhold by moving the
table continuously through the gantry while the X-ray tube is operated. Total scan time is shorter than
in conventional CT. (adapted from [Seeram, 1994]).
Major limitations of the standard slice-by-slice acquisition include:
- Long examination times because of the acceleration and deceleration of the
gantry components (steps 1,2,4) i.e. low duty-cycle,
- Loss of anatomical features owing to inconsistent interscan respiration (step 3),
- Inaccurate generation of volumetric image sets attributed to inconsistent
respiration (fig. 1-4),
- Limited scan volume in situations when contrast agents have to be used.
7Figure 1.4 Breathing artifacts in conventional CT. Left: coronal view of assembled CT study showing
inconsistencies in the imaged volume of the diaphragm (arrowheads). A number of contiguous slices
through the region of the diaphragm is shown to the right (slices 63, 65, 67, 69). The effect of
breathing is seen as a discontinuous appearance of the diaphragm (arrowheads) in these axial slices.
The introduction of continuously rotating scanners has led to a new scanning
approach, often referred to as helical CT by which the disadvantages of conventional
CT, such as interscan delays and respiration inconsistencies can be overcome.
1.1.4 HELICAL CT
During helical CT scans the patient is moved progressively through the gantry
while X-ray transmission data are acquired continuously for several full rotations of
the X-ray system. Helical CT is often referred to a volumetric CT since data are
collected as a volume rather than as a set of independent slices [Kalender, 1990].
Helical CT is made possible through the use of slip-ring technology. Slip ring
systems are electromechanical devices that consist of conductive rings and brushes
and allow the transfer of electrical power across a rotating metal surface.
Conventional CT scanner had to rely on long, high-tension cables that powered the
X-ray tube from an external high voltage generator. These cables had to be rewound
after every full rotation of the gantry components, i.e. after every single slice
acquisition. The major advantage of slip rings is that they allow CT scanners to
rotate continuously, so that volume data sets can be acquired in a shorter time frame
than with conventional start-stop scanners (fig. 1-3). The interscan delays are thus
omitted and most of the disadvantages of the slice-by-slice acquisitions described
above are eliminated.
Helical CT differs from conventional CT in two fundamental aspects. First, the X-
ray tube traces a helical path with a radius equal to the distance between the focal
spot and the centre of rotation around the patient. Thus an entire volume is scanned
during a single breath hold compared to conventional CT where only one slice is
scanned during a breath hold. Secondly, the patient is moved at a continuous speed
through the gantry. For example, during a 30s scan, with a scan time of is per slice, a
slice width of lOmm, and a table increment of 10nun/s an axial range of 300mm can
be scanned. Generally, table feed, scan time, and slice width are determined based on
the volume to be imaged. Total scan time per helical scan also depends on the heat
capacity of the X-ray tube, since volumetric data can only be acquired as long as the
8X-ray tube is . operated continuously and not overheated. Delays between helical CT
scans can occur in cases of multiple, repetitive scans when the generated heat from
operating the tube builds up and exceeds the heat capacity of the tube.
In helical CT the number and position of the images can be chosen
retrospectively, independent of the scan parameters and the pitch. The pitch is
defined as the dimensionless ratio of the distance D the table travels during a full
360° rotation of the X-ray system, divided by the collimator setting C:
D[mm]
Pitch=
	
	
Eqn. 1-1
C[mm]
The collimation C is equal to the nominal axial slice width and generally defined
by the user. For example, if a slice width of lOmm is defined, and helical CT data are
acquired with a table feed of 5mm/s for a 2s scan (time needed for a full 3600
rotation) then the pitch is equal to 1 (table 1.A). If the pitch is smaller than 1, helical
CT data are acquired with overlapping slices. Conventional CT can be regarded as
helical CT with a pitch of zero. Helical CT scanners offer pitch values typically in
the range from 0 to 2. The larger the pitch the more the acquired data helix is spread
out and the larger the volume that can be scanned for a fixed scan time, although at
the expense of coarser axial sampling of the transmission information.
Table 1.A Examples of helical scan parameters and pitches. An example of the total axial scan length
for a fixed scan time of 30s is also given. ( single slice only)
Slice width Rotation time Table move Pitch Total scan length
5 mm is 0 5 Inni
5 mm is 4 mm 0.8 120 mm
10 mm 2s lOmm 1 150 mm
10 mm 2s 16 mm 1.6 240 mm
10 mm 2s 20 mm 2 300 mm
Description 
conventional CT
overlapping slices
continuous slices
continuous slices
continuous slices
Owing to the continuous helical data acquisition, a number of problems arise in
helical CT imaging. Unlike conventional CT, the geometry of a single slice is not
limited to the defined slice but extends beyond, depending on the pitch chosen (fig.
1-5).
pitch 0	 pitch 1	 pitch 2
Figure 1.5 Comparison of the slice geometry in conventional (pitch 0) and helical CT (e.g. pitch 1 and
2).
In helical CT, the table increment per rotation can be selected independently of
the collimation and pitch (eqn. 1-1). A larger table increment, and hence a larger
pitch, give faster acquisition, but degrades the axial resolution. The axial resolution
is typically described by the slice sensitivity profile, SSP, and is shown in fig. 1.6 for
conventional CT
— pitch 1
— pitch 1.4
— pitch 2
Figure 1.6 Slice sensitivity profile (SSP) for
conventional and helical CT with 5mm
collimation. The FWHM values are indicated
by the horizontal lines; these values increase
with increasing pitch (from (Wilting, 19991).
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a number of _different pitches. The SSP shows the relative contribution of the
anatomy along the z-axis to the reconstructed image. In conventional CT, the axial
spatial resolution is determined entirely by the source collimation. In helical CT, the
axial resolution is also determined by the table increment per rotation and by the
interpolation algorithm used.
frnm]
Tomographic image reconstruction uses the projection data from at least one full
rotation around the patient. In helical CT, the patient is moved during the acquisition.
The sampling of the transmission data from the scanned volume depend on the slice
width and the table increment per rotation, as shown in fig. 1-5. Because of the
absence of a clearly defined slice in helical CT acquisitions the projection data are
said to be inconsistent, and require a special interpolation before the tomographic
reconstruction [Brink, 1994]. The post-processing of helical CT data has been
discussed extensively in the literature [Crawford, 1990; Wang, 1993], and various
interpolation schemes were suggested to synthesize planar data sets from helical data
(fig. 1.5).
The methods most currently used are the 1800 half-scan (HI) and the 360° full-
scan (H) interpolation algorithms. The HI uses the data from a single full rotation to
sample projections for a single slice. The helical projection data are thereby sampled
in planar projection data with a half-rotation difference. Alternatively, the FI
algorithm assembles single slice projection data from data acquired over two
complete rotations. The disadvantage of the FI is a significant increase in the width
of the SSP, and consequently a reduction in the axial resolution. On the other hand
noise is reduced by 10-20% in full-scan interpolation [Kalender, 1991], while noise
levels increase slightly in case of half-scan interpolation owing to the fewer
projection data used for the reformatting. Despite the necessary interpolation steps,
however, important image quality parameters of helical CT such as image
uniformity, spatial resolution, contrast, and image noise are similar or better than
those of conventional CT.
1.1.5 CLINICAL ASPECTS OF HELICAL CT SCANNING
Major advantages of helical CT include the ability to scan a whole volume in a
single breath hold. In practice, compromises must be made between narrow
collimation to optimize axial spatial resolution and obtaining sufficient axial
coverage with a given table increment. This is of particular importance when
10
scanning the lungs [Paranjpe, 19941 where the duration of the breath hold is the only
limitation of the helical CT scan.
Helical CT is the method of choice for detecting pulmonary nodules because of its
ability to avoid slice to slice misregistration [Padhani, 1998]. This is particularly
valuable for small nodules (< lcm) at the base of the lungs where respiratory motion
is greatest. It was shown that the variation in the depth of inspiration can explain why
nodules of varying sizes (some greater than 20mm) can escape detection with
conventional CT [Remy-Jardin, 1993]. In comparison, motion artifacts observed in
helical CT are almost exclusively limited to the lingula and lower lobe segments in
close contact to the left ventricle.
Helical CT allows for arbitrary fine spacing during the reconstruction while in
standard CT, the choice of thickness and spacing of the sections is fixed. Therefore,
the detection of small focal lesions in helical CT is further facilitated by the ability to
reconstruct slices at any given axial position. This typically permits at least one
reconstructed slice to cut through the centre of a nodule that would otherwise not be
detected in conventional CT with a fixed slice width and spacing [Dixon, 1989]. For
a given dose, helical CT thus offers better axial resolution and higher sensitivity than
conventional CT owing to the capability of retrospective image reconstruction at
arbitrary axial sampling [Wang, 1994a]. This may seem in contradiction to the fact
that the SSP is broadened in helical CT [Wang, 1994b] although it has been shown
that wider SSP profiles did not affect the clinical usefulness of helical CT [Polacin,
1992]. However, in order to exploit the advantages of helical CT, images should be
reconstructed at intervals less than half the table increment [Kalender, 1994]. For
example, for a 5mm lesion and 5mm collimation, overlapping images should be
calculated in increments of at least 2mm to allow for sufficient image contrast to
detect the lesion. Another study showed that for a set of pitches, assuming a fixed
scan range for the helical scan, optimal image quality parameters are achieved with a
pitch of 1.4 [Wang, 1997].
Areas of application of helical CT include the evaluation of head and neck lesions
[Suojanen, 1992], abdominal imaging, in particular of the liver [Silverman, 1998],
and imaging of the vasculature and muscoskeletal system [Heiken, 1993]. An
increasingly important area of application is the high temporal resolution CT using
contrast agents to improve the detection and characterization of hepatic lesions
[Heiken, 1993]. The short scan time with helical CT guarantees the imaging of a
certain volume or whole organ, e.g. liver, at the time of the peak contrast
enhancement (less than a minute after intravenous application). Generally, the total
dose in helical CT can be reduced by avoiding the acquisition of overlapping scans
and by eliminating the need for repeated scanning due to respiratory motion.
1.1 .6 THE SOMATOM A R.SP HELICAL CT SCANNER
State-of-the-art helical CT scanners from the major CT manufacturers (General
Electric, Elscint, Philips, Picker, Siemens, and Toshiba) all represent tradeoffs
between maximum performance and system cost. Table 1.B lists the ranges of
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system parameters found in contemporary helical CT scanners. It is noticeable that
key design figures, such as the number of detectors per degree of X-ray fan arc,
gantry aperture, and gantry dimensions are very similar. More significant variations
exist in the actual performance of the systems, such as the axial examination range,
tube parameters, and helical scanning capabilities.
Table 1.B Ranges of system parameters of state-of-the-art helical CT scanners (All) compared to the
Somatom AR.SP from Siemens Medical Systems, Erlangen, Germany. SS=solid state, v-
converter=high frequency converter.
	
GANTRY	 Height 
	
All	 190.. 210	 cm
	
AR.SP	 170 cm
SCANNER No. of detect.
	
All	 526 .. 4800
	
AR.SP	 512
	
BED	 Elevation 
	
All	 30.. 109 cm
	
AR.SP	 40.. 84 cm
X-TUBE Generator
	
All	 30 .. 60 kW
	
AR.SP	 14 kW
	
COMPUTER	 Display 
	
All	 >512
	
AR.SP	 1024
Width 
220.. 270 cm
170 cm
Detectors/fan
12-18
10
Axial travel 
143.. 182 cm
165 cm
Voltage
80.. 140 kVo
110, 130 kVo
Image matrix
256.. 1024
512
Depth 
90.. 110 cm
70 cm
Type 
SS, Xenon
Xenon
Scan length 
100.. 162 cm
122 cm
Current
50 .. 400 mA
63, 83, 105 mA
HU range 
-1024.. 6143
-1024.. 3071
Tilt 
-30.. 30 deg
-22.2222 deg
Slice width 
1.. 10 mm
1-3,5,10 mm
Weight limit 
135.. 215 kg
135 kg
Fan beam
43 .. 49 deg
52 deg
Image zoom
4.. 16
8
Aperture 
70 cm
60 cm
Centre dose 
 70 RGy/rnAs
94 i.tGy/mAs
Pitch 
.. 30
0.5 .. 2.0
v-converter
Yes
Yes
NEFLOPS
133 .. 200
N. A.
The range of parameters in table 1.B is then compared to a dedicated CT system,
the Somatom AR.SP (fig. 1.7), a third generation helical CT scanner (AR.SP),
introduced by Siemens in October of 1994. The Somatom AR.SP comprises a
noiseless, high frequency, single-tank generator which rotates with the X-ray tube-
detector assembly. The Siemens high performance M-CT 140 SR metal envelope
tube can be operated at a maximum voltage of 134kV p. The tube includes an
integrated oil-to-air cooling system and a 2.7mm Al equivalent filter. The detection
system is the self-collimating, QUANTILLARC xenon detector with 352 multi-use
chambers. Scanning is performed at tube voltages of 110kV p or 130kVp, and 1024
projections are acquired, each with 704 elements. Transaxial spatial resolution will
be about 0.55mm, and the slice thickness of 1, 2, 3, 5 or 10mm can be selected. The
system is capable of a scan time of 1.3-3s per slice with the option of repeat scan
cycles per slice.
The AR.SP scanner was chosen for the prototype PET/CT scanner that will be
described in more detail in section 4.2. Although the AR.SP is a low-end helical CT
scanner it compares favourably with top-of-the-line systems for the choice of scan
parameters. General scanner performance, however, is limited by the M-CT 141 X-
ray tube output (14kW) which is less than that of more contemporary tubes (30-
60kW). The low tube output limits the helical scanning performance of the AR.SP to
a narrow choice of tube accelerations (kV) and tube currents (mA). For example, the
maximum examination range for a pitch of 1 with top-end helical CT scanners is
between 40cm and 70cm, whereas only 20cm can be scanned with the AR.SP due to
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its limited tube capacity. In addition, the small heat capacity and heat dissipation of
the X-ray tube of the AR.SP make it difficult to perform multiple helical scans at
maximum coverage without an intra-scan delay for cooling. A detailed comparison
of current helical CT systems can be found in [Zeman, 1995].
Figure 1.7 Front view of the Somatom AR.SP, a third generation helical CT scanner manufactured by
Siemens Medical Systems, Erlangen, Germany. The bed support, the X-ray tube, and the detector arc
are marked. The tunnel opening is 60cm.
1.2 METHODOLOGY
1.2.1 X-RAY TUBES AND X-RAY PRODUCTION
The generation of the radiation that is used in Computed Tomography takes place
in the X-ray tube, which is part of every CT scanner. The X-ray tube can be
considered an energy converter that receives electrical energy and converts it into
two other forms: electromagnetic radiation (X-rays) and heat. The tubes are generally
designed to maximize the X-ray production and to dissipate the heat as quickly as
possible since it is an unwanted byproduct of the X-ray production.
A photograph of an X-ray tube is shown in fig. 1.8. The major components are a
cathode and an anode. The cathode expels electrons from a heated filament by
thermionic emission. The electrons are accelerated and directed towards the anode in
an electric field that is applied to the tube. The main function of the anode is to
convert the electronic energy into radiation; a process that is most efficient for high Z
anode materials, such as tungsten (Z=74). In addition, a high melting point, a good
thermal conductivity along with a high heat capacity are primary requirements for
the anode because of the predominant production of heat in the generation of X-rays
(see discussion of fig. 1.9). Therefore targets are typically made of tungsten (Z=74)
or an alloy of tungsten, molybdenum, and rhenium for maximum conversion
efficiency [Krestel, 1990, p. 68]. The anode is also rotated to facilitate better heat
dissipation.
Once a fast-moving electron enters the surface of the anode it undergoes multiple
interactions with the target atoms (fig. 1.9). The electron recedes with a reduced
kinetic energy, and the direction of the electron is likely to be altered. In interactions
aoptical
orbit
collisional losses radiative losses
Figure 1.8 Photograph of an X-ray tube
showing the anode disk, the cathode with
filament and the glass housing. The tube exit
window is not shown.
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with the atoms in the target surface the electron may also be backscattered. Generally
two fundamentally different energy loss processes may occur: collisional and
radiative loss. In collisional loss the electrons of the target atom are involved (fig.
1.9a-c), whereas in radiation loss the nucleus is involved directly (fig. 1.9 d,e). An
electron may suffer either energy loss alone or both collisional and radiation losses.
anode
cathode
Track a and b in figure 1.9 show collisions in which the trajectory of the incident
electron is altered and energy is transferred from the incident electron to the electron
knocked out from the atom. In a few collisional interactions the anode atom is
ionized and the knocked out electron will have enough kinetic energy to produce a
track of its own (fig. 1.9b) and undergo similar interactions to the incident electron.
The energy transferred in collisional interactions in track a and b will eventually
appear as heat and lead to an increased temperature of the anode.
e
b
ode-
Figure 1.9 Possible paths of interaction of incident electrons with target atoms of the cathode in an X-
ray tube. In all interactions the electron is likely to be diverted from its incident direction and to lose
energy to collisional interactions (a-c) and radiative losses (d, e). Only interactions d) and e)
contribute to the generated X-ray spectrum.
In track c (fig. 1.9) the incident electron collides with an electron from the inner
shell (K, L, M) and ejects it with an energy that is larger than the binding energy of
the inner shell electron. The hole in the inner shell is filled by an outer shell electron.
The difference in binding energies of the two shell electrons is emitted as
characteristic X-ray radiation (CXR). A given anode material gives rise to several
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characteristic X-rays because electrons from different shells (i.e. energy levels) can
be dislodged by the incident electron beam, and the holes in the inner shells can be
filled with electrons from different outer orbits. Therefore the typical CXR represents
a line spectrum with several discrete peaks.
Collisional losses occur with loosely bound electrons in the path of the incoming
charged particle (an electron in fig. 1.9a-c). For incident electrons with low kinetic
energies most of the energy losses are collisional ones, corresponding to trajectories
(a-c). The rate of energy loss to collisional interactions also increases with
decreasing energy of the incident charged particle. If the target material is of high
atomic number, radiative losses account for most of the energy loss. Most of the
primary electron energy is then converted into radiation and little into heat (fig. 1.9 d
and e). The most likely of the radiative losses occurs in track d when the incident
electron enters the vicinity of the nucleus of an anode atom (fig. 1.9d) but does not
collide with it. The electron will orbit partially around the nucleus and recede
(deceleration and change in direction of the electron) with an energy that corresponds
to the original energy less an amount of energy that is emitted as radiation
(Bremsstrahlung). The same interaction may occur, although with a much lower
likelihood, with the electron losing all its energy in a single deceleration very close
to the nucleus (fig. 1.9e).
The generation of X-rays can be modeled as follows: first, it is assumed that there
is a field, or space, surrounding the nucleus of an anode atom in which the incident
electrons experience the stopping or braking force. This gives the nuclear field the
appearance of a target zone with the nucleus located in the centre. The field can be
divided into concentric nuclear field zones (fig. 1.10). Although the zones have
essentially the same width, they have different areas depending on the distance from
the target centre, i.e. the nucleus. An electron striking anywhere within the target
zones experiences some electromagnetic interaction (braking force) and produces an
X-ray photon per interaction. Since the number of electrons hitting a given zone
depends on the area of the zone it becomes clear that outer zones capture more
electrons and create more photons than inner zones. Those electrons striking the
inner target zones are subject to greater force and deceleration than electrons striking
the outer zones, and thus produce higher energy Bremsstrahlung-photons (fig. 1.9d
and e). Generally, those electrons striking near to the centre of the anode atom are
subject to the greatest energy loss, while those interacting in the outer zones (low
energy atomic shells) experience weaker interactions and produce lower energy or no
photons.
The initial spectral distribution of all Bremsstrahlung-photons is composed of a
superposition of single thin target layer Bremsstrahlung-spectra. The spectrum for
each layer consists of Bremsstrahlung-photons with energies up to the maximum
energy of the incident electron per layer. All energies per layer occur with the same
probability (i.e. intensity). The superposition of the individual layer spectra
corresponds to a triangular histogram (fig. 1.10) with the base points at OkeV and the
maximum electron energy (kV). In practice, however, the distribution of the X-ray
photons varies from the unperturbed distribution. While some of the low-energy
100 keV electrons
from
.dett
anode atom . . •
nuclear field
zones
Photon energy
[keV1
100
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photons are already absorbed below the target surface, more photons of the lower
energy end suffer absorption when they pass through the special tube window that is
designed to restrict X-ray exposure. An example of the resulting X-ray spectrum is
shown in fig. 1.11. The spectral distribution of the X-ray photons emitted from the
tube peaks at some mid-range energy and falls off quickly towards low energies.
Self-absorption and tube filtration can reduce the area under the curve by 40% for a
100kVp and by about 12% for 200kVp. The peaks from the characteristic X-ray
radiation (CXR) that are superimposed on the continuous Bremsstrahlung-spectrum
are also seen.
Figure 1.10 A model for the generation of Bremsstrahlung in an X-ray tube. Electrons are emitted
from a heated cathode and accelerated in an electric field (e.g. 100kV p). High-energy electrons hit the
anode surface and are decelerated (see fig. 1.9). The anode atoms can be represented by atomic field
zones. The closer to the nucleus the electrons interact the more energetic is the emitted
Bremsstrahlung. More photons of lower energies are emitted by deceleration interactions with the
outer electron shells.
Two parameters strongly influence the production of X-rays: the tube current and
the tube voltage. The intensity of X-rays emitted by the anode is proportional to the
energy and the number of electrons which are accelerated in the electric field. This is
controlled by the temperature of the filament, which in turn is controlled by the tube
current. If a higher current is passed through the filament, the temperature rises and
more electrons are emitted from the filament wire and accelerated towards the anode.
The corresponding X-ray spectrum would have the same transmission properties but
more photons would arrive at the detector site thus reducing the noise of the
measurement. Tube currents are given in mA and are typically in a range of 50-
400mA (table 1.B).
In addition to controlling the intensity of the X-ray beam it is possible to control
the energy level of the X-ray photons. The X-ray photon energies are related to the
energy level of the electrons originating from the tube cathode which, in turn, is
controlled by the tube voltage. This value is generally referred to as the kilovolt peak
(kV) and determines the high-energy end of the spectrum (fig. 1.10). The X-rays
generated with higher tube voltages are of higher energy and are more penetrating
than those generated by a lower tube voltage. This is shown in fig. 1.11 where X-ray
spectra for different tube voltages are compared. The total area under the spectra
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corresponds to the number of X-ray photons created and the distribution would be
triangular if no filtration were present (fig. 1.10).
0	 25	 50	 75	 100	 125	 150
Photon energy [kV]
Figure 1.11 Typical X-ray spectra (calculated for a tungsten target and two tube voltages: 110kVp,
130kV p). Low-energy photons are eliminated by self-absorption below the anode surface and after
passing through the X-ray tube window. The spectral distribution shifts towards higher energies with
higher tube voltages. The peaks of the characteristic X-ray radiation emitted from the tungsten anode
arc superimposed on the spectrum.
1.2.2 ATTENUATION MEASUREMENTS OF X-RAYS AND HOUNSFIELD UNITS
When the beam of X-rays passes through the patient it is attenuated according to
the Lambert-Beer Law, an exponential relationship between the incident (I.) and
transmitted (I) beam intensity:
1= lo •	 Eqn. 1-2
The thickness of the object traversed is given by x, and the linear attenuation
coefficient is given by u. Equation (1-2) describes the reduction of beam intensity
due to photon scatter and absorption as it passes through an object of thickness x.
The linear attenuation coefficient depends on the number of atoms per unit volume
and the total cross-section per atom for all processes [Kouris, 1982]. For photon
energies below 1MeV the processes contributing to photon attenuation are coherent
(Rayleigh) scattering, incoherent (Compton) scattering, and the photoelectric effect.
In reconstructed CT transmission images, each pixel is represented by a numerical
value related to the linear attenuation coefficient of the tissue in each voxel. In
principle, the reconstruction process first calculates the attenuation coefficient within
each voxel from the measured transmission projections. The attenuation values are
then transformed into appropriate image pixel values, or CT numbers. CT numbers
(NcT) are related to the linear attenuation coefficients 1 .1 of the tissues by the
expression:
— fl
wNcr —	K	 Eqn. 1-3
where ,ut
 is the linear attenuation coefficient of the measured tissue, and ,a,„ is the
linear attenuation coefficient of water, and K is a contrast factor. In the first EMI
scanner, the value of K was set to 500, which results in a contrast scale of 0.2% per
CT number. These CT numbers were referred to as EMI numbers [McCullough,
1977]. Later the contrast factor K was set to a value of 1,000 and the corresponding
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CT numbers were referred to as Hounsfield units (HU). Using the HU scale, two
voxels have a difference in image contrast of 0.1% if their CT number differs by
1HU. Typical ranges of CT numbers (EMI and HU) for a number of biological
tissues are shown in fig. 1.12. Note the limited range of measured CT numbers i.e.
attenuation values of most soft tissues.
Hounsfield units
100
0
3 A	 5 6
EMI units
50
0
-200 -100
-400 -200
1 Adrenal gland 5 Fat 9 Liver
-600 2 Bladder 6 Muscle 10 Lungs -300
3 Blood 7 Intestine 11 Pancreas
-800 4 Breast 8 Kidney -400
-1000 -500
Figure 1.12 Typical range of CT numbers for various biological tissues.
CT numbers are established on a relative basis to allow for inter-comparisons of
attenuation values (densities) of various tissues of the same subject and to provide
quantification of attenuation values (densities) of tissues across subjects scanned
with different CT scanners. The attenuation values of air and water are used as
reference values. By definition, air and water have CT numbers of -10001-IU and
OHU, respectively. CT scanners generally operate at relatively high kVp settings
(table 1.B) where Compton interactions predominate in soft tissues (fig. 5.4). Since
the linear attenuation coefficients for Compton interactions are primarily determined
by the physical density, the CT numbers are closely related to the physical tissue
density [Rutherford, 19764 Therefore, tissues with densities less than that of water
(e.g. fat) generally have negative CT numbers. Positive CT numbers indicate a tissue
density greater than that of water. This is illustrated by a comparison of selected
tissues densities in fig. 1.13 and the corresponding CT numbers in fig. 1.12.
Tissue Zeff Pel
liver 7.419 3.51 1.05
kidney 7.697 3.48 1.05
muscle 7.698 3.48 1.04
fat 6.579 3.18 0.92
spleen 7.732 5.51 L06
blood 7.788 3.51 1.06
Figure 1.13 CT image of the abdomen showing various soft tissue organs (kidneys are enhanced
because of contrast agent application prior to the CT scan). The corresponding physical parameters:
effective atomic number (Zeff), electron density: Pel [m 3 10], and physical density: p [g•cm 31 arc listed
in the table. The effective atomic number Zcf, was calculated based on the atomic numbers of the tissue
composites [Krestel, 19901 using the formula by Spiers et al. [Spiers, 1946].
Tissue contrast in X-ray CT imaging is affected by the high sensitivity of
photoelectric absorption of the X-ray photons to changes in atomic number (Z),
which may offset the relatively low number of photons in the X-ray beam that
interact through this process [Cho, 1975b]. Therefore, CT numbers (eqn. 1-3) reflect
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a weighted average of the effective atomic number [Kouris, 1982, p.68] and electron
density of the tissues [Phelps, 1975a]. Experimentally, differences as low as 0.1% in
effective Z are discernible, although in practice this may not be detected due to the
limited photon statistics [Cho, 1975b].
Note that the same tissue will not have the same CT numbers when scanned with
different CT scanners because of the differences in X-ray beam energy [Zatz, 1976]
and filtration. CT numbers obtained with the same scanner can also vary with the
location of the specific tissue changes within the image area [Levi, 1982]. In addition
attenuation values are susceptible to a variety of artifacts caused by artifacts in the
CT images[Williams, 1980]. The most important artifacts will be discussed below to
provide a basis for discussion of the applicability of our proposed CT-based
attenuation correction algorithm (chapter 5).
1.2.3 IMAGE ARTIFACTS IN CT
The artifacts that are frequently observed in CT range from distortions of image
quality introduced by patient motion during the scan to distortions that are caused by
the polychromaticity of the X-ray radiation used [Duerimckx, 1978]. These artifacts
can degrade the image quality or the quantitative accuracy of the measured CT
transmission information to an extent that compromises the use of CT images for
diagnostic purposes. Some of the artifacts that are characteristic to CT will be
discussed here as they will be referred to later on when the use of CT transmission
images for correction of the PET data is described.
1.2.3.1 RING ARTIFACTS
Ring artifacts arise from one or more defective detectors in third generation CT
scanners (fig. 1.14). During the rotation of the X-ray system the rays measured by a
given detector are tangential to a circle centred on the FOV. Any malfunctioning or
miscalibrated detector will thus introduce a ring artifact with a diameter that depends
on the detector position.
ring artifacts
pent sup)291-;iii
Figure 1.14 Ring artifacts in third generation CT scanner.
This artifact is not present in fourth generation scanners since for any tube
position detector elements adjacent to the active elements can be calibrated before
the tube advances on its circular path, and the calibrated detector elements are
activated as part of the subsequent projection measurement.
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1.2.3.2 MOTION ARTIFACTS
Motion artifacts arise from the movement of organs or objects in the FOV during
the CT scan. Modern CT scanners use very short scan times (less than is per slice)
but some artifacts may still be generated from voluntary and involuntary patient
motion during the CT scan. These artifacts result in the appearance of streaks on the
images, which are tangential to high-contrast edges of the moving part [Alfidi,
1976]. Despite the short scan times, inconsistent breathing [Ritchie, 1994] or
cardiovascular motion [Reinhardt, 1998] may also result in axial discontinuities that
are seen in coronal views of the scanned patient volume (fig. 1.15).
Figure 1.15 Motion artifacts caused by
inconsistent breathing during a standard CT scan.
The arrows in coronal section through the thorax
and upper abdomen indicate inconsistencies in the
displayed morphology in the area of the
myocardium (white arrows) and the diaphragm
(black arrows).
1.2.3.3 PARTIAL VOLUME ARTIFACTS
The partial volume effect accounts for biases of attenuation values in CT images
particularly in regions of large gradients of tissue density (e.g. transition of grey
matter and skull bone in fig. 1.16) and may thus lead to serious image artifacts
[Glover, 1980].
Figure 1.16 Partial volume artifacts as observed
in a typical CT scan of the brain. The artifacts
appear as streaks of low density variations across
the lower cerebellum (arrows).
The calculation of CT numbers is based on the linear attenuation coefficient of
single voxels. The size of the un-truncated voxels is determined by the physical
detector width and the slice thickness (i.e. axial collimation). If a voxel contains
tissue types of different densities then the CT number for that voxel represents an
average of the attenuation properties of all tissues within that voxel. This is also
known as partial volume averaging since the attenuation properties of smaller tissue
densities that cannot be spatially resolved by the scanner are averaged over the entire
voxel and represented by a single quantitative value.
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Partial volume artifacts can be reduced by scanning thinner slices, although at the
expense of increased pixel noise, or by estimating a projection error introduced by
high attenuating objects through multiple half-scan images [Hsieh, 1999].
1.2.3.4 BEAM HARDENING
The increase in the mean energy of the polychromatic photon beam as it passes
through an object is termed beam hardening. As the multi-spectral beam traverses the
object the X-ray photons experience different attenuation losses depending on the
incident photon energy. Therefore, eqn. 1-2 must be applied to each energy interval
dE of the photon beam:
-	 x,E)dx
I = f 10 (E)e	 dE	 Eqn. 1-4
where 4, and t depend on the photon energy E, and p. also depends on the position x
along the measurement beam. The distribution of photon energies of the X-ray beam,
after passing through an object of a given material, shifts towards higher photon
energies of the spectrum. In other words, the mean energy of the X-ray beam
increases (beam hardening). Hence the linear attenuation coefficient for a given
material appears to decrease with increasing thickness of the transmitted object, as
lower energy photons are preferentially absorbed from the X-ray spectrum. In a
typical transaxial CT image of the abdomen (fig. 1.17) we found differences of up to
42HIJ between a region of the liver that was strongly affected by beam hardening
(region 2) and a background region in the frontal lobe of the liver (region 1) that was
less affected by beam hardening. Generally, changes in CT numbers appear as a
broad band or streak artifacts (fig. 1.17).
Figure 1.17 Beam hardening. A polychromatic X-ray spectrum (left) is hardened, i.e. the mean energy
is shifted towards the higher end of the spectrum, when passing through an object. Lower energy
photons are preferentially absorbed as the tissue is traversed (compare upper and lower spectrum at
the right). The dotted gray line gives an estimate of the mean energy of the spectrum. Beam hardening
results in low attenuation streak artifacts that are further enhanced when the arms of a patient are
placed inside the FOV (right).
Beam hardening results in a non-linear relationship between attenuation and the
projection data. Such a non-linear relationship is generally solved by an iterative
approach [Kijewski, 1977; Joseph, 19781 or by using correction coefficients obtained
from look-up tables [Krestel, 1990, p 105]. Although in many imaging situations,
Figure 1.18 High density
artifacts in CT introduced
by dense objects in the
patient: remaining contrast
agent from previous barium
fluoroscopy (left, arrow)
and post-operation surgical
clip (right, upper left
abdomen).
21
beam hardening is satisfactorily corrected, for large patients, the effect may still be
significant. The presence of arms in the FOV further enhances the band artifacts, as
shown in fig. 1.17. Additional pre-patient filtration of the X-ray spectrum could
reduce the spectral shift and beam hardening artifacts, however, at the expense of a
reduced photon flux, increased image noise, and a reduced contrast due to an
increase in average energy of the beam [Zatz, 1977].
1.2.3.5 METAL AND HIGH DENSITY OBJECTS
The presence of metal (e.g. dental fillings or prosthetic devices) in patients also
causes artifacts [deMan, 1999]. Since metal or any other high density object
significantly absorb radiation, certain projection profiles are incomplete. This loss of
information leads to the appearance of star-shaped artifacts (fig. 1.18). Metal artifacts
can be reduced by appropriate computer programs that interpolate the missing
projection values from a first estimate of the image before corrections for the
artifacts from the high density object are applied [Glover, 1981].
1.2.4 CONTRAST AGENTS
The purpose of contrast enhanced CT scans is to maximize lesion detection by
employing contrast material to accentuate differential blood flow and contrast
material diffusion rates between a lesion and the surrounding tissues. Positive
contrast media use high atomic number substances such as iodine, and more recently
gadolinium, increasing the attenuation values of vascular structures to levels above
those encountered in non-contrast images. Depending on the concentration of the
contrast agent (up to 350mg/mL), enhancements in CT attenuation values for soft
tissue of up to 200 HU are common.
CT contrast media are introduced either intravenously (i.v.) or orally. The use of
dilute oral contrast material to opacify or enhance the gastrointestinal tract is
important in the abdomen so that homogeneous, fluid-filled bowel loops are not
confused as space-occupying masses. Proper °pacification is also valuable in
extremely thin patients who lack the usual amount of intra-abdominal fat that is
necessary to outline various anatomical structures.
Intravenous contrast material are used to opacify blood vessels in larger lesions to
help determine relative vascularity. Apart from increased anatomical contrast (fig.
1.19), the observation of the time course of the i.v.-contrast medium distribution in
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organ areas of diagnostic interest provides unique information on local conditions of
blood flow [Gaeta, 19971 and vascularization of pathological tissues [Platt, 1997]
that would be not possible to obtain in non-contrast CT imaging. The observation of
the time course is often referred to as High Temporal Resolution CT, and made
possible with the introduction of helical CT that allows to acquire large volumes in
short scan times without a degradation of image quality compared to standard CT.
Optimum image quality of enhanced CT scans is obtained in temporal windows that
are coupled to the blood circulation time, and often delayed with respect to the
injection time to allow peak enhancement of the vascular structures in the area of
interest [Irie, 1996].
Figure 1.19 High density artifacts in CT
introduced by dense objects in the
patient: remaining contrast agent from
previous barium fluoroscopy (left,
arrow) and post-operation surgical clip
(right, upper left abdomen).
Helical CT makes rapid coverage of extended volumes possible, allowing
scanning to occur during the optimal phase of vascular and organ enhancement
[Foley, 1989]. An entire organ (e.g. liver) can thus be scanned at the time of the first
passage of a bolus injection while images acquired during the second passage are
often blurred due to increased dissipation of the contrast agent in the blood stream
[Schweiger, 1998]. Helical CT scanning technique adds flexibility to the choice of
slice thickness, dosage, and breath-hold interval, which makes it superior to
conventional CT in contrast-enhanced imaging situations [Polger, 1995]. The
combination of the helical scanning technique and contrast material administration is
beneficial in many difficult imaging situations, particularly in the abdomen [Heiken,
1993].
1.3 SUMMARY
Computed Tomography was invented in the early 70's by Godfrey Hounsfield
who shared the Nobel Prize for Physiology and Medicine with Alan Cormack in
1979. CT is a tomographic imaging technique that provides high resolution, high
contrast images of human anatomy. Clinical diagnosis is established based on
alterations of normal morphology that can be visualized with CT imaging.
CT uses an external source of radiation to produce incident X-ray beams. The
attenuation of the polychromatic X-ray spectrum is measured with a detector array
on the opposite side of the patient in the field-of-view of the scanner. From a variety
of scanner designs currently only fan beam systems with either an extended detector
arc or a full detector ring are in use. The introduction of the helical CT scanning
technique revolutionized CT imaging in the late 80's. Helical CT scanning allows an
extended axial volume to be imaged with high spatial and temporal resolution during
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a single breath. hold. The shorter scan times of helical CT help to reduce motion
artifacts from involuntary organ movement. Contrast agents facilitate the
discrimination of vascular structures from masses, and have application in helical CT
where entire organs (e.g. liver) can be imaged in a single scan within very short scan
times (several seconds).
Due to the polychromaticity of the X-ray spectrum, various image artifacts are
observed in clinical imaging situations and require correction. In most cases,
however, accurate attenuation information is obtained and CT images can provide
absolute measures of the attenuation properties of the tissues imaged. Comparison
between different tissues in the same patient, or between the same tissue types of a
patient population, are based on CT numbers. CT numbers represent the relative
attenuation of tissues with respect to the attenuation of water and are given in
Hounsfield units. Since attenuation properties in CT imaging are dominated by
Compton interactions, CT numbers can be correlated with density. Using the
Hounsfield unit scale, density differences of 0.1-0.5% can be visualized with CT,
which is of importance when imaging soft tissues in the abdomen.
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2. FUNCTIONAL IMAGING: POSITRON EMISSION
TOMOGRAPHY
In contrast to anatomical imaging techniques such as CT, radionuclide imaging
techniques obtain functional or metabolic information in-vivo by utilizing the
radiation emitted from radioactively labelled molecules that participate in metabolic
processes. Positron Emission Tomography (PET) is a functional imaging technique
that allows metabolic processes to be followed in-vivo. Based on the radiotracer
principle that was introduced by George de Hevesy in the 1920's, PET using positron
emitting radionuclides can be used to follow and measure trace amounts of
radioactively labelled molecules in-vivo in the living organism. Important
developments in radiochemistry and detection devices, as well as theoretical models
of image reconstruction preceded PET and shall be discussed briefly in the following
chapter.
2.1	 RADIOACTIVITY AND RADIOISOTOPES
2.1.1 THE DISCOVERY OF RADIOACTIVITY
With the discovery of X-rays by Wilhelm Conrad Röntgen in 1895, the medical
community was given for the first time a technique that allowed internal
morphological structures to be viewed non-invasively by using external
measurements. In 18%, shortly after the discovery of X-rays, Henri Becquerel
announced the discovery of another invisible radiation with similar penetrating
characteristics. Three years later, Marie and Pierre Curie discovered the first two
naturally radioactive elements (polonium and radium). The observation nuclear
transformation by Rutherford in 1914 was a major milestone in the developments
that in 1934 lead Irene and Frederic Joliot Curie to discover artificial radioactivity.
While the use of radiotracers in biology and medicine at that time was hampered by
the physical and chemical properties of the few naturally-occuring isotopes, the
cyclotron invented by Lawrence and colleagues [Lawrence, 1932] soon allowed
large amounts of artificial radioisotopes to be produced by bombarding various target
materials with high a flux of accelerated charged particles (e.g. protons and
deuterons). By 1938, more than 200 artificial radionuclides were known and had
been produced, many of which proved useful in biological and medical work
[Seaborg, 1996].
After the discovery of the fission process by Otto Hahn, Fritz Strassmann, Lise
Meitner and Robert Fritsch in 1938 a new source for medical radioisotopes became
available: the nuclear reactor, invented by Enrico Fermi in 1942. By 1945, the
number of artificially produced radionuclides had reached 2,000 of which, however,
only a small fraction of about 1% was and still is, interesting for diagnostic and
therapeutic applications in medicine. Although numerous important radioisotopes
can be produced in the reactor (as a rich source of neutrons) at low cost the cyclotron
is still required for the generation of highly important neutron deficient radionuclides
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that cannot be produced in the nuclear reactor [Myers, 1975]. The physical properties
of the cyclotron-produced radioisotopes are discussed in section 2.1.2 and 2.1.4.
2.1.2 MEDICAL APPLICATIONS OF RADIOISOTOPES
Medical radioisotopes can be used for diagnostic and therapeutic applications.
The choice of the radioisotope depends on the requirements for either application.
For therapeutic purposes, for example, the isotope should have particle emission and
little or no photon emission. Moderate half-lives are then desirable to increase
therapeutic efficacy while limiting risks from exposure to healthy tissues. Diagnostic
methods, on the other hand, require isotopes with biogenic behaviour and suitable
photon emission rates and energies. PET, for example, uses secondary annihilation
photons that arise from the disintegration of the emitted positrons with the electrons
from the surrounding tissue. Short half-lives are desirable to limit any harmful
interaction of the charged particles (positrons) with the healthy tissue. From a
radiation safety standpoint, the optimal physical half-life of a radionuclide used for
in-vivo diagnostics is slightly less than the time elapsed between administration of
the labeled substance and measurement of the emitted radiation [Ter-Pogossian,
1998]. Therefore, radionuclides are preferred that are characterized by both optimum
half-life and decay characteristics.
Radioisotopes for medical applications are produced artificially in a reactor by
nuclear fission, neutron capture (n, y), or neutron-induced transformations, and by a
cyclotron. While nuclear reactions in the reactor typically lead to nuclides with an
excess of neutrons, neutron deficient radioisotopes are produced in charged particle
reactions using accelerators such as a cyclotron. The light, short-lived positron
emitters for PET imaging are produced in highly selective reactions with small
dedicated medical cyclotrons. Cyclotrons provide protons and deuterons (of energies
between 5MeV to 20MeV) that interact with target materials to generate the desired
isotope. For the production of positron emitters, gas or water targets are used. With
increasing proton energy, the nuclear reaction becomes more non-specific and the
interaction cross-section decreases. In contrast to isotope production with small
cyclotrons, however, larger target volumes can be used for proton irradiation at
energies up to 1GeV (synchrocyclotron). Sophisticated multi-step chemical
procedures then have to be applied to separate one or more useful radioisotopes from
the irradiated target. Typical examples for this production route are 68Ge and 82Sr,
two long-lived mother isotopes that decay into medically useful radioactive daughter
isotopes 'Ga. and 'Rb, respectively.
2.1 .3 IN-VIVO DIAGNOSIS: THE RADIOTRACER PRINCIPLE
Nuclear medicine is based on the use of radiotracers to diagnose or treat disease.
Tracers refer to tiny amounts of radioactive substances that pass harmlessly through
the body and can be detected with special devices due to the particles and radiation
they emit [Myers, 1975]. George de Hevesy introduced the concept of using
radiotracers into the life sciences in the 1920s [Hevesy, 1923]. The idea of using
radiotracers is relatively simple. In an ideal physiological experiment or during the
26
observation of. physiological processes, the subject or system should not be
disturbed. The biological function of the system can then be studied by means of a
substance in very small quantities (tracer) that mixes immediately and uniformly
with the constituents of the system without causing any perturbation. The tracer
substance must follow the behaviour of the system, but at the same time it must be
identifiable. The tracer molecule are therefore labeled with a radionuclide to allow
the labeled tracer to be identified and followed in-vivo based on the radiation emitted
from the radiolabel. To ensure the labeled tracer enters and follows the metabolic
pathway to be studied, isotopic labeling of the tracer molecule with a radioisotope is
used. Radioisotopic labeling of the tracer does not significantly alter the chemical
properties of the tracer molecule that would otherwise be distinguishable from the
non-labeled metabolic constituents, and excluded from metabolic pathway.
The design of a radiotracer for functional imaging is based on regional
physiological and biochemical concepts, such as blood flow, metabolism, receptor
binding and others, The process of tracer design starts with the choice of the
radioisotope (e.g. positron emitter). Short-lived radioisotopes, such as ' 50 for PET
studies have to be produced on-site, longer-lived radioisotopes can be delivered from
a remote site. In many cases isotopic labeling is not possible and thus analogue, or
biogenic isotopes (section 2.1.4) are used, for example ' 8F is used to replace a
hydrogen atom (H) or hydroxy-group (OH). The position of the label then affects the
metabolism of the labeled tracer molecule and may lead to the accumulation of the
metabolized tracer (metabolic trapping, see section 2.1.5) after the initial steps in the
metabolic cycle under study.
2.1.4 RADIOISOTOPES FOR PET
From the variety of artificially-produced radioisotopes, neutron-deficient positron
(I3+) emitters offer a number of advantages over single photon emitters for medical
imaging. They were first discussed by Wrenn and co-workers in 1951 [Wrenn,
1951]. Accumulations of tracers labeled with 1r-emitters can be localized in-vivo by
coincidence detection (section 2.3.1), which is a more efficient process than the
physical collimation of gamma rays.
Coincidence detection also allows an accurate correction for attenuation of the
photons inside the imaged object as a prerequisite for quantification of the tracer
concentration in-vivo. In addition, measuring the annihilation photons in coincidence
would always be preferred over parallel counting using collimators when high spatial
resolution is needed [Dyson, 1960]. Although the short half-lives of radioisotopes
such as 150 (1' 112=2min) require a cyclotron and radiochemistry to be in close vicinity
to the PET tomograph, the half-lives of most positron-emitting radioisotopes are very
valuable in the study of metabolic processes with time scales of seconds up to a few
minutes with the possibility to perform repetitive studies.
The three positron-emitting radioisotopes that can be used for isotopic labeling or
organic tracer molecules are: "C, ' 3I•1, and ' SO. Radiochemistry with these
radioisotopes is, however, relatively difficult due to their short half-lives: 20min
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elmL.) 10min (51•1), and 2min (0). These half-lives require the production of the
isotopes in high doses and short labeling processes. The ability, however, to replace
an H- or OH-group in organic tracer molecules with fluorine gave rise to an
increased use of the positron-emitting fluorine isotope ( 18F, 110min half-life), in
particular for oncology applications. All four radioisotopes: "C, 150, and ' 8F are
often referred to as biogenic radionuclides since they can be used to replace their
stable isotopic counterparts in tracer molecules without significantly altering the
chemical properties of the tracer.
The usefulness of the biogenic radioisotopes in non-invasive physiologic
measurements was recognized as early as in the 1940s [Volker, 1940]. Subsequent
studies carried out in-vivo in humans used "C-labeled carbon monoxide [Tobias,
1945] and 150-labeled oxygen for respiratory and cerebral metabolic studies [Ter-
Pogossian, 1957]. This pioneering work and subsequent studies lead to the
understanding that the majority of metabolic processes that are fundamentally
important to life occur rapidly enough to be traced by means of short-lived
physiological radioisotopes such as "C, 13N, 150, and 18F.
2.1.5 [189-FDG: A PET TRACER FOR CANCER IMAGING
Since the early 1990s PET imaging has found an increasing acceptance in
diagnostic oncology and management of cancer patients (section 8.1-8.3). Cancer
generally refers to cell compounds that are characterized by uninhibited growth, and
thus have increased rates of DNA synthesis, amino acid transport and protein
synthesis, as well as increased rates of glucose metabolism compared to normal
tissue [Weber, 1977]. The quantitative level of upregulation of these processes
thereby is often greater in more aggressive than in less aggressive tumours [Wahl,
1997a]. Of the wide range of biochemical alterations in cancerous tissues, the one
most applied in PET imaging to date has been the increased consumption of glucose
by tumour cells, an observation that was made as early as 1931 [Warburg, 1931].
Many PET studies suggest that the use of 24 18F]fluoro-2-deoxy-D-glucose (FDG)
is useful for differentiating neoplastic cell-compounds from benign tissues [Biersack,
1997]. [' 8F]-FDG is a glucose derivative that is radiochemically produced from D-
glucose by replacing the hydroxy-group at the second carbon atom with a radioactive
fluorine-18 isotope as shown in fig. 2.1. The biochemistry of [' 8F]-FDG and its
metabolic pathway is described in some detail to illustrate the effect of metabolic
trapping (section 2.1.3).
Initially, at the beginning of the metabolic cycle, glucose and FDG are
indistinguishable to enzymatic activity. After injection FDG is transported into the
cells like glucose by facilitative glucose transporters (often GLUT-1). Both glucose
and FDG are phosphorylated to glucose-6-phosphate and FDG-6-phosphate,
respectively by the glycolysis enzyme hexolcinase. In areas with an increased
demand for glucose, hexolcinase has an increased activity, which leads to a higher
accumulation of both glucose- and FDG-6-phosphates (FDG-6P) in those areas.
Unlike glucose-6-phosphate FDG-6P is a polar intermediate which does not cross
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cell membranes well. In other words, owing to minor structural differences of the
original glucose molecule FDG-6P is trapped in the cells after completing the first
metabolic cycle (metabolic trapping). Glucose-6-phosphate on the other hand is
further metabolized via anaerobic and aerobic routes providing energy in the form of
ATP. FDG-6P can be dephosphorylated to FDG by glucose-6-phosphatase, but this
CH2OH	 CH2OH
0	 	 0
HO	 OH
a)
	 H	 OH	 b)	 H	 18F
reaction occurs very slowly. However, in tissues such as the brain and tumours
which have an accelerated glycolysis and little glucose-6-phosphatase activity, the
FDG-6P accumulates over time in a manner dependent on the rate of glycolysis.
Figure 2.1 Glucose (a) and 2-rF]fluoro-2-deoxy-D-glucose (FDG, b) molecule. In FDG (b) the
hydrogen at the second C-position is replaced with radioactive fluorine-18. FDG is a radiotracer used
in PET to determine areas of increased glucose metabolism.
In virtually every malignancy studied with FDG there is avid uptake of the tracer
[Conti, 1996; Biersack, 19971. In fact, increased levels and activity of glycolysis
enzyme hexolcinase is one of the most distinctive biochemical features of the
malignant state. However, distinct FDG uptake has also been observed in
inflammatory lesions [Larson, 1994], of which, for example, tuberculosis, fungal
infections, and abscesses have been associated with FDG uptake. Secondary
inflammatory reactions after radiotherapy may sometimes be associated with
hypermetabolic activity regions and thus lead to false-positive PET interpretation
[Wyngaarden, 1995]. In addition, benign physiological and artifactual FDG
accumulation are seen in PET studies [Bakheet, 1998]. In conclusion, FDG is by no
means a specific tracer of tumour metabolism, rather it traces glucose utilization, and
care should be taken when interpreting FDG accumulations in-vivo.
2.2 POSITRON EMITTERS AND COINCIDENCE DETECTION
2.2.1 POSITRON EMITTERS
Positron emitters are isotopes with a neutron deficiency (Z>Al2) that decay via
positron emission towards the stability line. Positron emission, also referred to as 13+-
decay, is one of three types of 13-decay by which unstable isotopes gain stability. A
proton is transformed into a neutron while a positron carries the excess positive and a
neutrino (ve) is emitted to ensure the conservation of momentum:
A v _ao Av_,_ 0R+ , 0,
Z 11	 Z-11- -1- 1P -r- O v e
Nuclei with a proton deficiency (neutron excess) instead gain stability through 3--
decay whereby a neutron is transformed into a proton while an electron (13-) and an
anti-neutrino, z, are emitted:
Eqn. 2-1
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The third of the p-decays is called electron capture (EC) and occurs when a
nuclear proton captures an electron from the nearest K-shell to form a neutron and a
neutrino which is created to ensure the conservation of momentum:
Eqn. 2-3Z	 z-I	 o e
In 1914 Chadwick found that the energy spectrum of the decay products from
decay was continuous, unlike the line spectra of the decay products for a- and y-
decays. This lead to the assumption that p-decay produced multiple decay products
over which the decay energy was distributed in a statistical manner. Apart from the
stable isotope and the positron the existence of a third particle, the neutrino, was thus
postulated and soon proven.
Positron emission is a three particle process, and therefore positrons are emitted
with kinetic energies ranging from a few keV to a few MeV. The end point energy
Em„, is a characteristic parameter of each positron emitter, and together with the mean
energy E determines the range of positrons in matter. Depending on the density of
the surrounding material or tissue the mean range from the point of emission to the
point where the positron annihilates is of the order of a few millimeters. Table 2.A
lists the maximum and mean kinetic energies of positrons for a number of
radioisotopes used in PET. Estimates of the range of positrons in tissue (represented
by water) have been performed using Monte Carlo simulations [Levin, 1999].
Table 2.A Maximum and mean energies, E n.„ and E, of the positrons emitted from biogenic PET
radioisotopes, and 68Ga and 82Rb. Also listed are the FWHM [mm] and the FWTM [mm] of the
positron range distribution in water [Levin, 1999]. Tabulated energy values for "Ga and 821Z13 are from
[Cho, 1975a].
Radioisotope	 Positron yield [%1 E„,„, [MeV] E [MeV] FWHM [mm] FWTM [mm]
"C	 99 1 0.4 0.188 1.86
' 11•1 99 L2 0.5 0.282 2.53
150 99 1.7 0.7 0.501 4.14
18F 97 0.6 0.3 0.102 1.03
68Ga 90 1.9 0.8 0.31 N.A.
82R b 96 3.1 1.4 0.42 N.A.
2.2.2 THE ANNIHILATION PROCESS
Following its emission from the unstable nucleus, a positron loses kinetic energy
in a series of interactions with electrons from the surrounding atoms. While there is a
finite possibility (3%) that the positron will annihilate at one of these interactions
before reaching its rest energy the majority of the positrons, however, are
thermalized within 10 - 's of emission. After deceleration to energies close to the rest
mass energy (511keV) the positron combines with a free orbital electron to form a
positronium similar to the hydrogen atom. The positronium can appear in two energy
states: para-positronium when the spins of the positron and the electron have
opposite directions, and ortho-positronium when the spins are parallel.
Parapositronium has a half-life of 10's before the electron and positron undergo
annihilation with the production of two annihilation photons of 511keV each that
travel nearly in opposite directions (fig. 2.2). The thermal motion of the electrons
introduces an uncertainty in the relative direction, which means that the two
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annihilation photons are not emitted perfectly back-to-back [Brownell, 1953] but
they are acolinear. Two photon annihilation is forbidden for orthopositronium, and
the compound annihilates with the emission of three electromagnetic quanta while
both the photon energy and the angular direction are distributed statistically. Only
one in 400 annihilations, however, is attributed to a three-quanta annihilation.
Figure 2.2 Positron emission and annihilation. A neutron deficient nucleus (e.g. 18F) undergoes 1-
decay whereby a proton transforms into a neutron and while a positron and a neutrino (not shown) are
emitted. The positron undergoes multiple interactions with electrons before annihilating at thermal
energies with an electron from the surrounding tissue. The mass equivalent of the two particles is
emitted as two 511keV photons that travel in opposite directions.
2.3 THE PRINCIPLE OF PET
2.3.1 COINCIDENCE DETECTION OF THE ANNIHILATION PHOTONS
Once the tracer is injected into the patient and allowed to concentrate in the organ
of interest, the distribution of the tracer can be recovered by collecting coincidence
pairs of annihilation photons. In PET two assumptions must be made prior to the
reconstruction of the tracer distribution: (1) the positron originated along the line that
is defined by the two detected annihilation photons, and (2) the annihilation photons
are emitted in opposite directions. These assumptions are only approximations (fig
2.3).
Tracer	 . Volume of interest
Figure 2.3 Annihilation photon
detection in a volume-of-interest.
Due to the positron range effects
and acolinearity of the annihi-
lation photons a single line-of-
response is only an approxi-
mation for the volume-of-interest.
Since the positron travels some distance (table 2.A) away from the emission site
before annihilation, the first assumption holds theoretically only for a volume-of-
interest (fig. 2.3) rather than a single line. This, together with the acolinearity of the
annihilation photons (section 2.2.2) limits the intrinsic spatial resolution of the
detection system, i.e. the accuracy of the localization of individual tracer molecules.
X1	 X2
D i	 I	 I D2
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The major advantage of coincidence detection in PET in comparison to the
detection of single photons is that the tracer distribution can be recovered
independent of the location and depth inside the body. Figure 2.4 explains the depth
independent recovery in more detail. Imagine a tracer distribution between two
detectors D, and D2 . An event in PET is accepted only if both photons from an
annihilation are detected by the detectors D, and D2within a certain pre-defined time
window (section 2.3.2). Given an emission rate No of annihilation photons at point x
inside the body, the following count rates NI and N2 will be measured at detectors D,
and D2 , respectively:
-f p(x).dx
	
No • e	 Eqn. 2-4
-f 9.dx
	
N2 = No • e	 Eqn. 2-5
whereby 1.1(x) represents the linear attenuation coefficient at 511keV along path x.
Since the photons are measured in coincidence, however, the measured event rate is:
-f p(x) . dx 	- f p(x)dx
N =Ni • N2 = No • e	 = No • e wR N0 •	 Eqn. 2-6
and thus independent of the position x of the source between two opposite detectors
D I and D2 . The measured count rate N is lower than the original count rate No owing
to the attenuation of the annihilation photons in the tissue between the point of
annihilation and the detectors. Generally speaking the measured coincidence rate N
only depends on the attenuation along the line-of-response (LOR). In other words,
with coincidence detection a tracer distribution can be quantified independently of
depth in the tissue.
annihilation
tracer distribution
Figure 2.4 Coincidence detection of two
annihilation photons arising from an
annihilation at (x,y) between two
detectors D, and D2 . The coincidence
count rate is independent of the location
x of the annihilation along the path D,
and D 2 . In other words, the count rate in
PET is independent of the depth of the
tracer accumulation in the tissue and only
depends on the distance between the
detectors D, and D2.
2.3.2 EVENT DEFINITION IN PET
Event detection in PET relies on electronic collimation, a term that describes the
ability to form a line-of-response by detecting two annihilation photons in
coincidence. An event in PET is regarded a valid event if (i) two annihilation
photons are detected within a short coincidence timing window (typically 12ns), (ii)
the line-of-response formed by these two photons is within the acceptance fan or
active ring difference of the tomograph, and (iii) both photons fall within a pre-
d) Random
Prompt eventsdetector ring	 I
a) Single e) Multipleb) True	 c) Scatter
32
defined energy window (typically 350keV — 650keV). Individual annihilation
photons are termed singles and form, if they satisfy the above requirements (i)-(iii),
prompt events, or prompts. Pairs of unscattered singles originating from the same
positron annihilation are referred to as true coincidences (fig. 2.5b).
Figure 2.5 Event definition in PET. A true coincidence event occurs when two singles events are
detected within a short coincidence time window, and both photons have energies that fall in some
pre-defined energy window. Random and scatter coincidences contribute to the background of the
scan data and can be corrected for post-acquisition.
When a pair of singles photons fall within the coincidence time window but
originate from different positron annihilations (spatial and temporal), they are termed
random coincidences (fig. 2.5d). These events are uncorrelated with the distribution
of the tracer. Random event rates (R12) between two detectors D 1 and D2:
R12 ccN1 N 2 . r	 Eqn. 2-7
are proportional to the single event rates N1 and N2 incident upon the detectors, and
the coincidence window resolving time 2r. The factor 2 in the coincidence
resolving time can be derived from the use of separate time windows for each of the
two annihilation photons forming a coincidence event [Moisan, 1997]. It is
reasonable to assume that N1 — N2 so that the random event rate increases
proportionally to N12. Since the singles rates N, increase linearly with activity the
probability of detecting a random coincidence increases with the square of the
activity in the FOV. Similar to random coincidences multiple events are formed by
detecting three single events from two annihilations within a single coincidence time
window (fig. 2.5e). A multiple event is typically disregarded owing to the ambiguity
in deciding which two of the three events arise from the same annihilation.
True coincidences where one or both photons scatter before reaching the detectors
are termed scattered coincidences (fig. 2.5c). Scatter, or Compton scatter, causes a
loss in energy of the scattered photon, which, owing to the energy resolution of
scintillation detectors, often cannot be discriminated against. As a consequence the
LOR assigned to a scattered coincidence is uncorrelated with the origin of the
positron annihilation. The fraction of scattered coincidences is independent of the
singles count rate. Scatter distributions for a particular tracer distribution show little
detail and represent a only a slowly varying background to the true coincidences. If
no scatter correction is performed the reconstructed emission images are biased and
typically exhibit a reduced image contrast.
In summary, the prompts count rate is composed of trues, scattered and random
coincidences (fig. 2.5). To extract from the measured prompts the true coincidence
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events for final image reconstruction, both randoms and scattered should be
estimated and subtracted from the prompts. Two common methods exist for random
event correction, which both estimate the random event rate before subtracting it
from the prompts: (i) applying a delayed coincidence window, and (ii) estimate the
random event rate from the single event rates, N 1 and N2 , using eqn. 2-7. The latter
method calculates the total flux of randoms from singles rates and detector
deadtimes, before this flux is subtracted uniformly from the prompt sinograms. The
singles-based random correction is, however, limited by the block architecture
(section 2.5.3) of most acquisition electronics that allow to estimate the singles rate
per detector block only but not for single crystal pairs.
The delayed coincidence method was proposed by [Dyson, 1960] and is based on
estimating the random event rate from the measured event rate during a delayed time
window that is purposely offset from the initial coincidence window. The event rate
in the delayed coincidence window contains only uncorrelated coincidences (i.e.
randoms) that are used to estimate the random events in the prompt coincidence
window. Estimated random event rates may then be subtracted in real time from the
acquisition sinograms (prompts), by decrementing sinogram pixels by delayed
coincidence events [Casey, 1986a]. This method makes the best use of the available
memory, but comes at the expense of increased statistical noise propagation into the
true, corrected sinograms. Additional one- or two-dimensional smoothing of the
randoms sinograms prior to subtraction from the prompts may be applied to limit
noise amplification of the true coincidences.
2.4 SINOGRAMS AND IMAGE RECONSTRUCTION
2.4.1 SORTING EVENTS INTO SINOG RAMS
In order to recover the original tracer distribution, annihilation photons have to be
detected, events have to be formed (fig. 2.5), and stored in an appropriate format. An
efficient method to sort and store the events in PET is a two-dimensional count
histogram, or sinogram. Each pixel of a sinogram corresponds to the number of
detected events along a particular line-of-response formed by two detectors (D1,D2).
These detectors can be part of the same detector ring or from different detector rings.
The line between a coincidence pair of detectors is termed line-of-response (LOR).
The LORs are mapped into sinograms as indicated in fig. 2.6. Each sinogram
contains measured coincidences within a particular detector ring (section 2.5.3.) or
between two separate, adjacent detector rings in multi-ring tomographs, typically
referred to as direct planes and cross-planes, respectively.
In 2D PET, for example, events are measured only for coincidences within a
single detector ring. Sinograms are composed of projections p(s4,z) for a particular
axial position z in the field-of-view of the tomograph. In practice, additional
sinograms are acquired for coincidences between two adjacent detector rings
p(s4,z±1) to increase the number of useful events arising from the injected activity.
The projections p are approximately parallel projections (fig. 2.7). Instead of forming
projections of: Da-Db, Da,/ -Db,„ Da+2-Db+2 , etc., radial oversampling is achieved by
Da
detector ring
Db_mm
	 Db_max
D b
Tomograph Sinogram
Sinogram
p(s,	 z)
p(s, i, z)
p(s, cp-Ao,z)
tracer distribution
Tomograph
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sorting lines-of-response into the following projection scheme: D a-Db, Da+I -Db , Da.0-
Db+1 , Da+2-D b+1 , Da+2-Db+2 , etc..
a)	 b)
Figure 2.6 Mapping counts into sinograms. (a) During a PET scan coincidence pairs of detectors are
formed (Da, Db). A single detector (D a) is in coincidence with a number of opposite detectors (Db,
b_minsbsb_max). All detected events are stored in sinograms (b) along with the spatial descriptors of
the LOR (s, 4)).
Because of the radial oversampling some compression of data by combining
neighbouring elements can be done to reduce the size of the data sets. Combining
adjacent sinogram rows p(s, 4),z) and p(s4-±A 4),z) is referred to as angular mashing,
and does not usually degrade spatial resolution or introduce significant artifacts in
the reconstructed images. Other compression techniques include axial mashing,
which is effectively combining adjacent sinograms (0±-A0), and trimming that refers
to reducing the transverse width (s) of a projection p(s, 4),z) by removing a number of
elements from either end of the projection outside the object boundaries.
Figure 2.7 Projection of a tracer distribution and sorting into sinograms. A projction p(s,4),z) is made
up of parallel LORs for a particular angle 4) and axial position (ring) z. Projections are sorted into
sinograms (s, 4)).
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2.4.2 IMAGE RECONSTRUCTION
The basic mathematical problem for all tomographic (tomos [greek]: slice, cut)
reconstruction is to determine an object function (e.g. tracer density distribution)
from measured line integrals. This inverse problem was solved more generally by the
Austrian mathematician Johann Radon in 1917 (translation of his original work in
[Parks, 1986]). Radon described the mathematical tools to recover an unknown {N}-
dimensional function from the measured projections (1N-11-dimensional) of this
function (also referred to as Inverse Radon Transform). This transform is known in
medical imaging as filtered back-projection (FBP), and used, for example, to
estimate an unknown PET tracer distribution from measured projections. The latter
are correspond to the measured emission count rates along parallel lines-of-response
that intersect the unknown tracer distribution from various directions (IL
The first reported transverse section scanning in diagnostic medical imaging was
performed by Kuhl and Edwards in 1963 [Kuhl, 1963]. Their image reconstruction of
the single transverse section was essentially an analogue method of obtaining cross-
sectional maps of a radionuclide distribution by optical interference and
superimposition, i.e. an optical back-projection without the filtering step. First The
image reconstruction efforts by Kuhl and Edwards were preceded by Bracewell who
in 1953 applied back-projection for the purpose of identifying microwave radiation
in radioastronomy [Bracewell, 1956]. Independently back-projection was used in
electron-microscopy to reconstruct molecular structures of complex biomolecules
from a series of transmission micrograms taken at various angles [Rosier, 1968].
Theoretical work by Cormack and others in the 1950s and 1960s [Brooks, 1976] led
to applicable mathematical concepts for accurately reconstructing images from
projections, known today as filtered back-projection. In 1975 Ter-Pogossian, Phelps
and Hoffman described a PET tomograph that employed the filtered back-projection
method of reconstruction [Phelps, 1975b; Ter-Pogossian, 1975]. Note the first CT
tomograph obtained 0' images from analytical reconstruction by solving a system of
equations with 28,000 unknowns [Ambrose, 1973].
Reconstruction by FBP involves filtering the data in 1D (projections) with a filter,
known as a ramp filter, before back-projection in order to remove the blurring of the
back-projection process (fig. 2.8). The ramp filter in spatial domain has several
negative sidelobes of decreasing amplitude symmetrically around a non-zero
hyperbolic peak. These sidelobes weight the blurred contributions outside of the
central value being back-projected and over a full set of directions will eventually
compensated for the blurring process (summation of projections) in the absence of
noise and systematic errors.
The advantages of FBP is that it is computationally efficient and well-suited to
optimization using vector-based parallel hardware reconstruction architecture [Egger,
19961. However, the measured projection data from different angles are inconsistent
due to attenuation and scatter of the annihilation photons, and may thus introduce
artifacts into the back-projected images if not corrected prior to the reconstruction
(see corrections for scatter and attenuation in chapter 5). Unlike iterative or statistical
image reconstruction algorithms it is difficult with FBP to include models of the data
a) Back-projection b) Filtering the projections
	
c) Filtered back-projection
p(s, f	 ) p*(x f, z)
p(x, f, z) * h(x)Reconstruction
matrix
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acquisition process or prior knowledge of the tracer accumulation [Defrise, 1998].
Filtered back-projection does not take into account the statistical noise of the
measured data, and filtering the projection data prior to image reconstruction
amplifies the high frequency components and thus increases the statistical noise in
the final image. Therefore windowing techniques are used to limit the noise
amplification by rolling-off the ramp filter at high frequencies, although at the cost of
smoother images and reduced spatial resolution.
Figure 2.8 Principle of filtered-backprojection in 2D. Back-projection (a) describes the uniform
distribution of the values of a particular projection along the projection line (i.e. line-of-response). The
measured projections are convoluted with a ID filter function (i.e. multiplication in Fourier space)
prior to the back-projection (b). The object is recovered completely after filtered back-projection (c) .
2.5 PET TOMOGRAPHS
2.5.1 RADIATION DETECTORS FOR MEDICAL IMAGING
The first experiments to measure the distribution of radioisotopes and radiotracers
in-vivo were carried out with a single Geiger-Muller (GM) counter (introduced in
1928). For most measurements a single counter was positioned over the organ to be
measured [Hamilton, 1940], or moved systematically in a grid-based pattern over the
organ of interest to screen an extended body surface area [Mayneord, 1951]. This
method of detection continued until the late 1940's. The development, around 1950,
of the scintillation counter represented a considerable improvement in sensitivity
over the GM counter that had until then been the radiation detector of choice. The
scintillation counter was incorporated into the first radioisotope scanner designed by
Cassen in 1950 for the in-vivo localization of radioiodine in the thyroid [Cassen,
1950]. The counter was moved in rectilinear mode, and counted at each position the
number of photons that were recorded as an intensity on a photographic plate. The
scintillation camera, first introduced by Hal 0. Anger in 1956, remains to this day
the most widely-used detection system in nuclear medicine. A single large area
sodium iodide crystal is viewed by an array of photomultipliers which determine the
position of scintillation from the distribution of the detected light [Anger, 1966].
When equipped with a multi-hole lead collimator, the device is not only capable of
counting but also of imaging the gamma radiation. In single photon emission
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tomography (SPECT) gamma radiation is detected by means of a gamma camera
equipped with collimators from a series of continuous views around the patient
[Kuhl, 1963; Ter-Pogossian, 1966]. These developments are summarized in table
2.B.
Table 2.B A simplified overview of detection devices in nuclear medicine.
Area of
sensitivity
Point Area Volume
Design GM counter, or Nal and Nal and Nal and many Scintillation
scintillator
with PMT
PMT many PMTs
(single head)
PMTs
(up to four
heads)
detector blocks
Introduction 1928 1951 1956 1966 1953/1975
Collimation Point Point Multi-hole Multi-hole Retractable septa
collimator collimator collimator collimator
Assembly Stationary Moving Stationary Rotating Stationary or
rotating
Classification GM counter Rectilinea
r scanner
y-camera SPECT PET
Measurement 1D 2D 2D planar 3D tomography 3D tomography
dynamic static dynamic dynamic dynamic
quantitative
After suggesting neutron-deficient nuclei (i.e. positron emitters) as medically-
useful radioisotopes (section 2.1.4), the coincidence detection technique was
developed and evolved with the introduction of positron scanners [Brownell, 1953].
The first positron scanner consisted of two NaI(T1) crystals that were moved
automatically, in a manner similar to the single photon scanner, so as to map the
distribution of the positron-emitting radionuclide. While positron imaging devices
were initially equipped with relatively large scintillation detectors, interest in both
higher spatial resolution and two dimensional localization encouraged some
researchers to explore the use of multiwire proportional chambers for the detection
of higher energy gamma rays. These efforts resulted in the design of a high-density
avalanche chamber (HIDAC [Townsend, 1987]) that, however, remained a research
tool owing to the low sensitivity compared to scintillation based cameras [Charpak,
1989].
2.5.2 SCINTILLATION DETECTORS
All state-of-the-art PET commercial tomographs use scintillation detectors. Ever
since the introduction of coincidence measurements, developments in detector
technology were based primarily on the use of inorganic scintillators [Heath, 1979],
such as sodium iodide (NaI(T1)) with its high light output. In recent years, however,
other scintillators, such as bismuth germanate (Bi 4Ge3012, BGO) and barium fluoride
(BaF,) became the focus of attention and, in case of BGO, were used as the detector
material of choice for the majority of commercially available PET tomographs. The
main characteristics of a variety of important scintillators are tabulated in table 2.0
[Derenzo, 1992].
The selection of the scintillation material for use as a PET detector should be
optimized with respect to a number of physical characteristics. High resolution PET
38
-
needs detector modules that identify single events with (i) high detection efficiency,
(ii) high spatial resolution, (iii) low cost, (iv) low dead time, (v) good timing and
energy resolution [Moses, 1995]. These demands can be related to the following
requirements for scintillation materials that are suitable for PET detectors [Derenzo,
1992]. In order of decreasing importance, the scintillator should have
- a short attenuation length (<1.5cm),
- high photoelectric fraction (>0.3),
- short scintillation decay time,
- low cost (<$20 per mL), and
- high light output (>8,000 photons per MeV).
Table 2.0 A number of scintillation materials for commercial and potential use in PET [Moses, 1999].
Density p and effective atomic number Zeff are physical characteristics of each scintillator and
determine the attenuation length 1 of the crystal. The coincident photoelectric absorption e is defined
as sqrtgc1p/(op+oc)1 2) with op and Cr, being the photoelectric and Compton cross section for 511keV
photons, respectively. Energy resolution AE [%FWHM] at 511keV, emission wavelength k ip , primary
decay constant , are also listed together with the number of scintillation photons N ph released per
MeV photon energy (hv/MeV) deposited in the detector. Scintillation light yield values Vol are
normalized to the yield of NaI(T1).
Material P
[g/cm3 ]
I	 c
[cm]
Light
yield
Nph
[103]
AE xen,
[nm]
Tpri„,,
[ns]
Handling
Established scintillators
NaI(TI) 3.7 50 3.1	 .18 100 38 7 410 250 fairly easy
BG0 7.1 73 1.1	 .43 15 8.2 10 480 300 easy
CsF 4.1 53 2.7	 .21 8 2.5 23 390 5 challenge
CsI(TI) 4.5 2.4 64 540 800 easy
BaF2 4.9 52 2.3	 .19 5 2 11 215 0.8 fairly easy
GSO 6.7 58 .26 10 440 60 easy
LSO 7.4 65 .34 75 30 10 420 40 fairly easy
Scintillators in limited availability
YSO/Ce 2.7 34 4.4	 0.05 118 45 8 420 70 easy
VAP/Ce 5.4 36 2.2	 0.05 52 20 390 31 easy
Each of these requirements affects the overall performance of the PET tomograph.
For example, with any PET detector design a high efficiency for the detection of the
annihilation photons is necessary. This implies that the depth of the detector should
be at least two to three times the attenuation length 1 (table 2.C) leading to crystals
about 3cm deep. An increased radial extent of the crystals in ring tomographs,
however, gives rise to an increased number of photons that penetrate the detector that
they impinge on before they are stopped and detected in a neighbouring detector. The
probability of detector penetration increases with the depth of the detector. The
degradation in radial resolution with sources placed further away from the transaxial
centre of the tomograph is often referred to as radial elongation or parallax error
(fig. 2.9). Apart from a short attenuation length and a high photoelectric fraction, a
short decay time is required to ensure both minimum countrate losses due to dead
time, and to provide good coincidence timing resolution. A shorter coincidence time
window ensures optimum separation of the true coincidences from the contamination
of randoms, as will be discussed in section 3.3.2.
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While the optimization of many of these parameters can be discussed in great
detail it can be seen from table 2.0 that none of the tabulated scintillators exhibits
more than two or three of the desired properties discussed above (the optimum
material in each class is highlighted in gray). While the ideal scintillation detector for
PET would combine the light output of NaI(T1) and CsI(T1), the stopping power of
BGO, and the speed of BaF2, most of the currently-available commercial PET
tomographs use BGO as the material of choice to compromise between performance
and cost. Other detector materials such as cesium fluoride (CsF) and gadolinium
orthosilicate (Gd 2Si05, GSO) offer similar characteristics as BGO in some categories
(table 2.C) but do not represent as good of an alternative to the use of BGO.
detector
••
_Ai A2_
Figure 2.9 Parallax error in ring PET tomographs.
Annihilation photons arising from position 2 can
penetrate more than one detector before being
stopped. The further the positron emitter source is
away from the centre (position 1) of the
tomograph, e.g. position 2, the more the radial
resolution is degraded as seen in the resolution of
the point sources in position 1 and 2.
The availability of scintillation detectors with faster decay times and higher light
output than BGO, however, have motivated research on designing special PET
detectors. In the early eighties, a number of groups explored the possibility of using
time-of-flight (TOF) information to localize the positron annihilation [Allemand,
1980; Mullani, 1980]. The detector materials used were BaF2 and CsF with primary
decay times of a fraction of that of BGO (table 2.C). Some improvement in the
signal-to-noise ratio was achieved when incorporating into the reconstruction process
the TOF information as a relative weight describing the probability that an event
occurred in a given region of the field-of-view. Generally, high light output from the
scintillator improves the localization of the annihilation photon in the detector block
(section 2.5.3); short decay times of the scintillator are important for high count rate
application and good timing characteristics.
In recent years a new scintillating material, lutetium oxyorthosilicate
(Lu2(SiO4)0:Ce, LSO) has been identified [Melcher, 1990] with properties that make
it very suitable for medical imaging in general and PET in particular [Melcher, 1992;
Minkov, 1994]. LSO has a similar physical density and effective atomic number as
BGO, while at the same time the decay constant is much shorter (40ns) and the light
output is a factor of five higher than that of BGO. Despite these many ideal
characteristics for application in PET, potential limitations include the expense of
growing LSO crystals and the 3% natural radioactive background (r6Lu,
T 112,---2.6. 10my) [Huber, 1999].
BOO block
detector face
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2.5.3 THE DETECTOR BLOCK DESIGN
Initially, scanner designs were based on hexagonal or circular arrays of individual
crystals imaging a single transaxial slice. In an effort to improve the axial coverage
for a single scan, multi-ring systems were developed by stacking individual rings. A
major advance in the design of multi-ring tomographs occurred when the scintillation
block detector [Casey, 1986b] was introduced (fig. 2.10), a cost-effective way of
coupling small crystals to photomultiplier tubes without requiring individual
detectors cut and glued to individual PMTs.
saw cuts
Figure 2.10 The detector block design introduced by [Casey, 1986]. A compact BGO detector block
(for example, 6cmx6cmx3cm) is cut into an array of individual crystals with gaps of various depths
between them, and coupled to an array of four PMTs. Localization of individual detectors hit by
annhilation photons is facilitated through light sharing of the PMTs.
The first block design was based on a block of BGO (7cm base length and 3cm
deep) cut into an array of 4 by 8 crystals and glued to four symmetrically arranged
PMTs [Casey, 1986b]. The crystals were not separated completely but the cuts
between the crystals were of different depth, and thus allowed for a unique light-
sharing for each individual crystal between the four PMTs. The original block design
has been altered little, although detector blocks with an axial depth of 2cm [Rogers,
1992], with various crystal-to-PMT coupling schemes [Koeppe, 1992], and finer
crystal sampling of up to 16 by 16 crystals for a 5cm by 5cm block [Rogers, 1994]
were suggested by others. Apart from large area PET detectors [Karp, 1993] the
block design has become the standard detector in commercial PET tomographs.
Depending on the axial field-of-view coverage required, a number of blocks may be
stacked axially. Current commercial state-of-the-art PET tomographs have an axial
FOV of over 15cm, sampled by up to 32 rings of detectors [Townsend, 1998].
An important feature of the early multi-ring tomographs was the presence of fixed
annular septa, composed of a lead-tungsten alloy that were positioned between the
detector rings (fig. 2.11b). The aim was to keep the multi-ring tomographs
essentially as a series of separate rings with little cross-talk between rings. The septa
are about 1-2mm thick and project between 8cm and 10cm from the detector face
into the FOV. The major purpose of the septa is to shield the detectors from photons
which scatter out of their original trajectory (fig. 2.11b). Reducing the accepted
scatter fraction eliminates the need for sophisticated scatter correction algorithms.
detector ring
1PLoRz
a) single ring
Patient
C) multi-ring (3D),
septa retracted
b) multi-ring (2D),
septa extended
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Septa also help reduce the randoms fraction that is partly generated from singles
events arising from annihilations in tracer distributions outside the FOV. Finally,
limiting the data acquisition to 2D also avoids the complexity of fully 3D image
reconstruction since image slices in 2D are reconstructed individually.
Figure 2.11 Scanner design: (a) single ring, (b) multi-ring with septa extended, 2D, (c) multi-ring,
fully 3D scanner with retracted septa.
2.5.4 SCANNER PERFORMANCE IN 2D
2.5.4.1 SPATIAL RESOLUTION
The spatial resolution in PET describes the minimum distance at which two
objects (tracer accumulations) are recognized by the PET scanner as distinct entities.
The resolution can be measured by imaging a point source or a line source of
radioactivity placed in the FOV of the scanner. Spatial resolution is then expressed as
the full-width half maximum (FWHM) of the profile through the reconstructed
images of the point or line source. The profile is often referred to as point or line
spread function, PSF or LSF; both of which can be approximated by a Gaussian
function.
In PET the spatial resolution is limited by physical factors and by patient motion.
Until the introduction of the detector block design, the largest contribution to spatial
resolution was the detector size. Compton scattering, although useful in large
uniform crystals, in detector blocks (fig. 2.10) causes energy depositions in two or
more individual crystals. High resolution PET based on small crystals therefore
requires detector materials with good stopping power as discussed in section 2.5.2.
With the introduction of high resolution tomographs, additional physical factors,
such as acolinearity of the annihilation photons and positron range effects, become
important. At the centre of the tomograph (diameter D) acolinearity accounts for a
contribution to the spatial resolution of 0.0022•D [Derenzo, 1993]. Measurements of
the positron range have shown that the distribution consists of a central peak
(FWHM<0.5mm) and tails that can extend for several mm [Colombino, 1965]. The
FWHM value describes the narrow central region of the distribution, but not the tails.
Therefore an effective FWHM, r, was introduced [Derenzo, 1993] to describe the
statistical broadening of the entire positron range distribution. In case of radiotracers
labelled with ' 8F, positron range effects account for only a fraction of the overall
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spatial resolution (0.54mm compared to a resolution of 3.1mm for a 60cm diameter
ring with 4mm crystals), and are thus small compared to contributions from the
detector size and angulation error [Derenzo, 1986]. A recent study [Levin, 1999]
models the positron range of selected isotopes and the spatial resolution in block-
based scanners of different ring diameters based on a complex model that goes
beyond the simple approach by Derenzo [Derenzo, 1979]. The new study is based on
the assumption that the spatial extent of the annihilation photon distribution is
important rather than the range or the maximum extent. They conclude from a series
of simulations that for smaller detectors and smaller scanner sizes, positron range
effects and detector size dominate, while for larger detector and scanner size,
acolinearity and detector size dominate the spatial resolution [Levin, 1999].
In addition to the above factors, light sharing and Compton interactions within the
detector block contribute to a degradation of the spatial resolution in tomographs
using light-sharing block detectors. While it was shown that for PET tomographs
with individually coupled detector elements, the combined effects of detector crystal
size, acolinearity, source distribution and reconstruction process yield predictions on
the spatial resolution that are about 0.3mm less than the measured resolution, similar
studies with block-based tomographs reported a significantly larger discrepancy
between the measured and predicted spatial resolution [Derenzo, 1993]. The
degradation in spatial resolution of block-based tomographs can be attributed to the
block decoding scheme. A simple expression for the combined reconstructed image
resolution F, as suggested by [Moses, 1993], combines the contribution from the
various physical and encoding scheme effects with the expression:
d
F = 1.25 . 4(—)2 +(0.0022 . D)2 + r2 + b2
2
Eqn. 2-8
where d is the detector element size, D is the detector ring diameter (acolinearity
term), r is the effective positron range, and b an additional factor accounting for the
block encoding scheme. Assuming an 80cm diameter tomograph with individual
coupling (b=0), 4mm crystals, and a ' 8F scan (r=0.54mm [Derenzo, 1993]), the
reconstructed image resolution would be 2.6mm. The factor b is affected by the light
output of the scintillator and varies between block designs. Typically 2mm FWHM
are assumed for b and added in quadrature to the other factors (eqn. 2-8). Thus for a
block based tomograph of the same dimensions as above, spatial resolution degrades
to 3.6mm. By accounting for a scanner specific sampling scheme, Levin and
Hoffman [Levin, 1999] estimated an overall spatial resolution of 4.4mm FWHM at
the centre of the same tomograph model, that corresponds well with the measured
resolution of 4.5mm using the ECAT HR+ (table 2.D), an 80cm ring diameter
tomograph with 4.0mm by 4.1mm crystals arranged in an 8 by 8 block.
By using crystals with a higher light output than BGO or NaI(T1) (table 2.C), such
as LSO, the value of b may be reduced and better image resolution achieved. Table
2.D gives values on the spatial resolution of a standard block-based PET tomograph
(ECAT HR+) operated in 2D. The resolution is usually specified as separate
components in the transaxial (in-plane) and axial direction owing to the different
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sampling schemes. In ring tomographs, such as the ECAT HR+, data are
oversampled transaxially (section 2.4.1) while axial sampling is only sufficient to use
the inherent resolution of the detectors. Transaxial resolution is subdivided into
radial and tangential components, which vary for measurements off the central axis
(table 2.D, source location 10cm) owing to different detector penetrations (section
2.5.2).
Table 2.D Spatial resolution as FWHM [mm] of the ECAT HR+ tomograph operated in 2D
[Townsend, 1998]. The HR+ is based on BGO blocks of 8 by 8 crystals with dimensions of 4.0mm
(radial) x 4.1mm (tangential) x 30mm (axial).
	
Source location
	
radial	 tangential	 axial
	
In air (1 cm)
	 4.5	 4.5	 3.9
	
In air (10 cm)	 6.0	 4.5	 4.8
As pointed out in the discussion of the attenuation length in section 2.5.2 parallax
errors may occur due to detector penetration and result in a radial blurring (table
2.D). This degradation in radial resolution can be reduced by measuring the depth-of-
interaction (DOI) of the first interaction of the photon in the detector [Moses, 1990;
Moses, 1991]. Measurements of the DOI have not been implemented yet in
commercial PET tomographs but are likely to become standard with new detector
materials being used for the next generation of PET tomographs [Moisan, 1995].
2.5.4.2 Couvr RATE
Most scanners are designed to achieve a given spatial resolution, thus fixing the
detector dimensions. Many of the remaining considerations then focus on
maximizing the count rate capabilities and thus the signal-to-noise ratio. The count
rate capability represents the response of the tomograph to changing activity levels in
the FOV. To compare countrates acquired with different PET scanners a simple but
meaningful figure-of-merit is needed that accounts for the variety of scanner design
parameters and acquisition.
A 20 cm diameter cylindrical phantom filled uniformly with a known amount of
activity has become the standard of comparing the countrate performance of PET
scanners [Karp, 1991]. The derived performance measures range from specifications
at low activity concentrations to the phantom activity concentrations for either 50%
deadtime, equal true and random countrates, or saturation of the acquisition system.
None of these parameters, however, is meaningful when comparing actual useful
counts (trues) that are obtained after the necessary corrections of the measured
prompts for random and scatter coincidences. A new figure-of-merit was therefore
suggested by Strother et al. [Strother, 1990]. The basic idea is to relate scanner
sensitivity, or performance to the image quality by means of the reconstructed signal-
to-noise ratio (SNR). The SNR can be expressed in terms of the true coincidences in
a reconstructed image element and weighted samples from all projections
contributing to the image element [Budinger, 19781. For a cylinder phantom an
expression is derived for the SNR [Strother, 1990] and the concept of noise-
equivalent-counts (NEC) is introduced:
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NEC —
1 + asp +
where T is total true image counts without corrections for deadtime and attenuation,
asp and a the scatter and random fraction, respectively, for the projection sample
at a particular angle. For this it is assumed that the number of scatters and randoms in
each projection are known without any significant measurement noise. The NEC can
then be interpreted as the reduced true image counts that, in the absence of random
and scatter components (asp=asp=0), would yield the same SNR at the centre of the
cylinder as the true coincidence rate obtained by subtracting measurements of the
randoms and scatter from the actual measured total coincidence count rate.
For the expression in eqn. 2-9 we require the random and scatter fraction for each
projection. Since these parameters are generally not known, eqn. 2-9 must be
rewritten to incorporate the total image random and scatter fraction, a s, and aro
respectively. When measuring the fractions a an care must be taken to reduce
random rates for the FOV to those that apply to the appropriate cylinder diameter
inside the object boundaries only. A factor fr is used to express the fraction of the
area of the FOV of the projection subtended by the object.
In deriving the NEC from the SNR [Strother, 1990] the knowledge of noiseless
estimates of image scatter and random coincidences is assumed. Random
coincidence rates are, however, typically estimated from the delayed coincidence rate
(section 2.3.2) and thus inherently noisy. By accounting for randoms subtraction
from the offset window an additional variance term is introduced leading to 2%,
instead of a eqn. 2-9 that is adjusted for the total counts. Although an additional
variance term should also be introduced to account for the noise contributions from a
measured scatter kernel, noiseless scatter correction for simple objects as the 20cm
cylinder that is used for most performance measurements is generally assumed. This
yields the following expression for the NEC that will be used for the performance
measurements discussed in this work:
NEC—
	
	 	
Eqn. 2-10
1 + a, + 2 far,
and by using the relations: a and cc, =R/T, where S, R, and T are the scatter,
random, and total coincidences (trues + scatter) within the object boundaries,
respectively:
c
NEC —
[T(1 — sf)12	 T2
Eqn. 2-11
T + 2f,R Tc + S + 2f,R
where Tc is the true coincidence rate TO-sf). The scatter fraction sf is typically
estimated according to the NEMA protocol [Karp, 1991]. Scatter fractions in 2D
tomographs are around 0.15. Figure 2.12 shows the measured countrates and the
NEC for a full-ring PET tomograph, the ECAT HR+, operated in 2D.
Ideally, all annihilation photons that arise from a tracer distribution should be
detected and used to recover the original tracer distribution. Generally, in a PET
tomograph, as the activity increases, deadtime in the detector electronics increases,
Eqn. 2-9
---*-- Trues
---- Randoms
— NEC (2D)
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thus limiting the observed true coincidence count rate as can be seen in the deviation
of the trues countrate from a straight line extrapolation at low activities
(-401d3q/mL) from fig. 2.12. The most important contribution to the deadtime of the
detectors arises from the slow decay time of the scintillators (table 2.C). As will be
explained in section 3.3.1 events are collected for a time at least as long as the decay
time of the scintillator. During that time (detector deadtime) no other annihilation
photons can be detected. In the case of detector blocks the observed count rate is
even less than the decay time might suggest. This is because the whole detector
block is 'dead' to new incoming annihilation photons that will be lost for the
duration of processing the previous event. Shorter scintillation decay times and
shorter dead times thus result in better count rate performance.
0 25 50 75 100 125 150
Activity concentration [kBa/m1]
Figure 2.12 Measured count rates (trues, randoms, NEC) in multi-ring PET scanner (ECAT HR+)
operated in 2D. Measurements were taken with a 20 cm cylinder.
2.5.4.3 ENERGY RESOLUTION AND SCATTER FRACTION
The energy resolution of a PET tomograph is the ability of the detector system to
precisely measure the energy deposited by the incident annihilation photon. The
better the energy resolution the better scattered events can be determined based on
their reduced photon energy from previous Compton interactions inside the body.
Energy resolution of the entire scanner is determined by the energy resolution of
each detector block and of the detector material in particular (table 2.C). Energy
resolution is typically measured by stepping a narrow energy window in small
increments over the energy range of interest (typically 350-850keV in PEI') while a
compact source is irradiating the detectors. The count rate in each window is plotted
and the energy resolution at 511keV is estimated as the FWHM of the peak around
511keV. The low-energy tail of the energy spectrum (fig. 3.14b) corresponds to
scattered photons inside the gantry and the detector.
The energy resolution is affected by (1) random statistical variations in the
number of scintillation photons produced per keV of annihilation photon energy
deposited in the detector, (2) statistical variations in the number of scintillation light
photons detected at the cathode of the PMT, (3) non-uniform sensitivity to the
scintillation photons over the active area of the PMT, (4) statistical variations in the
number of photoelectrons released from the photocathode and in the electron
cascade, (5) fluctuations in the high voltage applied to the PMT, and (6) electrical
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noise [Sorenson, 1987]. Because of these effects we observe variations in the signal
amplitude from the detector for events in which precisely the same amount of
radiation energy is deposited. The principle source of statistical variation arises from
(4). It is clear that the higher the light output of a scintillation detector, the more
photons hit the photocathode. The quantum efficiency of the photocathode
determines how many of the incident scintillation photons are converted into
photoelectrons. For example, 3,000, 400, and 800 photoelectrons are produced per
incident, totally absorbed 511keV photon in NaI(T1)-, BGO-, and BaF2—based
detectors, respectively [Derenzo, 1986]. The scintillation light output of the crystal is
often given as photons per deposited radiation energy (hv/MeV). From table 2.0 one
can see that the energy resolution is generally better for scintillators with high light
output that in turn lead to smaller statistical variation in the number of photoelectrons
released from the photocathode.
Good energy resolution is essential to reduce the level of scattered radiation.
Scatter correction techniques such as the dual-energy method [Grootoonk, 1992] rely
on accurate estimates of scattered coincidences (fig. 2.5c). Since annihilation
photons undergoing Compton interaction have a reduced energy they can
theoretically be separated from true coincidences by means of energy thresholding.
The scatter fraction is defined as the fraction of the total coincidences (prompts)
recorded in the photopeak window which have been scattered once or multiple times
before detection. The scatter coincidence may arise from either one or both
coincident annihilation photons scattering within the object, off the gantry
components, or within the detector block. Since the septa in 2D PET tomographs
limit the number of accepted counts from activities outside a given transaxial plane,
the scatter fraction in 2D is relatively small and typically less than 15%. Generally,
the magnitude of the scatter fraction is a function of the lower energy threshold that
is applied to reject scattered events. Since the scatter fraction in 2D is so low, scatter
corrections are usually not applied. Scatter corrections were, however, developed as
early as 1983 [Bergstrom, 1983].
2.5.4.4 SENSITIVITY
The sensitivity of a PET scanner depends on the geometry of the system (e.g. ring
diameter, axial length of the active FOV, length of the septa projecting into the
FOV), the shielding, the detector material and size, and other operational settings
(e.g. energy window, coincidence time). In 2D each transaxial plane is considered
independent and the overall sensitivity of the tomograph is given by the sum of the
sensitivities of all planes. Sensitivity is typically given as a volume sensitivity of the
tomograph [Karp, 1991]. Volume sensitivity corresponds to the counting efficiency
of the tomograph in the presence of a known amount and distribution of activity,
typically a 20 cm plastic cylinder filled with uniform activity (s4kBq/mL) placed in
the centre of the FOV. The fraction of scattered events is subtracted from the total
recorded coincidences, and the scatter corrected volume, or true, sensitivity ST:
ST = (1 — sf) •T	 Eqn. 2-12
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2.6	 3D PET
2.6.1 SCANNER PERFORMANCE IN 3D
The main motivation for 3D PET is to increase the sensitivity of the tomograph.
The inter-plane septa that were designed to limit scatter from activities outside a
single detector ring and from outside the FOV of the scanner are removed for 3D
PET acquisitions. By removing the septa all possible lines-of-response can be
acquired. These include the intra-plane LORs that are acquired in 2D PET with the
septa extended, as well as cross-plane LORs that intersect the planes formed by
single detector rings (fig. 2.11). Multi-ring PET tomographs with retracted septa
allow emission data to be acquired from the entire volume that is given by the
detector ring diameter and the number of rings stacked axially. The sensitivity in 3D
PET is increased due to the increase in the effective geometrical solid angle covered
by the tomograph when the septa are retracted. For example, the scatter-corrected
true sensitivity of the ECAT HR+ operated in 3D is 30cps/Bq/m.L [Townsend, 1998],
a factor of five higher than in 2D when measured according to the NEMA standards
[Karp, 1991]. As will be discussed in more detail later, the increased sensitivity of
3D PET acquisitions allows the injected dose to be reduced or to reduce the scan
time while maintaining or improving the signal-to-noise ratio compared to whole-
body PET imaging in 2D.
The demand for the increased sensitivity of 3D PET has facilitated the design,
construction and marketing of a variety of PEI' tomographs equipped with
retractable septa that are capable of either acquiring both 2D and 3D PET data, or
without septa, capable of acquiring 3D PET data alone. Since 1990, a considerable
number of commercial 3D PET scanners have been installed in PET centres world-
wide. A majority of these scanners is manufactured by CTI PET Systems Inc.
(Knoxville, USA) and includes the ECAT 953B, a 16-ring brain scanner [Spinks,
1992], the ECAT 951R, a 16-ring whole-body scanner [Barnes, 1997], the ECAT
EXACT, a 24-ring whole-body scanner [Wienhard, 1992], and the ECAT HR+, a
high resolution 32-ring brain scanner [Adam, 1997]. The performance characteristics
of some of these 2D/3D PET scanners are summarized in table 2.E together with two
3D-only tomographs, the ECAT EXACT 3D [Spinks, 1996], a 48-ring high
resolution brain scanner, and the ECAT ART [Bailey, 1997b], a 24-ring rotating
partial-ring tomograph.
The overall increase in sensitivity that is achieved by removing the septa from the
FOV is, however, accompanied by two disadvantages. As a result of the truncated
cylindrical geometry of the tomograph, the sensitivity is not uniform throughout the
FOV. Instead it peaks in the centre of the axial FOV and decreases towards either
end of the FOV. This is shown in fig. 2.14 where the relative sensitivity is plotted as
a function of the axial plane number for the ECAT HR+ operated in 3D [Hasegawa,
1999].
In addition, the increased sensitivity in 3D PET comes at the expense of a larger
scatter fraction and detection system saturation at lower activity concentrations. The
increased scatter fraction arises from the fact that photons that are scattered out of the
Ar=11
TIN
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plane are no longer eliminated by septa. A three-fold increase in the measured scatter
fraction due to septa removal for 3D acquisitions was observed during the first 3D
performance measurements [Spinks, 1992; Cherry, 1991]. The measured scatter
fraction does, however, not increase significantly with increasing axial length and
acceptance angle. For example, while the axial FOV of the HR+ and the EXACT 3D
is 15.2cm and 23.4cm, respectively, the corresponding scatter fractions are 37% and
40% (table 2.E). The scatter fraction in 3D systems shows a weak axial dependence,
decreasing by up to 30% to the edge of the FOV [Cherry, 1991]. The scatter
distribution is further increased in the presence of activities positioned close to the
edge, but outside, of the FOV. This increase is largest for transaxial planes furthest
away from the activity distribution [Jadali, 1995]. Considerable effort has been
invested in the problem of scatter correction, particularly in the presence of activity
distributions outside the measured FOV, a situation often encountered in whole-body
imaging situations (section 3.1.5).
Table 2.E Performance of ECAT scanners operated in 2D and 3D. The EXACT 3D and ART are
fully-3D tomographs without septa
ECAT
Scanner
Emission
data
True
sensitivity
[cps/Bci/mL]
Scatter 3D/2D sensitivity Peak NEC
[kcps at
Bq/m1-]
fraction
[To] Total(+scatter)
True
(-scatter)
953B 2D 3.5 13 75 at 111
3D 19.5 44 8.4 5.6 50 at 22
EXACT 2D 4.9 17 75 at 59
3D 21.0 48 6.9 4.3 38 at 7
HR+ 2D 5.7 17 84 at 130
3D 30.4 37 5.3 110 at 24
EXACT 3D 3D 69 40 - 173 at 7
ART 3D 7.5 37 - 27 at 15
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Figure 2.14 Simulated axial sensitivity profile of the ECAT HR+ operated in 3D (from [Townsend,
1998] with permission). The light shaded area corresponds to sensitivities obtained with a maximum
ring difference of 11 (Ar=11). Sensitivity is higher than in 2D and peaks in the centre plane for Ar=15
(black area).
The removal of the septa also leads to a significantly increased number of
accepted counts, both trues and randoms, due to the absence of the shadowing effect
of the septa. The whole detector surface is thus exposed to the incoming photons, the
solid angle coverage of the tomograph is increased and more counts are acquired.
The graph in fig. 2.15 shows the trues and randoms countrates for the ECAT HR+
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operated in 3D. The true coincidence countrate increases with the activity
concentration present in the FOV until the curve starts to decline at concentrations of
about 30kBq/mL owing to the saturation of the detection system, while the randoms
increase, as expected, with the square of the activity concentration. For comparison
the countrates for this scanner operated in 2D are shown in fig. 2.12. Note that in 3D
the maximum trues rate (665kcps) is about twice as high as in 2D (330kcps). The
maximum trues in 3D are, however, acquired at an activity concentration that is three
times lower than the concentration for which the trues rate is maximum in 2D (fig.
2.12). The gain in coincidence countrate in 3D compared to 2D scans is
approximately fivefold (table 2.E) and most dominant at low activity concentrations.
Although randoms rates are high in 3D, for a given true coincidence rate, the
randoms fraction is smaller in 3D than in 2D.
Figure 2.15 Measured count rates (trues, randoms, NEC) in multi-ring PET scanner (ECAT
operated in 3D. Measurements were taken with a 20cm cylinder.
Owing to the strong variations of trues and randoms rates and different levels of
scatter in 2D and 3D, it is difficult to ascertain the real advantages of 3D PET
imaging from increased countrates alone. These advantages can, however, be
assessed with the concept of noise equivalent counts that was introduced in section
2.5.4. The NEC curve for the HR+ operated in 3D is plotted in fig. 2.15. Note that
optimum countrate performance is achieved at activity concentrations five to eight
times lower than the activity concentrations at which the maximum countrate
performance of the HR+ is measured in 2D with the septa extended (table 2.E).
Figure 2.15 also shows that at higher concentrations the NEC in 3D starts to decline
rapidly until at around 45kBq/mL the 2D NEC exceeds the 3D NEC for the HR+
(compare fig. 2.12 and fig. 2.15). The gains in measured useful counts that can be
expected from 3D acquisitions (septa retracted) depend on the imaging situation and
the activity concentration that is typically found in these situations. At low activity
concentrations, for example, where randoms rates and deadtime losses are limited,
such as for ligand studies, gains in NEC of four to five are observed, while at higher
concentrations, such as for cerebral blood flow, the gain may be no more than a
factor of three [Townsend, 19934
The axial resolution of a full-ring tomograph operated in 3D is shown in table 2.F.
Unlike PET acquisitions performed in 2D, the spatial resolution in 3D is extrapolated
from an axial sensitivity profile. A small bead (less than 10MBq) is moved in 0.5mm
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axial steps through the FOV. For each of the steps a full 3D data set is acquired and
reconstructed. A Gaussian fit is applied to the total reconstructed countrate for a
single plane and the axial resolution is determined from the FWHM of the fitted
curve. The axial profile is used to account for the contributions from the direct and
cross-planes that are distributed over the entire 3D data set, while in 2D septa extend
into the FOV to ensure that all contributions to a transverse image plane are
contained in the data sampled for a single sinogram plane. Table 2.F illustrates that
the spatial resolution in 3D degrades towards the axial edge of the FOV. This may be
explained by the reprojection step in the reconstruction that produces more synthetic
projections at the axial extremities of the FOV that in the centre. For example, for the
HR+, at a radius of lcm, the mean resolution averaged over the central 30 image
planes is 4.5mm and 4.7mm, compared to 5.1mm and 4.9mm averaged over all 63
axial image planes [Townsend, 1998].
Table 2.F Spatial resolution as FWHM [mm] of the ECAT HR+ tomograph operated in 3D
[Townsend, 1998].
Source location radial tangential axial
In air (1 cm)
In air (10 cm)
4.7
6.0
4.5
4.5
3.9
5.3
For a multi-ring tomograph, at transaxial locations away from the centre of the
tomograph, an additional degradation of the radial component of the spatial
resolution is observed both in 2D and 3D (table 2.D and table 2.F). This degradation
in resolution is caused by increased detector penetration of the annihilation photons
impinging with increasingly oblique angles on the front face of the detector crystals
with increasing distance from the centre of the transaxial FOV. Since the reason for
this degradation is independent of 2D or 3D acquisitions, similar in-plane spatial
resolutions are expected in 2D and 3D PET images. As mentioned in section 2.5.4.1,
in future tomograph designs, the availability of depth-of-interaction information will
help to improve the spatial resolution off-centre.
2.6.2 THE ECAT ART
To address the relatively high costs of 3D PET tomographs arising from the large
amounts of detector material in the scanner, the concept of a partial ring rotating PET
tomograph was introduced in 1992. Using a prototype partial ring PET tomograph, it
was shown [Townsend, 1993b] that for a given number of detectors, the approach of
dual rotating, asymmetrically opposing arrays has a higher sensitivity than the
corresponding fixed-ring configuration. The original design of the prototypes of
rotating PET tomographs: PRT-1 [Townsend, 1993b] and PRT-2 [Townsend, 1994]
has been refined in the currently commercially-available Advanced Rotating
Tomograph (ECAT AR7) that is described in detail in [Bailey, 1997; Townsend,
1999a] and shown schematically in fig. 2.16. The ECAT ART design combines: (a)
the approach of rotating detector arrays to acquire a full 3D projection data set, (b)
state-of-the-art BGO block detectors, and (c) the intrinsically higher sensitivity of 3D
acquisition and reconstruction. The result is a low-cost, 3D PET scanner design with
clinically-acceptable sensitivity (7.5cps/Bq/mL compared to 5.7cps/Bq/mL for the
HR+ operated in 2D) [Townsend, 1999a].
detector bank
multi-slit
collimator
axial travel of
point source
(111211115airill11.2111171
'Cs point source
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The ECAT ART scanner comprises two arrays of BGO block detectors. Each
array consists of 11 blocks (transaxially) by three blocks (axially), covering an arc of
83°. The detector arrays are not symmetrically opposed but are offset by 15° so as to
increase the diameter of the transaxial FOV without requiring additional detector
blocks (fig. 2.16). The ART has 46% of the detectors in the corresponding stationary,
full-ring scanner, the ECAT EXACT [Wienhard, 1992]. The axial FOV is 16.2cm,
subdivided into 24 (partial) rings of detectors. Shielding from out-of-field activity is
provided by arcs of lead, 2.5cm thick, mounted on both sides of the detector
assembly and projecting 8.5cm into the FOV beyond the front face of the detectors.
Figure 2.16 The ECAT ART with front cover open (left). Two partial detector rings are mounted
facing each other on a common rotating support. The ART is equipped with dual collimated '37Cs
sources (right) for attenuation correction.
Unlike the other commercial ECAT PET systems listed in table 2.E, the ART has
no septa and the detector arrays and shielding rotate continuously at 30 rpm to collect
the full set of 3D projections required for complete image reconstruction. An optical
encoder monitors the position of the gantry during rotation, so that the acquired
lines-of-response (LORs) are assigned to the correct sinogram addresses. Power and
serial communications to the rotating assembly are transmitted over mechanical slip
rings, while high speed digital data transfer is by optical transmission. A detailed
description of the standard ART design, configuration, performance parameters, and
examples of imaging studies can be found elsewhere [Bailey, 1997; Townsend,
1998].
2.6.3 IMAGE RECONSTRUCTION IN 3D PET
A set of 3D emission sinograms consists of sinograms containing the measured
counts in lines-of-response oblique to the transaxial planes (defined by the detector
rings), in addition to the direct projections within the transaxial planes as acquired in
2D. While the emission data in 2D (direct projections) are sufficient to reconstruct an
unknown tracer distribution, 3D emission data are redundant. The data redundancy
arises from the available cross-plane projections that become available in 3D
together with the direct projections. In 3D scanners (septa removed) a projection
perpendicular to the axis of the cylindrical scanner is completely measured (direct
projection, OA, whereas projections along oblique directions (cross-plane
Data acquisition
scanner
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projection, OA) are truncated by the finite axial extent of the tomograph (fig. 2.17).
It can be shown using the 3D Central-Slice Theorem [Defrise, 1998] that the
information obtained from direct projections is sufficient to completely sample the
object. Any additional non-direct projection adds redundant information that can be
used to reduce noise in the reconstructed image. In practice, with a discrete set of
projections, there are many more with OA than with OA leading to a high degree
of data redundancy.
truncated views
incomplete projections
complete projection
tracer distribution
Figure 2.17 Data acquisition and truncated projections in 3D PET. The amount of truncation (not
measured projections) depends on the axial extent of the scanner as well as the projection angle e
(given by the ring difference).
Figure 2.17 can be used to illustrate another key point of 3D imaging: the spatial,
or shift variance of the axial sensitivity. If all projection in 3D were complete, the
sensitivity of the scanner would be independent of the position in the FOV (shift-
invariant). This is the case for reconstruction problems in 2D that can be considered
stationary, provided small effects such as the parallax error are neglected or
corrected. In contrast, the 3D problem is not shift-invariant because the solid angle
subtended by the scanner decreases with distance from the centre of the FOV along
the main scanner axis. Shift-invariance in 3D is expressed as an axially varying
sensitivity profile (fig. 2.14) and non-uniform noise characteristics along the scanner
axis.
With the development of 3D acquisitions in PET, the reprojection algorithm
[Kinahan, 1989] emerged as the most widely-used 3D reconstruction algorithm
(3DRP), and is based on an extension of standard 2D filtered backprojection (section
2.4.2) to three dimensions. Since in 3D the redundant projection data (0-A) are
incomplete owing to the unmeasured LORs, this truncated information has to be
estimated and inserted prior to image reconstruction. Filtered backprojection can
then be applied to the completed projections which are partly measured and partly
synthesized. This is shown in fig. 2.18 (based on [Defrise, 1998]) that explains the
data flow in backprojection reconstruction of 3D emission data.
As in 2D, it is assumed that all necessary corrections (normalization, scatter, and
attenuation) are applied prior to the back-projection reconstruction. Each back-
projection step is preceded by filtering the projections which is performed in Fourier
a)	 completed projections
Forward projection
first-pass
image
(2D)b)
€3>0
Backprojection of complete, filtered projections
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3D Backprojection	 ,-,'. . -*
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space in order to commute the convolution of projection and filter with a simple
multiplication of their Fourier transforms [Defrise, 1998]. While in 2D only one
possible filter (ramp filter) exists, in 3D an infinite number of filters exist [Defrise,
1989] of which the Colsher filter [Colsher, 1980] has minimal noise amplification
properties. The 3D reprojection algorithm incorporates a preliminary step (fig. 2.18a
and b) in which partially-measured projections are completed by forward projecting
(fig. 2.18b) through an initial, low statistics image. This initial image is an estimate
of the true image since it is obtained from backprojecting the completely-measured,
direct projections only (fig. 2.18a). After completing the missing projections, a
second-pass image, the final true image, is reconstructed using the complete and
filtered projection set. A version of the reprojection algorithm, or 3DRP, has been
implemented on all commercially-available multi-ring PET scanners [Defrise, 1990].
reconstruction matrix
Figure 2.18 3D reconstruction by filtered backprojection (3DRP [Kinahan, 1989]). See text for more
detail.
Several alternative reconstruction algorithms have been proposed, either to reduce
the reconstruction time or to improve image quality. These algorithms can be
classified into transform, rebinning and iterative algorithms (table 2.G). The speed of
the 3DRP can be increased by replacing the Colsher filter with another exact filter
that reduces to the 1D ramp filter for all truncated projections (FaVoR [Defrise,
1991]). The forward-projection step to synthesize missing projections is eliminated
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and speed increased by 50%. Another analytic method, 3D-Fourier [Stearns, 1990],
is based on Fourier reconstruction only. It makes extensive use of the Fast Fourier
Transform, but requires complex interpolation of the tranforms to a cubic grid.
Table 2.0 Classes of common 3D image reconstruction algorithms. Speed of OSEM and PWLS
reconstruction () depends on the choice of reconstruction parameters, but is generally considerably
faster than 3DRP.
Class Data size Speed Noise Accuracy
Analytic
3DRP large slow low high
FaVoR large slow low high
3D-Fourier large slow low high
Rebinning+2D FBP
SSRB small fast low some distortion
MSRB small fast some increase high
FORE large fast low high
Iterative
3D ML-EM large very slow low high
FORE+OSEM large fasts low high
FORE+PWLS large fast low high
Filtered backprojection is based on an ideal model that disregards the noise
properties of photon counting. Iterative methods allow a more accurate modeling of
the data acquisition than the line-integral method of backprojection reconstruction.
Another advantage of iterative methods is the ability to incorporate an accurate
model of statistical noise [Comtat, 1998] and a priori information about the image
into the reconstruction process. Although the total number of voxels in the
reconstructed image is the same as in 2D iterative methods applied to 3D data need
to handle large amounts of data since no factorization is possible and all voxels must
be processed simultaneously [Defrise, 1998]. The combination of 3D imaging with
accelerated 2D statistical image reconstruction by using the accurate FORE
rebinning was recently proposed to reduce statistical noise in PET images. Three
common iterative methods are listed in table 2.G: Maximum-Likelihood
Expectation-Maximization (ML-EM, [Shepp, 1982]), Ordered Subset Expectation
Maximization (OSEM, [Hudson, 1994]), and Penalized Weighted Least Square
Functions (PWLS, [Fessler, 1994]). OSEM in combination with a 2D data set from
FORE has been used as an alternative to 3DRP [Comtat, 1998]. In particular, in very
noisy imaging situations, such as whole-body PET imaging, FORE+OSEM was
shown to yield superior image quality compared to 3DRP (fig. 2.19).
2.7 SUMMARY
PET is unique in its ability to create quantitative functional images of metabolism
in-vivo, rather than the structural or anatomical images produced by CT or MRI. The
functional nature of PEI' data permits investigation and comparison of events
occurring on a cellular level. Compared to SPECT, another functional imaging
technique, PET has a higher sensitivity in detecting trace amounts of radioactively-
labelled molecules and allows metabolic activities to be quantified in-vivo. In-vivo
quantification in PET is enabled by the coincidence detection principle of the two
a) b)
itov
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511keV photons which arise from the annihilation of positrons that are emitted from
the radioisotope labelling the tracer molecule.
The concept of using tracer molecules labeled with radioactive isotopes to observe
physiologic and metabolic processes in living organisms without disturbing the
organism is based on the work by George de Hevesy in the 1920s. The discovery of
artificial radioactivity and the development of the medical cyclotron greatly
facilitated the increased availability of medically-useful radioisotopes for diagnostic
purposes.
Improved high energy radiation detection led to the concept of scintillation
detectors coupled to photomultipliers (detector blocks). By arranging these detectors
blocks in rings around the patient, or by rotating two opposite detector block
arrangements around the main axis of the patient, and by connecting two opposite
detectors through a coincidence circuit, it is possible to follow, image and quantify a
PET tracer distribution.
Figure 2.19 Whole-body FDG PET study from the PET/CT reconstructed with (a) 3DRP, and (b)
FORE+OSEM. CT-based attenuation and scatter correction was applied prior to the reconstruction.
Typically PET tomographs are composed of several rings of detectors that cover
an axial field-of-view of about 10-25cm. State-of-the-art PET tomographs are
equipped with retractable inter-plane shields (septa). For improved sensitivity and
countrate performance, septa are removed from the FOV and emission data are
acquired for a larger number of lines-of-response than for 2D acquisitions with the
septa extended. The higher sensitivity of 3D PET comes at the cost of large data sets
that require more storage capacity and the use of more complex reconstruction
methods, and non-uniform sensitivity. Overall 3D PET offers significantly improved
performance over 2D PET and should be the preferred acquisition mode when
accurate scatter and attenuation correction are applied to the data.
metastasis
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3. WHOLE-BODY IMAGING USING FDG PET
3.1 METHODOLOGY
3.1.1 WHOLE-BODY SCANNING
The sensitivity of FDG as a tracer for staging of tumours, for detection and
localization of metastatic disease, and for monitoring therapy, has stimulated an
increasing demand for FDG studies to be performed in cancer patients. In many
cases the PET scan findings modify patient management, particularly where surgical
intervention is planned. Surgical intervention is, however, often substituted or
supplemented by other therapies if metastatic disease is present. To utilize the
sensitivity of PET in tumour staging, and to screen tumour patients for remote
metastasis [Hoh, 1993] whole-body PET scan protocols have been developed
[Dahlbom, 1992].
Whole-body PET scans are performed by scanning the patient at multiple
contiguous bed positions. To perform the scan, the patient bed is moved through the
scanner in a sequence of discrete overlapping steps. At each bed position, data is
acquired with the bed stationary and the PET scanner covering an axial extent of
about 15cm. A total axial length of 80-100 cm, sufficient to cover the extent of the
patient from the chin to the thigh, thus requires up to eight bed positions. Adjacent
bed positions are overlapped slightly to account for the decrease in sensitivity at the
edge planes of the FOV. The axial overlap typically varies from a few millimeters in
2D studies, up to 4cm in 3D studies. The data for each bed position are acquired and
reconstructed independently, and when all sets are complete, the data are assembled
into a single whole-body volume taking into account the overlap between each multi-
bed position. Coronal and sagittal views (fig. 3.1), and weighted projection images of
the entire volume can then be displayed in addition to the usual transverse sections.
mediastinal
mass
0-
ft,
bladder	 kidneys
Figure 3.1 Whole-body FDG PET scan of a melanoma patient. PET data were acquired in 3D over
five contiguous bed positions. No attenuation correction was applied. Coronal sections (lcm thick)
show a large mediastinal mass and multiple metastasis in the lower abdomen.
Some aspects of whole-body acquisition protocols such as: the choice of bed
overlap, the total scan time the patient must remain in the scanner, the need to
acquire transmission scans to perform attenuation correction, and the effect of
emission activity outside the measured FOV are subject of controversial discussions.
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These issues are discussed briefly below. In section 3.2 steps to improve whole-body
image quality based on optimized scan time partition between emission and
transmission scans are presentecd. Section 3.3 summarizes investigations on
potential improvements of the countrate performance of the ECAT ART and full-
ring ECAT PET tomographs.
3.1 .2 BED OVERLAP
As described in section 2.6.1, the axial sensitivity profile in 3D peaks in the centre
of the FOV of the PET scanner [Townsend, 1998], resulting in highly non-uniform
noise properties in the coronal and sagittal sections. To compensate for the non-
uniform noise structure in the end slices of individual PET scan volumes (fig. 2.14),
adjacent bed positions in whole-body PET scans are overlapped by a fraction of the
axial FOV (fig. 3.2). Cutler and Xu [Cutler, 1996] showed that, for an ECAT
EXACT tomograph [Wienhard, 1992], an overlap of 11 detector rings (-7cm)
improved axial uniformity in a cylinder phantom from 23% to 8%. Associated with a
larger bed overlap, however, is also a reduced axial coverage for the same total scan
time. Best trade-offs between axial coverage, image uniformity, total scan duration,
and reconstruction time have to be determined, and depend on the axial FOV of the
scanner [Cutler, 1996].
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Figure 3.2 Whole-body PET scan with overlapping bed positions. Sensitivity profiles of individual 3D
PET scans (bed 1-4) plateau in the centre of the axial FOV. By overlapping adjacent bed acquisitions
pixel variance and SNR can be made more uniform in the axial direction (red sensitivity profile).
However, artifacts in the overlapping regions are still present in the assembled images (right).
Recently, a number of authors have studied ways to further improve image quality
in whole-body scans and to characterize the axial sampling schemes that lead to an
optimal signal-to-noise ratio [Schubert, 1996]. The only axial sampling scheme that
results in the optimal SNR and eliminates resolution artifacts is continuous axial bed
motion [Dahlbom, 1994]. The advantages of true continuous axial sampling include
elimination of resolution artifacts due to axial undersampling, and a reduced
sensitivity to small patient movements. The major advantage, especially for 3D data
acquisition is a uniform axial SNR (except at the ends of the FOV) eliminating the
periodic variation in noise texture seen in fig. 3.2 that may affect lesion detectability.
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3.1.3 TOTAL SCAN TIME
The major limitation when scanning oncology patients is the total time the patient
can remain on the table. This time is given by the degree of the disease, the age and
the general state of the patient. Typically, whole-body scan times do not exceed
60min. For a given PET tomograph with a fixed axial field-of-view two parameters
need to be defined: the number of bed positions, i.e. the axial volume to be scanned
and the scan time per bed position. The extent of a whole-body scan generally
depends on the clinical indication. If the total scan time is fixed and the axial volume
is variable, image quality can be improved by scanning fewer bed positions for
longer times.
Due to total scan time limitations in many whole-body scan protocols,
transmission scans are not performed, and the emission scans are reconstructed,
displayed and interpreted without attenuation correction [Engel, 1996]. An example
of such a scan, performed in 3D on the ECAT ART is shown in fig. 3.1. The
apparent increased uptake in skin and lungs is due to the absence of attenuation
correction [Cook, 1996]. The accumulation of FDG in kidneys and bladder is due to
normal excretion of FDG through the urinary system.
3.1.4 ATTENUATION CORRECTION
The usefulness of attenuation correction in whole-body imaging is a subject of
debate. Generally, attenuation correction is required to eliminate the artificial skin
and lung uptake seen in fig. 3.1 and to avoid spatial distortions of focal uptake
[Bengel, 1997]. The uncorrected emission projection data are inconsistent, and
reconstruction artifacts are evident in the non-corrected images such as the increased
skin uptake and transaxial smearing [Zasadny, 1996] of focal uptake regions such as
tumours (fig. 3.3). Measurements of tumour size and relative uptake, crucial for
therapy monitoring are therefore unreliable. In a recent study quantification of FDG
uptake in attenuation corrected emission images provided a more reproducible and
accurate measure of treatment response than on uncorrected images [Yanez, 1999].
However, many researchers argue that the ability to quantify whole-body FDG
PET studies is less important than the ability to screen the entire patient for distant
disease [Pieterman, 1999]. The impact of attenuation correction on the staging of a
disease is also controversial. While several authors conclude that attenuation
correction is not advantageous for staging disease in non-small cell lung cancer
[Pieterman, 1999], in the human chest and axilla [Raylman, 1999], or in the primary
staging of malignant lymphoma [Kotzerke, 1999], other authors have indicated the
positive impact of attenuation correction on the accuracy of staging of abdominal
tumours [Hustinx, 1999].
Attenuation correction can also help reduce the risk of missing lesions in regions
of the body of high attenuation [Kotzerke, 1999], and where muscles are exercised
during the uptake period, thus leading to a fairly 'hot' background activity [Engel,
1996] and in turn to reduced contrast of soft tissue lesions in these areas. This is
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particularly critical in the head and neck unless the patient is asked to remain silent
in a relaxed resting position during uptake [Cook, 1996].
a) X
I	 #
b)
Figure 3.3 Whole-body FDG PET study of a melanoma patient, metastatic to the lung. The coronal
images are senes of 5mm thick sections from anterior to posterior, (a) without and (b) with attenuation
correction. The images show an intense focal uptake in the right lung, which extends over nine
corona] cuts of the uncorrected image. Attenuation correction corrects for the misrepresentation of the
tumour in the trans% crse direction that is seen in only four consecutive coronal slices.
Accurate attenuation correction is based on measured transmission information of
the patient at all bed positions scanned in emission mode (fig. 3.4). A transmission
scan, however, is often not acquired because of the increase in overall scan time. It is
often assumed that for optimum attenuation correction the measured transmission
and emission scan time must be comparable [Engel, 1996; Pieterman, 1999]. We
have shown, however, that short transmission scan times of 40% and less of the total
scan time per bed position may be adequate, and longer transmission scans do not
reduce the overall noise in the attenuation corrected image [Beyer, 1997a]. These
results are discussed in more detail in section 3.2.
Figure 3.4 Whole-body scan performed on the
ECAT ART with attenuation correction and
reconstructed with (a) 3D filtered back-
projection, and (b) FOREIOSEM approach.
The significant improvement in contrast and
noise reduction is evident with the
FOREJOSEM approach.
a)	 b)
It is obvious that while attenuation correction is clearly important, the high
emission noise levels from count-limited acquisitions often result in attenuation-
corrected images that are difficult to interpret. This is the case even when calculated,
noiseless attenuation correction is used. Recently, a significant improvement in
image quality has been achieved by the use of iterative reconstruction techniques,
such as the ordered subset approach, OSEM [Hudson, 1994]. Combined with the
Fourier rebinning technique, FORE, [Defrise, 1997] which noiselessly rebins a 3D
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data set into a 2D set, FORE/OSEM provides a fast and practical reconstruction
technique, which achieves significantly improved image quality compared with
standard 3D filtered backprojection.
Figure 3.4 shows an example of a whole-body scan with the ECAT ART on a
patient with a large liver metastasis and abdominal lymph node involvement. The
improved image quality demonstrated by the FORE/OSEM approach is evident in
the higher contrast [Meisetschlager, 1999] and lower noise levels compared with
filtered back-projection.
3.1.5 ACTIVITY FROM OUTSIDE THE FOV
Out-of-field activity is challenging to 3D whole-body imaging (section 2.6.1). In
2D scanners with septa extended, the detectors are well-shielded from the high levels
of activity in organs outside the measured FOV. In open 3D systems, septa are
retracted or eliminated and while all detectors are exposed to external activity
increased levels of scatter and randoms are observed. For the brain additional lead
shielding can be introduced into the patient port of the tomograph [Grootoonk, 1996]
to reduce the single photon flux from out-of-field activity, whereas additional
shielding in whole-body situations is difficult due to the changing body size and
shape as the patient is moved through the scanner. Figure 3.5 illustrates the
significant increase in the randoms-to-trues ratio that arises in 3D due to the
contributions from activity concentrations in the heart, brain, and bladder when
located outside the FOV. As a consequence the improvement in NEC in 3D
compared to 2D systems decreases from a factor of five in the region of the brain to a
factor of two in the abdomen. While the randoms-to-trues ratio in 3D varies
considerably, as shown in fig. 3.5, the same ratio for the corresponding 2D study is
essentially constant for all bed positions since the variable contributions from
external activity are limited by the presence of septa in 2D systems.
Figure 3.5 The randoms-to-trues ratio at
contiguous bed positions for a whole-body PET
scan in 2D and 3D. More randoms than trues can
be created when organs such as the brain or the
heart are just outside the measured FOV.
Although the randoms are corrected for by the
measurement of a delayed coincidence time
window, the high random rates increase image
noise and degrade image quality in 3D.
Bed position
The high levels of scatter and random events in 3D whole-body studies arise from
the contributions from activities outside the FOV of the scanner. The closer an
external activity concentration, e.g. brain or heart to the FOV the more the detectors
are exposed to single events from that activity. Consequently, more random
coincidences are registered that ultimately degrade image quality. Out-of-field
activity also contribute to a non-uniform scatter distribution inside the measured
single bed t
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FOV [Jadali, 1995] that can be best corrected for by the dual energy window
approach [Grootoonk, 19921.
The general problem of out-of-field activity in 3D systems has still to be
satisfactorily resolved, particularly for low-cost PET scanners, such as the ECAT
ART that have no septa and cannot perform whole-body studies in 2D. Since the rate
of accepted random events is proportional to the width of the coincidence time
window, we have performed a series of experiments on the ECAT ART to study the
effect of shorter coincidence time windows on the count rate performance in whole-
body imaging situations. The results are discussed in detail in section 3.3.
3.2 SCAN TIME PARTITION
3.2.1 WHOLE-BODY PET SCAN WITH ATTENUATION CORRECTION
Whole-body imaging is becoming an increasingly important application of
clinical PET because of its ability to detect and localize unsuspected malignancies.
Whole-body images reconstructed without attenuation correction are non-
quantitative and the relative tumour uptake values that are used to distinguish benign
from malignant lesions are inaccurate. Diagnostic utility is also reduced because of
the increased risk of missing tumours located deep within the body and by flare
artifacts arising from inconsistent projections (section 2.4, and 2.6.3). Attenuation-
corrected whole-body images are therefore required for an accurate and reliable
diagnosis [Yanez, 1999].
In attenuation-corrected whole-body imaging, where the emission and
transmission data are not acquired simultaneously, the total scan time must be
divided between the emission (Em) and the transmission (Tx) scans. Since the total
imaging time, T, is limited by the ability of the patient to remain immobile during the
scan, the division of time between the emission and transmission scans must be
carefully chosen (fig. 3.6).
Figure 3.6 In attenuation-corrected whole-body PET the total scan time T, and thus the scan time per
bed t, can be divided between the transmission (Tx) and emission (Em) scans such that an optimum
partition ; exists for which the attenuation-corrected PET images have the least noise and artifacts.
An example of an esophageal cancer is shown on the right for different scan time partitions.
0!
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63
The goal is, for a given scan duration, to divide the time between Em and Tx so as
to optimize the signal-to-noise ratio in attenuation-corrected whole body images. The
noise and, hence the diagnostic utility, in reconstructed attenuation-corrected images
will be a function of the object size and the number of counts acquired in the
emission and transmission scans [Dahlbom, 1992]. Using the ECAT ART PET
tomograph we have performed a series of torso phantom studies where we varied the
fraction (r) of transmission and emission scan time while keeping the total scan time
(t) fixed (fig. 3.6). For each study, we measured the noise in the reconstructed image
and estimated the optimum scan time partition (;) based on a modification of a noise
model proposed by Stearns and Wack [Stearns, 1992]. This section has been adopted
from our published data [Beyer, 1997a1. At the end of this section a few clinical
examples will be given that were previously presented [Beyer, 1997b], underlining
the applicability to whole-body PET imaging independently of the tomograph used.
3.2.2 PHANTOM EXPERIMENTS
3.2.2.1 METHODS
The elliptical phantom simulating a human torso is shown in fig. 3.7. The
phantom has a cross-section of dimensions 32cm by 24cm and cylindrical arms, each
with a cross-sectional diameter of 5cm, were added to either side of the torso. Saline
bags were attached to the front of the torso to simulate breast attenuation. The axial
extent of the phantom and the attached arms was 20cm and 18cm, respectively, both
of which exceed the axial field-of-view of the scanner (16cm). All parts of the
phantom were filled with a uniform activity concentration of 2.71d3q/mL
corresponding to typical uptake levels to be expected following a patient injection of
220MBq of FDG. A cylindrical insert (7cm cross-section diameter and 20cm axial
extent) filled with non-radioactive water was positioned 6cm off-centre within the
torso to estimate the noise in regions with no tracer uptake.
32		 water+18F
—7-- 	 background cold ROI
42 	 ROI
Figure 3.7 Torso phantom simulating trunk, arms and breasts for additional attenuation. The phantom
was filled with water and ' 8F activity [2.7kBq/mL]. A cylindrical insert was filled with non-
radioactive water to estimate noise in regions with no uptake. Circular regions-of-interest on cold
insert and warm background are also shown.
Acquisitions were performed for a total scan time of 5min, corresponding to a
typical whole-body imaging time per bed position. For each scan, the fraction of time
spent acquiring the transmission and emission data was varied such that the total
scan time was 5min. Transmission data were acquired post-injection with two rod
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sources (68Ge/68Ga) of 296MBq each. The attenuation correction factors (ACFs) were
obtained either directly from the measured transmission scan or after segmentation of
the transmission image according to the method developed by Xu et al. [Xu, 1996]
followed by reprojection of the segmented image. The emission data were corrected
for decay, scatter (model-based [Watson, 1996]) and randoms (delayed coincidence
window) prior to reconstruction.
The attenuation-corrected emission data were reconstructed using two different
reconstruction algorithms: the standard reprojection algorithm 3DRP [Kinahan,
1989], and the recently-developed Fourier rebinning algorithm FORE [Defrise,
1995] Together with the ordered subset (OSEM) approach developed by Hudson and
Larkin [Hudson, 1994]. The 3DRP reconstruction was performed with a Hanning
smoothing window at three different cut-offs: 1.0, 0.75, and 0.5 of the Nyquist
frequency. The subsets and smoothing for the OSEM algorithm were chosen to
achieve image resolutions comparable to 3DRP with the three different Hanning
window cut-offs.
3.2.2.2 DATA ANALYSIS
The mean pixel standard deviation, (S), over the central 30 planes (P) was taken as
a measure of reconstructed image noise and was calculated from:
1(S) = i, E sp	 p=1, ..., P	 Eqn. 3-1
where S p is the standard deviation in a 5 cm diameter region of interest over the cold
insert and in a uniform warm background region within the phantom (fig. 3.7). The
mean pixel standard deviation was determined as a function t of the fraction of
transmission scan time. To describe the behaviour of the measured image noise (s) as
a function of the scan time partition T, the basic noise model proposed by Stearns and
Wack [Stearns, 1992] was modified. The noise model provides a basic noise figure,
NF, for the signal-to-noise ratio in the corrected emission sinograms:
A B
NF= —+ —	 Eqn. 3-2
1 – T I"
where A and B are parameters that depend on the NEC of the emission and
transmission scan, respectively. For our purposes we assume that the mean standard
deviation (s) is a good measure of the noise figure NF in the corrected reconstructed
images [Beyer, 1997a]. Therefore we estimated the optimum scan time partition T,
which minimizes the noise in the reconstructed image from a least-squares fit [Press,
1992] of the model in eqn. 3-2. This model was only applied to images reconstructed
with the 3DRP algorithm from data corrected with measured attenuation factors.
Contributions to the NEC and hence to the parameters A and B in eqn. 3-2 from the
segmentation procedure are difficult to estimate and are not included in the noise
model.
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3.2.2.3 RESULTS
The graphs of measured noise 0) for a warm background region as a function of
the fraction t of transmission scan time are shown in fig. 3.8a for different Hanning
window cut-offs for a total scan time of 5min. In all cases the optimum scan time
partition To was 0.4. The results of the model fit, eqn. 3-2, to the mean pixel standard
deviation C) in a background region as a function of T are shown in fig. 3.8b for the
3DRP with a Hanning cut-off at 0.75 of the Nyquist frequency. The optimal fraction
To for minimum noise was estimated from the minimum of the fitted curve:
;=0.41±0.02 and agrees with the measured data.
Fraction Em Time (1-T) 	 Fraction Em Time (1-T)
Figure 3.8 Finding the optimum scan time partition T.: (a) measured mean pixel standard
deviation (S)in the warm background as a function of the scan time partition T for different levels of
smoothing in the 3DRP: (Hanning cut-off frequency at 0.5 ( • ), 0.75 ( 0) and 1.0 ( • ) of the Nyquist
frequency). (b) model fit to the measured noise S for Harming cut-off frequency at 0.75. Total scan
times per bed position: 5 min
Examples of the images obtained with the 3DRP and measured attenuation
correction for 5min total scan time and three different scan time partitions (r=0.1,
0.4, 0.8) are shown in Figure 3.9. The image reconstructed with T=0.4, i.e. 2min
transmission and 3min emission scan duration, had the lowest noise level and least
number of streak artifacts.
Figure 3.9 Emission images of torso phantom corrected for attenuation (measured) and reconstructed
with 3DRP (Hanning, cut-off at 0.75 of the Nyquist frequency). From left to right increasing
transmission time and decreasing emission time: T=0.1, 0.4 (minimum image noise), 0.8.
For comparison, emission images reconstructed with FORE/OSEM after
segmented attenuation correction are shown in fig. 3.10 for 5min total scan time.
Note the improved image quality compared with the images reconstructed with
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3DRP in fig. 3.9. In particular, better contrast of the cold insert is achieved with
iterative reconstruction.
T=0.1	 T=0.8
Emission [min] 4.5 3 1
Transmission [min] 0.5 2 4
Figure 3.10 Central transaxial planes of emission images reconstructed with FORE/OSEM (9mm
smoothing, 24 subsets, 7 iterations) after segmented attenuation correction. From left to right
increasing transmission time and decreasing emission time: T =0.1, 0.4, 0.8.
The effects on the noise in the reconstructed images of using different
reconstruction algorithms in combination with measured and segmented attenuation
correction are summarized in fig. 3.11. We compare the 3DRP and the FORE/OSEM
algorithm based on the mean pixel standard deviation (s) in the cold insert region
(low counts) of the torso phantom. The noise in the cold region was chosen as more
representative of the noise reduction achievable with iterative reconstruction in a low
count region. Note that the major contribution to noise reduction arises from the
iterative reconstruction (FORFJOSEM). Further noise reduction is achieved by using
segmented attenuation, which limits the transmission scan noise, as illustrated by
comparing fig. 3.10 with fig. 3.9. In the case of segmented attenuation correction, the
final image noise is less sensitive to the fraction of transmission scan time as
reflected in the absence of a well-defined minimum in the curve for segmented
attenuation correction in fig. 3.11. These results suggest that, when segmented
attenuation correction is used, a transmission scan time of 20% of the total scan time
(t0=0.2) is adequate to optimize the noise level in the final reconstructed images
3DRP, meas ACF
3DRP, segm ACF
FORE+OSEM mess ACF
FORE/EM segm ACF
Figure 3.11 Image noise in the
cold region (phantom insert)
relative to the warm back-
ground as a function of T for a
total scan time of 5min. Two
different reconstruction algo-
rithms (3DRP and FORE/
OSEM) are compared for the
same image resolution. Attenu-
ation (atn.) correction was
performed prior to the recon-
struction using both measured
(meas.) and segmented (segm.)
ACFs.
a)
b)
c)
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3.2.3 CLINICAL EVALUATION
The phantom study described above leads to the conclusion, that 20%-40% of the
available scan time per bed position should be dedicated to the transmission scan
(0.2t0s0.4) to minimize the noise in the attenuation-corrected emission images. The
optimum scan time partition depends on the attenuation correction (measured or
segmented) and chosen reconstruction method. We verified the applicability of these
findings in a series of clinical whole-body studies [Beyer, 1997b] by defining the
optimum scan time from visual evaluation of reconstructed patient images with
various scan time partitions (fig. 3.12).
T=0.15	 T=0.3	 T=0.7
Emission [min] 6 5 2
Transmission [min] 1 2 5
Figure 3.12 Clinical evaluation of optimum scan time partition in whole-body PET scanning: (a) lung
carcinoma, (b) pulmonary neoplasm, and (c) adenocarcinoma. Total scan time was 7min. Measured
attenuation correction was performed based on post-injection transmission acquisitions. Injected
activity was 300MBq-400MBq. Data were acquired on an ECAT EXACT operated in 2D. Scan time
partitions t (0.15,0.30,0.70) are shown together with emission and transmission scan times.
All scans were performed on an ECAT EXACT in 2D at the Northern California
PET Center (Sacramento, USA). The ECAT EXACT has a 2D sensitivity of
4.9kcps/kBq/mL, slightly less than that of the ECAT ART. Patients were injected
with about 370MBq of FDG. Whole-body scanning over six to eight bed positions
was initiated after a 30min uptake period. After the whole-body acquisition, a single
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bed position was acquired over the most obvious lesion. Emission data were
collected for a total of 10min (10 frames of lmin each). Transmission scans were
acquired in 2D for 5min (five 1 min frames). Measured attenuation correction was
applied to the emission data after composing emission and transmission data for a
total scan time of 7min.
Three clinical examples were shown in fig. 3.12. Comparison of the image sets
confirmed that the reconstruction with T=0.3 showed less noise, fewer streak artifacts
and clearer delineation of low-activity structures than reconstructions based on other
partitions, particularly with longer transmission and shorter emission times. We
conclude that, in clinical imaging situations, for a fixed total scan time, attenuation-
corrected whole-body scans should be performed with a transmission scan time
which is less than half that of the emission scan time. In addition, longer
transmission scans do not reduce the noise level in the reconstructed emission
images.
Although we found similar optimum scan time partitions for 2D and 3D whole-
body acquisitions, further studies may be required to determine lesion detectability in
attenuation-corrected images as a function of patient and lesion size. Our qualitative
evaluation of clinical data indicates that if attenuation correction is desired in whole-
body imaging situations then there exists an optimum partition of the total scan time
between the transmission and emission scan duration. This partition will depend on
the patient size, the injected activity and the transmission scan parameters (e.g.
transmission source and source strength) that were not discussed here.
3.3 COUNT RATE PERFORMANCE OF PET TOMOGRAPHS
Sensitivity and count rate performance are key parameters for a PET scanner. In
the case of the partial ring ECAT ART tomograph (section 2.6.2) the decreased
number of detectors obviously reduces both cost and sensitivity relative to a full ring
scanner. The goal of the ART design is to achieve a sensitivity which is acceptable
for clinical and research applications at a cost which is significantly less than that of
a full ring scanner. However, the quality of some of the studies, and particularly the
attenuation-corrected whole-body studies in large-sized patients, has not been
satisfactory, and therefore a re-evaluation of some of the performance parameters is
worthwhile.
Compared to the performance of the standard ART scanner [Bailey, 1997b],
improvements in count rates and noise equivalent counts can, in principle, be
achieved by modifications to the detector block integration time and the coincidence
time window (fig. 3.13). Corresponding improvements in image quality can then be
expected. This section will describe the modifications required for the ART scanner
to improve count rate performance and reduce randoms rates. The corresponding
improvement in image quality is illustrated with phantom data. Much of the data
presented in this section has been recently published [Townsend, 1999a].
detector
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3.3.1 ECAT ART: SHORTER BLOCK INTEGRATION TIMES
An important parameter limiting the count rate performance of the detector block
is the signal integration time. During coincidence detection the energy deposited by
an incident 511keV annihilation photon is converted by the scintillator material
(BGO) into UV photons which eventually reach the photocathode of a
photomultiplier tube bonded to the scintillator block. The signal from the
photoelectrons emitted from the photocathodes appears as a pulse at the output of the
PMT (fig. 3.13). An integration circuit at the output of the PMT then integrates the
photoelectric current for a preset time to yield a pulse with an amplitude related both
to the position of the incident photon within the detector block and the energy
deposited by the photon. In order to minimize statistical fluctuations of the signal,
the integration time should be set to enable as much of the UV light as possible to be
collected. Since the duration of the UV light emission is determined by the decay
time of the scintillator, the integration time should be equal to or greater than the
scintillator decay time. The decay time for BGO is 300ns [Grabmeier, 1984], and in
the standard ART, the integration time is set to 768ns. The detector deadtime, and
hence the count rate performance, is determined by both the integration time and the
reset time of the electronics, which is currently 256ns.
Figure 3.13 Acquisition
parameters for the ECAT ART.
Shortening the block integration
time is equivalent to reducing the
detector deadtime and thus
increasing the number of
accepted counts. If two events
(#1, 2), processed by the constant
fraction discriminator (CFD) are
detected within a coincidence
time window (typically 12ns)
then they are counted as a true
coincidence. Shorter coincidence
windows are assumed to reduce
the number of uncorrelated
coincidences (randoms).
Shortening the integration time potentially increases the statistical uncertainty in
the output pulses from the four PMTs attached to a BGO block. While this procedure
could improve the count rate performance of the block, the improvement may be at
the expense of a degraded spatial or energy resolution, with the latter resulting in an
increased scatter fraction. To investigate the effect of different block integration
times on scanner performance, the integration time was varied from 768 ns (default)
down to 384ns in steps of 128ns. Measurements of performance parameters, where
appropriate, were performed using a protocol similar to the NEMA specifications
[Karp, 1991] to determine: (a) trues and randoms count rate, (b) scatter fraction, (c)
energy resolution, and (d) in-plane spatial resolution. The measurements are
described in more detail in [Townsend, 1999a] and summarized in table 3.A.
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Table 3.A Measurements of performance parameters of the ECAT ART as a function of the block
integration time (Tit). Most measurements were based on the NEMA protocol [Karp, 19911.
	
Performance	 [ns]	 Measurement 
Count rates 768, 640, 512, 384 NEMA: 20 cm cylinder filled with ' 8F of 3.7kBq/mL
Scatter fraction 768, 640, 512, 384 NEMA: Line source at three radial positions in 20cm
water phantom
	Energy resolution
	768, 384	 Plot of singles rate from a line source in the centre of
the FOV as a function of energy window, window
was stepped in 10keV units from 100keV to 850keV
Spatial resolution 768, 640, 512, 384 Line source of activity in air at three radii from centre
	
(in-plane)	 of the FOV
NEC 768, 640, 512,384 NEMA: 20cm water cylinder filled with ' 8F, and
scanned over six half-lives
True sensitivity 768, 640, 512, 384 NEMA: 20cm cylinder filled with ' 8F of 3.7kBq/mL 
It is evident from fig. 3.14, that compared to the standard ART performance
[Bailey, 19971A reducing the block integration time to 384ns incurs no degradation
of either spatial or energy resolution. In addition, the scatter fraction is not expected
to change since there is little change in the width of the 511keV peak at the shorter
integration time (fig. 3.14b). This was verified by making measurements of scatter
fraction according to the NEMA procedure which led to a value of 36%±2% for all
integration times.
a)	 b)
Figure 3.14 Spatial resolution (a) and energy resolution (b) measured with the ECAT ART as a
function of the block integration time: a) 768ns, 640ns, 512ns, 384ns, b) 768ns, 384ns. Spatial
resolution was measured at the centre and 10cm off-centre of the FOV.
The noise equivalent counts (NEC), defined by eqn. 2-11, is a measure of signal-
to-noise ratio. By following the count rates (trues and randoms) in a uniform cylinder
as the activity decays, and using the measured scatter fraction, NEC curves were
obtained for different integration times, as shown in fig. 3.15. A useful quantitative
description of these curves is the maximum NEC and concentration at which the
peak is attained. These values and estimates of the true sensitivity for the four block
integration times are listed in table 3.B. There is a significant improvement in count
rate performance resulting in a 24% increase in maximum NEC for an integration
time of 384ns compared to the standard 768ns.
The improvement in maximum NEC with little or no degradation of either spatial
or energy resolution may appear surprising, given that both position and energy are
obtained from the integrated PMT signal. In general, a shorter integration time would
imply fewer integrated photons, and hence poorer statistical quality of the signal.
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However, a similar observation of increased NEC for shorter block integration times
was made by Moisan et al. [Moisan, 1997]. They authors conclude from a series of
simulations that the spatial resolution in a detector block is mainly determined by the
amount of Compton scatter rather than by statistical effects of the light output.
Therefore improved countrate performance must not be accompanied by
degradations in spatial resolution
0
0 5 10 15 20 25 30 35	 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0
a)	 Activity concentration [kBq/m L.] 	 b)	 Activity concentration [kBq/m L]
Figure 3.15 Trues and randoms count rates (a) and NEC (b) as a function of the block integration time
(768ns and 384ns shown) for the ECAT ART. Three areas of application of PET at various activity
concentrations are indicated within the NEC plots (b). Maximum gain in NEC owing to shorter
integration time is achieved at high activity concentrations while at lower activities the gain is less
dramatic.
Table 3.B Peak NEC, gain f%1 in peak NEC, and true sensitivity as a function of the block integration
time for the ECAT ART.
Tit Ens] Maqximum NEC
[kcps at kBq/mL]
Gain [%] in peak
NEC
True sensitivity
Ecps/Bq/mL]
768 ns 31.8 at 17 7.5
640 ns 34.5 at 18 9% 7.0
512 ns 38.0 at 19 19% 8.0
384 ns 39.5 at 19 24% 8.1
Since it is evident from fig. 3.15b and table 3.B that the significant gains observed
in peak NEC may not be reflected in similar improvements at low activity
concentrations, a series of phantom measurements was carried out at activity
concentrations closely approximating those encountered in clinical studies (fig.
3.15a). Whole-body imaging was simulated by scanning an elliptical abdominal
phantom containing low activity concentration (3.7kBq/mL) for 10min. The phantom
measured 29cm x 23cm x 16cm. Two spherical hot lesions (volumes of 2mL and
21mL) and one cold lesion (volume 21mL) were positioned symmetrically around
the edge inside the phantom. For the hot lesions, the lesion-to-background activity
ratio was 5:1, corresponding to a ratio typically encountered in clinical imaging
situations. Emission images were reconstructed using 3D filtered backprojection with
scatter correction, calculated attenuation correction, and a Harming smoothing
window with a cut-off at 80% Nyquist. The reconstructed images are shown in fig.
3.16. Using the contrast-to-noise ratios (CNR) a 12% improvement in CNR is
measured for the cold lesion and a 4% improvement for the hot lesions when the
integration time is reduced from 768ns to 384ns. The emission images reconstructed
from scans acquired at shorter block integration time appear generally less noisy and
contain fewer artifacts.
fi
a) 788 ns	 b) 384 ns
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Figure 3.16 Examples of image quality achieved with emission data of the whole-body phantom
acquired for 10min at (a) 768ns, and (b) 384ns block integration time. The phantom contained two hot
lesions (arrows) and one cold lesion (arrowhead). Emission data were corrected for scatter and
attenuation. Overall image quality and lesion contrast are improved at shorter integration time.
To cover the range of higher activity concentrations encountered in clinical
studies phantom experiments were performed to simulate a brain FDG and a brain
mapping study using H 2 150. A Hoffman brain phantom containing the appropriate
activity concentration (12kBq/mL and 241c13q/mL, respectively) was used and
scanned for 10min and 1 min, respectively. Central transaxial slice through the
reconstructed images are shown in fig. 3.17.
768 ns
	 384 ns	 768 ns	 384 ns
a) brain FDG study (10 min) b) brain activation study (1 min)
Figure 3.17 Hoffman brain phantom imaged with activity concentrations of (a) 12kBq/mL and (b)
24kBq/mL to simulate (a) a typical brain FDG scan and (b) a brain mapping study with '50-water.
Emission data were acquired at 768ns (left) and 384ns (right) block integration time. The images are
corrected for scatter and attenuation (calculated).
3.3.2 ECAT ART: SHORTER COINCIDENCE WINDOWS
As described in section 2.6.1 a major limitation of 3D whole-body PET imaging is
the high rate of random coincidences which due to the open geometry of 3D
scanners. The lack of septa and the presence of distributed activity outside the field-
of-view (e.g. bladder, kidneys, brain) lead to an increased singles rate. Since the
random coincidence rate, R, varies with the singles rate, S, according to:
R cc S 2 2,z„	 Eqn. 3-3
large random fractions are observed in 3D whole-body PEI' due to out-of-field
activity. The randoms rate also depends linearly on the width of the coincidence time
window, 2-gew. Ideally, a minimum coincidence time window would depend only on
the diameter, D, of the detector ring, and the speed of light, c. In practice, however,
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the coincidence time window is dominated by the time resolution, tBco, of the BGO
detector blocks [Moisan, 1997]:
2D
Tcw = + 2 o •	 Eqn. 3-4
Based on a 4-5ns FWHM timing resolution for BGO the typical block design, the
default coincidence time for the ECAT ART (ring diameter —80cm) is 12ns.
Theoretically, if the default window was chosen wider than 12ns then only the
accepted randoms should increase while the measured trues rate remains constant.
For shorter coincidence time windows (s 12ns) mostly randoms are expected to
decrease leading to a potential improvement in NEC (eqn. 2-11).
To explore the effect of changing the coincidence time window, count rate
performance was measured with a 20cm diameter uniform cylinder phantom
according to the NEMA standard [Karp, 1991]. All measurements were performed at
four values of 2-r: 18ns, 14ns, 12ns, lOns and 6ns, while the block integration time
was fixed at 384ns. The true coincidence count rate curves as a function of activity
concentration and the corresponding random coincidence count rates are shown in
fig. 3.18a. These data can be used in eqn. 2-11 to estimate the NEC at each activity
concentration and for each coincidence time window, and the resulting curves are
plotted in fig. 3.18b for time windows of 18ns, 14ns, 12ns, lOns, and 6ns.
Reducing the coincidence time window was found to have a less significant effect
than anticipated on the performance of the ART scanner. As shown in fig. 3.18b, the
NEC curves are essentially identical for time windows of 18ns, 14ns, 12ns and lOns.
At 6ns, a significant decrease is observed in the NEC throughout the range of activity
concentrations. An explanation for this effect can be seen from fig. 3.18a which
shows the corresponding count rate curves for the trues and randoms at each time
window. The expected decrease in the randoms rate is accompanied by a
corresponding decrease in trues rate, resulting in the same behaviour for the NEC
curve at each time window. This unexpected decrease in true count rate at shorter
time windows can be explained by the timing jitter [Paulus, 1985] in the acquisition
electronics of the ART scanner. An estimated time jitter of ins in the ART
electronics results in a 2ns uncertainty in the coincidence time window, although this
may well be an underestimation. Using the estimate (eqn. 3-4) given by Moisan et al.
[Moisan, 1997], the minimum coincidence time window is estimated as 12ns. For
coincidence time windows in the range lOns-14ns, there is little change in the NEC
performance (fig. 3.18b), whereas below lOns, a significant decrease in maximum
NEC is observed.
To specifically determine the influence of activity outside the field-of-view, the
abdomen phantom (fig. 3.7) was scanned at the same five different coincidence time
windows both without and with additional activity positioned just outside the field-
of-view. Firstly, the elliptical abdominal phantom (volume 9.6L) was filled with an
' 8F solution of 3.7kBq/mL and positioned symmetrically in the field-of-view of the
ECAT ART without activities placed outside the phantom. Count rates were acquired
for coincidence windows of 18ns, 14ns, 12ns, lOns and 6ns. The noise-equivalent-
counts were calculated based on a measured scatter fraction of 40%. In a second
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experiment, the same phantom was scanned but with an additional 40MBq of '8F
solution in a 1 liter plastic bottle on one side of the phantom, and 220MBq of '8F
solution in a 20cm diameter uniform cylinder placed on the opposite side of the
phantom (fig. 3.19). All the additional activity was outside the imaging field-of-
view. Count rates were measured for all coincidence time windows and peak NEC
values compared to the imaging situation without activity outside the FOV (fig.
3.19).
Figure 3.18 The effect of varying coincidence time window width on (a) trues and randoms count
rates, and (b) NEC measured with a 20cm cylinder in the ECAT ART.
Unfortunately, even in the presence of a high level of randoms from activity
outside the FOV, reducing the coincidence window has minimal effect upon the peak
NEC, as shown in fig. 3.19. For all three phantom measurements, the maximum NEC
remains the same from 14ns to lOns, then decreasing significantly below lOns. It is
also interesting to note the overall decrease in NEC from the 20cm diameter uniform
cylinder phantom to the elliptical phantom, and the further decrease in maximum
NEC as a result of the additional activity outside the FOV. Therefore, a reduction in
the coincidence time window (2-g0„) below 12ns did not improve the performance of
the current ART scanner significantly.
0	 4	 8	 12	 16	 20
Coincidence window Ens]
Figure 3.19 The effect on the peak NEC value of changing the coincidence time window without and
with activity outside the FOV. The curves are for: (a) the abdomen phantom containing an activity
concentration of 3.7kBq/mL; no activity outside the FOV, (b) as in (a) but with two additional sources
of activity (37MBq and 220MBq) positioned on either side, immediately outside the FOV (setup
shown at left) For comparison, the corresponding curve (a) for a 20cm diameter uniform cylinder
containing the same activity concentration (3.7kBq/mL) is shown in (c).
An alternative approach to reduce the randoms rate is to measure the singles rate
[Casey, 1986a] on a block or detector level and to estimate the randoms directly from
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eqn. 3-3. This technique, however, is limited by readout electronics that allow the
total bucket singles rates to be measured only, and not the singles rate at the detector
or block level.
Finally, the rise time of the signal from the scintillator plays an important role in
defining the appropriate coincidence window width. Although the coincidence
window cannot be shorter than the maximum time difference between the two
annihilation photons from disintegrations at the edge of the imaging field-of-view,
shorter coincidence windows seem practical when using scintillators with faster rise
times than BGO, e.g. LSO [Casey, 1997]. Faster rise times allow earlier signal
formation by the constant fraction discriminator and subsequent faster processing.
Hence, faster rise times allow the coincidence window to be reduced, limit randoms
rates and thus reduce image noise.
3.3.3 PRELIMINARY RESULTS FROM OTHER WHOLE-BODY PET TOMOGRAPHS
3.3.3.1 RESULTS FOR THE ECAT HR+
We have also compared the count rate performance of the ECAT HR+ at two
block integration times: 768ns (default) and 384ns (table 3.C). The HR+ is a full ring
scanner with retractable septa, described in detail in [Brix, 1997]. The scatter fraction
was measured as 37%±7% for both integration times. The spatial resolution at the
centre of the FOV was 4.76mm x 4.45mm (radial x tangential) and 4.60mm x
4.28mm for 768ns and 384ns, respectively. At 10cm we measured 4.77mm x
6.02mm (radial and tangential) and 4.75mm x 6.09mm. Although no degradation
was observed at shorter integration times, a worsening of the tangential resolution
was notable away from the centre.
Table 3.0 Performance paramters of the ECAT HR+ at two block integration times: 768ns (default)
and 384ns. Transaxial spatial resolution: centre (r=0cm) and off-centre (r=l0cm).
Performance 768ns 384ns
Radial spatial resolution [mm] : r=0cm 4.8 ± 0.2 4.6 ± 0.1
r=l0cm 4.8 ± 0.1 4.8 ± 0.1
Tangential spatial resolution [mm]: r=0cm 4.6 ± 0.1 4.3 ± 0.1
r=l0cm 6.0 ± 0.1 6.1 ± 0.1
Sensitivity [cps/Bq/mL] 31 29
Scatter fraction 0.37± 0.06 0.37 ± 0.07
Maximum NEC [kcps] 136 at 21 kBq/mL 160 at 22 kBq/mL
The NEC estimated from the trues and randoms count rates measured at 768ns
and 384ns are shown in fig. 3-20. We observed a gain of 12% in peak NEC at around
22kBq/mL. As with the ECAT ART, the gain in NEC at activity concentrations
relevant to whole-body imaging was marginal. We did not estimate the effect on
reconstructed image quality. The true sensitivity values were estimated as
31cps/Bq/mL and 30cps/Bq/mL for 768ns and 384ns, respectively.
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Figure 3.20 NEC of the ECAT HR+ operated in 3D at two different block integration times: 768ns
and 384ns. We measured a 12% gain in peak NEC when reducing the default integration time by a
factor of two.
3.3.3.2 RESULTS FOR THE ECAT EXACT
Performance measurements were also made for the ECAT EXACT, a dedicated
whole-body PET tomograph [Wienhard, 19921. The estimated NEC from the trues
and randoms count rates measured at 768ns and 384ns are shown in fig. 3.21. We
observed a gain of 12% in peak NEC at around 141cBq/mL. The gain in NEC at
activity concentrations relevant to whole-body imaging was marginal, similar to the
observations with the ECAT ART (fig. 3.15) and HR+ (fig. 3.20). The true
sensitivity value was estimated as 28 cps/Bq/mL for both 768ns and 384ns.
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Figure 3.21 NEC of the ECAT EXACT operated in 3D at two different block integration times: 768
ns and 384 ns. We measured a 12% gain in peak NEC when reducing the default integration time by a
factor of two.
With both scanners, the HR+ and the EXACT, we performed a series of phantom
experiments to estimate the effect of shorter coincidence time windows on the
randoms count rate. Similar to our results from experiments with the ECAT ART, we
found that for coincidence windows between lOns and 14ns similar randoms-to-trues
fractions were achieved leading to no improvement in NEC. For coincidence
windows shorter than lOns or longer than 14ns, significant degradation in count rate
performance was observed that led to a significant decrease in NEC. For example,
for a 6ns coincidence time window the peak NEC of the HR+ and the EXACT was
reduced to about 75kcps (compared to 136kcps for a 12ns coincidence window) and
105kcps (compared to 95kcps), respectively, thus degrading the performance of the
two scanners operated at those coincidence windows.
1/0.0
4\.	 384 ns
"	 768 ns
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3.4 SUMMARY
Whole-body scan protocols have become standard procedures in FDG PET
imaging. PET scanning at multiple contiguous bed position results in a volume
image of metabolic information that can be displayed in transaxial, coronal, and
sagittal views. Whole-body PET is limited by the total scan time the patient can
remain in the scanner. Although many users advocate to use the total scan time
available for emission scans only, transmission scans should be performed to allow
the correction of the emission data for attenuation and to eliminate artifacts arising
from the inconsistent projections in non-corrected emission data.
We have shown that an optimum scan time partition of the total scan time exists,
such that optimal noise properties for attenuation-corrected 3D whole-body scanning
may be achieved with transmission scan times which are less than half those of the
emission scan time. In a small series of patient studies, we verified that longer
transmission scans do not improve the noise level in the reconstructed image.
Significant noise reduction is achieved by using segmented attenuation correction
and a statistical image reconstruction algorithm such as OSEM, both techniques
being essential to limit noise propagation in count-limited whole-body imaging
situations. The availability of singles transmission scanning could further improve
image quality of corrected whole-body PET images and will be discussed in detail in
chapter 6.
The ECAT ART is an example of a low cost PET scanner targeted for clinical
applications, particularly in oncology. The ART was used to investigate potential
improvements of count rate performance in whole-body imaging situations by
operating the scanner with a decreased block integration time and reduced
coincidence time window. Shortening the block integration time by a factor of two
from the default 768ns to 384ns resulted in a 24% improvement in maximum NEC,
with no degradation of either spatial or energy resolution. The use of a shorter
coincidence time window did not result in any obvious improvement in NEC owing
to a decrease in both the randoms and true coincidence rates. This effect is attributed
to a time jitter in the coincidence time window. The use of a 384ns block integration
time is therefore recommended for standard ART operation, and has been
implemented in the PET operation of the combined PET/CT tomograph. Similar
improvements in NEC were found when operating the ECAT HR+ and ECAT
EXACT in 3D and indicate that the performance of BGO based tomographs could
generally benefit from shorter block integration times. However, more thorough
investigations need to be performed to evaluate improvements of image quality in
whole-body imaging situations when activity concentrations are low and gains in
NEC are less dramatic than at higher concentrations of activity.
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4. THE COMBINED PET/CT SCANNER
4.1	 MOTIVATION
4.1.1 PET AND CT: COMPLEMENTARY IMAGING MODALITIES
Clinical diagnosis and subsequent planning and evaluation of therapy are often
supported by different imaging modalities, which can provide complementary
information. There are many instances in which it would be desirable and beneficial
to the patient to combine the information obtained from two or more imaging studies.
Imaging studies from anatomical (CT or MRI) and functional (PET or SPECT)
modalities provide complementary information.
In the discrimination of a benign versus a malignant mass, a CT scan typically
defines the borders of the mass, while a PET scan visualizes the underlying
metabolic activity of the tissues. As a result of the incorporation of FDG into
tumours, they appear as focal uptake or 'hot spots' on FDG PET scans. In addition,
diffuse normal uptake of FDG typically appears in the brain, in the myocardium
(depending on the glycolytic state of the patient), in liver, and in bone marrow, to a
variable degree in the thyroid, in muscles and bowel, and in the kidneys and bladder
as a result of the excretion of the tracer through the urinary system (fig. 4.1).
b)
bone marrow
kidney -1.)s k
muscle -fog
bowel vh,
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a)	 c)
Figure 4.1 Examples of whole-body FDG PEI' scans showing normal FDG accumulation (a) in the
bone marrow (after chemotherapy) and bladder, (b) in the muscle and kidneys, and (c) in the bowel.
Images are not corrected for attenuation.
It is evident that in regions such as the thorax and abdomen, the demonstration of
increased FDG uptake is limited in value without an unambiguous localization of
tracer uptake to a specific structure (e.g. a tumour) seen on the corresponding CT
image (fig. 4.2). An accurate co-registration of CT and PET data would not only
facilitate an improved localization of metabolic activity but could allow a more
accurate quantitative evaluation of the underlying metabolic activity. In certain
organs, where nearby structures have a high concentration of excreted tracer, such as
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FDG in the renal pelvis, exact registration of PET and CT would allow a finer
discrimination of the etiology of 'hot spot' focal uptake. This could avoid falsely
identifying the mass as tumour, or misjudging a focal accumulation of tracer as
probable urine activity. For future tracers which may have labeled metabolites
excreted via the hepatobiliary system and bowel this may be even more crucial.
a)	 b)
Figure 4.2 Transaxial image from FDG PET scan of the abdomen (a) showing an extended area of
slightly elevated metabolic activity. Comparison with CT information assigned this elevated FDG
accumulation to a large pancreatic mass (b). Other areas of FDG uptake correspond to the lower lobe
of the liver (small arrow) and the right kidney (arrowhead).
4.1 .2 IMAGE ALIGNMENT
In recent years, there has been considerable progress in the development of
techniques to co-register and align functional and anatomical images [Eisen, 1993;
Wagenknecht, 1999] (table 4.A). This has been driven primarily by the demand for
accurate localization of cerebral function visualized in PET studies where low
resolution morphology is, in most cases, insufficient to identify the related cerebral
structures. Techniques to overcome this problem have been developed based, for
example, on the use of stereotactic frames [Schad, 1987] and facial masks [Miura,
1988]. Masks and frames need to be rigidly attached to the patients body surface,
which often requires physical intervention. Today these types of registration are
limited to radiation therapy planning where (sub)-millimeter accuracy is required
when estimating the delivered dose.
Less invasive approaches to retrospective image alignment utilize external
fiducial markers that are attached to the imaged body surface area before scanning
commences. The major limiting factor with this method (as well as when using
sterotactic frames or facial masks) is that subjects must be known in advance, as
fiducial markers or masks must be placed on the subjects prior to the scanning
procedures. This also precludes the alignment of image sets that were acquired
without external landmarks.
Identification of the skull and brain contour from either the PET transmission or
emission scan and the MRI or CT scan has also been employed as an alignment
technique using an iterative least-square fitting procedure [Pelizzari, 1989].
Following the identification of common structures in the two modalities, a rigid-body
transformation is used to rotate and translate the MRI or CT scan into the reference
frame of the PET image, accounting for differences in pixel size between the two
80
imaging modalities. Recently, a technique which uses a least squares approach to
minimize the distribution of pixel-to-pixel ratios between the two images requiring
alignment has proved successful both for PET to PET [Woods, 1992] and PET to
MRI [Woods, 1993]. Computational approaches to image registration are
advantageous over registration methods that rely on extrinsic properties. The
advantages include improved technical feasibility, and less demands on the personnel
to affix head holders, masks and frames. An interactive method has also been
published where a human observer makes alignment decisions based on visual
inspection of images of brain sections displayed on a computer screen [Pietrzyk,
1994].
Table 4.A Examples and classification of multi-modality image alignment procedures.
Reference	 Landmarks Anatomy Transformation Accuracy
Schad, 1987	 stereotactic frame Brain Rigid,
PET-CT,MRI
0.5mm (centre)
Miura, 1988	 facial mask Brain Rigid,
PET-CT
<2mm (axial)
1 deg (angle)
Pelizzari, 1989	 surfaces Brain Least-square, rigid,
PET-CT,MRI
1-2 pixels
Alpert, 1990	 Principle axes Brain Rigid,
PET,-MR1, CT
—1mm
Pietrzyk, 1990	 contours/contrast Brain,
Whole-body
Rigid,
PET-SPECT-MRLCT
—4mm
Birnbaum, 1991	 Intrinsic landmarks Liver Warping, curved,
SPECT-MRI,CT
<1.5 pixels
Woods, 1993	 Intrinsic landmarks Brain Rigid,
PET-MR'
3mm
Wahl, 1993	 Internal + external
landmarks
Lung Rigid,
PET-MRI,CT
<6.3mm
Wahl, 1994	 Internal + external
landmarks
Lung Rigid,
PET-CT
3.5mm
Yu, 1995	 surfaces Lung Least square, rigid,
PET-CT
2.3mm (x,y)
3mm (axial)
Wong, 1996
	 Internal landmarks Head/neck Rigid,
PET-MRI,CT
3.8mm
Tai, 1997	 Intrinsic landmarks Chest 3D elastic mapping,
PET-CT
>4mm
Essentially all the techniques mentioned above have been developed for use in
cerebral studies, and in particular in brain activation. This is to some extent because
PET images of cerebral flow and metabolism already contain a limited amount of
low-resolution anatomical information which can be effectively exploited by the
alignment procedures. However, the problems of image alignment and co-
registration in other regions of the human body are more difficult to solve owing to
the absence of even low-resolution morphology in the functional image. This is
particularly acute in the abdomen, where the PET emission scan shows little or no
anatomical detail (fig. 4.2a).
Wahl and co-workers have highlighted the difficulties of aligning organs which
are not rigidly attached within the body [Wahl, 1993]. The authors concentrated on
tumours in the thoracic and abdominal regions using both external markers, and, in
the thorax, internal anatomical landmarks such as the carina. Functional and
anatomical images were aligned to within an error of magnitude 5-6mm, allowing
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more precise information to be obtained on the extent of the tumoural involvement of
surrounding soft tissues than would have been possible from the PET scan alone.
However, the authors point out that the following difficulties in retrospective image
alignment:
• Shape differences of the patient bed support in the complementary imaging
devices cause the set of external markers to shift. In addition, internal landmarks
(e.g. kidneys, liver and breasts) can shift between scans.
• The anatomy in the abdomen may change due to changes in the patient's bowel
and stomach content. This is likely when the different scans are not performed
consecutively or on the same day.
• The patient can move during the scans.
• Respiratory motion affects the CT scans (short) and PET scans (long) differently
and makes alignment more difficult.
Thus, retrospective image alignment is affected by different internal relationships
and deformations within the body and may require the input of an operator or the use
of 3D elastic transformations. In areas other than the brain, alignment procedures for
MRI and PET images, for example, ultimately require operator assistance [Wahl,
1993]. Alignment of PET and CT data does not necessarily require observer input,
since it can be regarded as uni-modality registration if PET transmission information
is used to facilitate the alignment of the PET emission data to the CT. Both, PET
transmission and CT scans contain similar information about the attenuation
properties of the patient, and retrospective PET-CT alignment can be performed by
the use of computerized 3D elastic transformations [Tai, 1997] without the
interaction of an operator.
It is evident that, in order to take full advantage of the range of available PET
tracers for oncology, accurate alignment of function and anatomy is essential
[Strauf3, 1996a]. For extracranial regions of the body, when the anatomical and
functional images are acquired at different times on different scanners, the difficulty
and complexity of the alignment procedure has been convincingly demonstrated. A
single tomograph with the unique capability of acquiring both functional and
anatomical images of the same patient in a single scan session would therefore be a
significant advance in this area.
4.2 PROTOTYPE SCANNER DESIGN
4.2.1 COMBINING A SOMATOM AR.SP AND AN ECAT ART
A combined PET/CT prototype scanner has been built in a collaboration between
the University of Pittsburgh and CT! PET Systems Inc. The prototype PET/CT
scanner combines commercially-available low-cost PET and CT scanners within a
single gantry. The PET scanner is the ECAT ART, described in section 2.6.2. The
ART is the commercial product from a research development of partial ring PET
scanners: PRT-1 [Townsend, 1993b], and PRT-2 [Townsend, 1994]. The ECAT
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ART (fig. 4.3a) is manufactured by CTI PET Systems (Knoxville, TN, USA) and
distributed through Siemens. The CT scanner for the combined system is a Somatom
AR.SP (fig. 4.3b), a third generation, helical CT scanner, described in section 1.1.6,
that is manufactured by Siemens in Erlangen, Germany.
a)	 b)
Figure 4.3 The (a) ECAT ART PET tomograph and (b) the Somatom AR.SP CT scanner.
It was originally anticipated that the CT components of the rotating gantry could
be merged into the space between the opposing PET detector arcs such that both
modalities were located within the same axial volume (fig. 4.4). However, the
packing density of the CT components precludes the possibility to mount the PET
detectors on the same side of the rotating support as the CT. Instead the closest
integration of the two scanners was to mount the CT and PET components back-to-
back on a common rotating support.
Figure 4.4 First design concept of a prototype
PET/CT scanner from 1992. Frontal view of the
PRT-2. PET components are highlighted in yellow.
It was anticipated that the PET and CT components
could be mounted on the same side of the gantry.
The X-ray system from the CT scanner is outlined
in the spaces between the detector arcs.
To combine the two systems a cylindrical aluminum tunnel with flanges on either
end was attached to the CT support ring with the main tunnel axis extending to the
back of the CT. An aluminum annulus was attached to the rear end of the tunnel
away from the CT. The PET detectors from an ECAT ART are mounted on the rear
side of the annulus. The CT components, including the X-ray tube, cooling system,
X-ray detectors and readout electronics, are mounted unmodified on the front of the
rotating support (fig. 4.5a). The PET components (fig. 4.5c) include the detectors and
electronics, coincidence processor, and optically-coupled data transmitters. Rotation
of the entire assembly of PET and CT components is provided by the original
asynchronous motor installed in the AR.SP.
Since the original CT unit was not foreseen to carry additional load, extensive
centre-of-mass calculations were performed to estimate the amount and distribution
of counterweights needed to balance the combined PET and CT components. Prior to
CT side: AR.SP V PET side: ECAT ART
detector arc
a)	 b)
83
the construction of the combined system we ensured that the CT turntable bearing
was capable of operating with the additional load of the PET components.
Figure 4.5 Front (a), side (b), and rear (c) view of the combined PET/CT tomograph. The front view
(a) showing the CT components, and rear view (c) with the PET components mounted on a common
gantry. The patient bed is mounted on the front side of the combined tomograph (a). A three-bar
aluminium construction is installed at the rear to support the extended gantry housing (c).
The complete PET/CT scanner is shown in fig. 4.6. The combined detector
assembly rotates at 30 rpm and is housed within a single gantry with dimensions of
168cm in height and 170 cm in width. The patient entry port is 60cm in diameter and
the depth of the tunnel is 110cm. The centre of the PET volume is displaced 60cm
axially from the centre of the CT slice, as shown in fig. 4.6.
41-60
Figure 4.6 The combined PET/CT tomograph as installed at the UPMC PET Center. A common
patient support is mounted to the front of the gantry. The location of the CT and PET components are
outlined. Dimensions are given in cm. The centres of the FOV of the PET and the CT are 60 cm apart.
A new strengthened tunnel cover extending from the CT field-of-view to the rear
gantry support was installed. The lasers for the PET imaging volume and the CT
encoder are mounted on the outer surface of the cylindrical tunnel (fig. 4.7). The
encoder operates optically, with a copper ring containing 2048 slots passing through
the encoder slit. The positional information of the X-ray tube is obtained from the
number of angular pulses generated by the slotted ring running through the optical
encoder light switch as the assembly rotates. The zero position of the X-ray tube is
Figure 4.7 Close-up of the rear
upper left corner of the gantry.
The positioning laser (L) for the
PET mounted on the extended
tunnel (T), and the optical
transmitter (0) from the PET
components can clearly be seen.
Fans (F) start automatically
when gantry rotation is halted.
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determined from an index slot on the encoder ring. The CT frequency encoder was
adjusted to take into account the slower acceleration of the gantry due to the
additional load of the PET components. The positional information from the CT
encoder is shared with the ART communication controller so that the lines-of-
response from the PET acquisition are assigned to the correct bins in the sinogram.
Power supply and data transfer to and from the rotating PET and CT components
follow separate paths. The input voltage for the X-ray tube is transformed from 110V
to 500V outside the CT gantry and is transmitted over mechanical slip rings. Power
and serial communications to the ART components are transmitted over a different
set of mechanical slip rings mounted with the ART detector arrays. High speed
digital data transfer from the ART is by optical transmission (fig. 4.7).
As with the standard ART scanner, the combined PET/CT scanner rotates
continuously, eliminating the need for additional gantry cooling for the PET
components. Fans start automatically if, for any reason, gantry rotation is halted.
The CT is cooled by two fans in the upper corners of the gantry that operate at all
times. As mentioned before the X-ray tube itself is oil-cooled.
4.2.2 COMMON BED SUPPORT AND BED DEFLECTION
The original patient positioning system from the Somatom AR.SP is installed in
front of the combined PET/CT gantry and used by the two imaging modalities. The
positioning system consists of a patient table that is raised and lowered vertically by
a pantograph assembly mounted to the floor at the front of the combined gantry and
parallel to the scanner gantry opening. The original patient table is 194cm long and
39cm wide, with a curved top comprising layers of wood. Once the patient table is
raised to a vertical height between 74.5cm and 78.0cm above floor level the table top
can be moved horizontally to position the patient anywhere along the 180cm
longitudinal travel range with sub-millimeter accuracy (table 4.B).
In its fully retracted position the end of the table top facing the gantry is offset
from the CT FOV by 60cm. The actual CT examination range is therefore 60cm less
than the table top range. The offset between the retracted table top and the scan field
is required to allow easy patient positioning on the bed prior to scanning. Some of
the bed support parameters of the Somatom AR.SP are listed in table 4.B.
Siemens pallet CT PETICombined pallet
30cm	 100cm
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Table 4.B Comparison of commercial bed supports of the Somatom AR.SP and the ECAT PET
systems. Dual-modality examination range refers to the horizontal range of the table top assuming that
either bed support was installed at the front of the combined gantry.
Somatom
	 ECAT 
	
Table motion	 continuous	 step-by-step
	
CT examination range [cm]	 12-	
-
	
PET examination range [cm]	
-	
170
	
Horizontal table top range [cm] 	 160
	
180
	
Dual-modality examination [cm] 	 36	 127
	
Positioning accuracy 1mm] 	 .5	 .25
	
Vertical range [cm]	 35 ... 78	 57 ... 93
	
Table load capacity [kg]	 Is 200	  159
Since the PET and CT components in the combined gantry are axially displaced
by 60cm, using the original CT bed support would only allow 36cm to be covered in
dual-modality PET/CT mode (fig. 4.8a). This is insufficient to scan a typical whole-
body range, where the patient is examined from the upper neck down to the pelvis
over an axial extent of about 100cm depending on the actual patient size. This bed
movement could not be accompanied with the Siemens bed support, and hence an
alternative was to replace the original bed with a standard ECAT PET bed. The
parameters of the PET bed are listed in table 4.B. Although the ECAT bed would
extend far enough into the gantry, it was not designed for continuous table motion, a
feature that is required for helical CT scanners, but currently not for standard PET
tomographs.
Figure 4.8 Longitudinal bed travel in case a) the original Siemens bed was mounted to the front of the
protot)pe PET/CT gantry. The original bed with an additional extended and offset pal/et (b) allows to
scan 110 cm in both PET and CT mode, thus covering a region sufficient to image most patients from
the neck to the pelvis.
Instead of upgrading the ECAT bed system to allow for continuous bed travel for
the duration of a combined PET/CT examination, we chose to mount a standard
ECAT pallet on top of the original Somatom patient bed. By mounting the additional
table top closer to the CT FOV the horizontal travel of the CT bed support can be
utilized more efficiently (fig. 4.8b). The ECAT pallet is fixed with an aluminum
brace to the distant end of the CT pallet thus eliminating any axial or transverse shift
of the combined table tops during patient positioning and scanning. In its fully
retracted position, the end of the combined pallet facing the gantry extends 14cm
from the CT scan field-of-view. With the combined pallet design dual-modality
whole-body studies over an axial range of up to 100cm can be performed using the
PET/CT scanner.
The cross section of the pallets is shown in (fig. 4.9). At 130kV p the attenuation of
the wood-kernel Siemens pallet, and the glass-fiber ECAT table top was —555HU
and —890HU, respectively. Although the additional attenuation of the ECAT pallet is
86
very small, we verified that accuracy of CT acquisitions is maintained and no image
artifacts are created.
A major problem with the extended pallet design and the axial displacement of the
imaging components is the deflection of the bed when extended into the gantry. The
further the pallet is extended into the gantry the more it deflects vertically. Although
the combined design of the two slightly curved pallets provides additional strength
against deformation we noticed significant vertical deflections of the pallet
depending on the bed extension and the patient load. We have estimated this
deflection by attaching a laser pen to the lower surface of the bed, and extrapolating
the vertical offset inside the gantry from various offset measurements of the laser
point at a distant wall. Since both tomographic components remain fixed in the
gantry, any bed deflection between the imaged patient volume on CT and PET can
then be estimated using simple algebraic transformations.
a)	 b)
Figure 4.9 The combined pallet (a) is made of a standard ECAT table top attached to the upper side of
the Somatom patient support. Transverse CT image of the ECAT ART pallet (b) to illustrate the
internal uniformity (made of glass fibres, window settings: [-910:-720] HU. The CT display window
is set to [-870:-120] HU to visualize the internal non-uniformities in the Siemens pallet (made of
wood plates).
Table 4.0 lists the vertical table top displacement when patients of various
weights were positioned on the table and extended into the gantry. The
displacements refer to a single vertical dislocation between complementary PET and
CT image volumes of the upper abdomen. Similar measurements were made for
other horizontal table positions. It was noted that the pallet deflection within the CT
FOV did not depend on the patient weight owing to the support given by the bed top
that is mounted in close proximity to the front of the gantry, only 40cm away from
the CT FOV. Vertical bed deflection at the PET FOV with maximum extension of
the table top could reach up to 7cm with a heavy patient in place.
Table 4.0 Vertical bed deflection [mm] between volumes measured in CT and PET mode as a
function of patient load.
Table load
No patient
72 kg
80 kg
100 kg
Deflection [mm]
-9.9
-30.7
-34.9
-48.9
To avoid flexing of the patient table between the PET and CT scans with
consequent misregistration, the patient table must be supported internally, between
the CT and PET fields-of-view. Ideally, at the beginning of each scan, when the
combined pallet is extended to the CT FOV, the table should rest on an external
support mounted between the pantograph and the front of the gantry. Additional
supports inside the combined gantry would ensure minimum vertical deflection along
the axial scan length of the whole-body scan. These mechanical supports were,
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however, not implemented on the current prototype due to the design constraints of
the combined rotating gantry that left no space for separate supports inside the
combined gantry without obstructing either the CT or the PET FOV. Alternatively,
we evaluated a curved support made of aluminum and rubber rolls to allow smooth
horizontal translation of the table top. This support was positioned inside the tunnel
and supported by two telescopic feet on either end of the combined gantry housing.
Although vertical deflection could be limited with this 'bridge' support, insufficient
support both inside and outside the gantry caused the supported pallet to shift in the
transverse direction. This instability introduced additional misregistration. Therefore,
we agreed on a simple post-acquisition correction method that accounts for vertical
bed deflection during the whole-body image assembling. The vertical shifts are
estimated from a look-up table for a limited number of bed extensions and patient
loads. This method is described in more detail in section 7.2.
4.2.3 MECHANICAL LIMITATIONS
As a consequence of the extended length of the gantry, the tilt capability of the CT
was disabled. Tilting the CT gantry is necessary when performing CT guided
biopsies where the insertion of the needle is followed by frequent, repetitive scans to
ensure optimal localization of the biopsy site. The tilt option is also used frequently
when scanning the brain when the transaxial image plane is to be aligned to the
cantho-meatal plane. The Somatom AR.SP can be through tilted ±22°. The tilt angle
is restricted by the depth of the CT gantry and other mechanical limitations. The
depth of the combined PET/CT gantry is 60% greater than the original CT gantry,
and hence the standard tilt option was disabled. This was also necessary because the
original tilt motor would not have been able to handle the additional weight from the
PET components, keeping the combined system in a stable, non-vertical position for
an extended period of time.
The combined assembly is belt-driven through a 3-phase induction motor (370
W). The motor is the original CT motor and has been operated for less than 500 run-
time hours. However, despite the properly added counterweights for the additional
PEI' components, the operating life-time of the motor is expected to be reduced,
requiring replacement with a higher power motor in the future.
A major drawback of the current design is the limited service access to the
scanner components. The gantry housing consists of the original CT housing and an
additional cover of similar dimensions for the PET components. The two housings
are attached back to back and can not be removed. For service access, the front CT
cover can be raised and the rear PET cover can be removed. Access to the rear slip
rings of the CT scanner is facilitated through a 23cm x 34cm window panel (fig.
4.5c, lower right) that is closed before the combined scanner is operated. The
mechanical slip rings of the PET components require frequent cleaning in the
combined gantry enclosure due to the graphite dust generated from the CT slip ring
assembly. In contrast to the standard operation of the Somatom AR.SP, more dust is
produced in the combined PET/CT scanner from the graphite brushes owing to the
relatively long continuous acquisition and operation times. The dust from the CT
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graphite brushes is distributed mainly in the area of the slip rings between the two
systems and cause the PET data transfer to be interrupted due to oxidising effects on
the ECAT ART slip rings. The access to the slip rings can be improved in future
single-support prototypes by either introducing an access window at the side of the
combined housing or by allowing the user to remove the combined housing
completely, such as by sliding it to the rear.
4.3 COMBINED SCANNER OPERATION
4.3.1 GANTRY TEMPERATURE
The performance of BGO-based PET detectors is known to be affected by
temperature fluctuations within the scanner environment [Reist, 1989]. The standard
ECAT ART is equipped with four fans mounted in each of the four corners of the
gantry. The fans are turned on automatically when the rotation of the scanner is
stopped to facilitate a constant air flow inside the gantry, and to dissipate the heat
generated from the scanner electronics. During the operation of the ART, cooling is
facilitated by the airflow generated from the rotation of the scanner components.
While stationary and during continuous, rotation temperature fluctuations are
assumed to be minimal if the ambient temperature in the scanner room is kept
between 20°C and 24°C.
While the temperature inside the standard ECAT ART gantry is stable during the
continuous rotation of the scanner, additional temperature fluctuations inside the
combined PET/CT gantry may be caused by heat dissipation from the operation of
the X-ray tube. When fitting the PET components into the extended gantry cover of
the Somatom AR.SP scanner, only three of the four standard ECAT ART fans could
be mounted in the two upper and one lower corner of the gantry (fig. 4.10). This may
have an additional effect on the base-line temperature at stand-still, and potential
temperature fluctuations inside the combined gantry.
fan fan
fan
Figure 4.10 Rear view of the PET/CT
scanner. The position of the three fans
facilitating airflow cooling during stand
still is indicated. The six detector buckets
are visually enhanced and numbered. The
direction of rotation of the combined
gantry is indicated by the red arrow, the
airflow as generated by the fans is
simulated by blue arrows.
In order to estimate the effect of X-ray operation on the temperature inside the
scanner during the continuous rotation of the combined PET/CT scanner, individual
temperature readings of all six buckets were performed every five minutes. Baseline
temperatures were measured over a period of one hour of continuous rotation. Then,
Figure 4.11 Measured bucket
temperature as a function of time
during continuous rotation.
60min two helical CT scans were
simulated with a total dose of
7,000mAs in less than 3min.
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two consecutive whole-body CT scans were simulated (130kV p, 160mAs per slice,
axial scan length 32cm) over a time of less than three minutes. Bucket temperatures
were followed for another hour. Figure 4.11 shows the temperature readings from
buckets 0 to 5 over two hours. Prior to X-ray operation a variation of the measured
temperature was observed that ranged from 35°C (bucket 3) to 45°C (bucket 1). This
dispersion may be caused by the asymmetrical mounting of heat dissipating
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electronics on the rotating part of the scanner. Before X-ray operation, however, the
temperature at every bucket was stable. Immediately after X-ray operation the
temperature in buckets 0 and 4 was seen to increase by 1°C. The temperatures of the
other buckets did not change. Since occasional temperature fluctuations of 1°C were
observed for different buckets even without X-ray operation, we conclude that
potential heat dissipation from the X-ray tube is minimal and does not affect the
efficiency of the detector blocks.
During our measurements we noticed a gradual change in temperature during
spin-up and spin-down of the scanner. When starting to rotate the gantry from its
stationary position up to 30 rpm, for example, we observed changes in temperature
of up to 9°C. While the temperature for buckets 3 and 4 increased, temperature
generally decreased for the other buckets (fig. 4.12a). This can be explained by the
location of the various buckets at the stationary position of the scanner: bucket 3 was
closest to the ground and bucket 0 was closest to the top of the gantry cover (fig.
4.10). Although the air inside the gantry is circulated by operating the three fans
when the gantry is stationary, convection must increase the temperature in BO and
the bucket closest to the ground (B3) has the lowest temperature. This was confirmed
by rotating the scanner 180° and showing that the lowest temperature was in the
bucket closest to the ground.
From the graphs in fig. 4.12 we estimated that it takes approximately 30min for
the temperature to stabilize after starting up rotation. Similarly, it takes
approximately 30min for the temperature to reach a plateau after the scanner has
been spun down. The effect on the temperature inside the gantry from starting or
stopping the rotation (fig. 4.12) is therefore much larger than the marginal increase in
temperature from operating the X-ray tube for short scan periods (fig. 4.11).
Although PET emission scanning can be initiated after a warm-up rotation of the
scanner (30 min or longer), it remains to be shown how much longer it takes for the
temperature in the individual detectors to stabilize. There is a general tendency for
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the luminescence of BGO to increase with decreasing temperature [Grabmeier,
198411. The actual change in efficiency of the BGO detector for temperature gradients
of up to 9°C, however, is difficult to assess from this reference alone. Until the
temperature can be determined at the level of detector blocks as a function of rotation
time (spin-up and down), we assume a conservative start-up rotation time of 30min
to 60min from standstill to initiation of PET scanning.
Figure 4.12 Measured bucket temperatures as a function of time during (a) spin-up, and (b) spin-down
of the combined gantry. During stand still gantry fans turn on automatically to generate cooling
airflow inside the PET gantry. Bucket 3 was closest to the floor level and bucket 0 was closest to the
top of the gantry at the stand still position. Continuous rotation was at 30 rpm. Temperature curves in
(a) and (b) indicate a ramp up and ramp down time of approximately 30min.
4.3.2 CROSS-TALK OF THE PET AND CT COMPONENTS
As described in section 2.5.3 PET detectors consist of inorganic scintillating
crystals and photomultiplier tubes. The crystals are arranged in a block design that is
coupled through a light guide to a set of four symmetrically arranged PMTs at the
back of the detector block. One concern with the design of a dual-modality PET/CT
scanner is that the PET detector performance would be affected by the operation of
the X-ray tube of the CT. Magnetization effects of the PMTs and pulse pile-up in the
in the PET detector electronics are likely to occur and cause performance
degradations during sequential or simultaneous PET/CT acquisitions. However, with
currently available BGO-based PET technology simultaneous PET/CT acquisitions
offer little advantage with respect to the total scan time since the time for CT
acquisitions is small compared to the scan time for the corresponding PET
acquisitions (section 7.1.3).
Most photomultiplier tubes are affected by the presence of magnetic fields that
may deflect the photo-electrons from their normal trajectories and cause a loss of
tube gain reflected in a reduced output voltage signal. The extent of the loss of tube
gain depends on the type of PMT and its orientation with respect to the magnetic
field. Magnetic influence is greatest in the electron-optical input system, where
electron trajectories from the photoelectrons released by the incoming scintillation
photons are longest. Since the performance of a photomultiplier can be affected by
magnetic fields as weak as the earth's magnetic field (75RT), PMTs are typically
covered with a pt-metal shield that extends beyond the actual PMT tube length by at
ADC
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least half the diameter of the PMT. Supplementary soft iron shielding is provided to
further increase the effectiveness against external magnetic fields, including
magnetic fields created from the operation of the CT X-ray tube.
Estimating changes in the performance of the PET detector blocks during and
after X-ray generation requires an easily accessible parameter. We decided to
observe the tube gain factors of the four PMTs of a single detector block (section
2.5.3) exposed to X-rays, as a measure of cross-talk between CT and PET. The tube
gain factors are used by the PET acquisition electronics to equalize the output
voltages from the four PMTs in each detector block. The tube gains are typically
adjusted around an arbitrary value of 110 during standard operation of the PET
components as followed (fig. 4.13): The output of a PMT is typically a very small
voltage (in the range of a few RV) that is amplified to a few mV to increase the
magnitude of the signal for subsequent electronic processing. In each detector block,
the amplification is set individually for each of the four tube signals, so as to equalize
the gains of all tubes. In order to adjust the amplification, the bucket firmware
provides an 8-bit signal to a digital-to-analog converter (DAC) that translates the
binary 8-bit signal into a voltage applied to the amplifier between OV and 10V. In
other words, the operating range of the amplifier can be adjusted in 256 steps (8 bit
signal). The 8-bit signal provided by the firmware is called the tube gain factor since
it indirectly represents a measure of the actual tube gain of a given PMT. Note that
the operating values of the tube gain factors are typically set around 110. Subsequent
adjustment due to changes in tube gain may cause the operating value to deviate
from the default mid-range value. The tube gains of all four PMTs in a single
detector block are adjusted by feed back from the amplifier output so as to equalize
the output of all four PMTs.
	
bucket	 8-bit
	
firmware
	 0..255
tube gain factor
Figure 4.13 Adjusting tube gain factors in an ECAT PET detector block. This chart simplifies the flow
of information and does not represent a complete view on acquisition electronics.
For the first experiment, we observed the tube gains of the PMTs in a single
ECAT ART detector block to evaluate lasting effects of X-ray operation on the PET
performance. The experiment was performed before the combined tomograph was
completely assembled. The PET detector block was mounted on the support disk for
the PET components that was attached to the rear of the common rotating support
inside the combined PET/CT gantry. We recorded the tube gains of the four PMTs
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inside the PET detector block before and several times after X-ray operation. This
setup represents a worse situation than that actually occurring in the combined
scanner since it was performed before the complete assembly of the combined
tomograph, when no additional shielding between the two systems was installed.
Three scan conditions were simulated: (1) the CT scan field was empty and no X-
rays were produced. The measured tube gain factors were taken as the standard gains
against which all subsequently measured gain factors were compared; (2) the CT
scan field was empty and the X-ray tube was loaded with about 4,000mAs; (3) a non-
activate whole-body phantom was positioned inside the CT scanner and the X-ray
tube was operated with about 4,000rnAs. All four PMTs were calibrated prior to the
experiment and tube gain factors were noted. The gain factors for the four tubes are
listed in table 4.D for the initial setup procedure and all three scan conditions. The
tube gains did not change after X-ray tube operation. This indicated that the PET
detector block was insensitive to potentially existing and created magnetic fields by
the operation of the X-ray tube. Similar tube gains and insensitivity to X-ray tube
operation were found with a PET detector block mounted tangential to the
connecting line between the X-ray tube and the CT detector array, on the side of the
PET components. We therefore conclude that for sequential PET/CT acquisitions,
tube gains of PET detector blocks are unaffected by the X-ray operation.
Table 4.D Tube gains of the four PMTs (A-D) in the ECAT ART detector block that was placed on
the rear of the CT scanner during X-ray operation. The gantry was not rotated during the acquisition.
PMT Setup (1): empty CT
FOV, no X-rays
(2) empty CT FOV,
X-rays
(3) whole-body
phantom, X-rays
A 108 109 109 109
B 113 114 115 116
C 108 109 109 110
D 109 110 110 110
In addition to tube gain factors, we may observe the tube energy histograms as a
function of the X-ray operation. Tube energy histograms represent the energy
distribution of the photons impinging on the scintillating crystal attached to the PMT.
These histograms are calibrated on a regular basis for a 511keV source, such that the
photopeak at 511keV corresponds to a particular channel (about 40). Magnetization
effects from operation of the X-ray tube should be result in shifts in the recorded
photopeak bin in the energy histogram of the PET detector block. We recorded tube
energy histograms for all four photomultiplier tubes in the PET block that was placed
in the same position inside the gantry as in the previous experiment (fig. 4.14).
A baseline energy histogram was acquired prior to X-ray exposure, and two
histograms were recorded after X-ray exposure (immediately after and 15min post-
operation). These histograms are shown in fig. 4.14. Since no shifts in the energy
histograms of the PMTs were observed as a result of the operation of the X-ray tube,
we conclude that the PMT operation was unaffected by the X-ray generation. In
other words, any potentially existing magnetization cause no harm to the PET
detector operation when acquiring PET and CT data sequentially.
— no X-rays
- - post X-ray
— 15min post X-ray
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Figure 4.14 Tube energy histograms for the four PMTs in the ART detector block. The block was
mounted on the rear support of the CT and was fixed with respect to the tube (facing). Three
histograms were recorded: (1) no X-rays, (2) immediately after X-ray operation, and (3) 15min post-
operation.
While the above experiments were performed with the X-ray assembly stationary
and the PET detector block in a fixed position with respect to the X-ray tube, we
designed a further experiment for which the tube gains of the four PMTs were
measured at different orientations of the block with respect to the X-ray tube. The
experimental setup is summarized in fig. 4.15.
Figure 4.15 Experimental setup to measure tube gains of PMTs in a single ECAT ART detector block
positioned inside the CT scan field of the combined PET/CT system. The X-ray tube was operated
either in stationary mode (b, c) or in helical scan mode (d). Tube gains were recorded immediately
after X-ray exposure.
The detector block was positioned on the patient table and moved to the scan field
of the CT at the front of the combined gantry. A lead brick (25cmx10cmx6cm) was
placed between the block and the block electronics to avoid damage of the electronic
circuits by the scattered X-ray flux. During the X-ray exposure high voltage was
applied to the PET detector block and the detector electronics. Prior to the X-ray
operation cold tube gains were determined with a rod source placed 20cm from the
front plate of the detector block (fig. 4.15a). Next the detector block was positioned
facing the stationary X-ray detectors and with the PMTs facing the X-ray tube (fig.
4.15b). X-rays were produced with 3,700 mAs without moving the bed. Tube gains
were recorded immediately after X-ray exposure of the block. The detector block
was then turned upside down (fig. 4.15c), and exposure and tube gain recordings
were repeated as in (b). Finally, the X-ray assembly was rotated around the field-of-
94
view of the CT without moving the bed (fig. 4.15d). Exposure to the block was
3,500rnAs. Tube gains were again recorded immediately after the X-ray exposure.
Note that there was a 30min waiting period between the four experimental setups.
All tube gain factors for experiments (b-d) are listed in table 4.E. Note the
decrease in tube gains immediately after X-ray operation for each orientation of the
PET detector block (b-d) compared to the cold gains. Lower tube gain factors
indicate higher fluxes of photoelectrons, which may arise from more incoming
scintillation light due to the influx of X-ray photons into the scintillator. Apparently
the increased flux of X-ray photons is independent of the orientation of the PMTs
(fig. 4.15b-d) with respect to the source of the X-rays. Although the setup described
here, is an unrealistic situation for a combined scanner, it nevertheless simulates the
highest possible exposure of a PET detector block. Therefore any effect on the tube
gains, should represent the upper range for possible shifts in tube gains during the
operation of a combined PET/CT tomograph. Since the tube gains vary only slightly
due to direct X-ray exposure, we assume less effect for PET detectors mounted in
their anticipated position, 60cm away from the CT FOV (fig. 4.6). A period of
approximately 20min should, however, be allowed for the tube gains to return to
their baseline values prior X-ray exposure.
Table 4.E Tube gain factors of the four PMTs (A-D) in the ECAT ART detector block for the four
setups (a-d) described in fig. 4.15. Gains were measured immediately after X-ray exposure.
PMT Setup (a) (b) (c ) (d)
A 109 102 104 101
B 115 111 112 108
C 111 108 108 107
D 109 109 108 107
Despite the observed limited sensitivity of PMT gains to sequential X-ray
operation, these effects will be less important in the current prototype design (fig.
4.6) for the following reasons:
• The PET detectors are mounted 60cm away from the X-ray tube and detectors
on the opposite side of the support. Magnetic field strength decreases with the
inverse of the distance from the field. Any effect of magnetic sensitivity (as reflected
by shifts in tube gains) will consequently be reduced.
• Above experiments were performed without the PET components in place. In
the fully assembled combined tomograph additional shielding will be provided by
the aluminum ring to which the rotating PET components are mounted (section 4.2),
which will reduce the magnetic field even further on the side of the PET
components.
Simultaneous PET/CT acquisitions have been discussed, but is not anticipated to
be practical or necessary. The major motivation to acquire PET and CT data at the
same time would be to limit the total scan time the patient has to remain motionless
on the scanner table. Since, however, the whole-body CT scan takes only a fraction
of the time dedicated to the PET scan, total scan time may not be reduced
significantly by simultaneous acquisitions. Furthermore, this approach appears
impractical due to limitations of current PET detector technology, such as high
X-ray photon + Co
a)
	 Tube energy bin	
b)
	 Tube energy bin	
C)
	 Tube energy bin
511keV pholopeak
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detector dead-time and pulse pile-up from high photon influx to the scintillator.
Figure 4.16 shows the tube energy spectra for a single PET detector block in the fully
assembled prototype scanner before, during and after X-ray operation. The recorded
tube energies change significantly during the operation of the X-ray tube (fig. 4.16b),
thus illustrating the high influx of scattered X-ray photons from the X-ray tube. Due
to the limited energy resolution of the BGO detectors, pulse pile-up of lower energy
(X-ray) photons may lead to output signals that are inseparable from photopeak
counts, thus leading to degraded countrate performance of the PET acquisition
(section 2.6.1).
Figure 4.16 Tube energy spectra of block 0-0 in fully assembled PET/CT tomograph during
continuous rotation: (a) no X-rays, (b) during X-ray exposure (eight times 160mAs), and (c)
immediately after X-ray exposure (five times 160mAs). Each graph shows tube energy spectra for all
four PMTs of block 0-0.
4.3.3 EMISSION CONTAMINATION OF THE CT
For clinical, attenuation-corrected, whole-body imaging with FDG, it is important
to acquire the transmission data post-injection to avoid having the patient occupying
the scanner for the full uptake period of FDG (45-60min). To verify that the CT
images are unaffected by the presence of positron-emitting activity in the patient,
helical CT images were acquired for two, 20cm diameter resin-filled cylinders, one
containing no radioactivity, and a second cylinder containing 130MBq of 68Ge/68Ga.
Helical CT scans were acquired at 130kVp, 160mAs, pitch 1.5, and with a slice width
of lOmm. Contiguous CT images were reconstructed at lOrnm spacing, and 15cm
diameter ROIs, centred over the cylinder, where placed on each slice. The mean ROT
values and variances for the cylinders with and without activity were compared to
determine any effects that might be due to activity in the cylinder, and which would
suggest emission contamination of the CT scan. The data are plotted in fig. 4.17, and
indicate that the absolute value of the attenuation measured by CT was unaffected by
the presence of positron-emitting activity inside the FOV of the CT. Given the high
concentration of emission activity in this experiment (21kBq/mL) compared to
clinical whole-body situations (<41(Bq/mL) it can be assumed that in patient studies
the accuracy of post-injection CT scans will not be affected.
This result was further confirmed in a second experiment in which three 5cm
diameter cylindrical inserts representing air, spongiosa and cortical bone were
positioned in a 20cm diameter, water-filled cylinder (NEMA phantom [Karp, 1991]).
Ge-68 cylinder
• cold cylinder
Figure 4.17 Mean ROI values [HU]
from a set of transaxial CT images of a
hot (active, 20.7IcBq/mL 68Ge) and
cold (non-active) resin filled 20cm
plastic cylinder.
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Helical CT images of the phantom were acquired in the Somatom AR.SP, without
activity (pre-injection) and with an activity concentration of 3.7kBq/mL (post-
injection) in the main cylinder. CT scan parameters were 130kV p, 200mAs, a pitch of
1.6, and a 3mm slice width. Contiguous CT images were reconstructed and circular,
2.5cm diameter ROIs placed over the inserts and the water cylinder. As for the
previous study, the ROI mean and standard deviation were compared for each insert
pre- and post-injection (table 4.F). As in the previous experiment, no effect was
noted on the quantitative accuracy of the CT measurements when emission activity
was present during the CT scan.
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The insensitivity of the CT measurements to the presence of positron activity
concentrations of up to 4kBq/mL in the scan field of the CT can be explained by the
high source strength of the X-ray tube. According to [Birch, 19794 a constant
potential X-ray tube running at 130kV p with 2.7mm Al filtration (values for AR.SP
with 8° tilted anode, and tungsten target) provides a photon flux of 6.86.106
photons/mA/mm2/s at 750mm distance from the tube anode. This translates into a 4n
output of the X-ray tube of 2.35 .10'3 photons/mA/s. Using a standard tube current of
83mA for the AR.SP gives a X-ray photon flux of 4.03.10's photons/s. Assuming that
a single disintegration per second (1Bq) yields two annihilation photons, the X-ray
photon yield corresponds to an equivalent un-attenuated activity of 2.01.109MBq
(seven orders of magnitude greater than the activity injected into patients for whole-
body scans). Although this is an overestimation of the number of generated X-ray
photons that contribute to the actual CT image, the equivalent activity of the X-ray
tube is still several magnitudes higher than the emission activity of a clinical patient.
The fraction of accepted photons from the positron-emitting distribution is further
reduced by the low detection efficiency by the Xenon gas detectors for 511keV
photons.
Table 4.F Accuracy of CT attenuation values [HU] in the presence of post-injection emission activity.
Material Pre-injection Post-injection
Air -997.5 ± 0.8 -998.4 ± 0.8
Water 0.4 ± 4.0 0.5 ± 3.0
Spongiosa 319.9 ± 0.6 319.0± 1.0
Cortical 1389 ± 3 1389 ± 3
Time [s]	 100 0	 Time [s]	 100
Trues
Randoms
100
a)	 I
Time fsl
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4.3.4 SCATTER FROM CT INTO THE PET EMISSION DATA
Scattered photons from the X-ray tube will only affect the PET emission scan
when both the PET and the CT images are acquired simultaneously. Simultaneous
CT and PET acquisitions may become an interesting option for operating the
combined PET/CT tomograph when continuous bed motion is implemented for
whole-body PET acquisitions (section 3.1.1). The current prototype scanner allows
only sequential CT and PET acquisitions. We were nevertheless able to perform a
few basic experiments to estimate the effect of scattered CT X-rays on PET emission
data.
In the first experiment, we centred a 20cm diameter resin-filled plastic cylinder in
the FOV of the PET scanner. The resin was mixed with 68Ge activity (2.91d3q/mL).
No object was placed inside the CT scan field (fig. 4.18a). The measured trues and
randoms rates are shown in fig. 4.18 and represent the original count rates of the
unperturbed emission scan. Trues and randoms peaked at about 33kcps and 3kcps,
respectively with a deadtime of around 15%. Trues and randoms count rates were
then acquired while the X-ray tube was operated either in sequential or in spiral
mode. The bed was not advanced axially during the sequential CT scan, and the
spiral scan was acquired with pitch 1 to minimize bed travel during X-ray operation.
Since the phantom exceeded the PET FOV extent on both sides by 2cm, it remained
completely in the FOV even when the bed was moved slightly during the spiral CT
scan.
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Figure 4.18 Experimental setup to estimate the count rates of a 68Ge-filled plastic cylinder in the
presence of CT X-rays: (a) the cylinder was scanned in 3D emission mode without the CT turned on,
(b) the X-ray tube was operated in sequential and spiral mode during the emission acquisition, (c) the
cylinder was removed from the PET FOV and sequential CT scans were performed similar to (b).
The trues and randoms count rates for the experiments are plotted over a duration
of 100s at the right. Individual phantom setup is outlined on the left.Sequential CT
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scanning was performed at 130kVp, 160mAs, with a lmm slice width, and without
advancing the table. From fig. 4.18b, it can be seen that the trues decrease and the
randoms increase dramatically during the duration of the X-ray exposure. The trues
drop to about 10kcps while the randoms peak at 10kcps. Similar effects are seen
when spiral scanning was initiated. Since there was no object placed inside the FOV
of the CT scanner, we assume that X-ray photons were scattered from the bed
support or within the gantry into PET scanner. Since random and true coincidences
in PET are formed from single events above a certain energy threshold, typically
350keV, scattered X-ray photons must pile up in the BGO detectors to be detected as
single PET events. Since high fluxes of X-ray photons are generated during the tube
operation a significant number of scattered X-ray photons will reach the side of the
PET, and increase the existing fraction of randoms by a factor of 3 (fig. 4.18b). We
assume that the proportionally-large drop in trues can be attributed to an
overcorrection for randoms. Fewer randoms are created in the PET FOV when no
scattering object is present during X-ray operation (fig. 4.18c). However, the
generated random fraction is still relatively high (5kcps maximum).
Since in clinical whole-body studies part of the patient will always be present in
the FOV of the CT scanner, we repeated the above experiment with a phantom
assembly that extended over 80cm, thus covering both the FOV of the CT and the
PET and the space in between. The phantom assembly was pieced together from two
elliptical abdominal phantoms filled with water, a non-active resin filled cylinder
placed outside the CT FOV, and the 68Ge-filled cylinder described above that was
centred in the FOV of the PET.
The same experiments as described above were repeated with the new whole-
body setup, and the measured count rates are shown in fig. 4.19. As expected the
default true and randoms rates did not change. When operating the X-ray tube in
sequential or spiral mode, however, the changes in count rates were less dramatic
than in the case when no scattering medium was present between the CT and the
PET (fig. 4.18b). Similar to the previous experiment without the active cylinder in
the FOV of the PET scanner (fig. 4.18c), almost no counts were measured inside the
PET scanner when the X-ray tube was operated (fig. 4.19c).
From comparison of fig. 4.18b and fig. 4.19b, and fig. 4.18c and fig. 4.19c,
respectively it could be argued that objects placed between the CT and the PET
increase the likelihood for X-ray photons to scatter out of the gantry and away from
the PET. Those photons that eventually reach the PET FOV after multiple scatter
interactions have lost too much energy to generate a single PET event through pile
up in the BGO detectors. Hence more scattered X-ray photons are needed to exceed
the energy threshold of 350 keV. The likelihood, however, for more X-ray photons to
arrive at the same detector at the same time decreases with the square of the accepted
singles count rate and hence less randoms (eqn. 3-3) are generated in the presence of
an attenuating object inside the combined gantry. In conclusion, these observations
indicate that in clinical whole-body studies, minor cross-talk is to be expected from
CT transmission scans performed simultaneously with the PET emission scans. More
investigations with a uniformly filled whole-body phantom (e.g. Alderson phantom)
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are, however, needed to account for the constantly changing activity distribution
inside and outside the PET FOV during continuous bed movement.
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0
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Figure 4.19: Experimental setup to estimate the scatter contamination from CT operated
simultaneously with the PET. A 68Ge-filled plastic cylinder was placed inside the FOV of the PET
scanner while non-active elliptical and cylindrical phantoms were positioned inside the rest of the
gantry to simulate attenuation and scatter in a whole-body scan. Emission count rates were acquired in
the absence or presence of CT X-rays: (a) the cylinder was scanned in 3D emission mode without the
CT turned on, (b) the X-ray tube was operated in sequential (left) and spiral (right) mode during the
emission acquisition, (c) the active cylinder was removed from the PET FOV and sequential CT scans
were performed similar to (b). The trues and randoms count rates for the experiments are plotted over
a duration of 100s at the right. Individual phantom setup is sketched at the left.
4.3.5 OCCUPATIONAL DOSE FROM COMBINED PET/CT OPERATION
When operating the PET/CT scanner, precautions have to be taken similar to
operating each scanner individually. The scanning procedure is described in chapter
7. The medical personnel is present at the scanner only during the preparation of the
scanning procedure, for patient positioning, and to help the patient off the bed after
the scan is finished. Since the patient is always injected with a radiopharmaceutical
for the purpose of the PET acquisition, the medical personnel is exposed to minor
amounts of radiation during patient handling. It is not anticipated to access the
patient during CT operation. In case of an emergency situation, the CT is shut off
immediately and exposure is limited to scattered annihilation photons from the PET
exam. The exposure of the patient and dose received by the patient during a PET/CT
exam will be discussed in section 8.4.
A major consideration when installing a CT scanner is the occupational dose
arising from the scattered X-rays from the scanner [Simpkin, 1990]. Figure 4.20
shows the isodose curves measured with the PET/CT scanner operated at 1,000mAs
(equal to five scans of 100mA with a 2s scan time), and represent constant exposure
from scattered X-ray photons in the environment of the scanner for a given amount
of radiation produced by the system. The curves are skewed to the rear of the scanner
1—
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and spread out to the front as a consequence of the asymmetric distribution of
scattering media in the combined gantry [Harpen, 1998].
Despite the altered shape of the isodose curves, the total occupational dose from
the combined PET/CT scanner is similar to the dose from a single clinical CT
system. However, compared to a clinical CT installation, the low number of PET/CT
studies and the limited occupancy of radiation workers around the PET/CT suite
warranted appropriate lead shielding [Archer, 1983] only for the side of the scanner
room facing the control area. The walls and the door facing the control area were
lined with 1 mm thick lead foils. The remaining concrete walls were left intact. A
lead glass window with attenuation of lmm lead-equivalent was installed to allow to
observe the patient from the control area.
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Figure 4.20 Isodose curves [iGy] for a 1,000mAs scan measured in the vicinity of the PET/CT
scanner.
4.4 PERFORMANCE MEASUREMENTS
4.4.1 PET — THE ECAT ART
The performance characteristics of the combined PET and CT components are
anticipated to be the same as the performance of the ECAT ART (section 2.6.2 and
3.3.1) and Somatom AR.SP (section 1.1.6). A summary of the performance of the
ECAT ART assessed based on the standard NEMA protocol [Karp, 1991] can be
found in [Bailey, 1997b].
As discussed in section 3.3.1, the count rate performance of the ECAT ART can
be significantly improved by reducing the block integration time from 768ns to
384ns, without any observable degradation in other performance parameters such as
spatial and energy resolution. Details of these measurements can be found in
[Townsend, 1999a]. The ART components of the combined scanner are therefore
operated with a block integration time of 384ns. To verify that the ART components
in the combined scanner have equivalent performance to a commercial ECAT ART
operated at a shorter block integration time, spatial resolution, energy resolution,
_J
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scatter fraction, and count rate performance were measured according to NEMA
standards [Karp, 1991] (table 4.G).
Table 4.G Comparison of performance parameters of the commercial ECAT ART and the ECAT ART
PET components of the combined PET/CT tomograph when operated with 384ns block integration
time.
Performance ECAT ART PET/CT
Transaxial spatial resolution [mm], r=0cm 6.2 ± 0.3 6.38 ± 0.05
r=l0cm 6.5 ± 0.1 6.4 ± 0.1
Axial spatial resolution [mm], r=0cm 6.0
Sensitivity [cps/Bq/mL] 8.4 8.2
Scatter fraction 0.36 ± 0.02 0.34± 0.01
Maximum NEC [kcps] 39.5 (at 18kBq/mL) 36.4 (at 151d3q/mL)
Standard performance measurements for the ART components in the combined
scanner are listed in table 4.G. For convenience the previous measurements with a
standard ECAT ART operated at 384ns as described in section 3.3, are included in
table 4.G. A comparison of the performance measurements of the ART components
in the PET/CT scanner with those of the standard ART scanner operated with 384ns
block integration time demonstrated that both systems perform equally.
4.4.2 CT - THE SOMATOM A R.SP
The performance of the CT components was evaluated according to standard
procedures for clinical CT scanners. These procedures include determination of the
attenuation values for air and water, and measurements of image pixel noise and
spatial resolution. The attenuation value of water was measured using the test
protocol of the Somatom AR.SP. A 20cm diameter, water-filled cylinder was placed
in the centre of the FOV and tomograms were acquired at 110kV p and 130kV p. The
mean pixel value and standard deviation were calculated for a circular region-of-
interest covering 80% of the area of the water phantom. A similar measurement was
performed with no phantom in the FOV to determine the attenuation value for air.
The values for air and water are defined to be 1000HU and OHU, respectively, and
should be independent of the X-ray tube voltage, which was confirmed by our
measurements (table 4.H).
Table 4.H Performance measurements of the CT components of the combined PET/CT scanner.
CT value of air [HU] -999.1 ± 0.6 (110 kVp)
-997.2 ± 0.6 (130 kVp)
	
CT value of water [HU]	 1.2 ± 4	 (110 kVp)
0.4 ± 3	 (130 kVp)
	
Cross-field uniformity [HU] 	 <0.5 (20 cm water cylinder)
	
Transaxial resolution [mm]	 0.45 (at 1.9s scan time)
Contrast resolution 3 mm/6 HU/ 3.0 s
The water phantom was then positioned in the centre of the FOV and tomograms
were again acquired at 110kV p and 130kV p. Mean CT numbers were determined for
five, 4cm diameter, circular ROIs, positioned with one central ROT and four others
equally spaced peripherally. The absolute value of the difference between the
average CT numbers of the central test area and the CT numbers of the four
peripherally-placed ROIs represents the homogenity at 110kV p and 130kVp. The
results listed in table 4.H correspond well with the factory limits of (0±4) HU.
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The spatial resolution was determined by scanning a phantom comprising an air-
filled cylinder with a thin metal wire along the major axis, positioned parallel to the
main scanner axis. The CT resolution was measured as 9.75 line pairs per cm.
Contrast resolution was measured with a low contrast phantom of a water-equivalent
plastic material. A series of low contrast plastic pins of different diameters were
immersed in the cylindrical phantom. The contrast of the smallest visible pin was
determined by the difference in a circular region-of-interest placed over the pin and
the background. Contrast was recorded at 130kV p and 3s scan time per slice.
4.5 SUMMARY
The design of the prototype combined PET/CT tomograph has been described in
this chapter. A low-cost 3D rotating PET tomograph has been mounted back to back
with a third generation helical CT scanner. Both devices share a common rotating
support and are housed inside a single compact gantry. Whole-body PET and CT
imaging can be performed over an axial range of 110cm, thus covering the patient
from the chin to the lower pelvis. PET and CT scans are acquired sequentially
without moving the patient off the bed between scans. The PET and CT images are
thus intrinsically aligned, and the known difficulties of retrospective image
alignment can be avoided.
The performance of both imaging modalities was shown to be unaffected by the
combination of the two scanners in a single gantry. While the operation of the X-ray
tube was shown to have no measurable effect on the gantry temperature, we found
the gantry temperature to be sensitive to the change of the rotational state of the
combined system. Magnetic shielding of the PET components is sufficient to prevent
shifts in the gains of the photomultipliers when the X-ray tube is operated.
Simultaneous operation of the X-ray tube during the PET acquisition does affect the
PET detector performance and degrades its count rate performance. Since the total
scan time for the CT is very short compared to the time needed for a whole-body
PET study, the scans can be performed sequentially, without a loss in performance or
patient throughput. Compared to standard PET acquisition protocols, post-injection
emission contamination had no effect on the accuracy of the CT transmission
measurements.
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5. CT BASED ATTENUATION CORRECTION
5.1 GENERAL ASPECTS
A major advantage of acquiring both anatomical (CT) and functional (PET) data
with the same scanner is that the two data sets will be closely aligned, eliminating the
well-known co-registration problems arising when the studies are performed on
separate scanners. In addition to the complementary metabolic and morphological
information of the PET and CT the available CT transmission information may
theoretically be used to calculate the attenuation correction factors for the PET
emission data. Since the CT images contain low-noise transmission information of
the patient, noise amplification during the attenuation correction procedure would be
limited. The challenge of CT based attenuation corrections, however, is to account
for the difference in energies at which the CT transmission data are acquired
(continuously between 40keV and 140keV), and the emission energy of the PET data
(mono-energetic at 511keV).
5.1.1 BACKGROUND
The use of transmission data acquired at energies different from those of an
emission data set for the purpose of attenuation correction is not new. In 1991 a
prototype of a hybrid Emission-Transmission Computed Tomography (ETCT)
imaging system was developed by a group at the University of California San
Francisco [Lang, 1991]. Similar to the PET/CT project, the primary goal of this
development was the acquisition of directly co-registered CT and metabolic SPECT
data of the same patient. The authors also pointed out the possibility to derive a
SPECT attenuation map from CT transmission measurements. By acquiring CT
scans with the X-ray tube operated at two different tube potentials an energy-
corrected attenuation map was derived for use with the radionuclide data [Hasegawa,
1993]. This attenuation map was then incorporated directly into the SPECT
reconstruction process [Tsui, 1989; Hasegawa, 1993]. Operating the device with two
energy windows also allowed simultaneous emission-transmission acquisitions to be
performed, although the authors reported a certain level of contamination of the
emission scan by the transmission X-ray beam [Lang, 1992]. Although this prototype
was not suitable for patient scanning, it can be considered pioneering work because it
demonstrated for the first time the potential of a device capable of performing both
anatomical and functional measurements
5.1.2 ATTENUATION CORRECTION FOR PET
Attenuation correction of emission data is necessary if quantitative analysis of the
reconstructed tracer distribution is performed. Attenuation correction in PET is much
more straightforward to perform than in SPECT since the measured emission rate in
PET is independent of the location of the annihilation along the line-of-response
projectionsource
ACF Transmission scanBlank scan Emission scan
sinogram
projection
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(section 2.3.1). The challenges of attenuation correction for both PET and SPECT
imaging are illustrated and compared in [Bailey, 1998].
For the purpose of this work we briefly rehearse the underlying principle of
attenuation correction in PET. An event in PET is formed when two annihilation
photons are detected within a given time window (coincidence time window) by two
opposite detectors (section 2.3.2). Since the attenuation along the lines formed by
these detectors is independent of the location at which the emission occurred (fig.
2.4), attenuation correction factors (ACF) can be determined from measurements of
the total attenuation along this line-of-response. The ACF for a particular line-of-
response (LOR) is defined as:
f P(x. Y)ds
ACFLoR = el"	 Eqn. 5-1
where ,u(x,y) represents the linear attenuation coefficient at a point (x,y) along the
LOR s. The ACF for that LOR can be determined from an independent transmission
measurement, N, with a source of known strength, No (eqn. 2-6).
These measurements are typically done in coincidence mode with up to three
'Ge/68Ga-rod sources of 511keV annihilation photons [Huesman, 1988]. The sources
rotate around the patient for a given length of transmission scan to yield attenuation
measurements along all LORs (fig. 5.1) [Bailey, 1998]. When not required for
transmission scanning, the rod sources are retracted from the field-of-view into
shielded containers.
Figure 5.1 Measurements for attenuation correction in PET. A blank scan is acquired without the
patient in the FOV. A transmission scan measures transmitted photons from the same external source
for all LORs as the blank scan, however, with a patient inside the FOV. During the blank and
transmission scan the sources rotate around the FOV to acquire a complete set of sinogram data. ACFs
are calculated for all projections measured during the emission scan.
Two measurements must be performed in order to determine the incident and
attenuated number of events for all active detector pairs. A blank scan measures the
strength of the transmission sources, No , from a scan without the object in the FOV
of the scanner. A transmission scan with the patient positioned in the scanner
measures the attenuated countrate N along all LORs (fig. 5.1). For every LOR the
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ACF is then calculated from the ratio of the detected events in the blank and
transmission scan.
Typically septa-retractable multi-ring scanners equipped with rotating rod sources
acquire blank and transmission scans in 2D mode (septa extended), because the
activity of the sources (approximately 70MBq each) would result in excessive dead
time in the detector closest to the source if no septa were present during the
transmission scan. To reduce dead time effects in scanners that operate in 3D only,
like the ECAT ART, lower activity rod sources (approximately 30MBq) are used.
Due to the limited counting statistics in the measured rod source transmission data
statistical noise of the emission data corrected for attenuation based on the measured
transmission data is amplified.
Another factor contributing to sub-optimal quality of standard transmission data is
the Poisson component due to the relatively high level of scatter in the transmission
scan. However, when using rotating rod sources in multi-ring scanners equipped with
septa, the position of the sources are monitored and only detected coincidence events
which pass close to one of the rods are accepted [Jones, 1995]. This imposed
colinearity is often referred to as electronic windowing, since most of the scattered
and random coincidences can be rejected (windowed) by the electronics. Electronic
windowing helps to eliminate much of the scatter, with the possible exception of
very small angle scatters. Scatter contamination in the transmission scan results in an
underestimate of the linear attenuation coefficients, and consequently to an under-
correction of the emission activity. While this effect can arise in any scanner, it is
particularly serious for the ECAT ART where septa are not available and rod-
windowing cannot not reduce the high level of out-of-plane scatter.
Although blank and transmission data are collected for all 3D LORs, on-line
single slice rebinning [Daube-Witherspoon, 1987] into a 2D data set is the default
acquisition mode for the blank and transmission scans in 3D-only PET tomographs.
Nevertheless, a complete set of 3D attenuation correction factors can be derived from
the 2D transmission measurements (fig. 5.2).
Figure 5.2 Scans and processing steps to obtain attenuation-corrected emission images in 3D PET.
Emission data are acquired in 3D, blank (B1) and transmission (Tx) data are acquired in 2D, and used
to reconstruct (R) a 2D attenuation image 1.4x,y). The 3D ACFs are calculated from the exponent
(exp) of the line integrals (F, forward-projection) through the attenuation image along LORs for which
3D emission data have been acquired. Final emission images (Em) are reconstructed (R) from the 3D
set of corrected emission sinograms.
First, a set of 2D attenuation images [t(x,y) is reconstructed from the logarithm of
the ratio of the blank and transmission scan. The 3D ACFs are then calculated from
v(x,y,EcT)	 v(x,y,511keV)
Transforr-:r48.- F+exp--lnEFT-x.1"
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the exponent of the line integrals (forward-projection) of the independent attenuation
images exp{fli(x,y)} along any required direction through the 3D image volume
[Townsend, 1991]. The data flow for standard 3D attenuation correction in PET as it
applies to the ECAT ART and multi-ring PET tomographs operated in 3D is
illustrated in fig. 5.2.
The attenuation correction procedure for 3D PET typically involves two
reconstruction steps: to estimate the attenuation images [t(x,y) and to obtain the
corrected emission images. Iterative reconstruction methods (section 2.6.3)
sometimes replace standard filtered-backprojection reconstruction (section 2.4.2 and
2.6.3) to limit noise propagation during the process of attenuation correction. The
low-noise CT transmission images available when using a combined PET/CT
tomograph would intrinsically limit noise propagation through attenuation
correction. The schematic representation of CT based attenuation correction is shown
in fig. 5.3. Additional advantages over standard rod based attenuation correction are
expected from the low scatter fraction in CT images. In addition, CT transmission
images are expected to be less sensitive to post-injection emission activity present in
the FOV. Additional corrections that must be applied to the standard transmission
data when acquired post-injection [Hooper, 1996; Smith, 1996; Zaers, 1998] may not
be required if CT data are used for attenuation correction of the PET emission data.
These issues will be discussed in detail in the following sections.
Patient
Figure 5.3 Schematic representation of the use of CT transmission data for PET attenuation correction
in case data are acquired with a PET/CT scanner. A single CT scan then replaces standard blank and
transmission scans. The CT transmission image that is transformed and used to calculate the 3D
ACFs.
5.1 .3 THE ENERGY DEPENDENCE OF THE LINEAR ATTENUATION COEFFICIENT
The PET attenuation correction factor (eqn. 5-1) is calculated from the line
integral of the linear attenuation coefficient for each LOR, where (x,y) are the spatial
coordinates along the LOR. The attenuation coefficient ra(x,y) is, of course, energy-
dependent (fig. 5.4), and some scaling algorithm is needed if these coefficients are to
be used to calculate attenuation coefficients at an energy other than the energy they
were acquired at. PET uses mono-energetic 511keV annihilation photons, whereas
the X-ray source in CT emits photons with a broad energy spectrum from about
40keV to 140keV (section 1.2.1). This presents two challenges when adjusting the
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measured attenuation coefficients at CT energies to the attenuation coefficients at
511keV:
• the large difference in photon energies between PET and CT, and
• the representation of the multi-spectral attenuation values in CT.
Figure 5.4 Linear attenuation coefficient of (a) striated muscle, and (b) cortical bone as a function of
photon energy [Hubbell, 1969]. The major contributions to the total attenuation (photoelectric
absorption and Compton scattering) are also shown. Note the differences at low photon energies.
For energies below the pair-production threshold of 1022keV, attenuation is
dominated by Compton scatter and photoelectric absorption [Hubbell, 1999]. The
probability of Compton scatter and photoelectric interactions depends on the photon
energy E, and decreases with E and Ea (3a4), respectively. At 511keV the
contribution of photoelectric absorption is negligible for all biological materials. In
the range of lower energies covered by the CT X-ray spectrum, however,
photoelectric effect accounts for most of the attenuation of the photons. Figure 5.4
illustrates the contributions of Compton scatter and photoelectric effect to the total
attenuation of bone and muscle [Hubbell, 1969].
The second challenge for CT based attenuation correction is the polychromatic
nature of the measured CT attenuation values at CT energies. Each individual tissue
voxel, it(x,y), of the CT volume represents a weighted sum of attenuation values,
p(x,y,E,), for X-ray photons with photon energies, E1, covered by the incident X-ray
spectrum [Phelps, 1975a]:
ii(x,Y) =Ill); • 1.4x,y,E,), 0 keVsE,<F.(kVp)	 Eqn. 5-2
The weights, wi, for the individual X-ray photon energies, Ei, are given by the X-
ray tube energy histogram (fig. 1.11). Note that eqn. 5-2 assumes that changes in the
photon energy distribution due to beam hardening at point (x,y) have already been
accounted for. As discussed in section 1.2 the X-ray spectrum depends on physical
parameters of the tube operation, and tube design parameters, in particular the anode
target material. A number of models have been proposed to realistically describe
typical X-ray spectra as a function of filtration, target angle, and tube voltage [Birch,
1979b]. Due to the complexity of modeling X-ray spectra [Sundararaman, 1973] and
polychromatic attenuation coefficients, the polychromatic X-ray energy distribution
is sometimes described by a single effective CT energy. Thus, the linear attenuation
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coefficient [i(x,y) represents the mean attenuation at some effective energy. The
effective energy corresponds to the energy of an equivalent monoenergetic beam of
photons with the same attenuation properties as the polychromatic X-ray spectrum.
This concept will be discussed in more detail in section 5.2.4.
5.2	 METHODOLOGY
5.2.1 THE EXACT WAY: DUAL-ENERGY BASIS MATERIAL DECOMPOSITION
Standard image reconstruction of CT data is based on measurements of
transmitted X-rays integrated over energy. By reconstructing the linear attenuation
coefficient at a single effective energy the spectral information of the attenuation
coefficient is typically ignored. Dual-energy basis material decomposition allows one
to extract the individual photoelectric and Compton contributions to the attenuation
value [t(x,y) of individual voxels in CT transmission images. The different
contributions can then be combined to synthesize a monoenergetic attenuation map
at any energy below the pair production threshold of 1022keV. Although this method
is simple in concept and used routinely in bone densitometry, dual-energy
tomography is more challenging in both data acquisition and data processing, and
requires higher levels of radiation dose.
The dual-energy basis material decomposition method was first suggested by
Alvarez and Macovski [Alvarez, 1976] to extract energy dependent information from
conventional CT techniques at any point within the cross section of an object. The
decomposition method is based on the premise that the linear attenuation coefficient
Um(E) of any material m at any given X-ray energy E can be expressed as a linear
combination of the linear attenuation coefficients p1(E) and ii2(E) of two basis
materials 1 and 2:
/1„,(E) = cm, • ,u,(E)+c,„,• p2(E)	 Eqn. 5-3
The basis coefficients cm, and cm2 are assumed to be energy independent. The
attenuation coefficient ,u(x,y) may be expressed as a linear combination of basic
functions j(E) by:
"t(E)=Ia, • j(E)	 Eqn. 5-4
The ultimate choice of the basis functions f is empirical, but two basis functions
approximating the photoelectric and Compton (fco Klein-Nishina function [Klein,
1929]) interactions were found to fit existing data best:
1It( E) = al • — + a2 • frv (E)	 Eqn. 5-5
E3
Basis material decomposition of the attenuation coefficient therefore corresponds
mathematically to the Photo-/Compton-effect decomposition [Gingold, 1991]. In CT
integral measurements of the transmitted intensity are obtained, which are equivalent
to making measurements of the line integrals of al and a2. Since
1
,u(x, y, E) = a i (x, y) • — + a2 (x ,y)- Lev (E)	 Eqn. 5-6
E3
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then
f ,a(x,y,E)dxdy =A, •---T + A2 • f(E)	 Eqn. 5-7
where
A, = f	 y)dxdy, and A2 = f a2(x y)dxdy	 Eqn. 5-8
The reconstruction of the parameters al and a2 that represent the fractional
contribution of photoelectric effect and Compton scatter at any point (x,y) of the
measured transmission map, requires the measurement of A1 and A2 for all
projections of the image. These may be obtained by performing intensity
measurements with two different source spectra SL and SI,. The spectra SI, and SH can
be composed of monoenergetic radiation, or they could be obtained by filtering a
single X-ray spectrum through the insertion of a physical filter into the beam path
(for example, [Gauntt, 1994]). Filters selectively attenuate higher or lower energy
photon fluxes after leaving the tube and before entering the scan object, and thus
yield an incident X-ray spectrum with distinct distributions of photon energies in the
lower and higher energy range, respectively. The values for A, and A2 can be
obtained from intensity measurements (/) with these two photon distributions, SI, and
SH:
/z, (A, A2 ) = f SL (E) • e "I E3 + A2 fiN( E)}dE 	 Eqn. 5-9
(A, A.2) = fS (E) • e-{A, 7+A2f.v(E)}dE.
This system cannot be solved analytically since the spectra SL and SH are usually
not known. Power series are therefore introduced to approximate eqn. 5-9 [Alvarez,
1976];
ln =	 Ai+ b2L A2	 L •2	 L 2	 L13, A, + b, A, + b5 A,A2 + b6LA,3 + A. 	 Eqn. 5-10
ln /H =	 + btu	b2HA2 b3H Al2. b4HA2  b51/ Ai A2 4. b6HA13 	 A32
A calibration measurement with a phantom containing two basis materials
(typically aluminum and acryclic as representative for bone and soft tissue,
respectively [Gingold, 1991; Goh, 1997]) is performed to determine the sets of
coefficients {bi } and {bi } for the two basis materials with known A, and A2 . The
calibration thus relates the low- and high-energy data pairs (1n(IL) and ln(IH)) in a
unique way to a specific combination of the basis material thicknesses A 1 and A2.
Two look-up tables of log intensities are generated as a function of the thicknesses of
both materials. By repeating these measurements for an object of unknown
composition using the same spectra SI., and SH, the fractional contributions of the
basis materials in every point (x,y) of the reconstructed CT transmission image can
be obtained, and used to synthesize an object-specific monoenergetic attenuation
map 1.4x,y,Eern) for all tomographic slices at the energy, E e„„ of the radionuclide
[Hasegawa, 1993]. The dual-energy decomposition can be used to account for both
the polychromaticity of the CT X-ray photons and the energy difference between the
transmission and emission scan.
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Although the decomposition method has been successfully implemented on the
prototype SPECT/CT scanner [Hasegawa, 1993], we did not use it to synthesize
attenuation maps at 511keV for CT based attenuation correction in the PET/CT
tomograph. With the current CT tomograph (Somatom AR.SP) it would be difficult
to generate two different X-ray distributions SL and SH from the same tube spectrum,
such as by mechanically switching the foil filters [Lang, 1992]. After switching the
foil filter a second CT scan must be acquired, which leads to an increase of the total
dose delivered to the patient. In addition patient motion between the two scans can
hamper the accuracy of the final estimates of A1 and A2 . Alternatively, the
distributions SI, and S H may be generated by rapidly switching the tube accelerating
voltage [Kalender, 1986] which may eliminate patient motion artifacts but may lead
to overheating of the tube. Total patient exposure could be limited by switching the
tube voltage for alternating slices only [Guy, 1998] but not by reducing the tube
voltage or current since the calibration procedures (eqn. 5-10) require low-noise
estimates of the fractional descriptors al and a2 [Alvarez, 1976]. Without extensive
modifications to the existing CT components in the combined PET/CT scanner this
methodology could not be implemented. Therefore we have pursued simpler
algorithms for the purpose of CT based attenuation correction that would not depend
on major hardware modifications of the scanner [Kinahan, 1998].
5.2.2 FIRST APPROXIMATION: SEGMENTATION
Segmentation techniques have been previously used to suppress noise propagation
in attenuation correction based on measured PET transmission data [Xu, 1991].
While noise in the measured transmission data (sinograms) can be reduced by
smoothing the projection data at the cost of degrading spatial resolution [Dahlbom,
1987], image segmentation has been suggested as an alternative technique by Huang
et al. [Huang, 1981]. The transmission image is thereby partitioned into discrete
regions of voxels with similar attenuation. A single representative attenuation value
is then assigned to all pixels within a particular partition. This value is typically
determined from the pixel average in the segmented region or taken from the
literature for reference tissues.
Because of the small dispersion of attenuation coefficients of biological tissues at
511keV [Hubbell, 1995] (fig. 5.5), pixels from transmission images are typically
classified into bone and non-bone regions, whereby 'non-bone' is often separated
into lungs and soft tissue. These partitions can be defined either by using tissue
boundaries and gradients [Canny, 1986] together with knowledge of the morphology
of the subject [Brown, 1997], or by thresholding the pixel intensity histogram of the
transmission image [Xu, 1993]. Both methods work well, but unlike boundary
algorithms, thresholding techniques typically do not require any user interaction.
Depending on the segmentation technique used, noise from the transmission
measurement is either eliminated or reduced if adaptive techniques are used [Xu,
1996], and noise in the attenuation correction procedure is limited.
In our case, segmenting the CT image is not aimed at reducing the noise of the CT
transmission data, since the CT measurements are intrinsically low-noise owing to
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high source strength and transmitted photon flux. Instead, segmentation may be used
to avoid the challenge of accounting for the polychromaticity of the measured
attenuation values when transforming the CT transmission images to attenuation
maps at 511keV. CT images have intrinsically high contrast, and therefore many
small anatomic areas of uniform attenuation may be defined. However, since most
soft tissues have similar attenuation properties at 511keV (fig. 5.5), it is sufficient to
distinguish only three or four tissue classes in CT images for the purpose of
segmented attenuation correction.
Figure 5.5 Mass
attenuation coefficients of
bone, various soft tissues,
and lung [[Hubbell, 1969
#229]].
These tissue classes are typically derived from a pixel value histograms. The pixel
values in each of these segmented tissues are then uniformly assigned a reference
value taken or interpolated from published reference measurements with mono-
energetic photon beams [Hubbell, 1969]. The segmented and transformed CT images
are then forward-projected to calculate the attenuation correction factors (ACFs).
The data flow for segmented attenuation correction is illustrated in fig. 5.6.
Figure 5.6 Data flow when using segmented CT images for attenuation correction of the PET data.
Insert this partial flow diagram in fig. 5.3 for complete scheme. Note that segmentation is subject to
mis-classifying pixel values. Misclassification may translate through the attenuation correction
(F+exp) into the final images and introduce a bias in the reconstructed activity distribution.
While many approaches to image segmentation exist, we segment CT images
based on thresholding the pixel value histogram from the CT data. Figure 5.7 shows
an example of pixel value histograms for two normal sized patients scanned on the
PET/CT scanner. In addition to extracting the background (no attenuation) three
tissue classes are derived from thresholding the pixel value histogram: lung, soft
tissue (fat, muscles, blood), and bone. These classes of tissues are derived from
extracting pixels with values in close range of local maxima in the pixel value
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histogram. Threshold values thereby help to separate neighbouring pixel value
distributions. The thresholded pixels values are then uniformly replaced with a
reference attenuation value, i, at 511keV for the segmented tissues class (e.g.
0.0961cm-1 for soft tissue). In our studies, for example, we estimated the reference
attenuation values at 511keV for lung, soft tissue, and compact bone from linear
interpolation between the values listed at 500keV and 600keV [Hubbell, 1969].
Figure 5.7 Pixel value histogram of a CT study of a male and female patient of similar size, with an
axial coverage of 144 planes (upper neck to pelvis).
The segmentation method was first tested in a simple phantom study [Beyer,
1995]. The cylindrical 20cm phantom (NEMA phantom [Karp, 1991]) was filled
with a background concentration of 3.7kBq 18F in water. Three non-active inserts:
cortical bone [RSD], and two plastic cylinders filled with water and air, respectively
were placed symmetrically in the phantom before it was filled with the activity
distribution. All inserts measured 5cm in diameter and extended over the axial length
of the NEMA phantom (fig. 5.8). The phantom was positioned in the central field-of-
view of the scanner and scanned in CT and PET mode. After separating the
background from the phantom cross-section, the CT images were segmented into air
(0.01cm-1 ), water (0.0962cm-1 ), and bone (0.1694cn1 1 ). The corresponding thresholds
were —50HU and 300HU. Note that for the case of this phantom experiment, the
reference attenuation values were taken from previous reference transmission
measurements with rod sources on an ECAT 951 scanner. After calculating the
ACFs the corrected emission images were reconstructed with the 3DRP
reconstruction. Transaxial sections through the images are shown in fig. 5.8. The
segmentation method is described in more detail in [Beyer, 1995; Kinahan, 1998].
We found segmented attenuation correction to work sufficiently well in
geometrically simple phantom studies. The corrected emission images showed a
uniform background activity while the three inserts exhibited no misleading activity
concentration after scatter correction was applied. Generally misclassification of
pixels with values in the valleys of the pixel value histogram (fig. 5.9) during the
thresholding may not be excluded. For example, misclassification of a few pixels can
be seen in the lower left of the transaxial sections through the CT image in fig. 5.8c;
while all pixels in that area originally represent water, few pixels were falsely
classified as bone (black dots). These misclassifications may introduce a bias in the
corrected emission images, in particular if the mis-classified pixels have values that
are either significantly lower or higher than the surrounding tissues. For example,
misclassification of pixels with moderate attenuation (water) as high density (bone)
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or low density (air) pixels, caused artifacts in larger regions of the image [Beyer,
19951. In other words a bias from the transformed CT attenuation map may translate
into a spatially extended bias in the corrected emission image. This was shown in
previous phantom experiments [Kinahan, 19981.
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Figure 5.8 NEMA phantom with three non-active inserts (air, water, bone). The background was filled
with water and 19MBq ' 8F (a). Transaxial sections are shown through (b) the CT image, and (c) the
segmented CT attenuation map. Arrows in (c) point to misclassification of some 'soft tissue pixels' as
'bone'. The corresponding slice through the corrected PET image (d) before, and (e) after dual-energy
scatter correction [Grootoonk, 1992] was applied are also shown. Note overestimation of activity in
cold bone insert before (d, arrow) scatter correction was applied.
While the different materials in the NEMA phantom experiment (air, water, bone)
were clearly separable, human tissues exhibit a wider variety of attenuation values
and gradually varying tissue densities (e.g. lung boundaries) that may not be
accurately represented by a segmented map. Although thresholded attenuation maps
may be filtered to introduce smooth pixel value gradients across tissue classes (e.g.
lung boundaries) the problem of assigning a single reference value to the segmented
human tissue classes remains.
To study the variability of CT attenuation measurements of various tissue classes
in patients, we have acquired pixel value histograms from CT scans of ten PET/CT
patients. First, we related the pixel value distributions around local maxima in the
pixel value histogram to anatomical regions in the imaged CT volume. The CT
image sets were thresholded according to the ranges of pixel values defined on the
corresponding pixel value histograms, and the thresholded regions were compared to
the original CT images.
Figure 5.9 shows the low attenuation range of the histogram in fig. 5.7. The local
maxima are enhanced and shown to correlate with important anatomical features of
the human anatomy. Based on these findings, we have defined threshold values to
facilitate segmentation of the CT images into areas of lung (-1000HU to -50HU), soft
tissue (-50HU to 300HU), and bone (>300HU). It was interesting to note that while
we measured an average attenuation of 1300HU for the NEMA insert representing
cortical bone [RSD], cortical bone in humans presented with much wider distribution
of attenuation values, from 300HU and above, thus illustrating the general problem
of finding appropriate tissue substitutes for a range of tissues and photon energies
[White, 19781.
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Figure 5.9 Partial pixel value histogram of whole-body CT patient scan (a). The range of a few
morphological features is illustrated in the graph. A transaxial section through the CT image is shown
for four thresholds [HU]: (b) [-915:-1551, (c) [-125:-45], (d) [0:75], and (e) [>100], representing (b)
lungs, (c) fat and body fluids, (d) blood pool and muscle tissue, and (e) bone structures, respectively.
The above threshold segmentation method is very simple, and when used in CT
based attenuation correction a few factors must be considered. First, the threshold
values for lungs, soft tissue and bone may vary between subjects, and depend on the
spatial position within the CT volume. The range of lower and upper threshold
values for a few tissue classes are listed in table 5.A. These ranges were estimated
from ten clinical CT studies from the PET/CT. Note that although both fat and body
fluids, and vascularized structures (blood, arteries, muscles) may be separated as
regions of uniform attenuation, for the purpose of segmentation they were all
considered soft tissue. Nevertheless, the rather large variability across subjects of the
threshold values for human tissues makes the thresholding technique subject to
misclassification of pixels. This is illustrated by the overlapping ranges for the upper
and lower threshold values for soft tissue and bone, respectively (table 5.A).
Table 5.A Threshold values for four major classes of tissues as determined from correlating CT pixel
value histograms with anatomical features of CT image volumes of eight patients from the PET/CT.
Tissue class Tissue Lower threshold [HU] Upper threshold [HU]
Cortical bone 125...375 maximum
BONE Spongiosa bone 75...125 175...245
Muscles, blood -25...25 75..110
SOFT TISSUE Fat, body fluids -125...-100 -55...-25
Lungs -940...-925 -125...-100
Another known problem is variable density of human tissues. For example, for
lungs average density variations have been reported, as much as 30% across subjects
[Rosenblum, 1980] and 10% across selected lung zones in individual subjects
[Robinson, 1979]. In addition to a vertical gradient [Millar, 1989] lung densities also
exhibit an anterior-posterior gradient [Robinson, 1979] that can be seen in fig. 5.9a.
This variability is reflected in the range of attenuation values ix at 511keV that have
been used in recent studies involving segmented attenuation correction (table 5.B).
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Table 5.B Linear attenuation coefficients [cm 1 ] for lung tissue, soft tissue, and bone from references
on the use of segmented attenuation correction in PEI'.
Reference Lung Soft tissue Bone
Ranger, 1989 0.152
ICRP, 1975 0.174
Price, 1996 0.021-0.053 0.072-0.090
Ollinger, 1994 0.043 0.096 0.152
Bergstrom, 1982 0.096 0.192
Jadali, 1995 0.020 0.100
Yu, 1996 0.186
Bailey, 1997a 0.033 0.092 0.11
Due to the variability of attenuation coefficients of human tissues across subjects
and across the CT volume of a single subject, a discrete set of reference attenuation
values may therefore not be adequate to compose an attenuation map of the imaged
tissues. This is illustrated by a set of transaxial CT images through the upper thorax
before and after segmentation was applied (fig. 5.10). The transaxial CT images were
thresholded to determine three classes of tissue: lung, soft tissue, and bone. Owing to
the variability of human tissue densities some soft tissue pixels were falsely
identified as lung tissue (arrows in fig. 5.10a,b), while some pixels belonging to the
shoulder blade bone structure were identified as soft tissue (arrowheads in fig.
5.10a,b) during the segmentation. In addition some pixels in the lung are identified as
background, which illustrates the difficulty to define a lower threshold for pixel
values in the lung (table 5.A). Finally, the uniform attenuation imposed by the
thresholding on inhomogeneous tissues (lungs) may suppress gradual variations in
background activity, and thus potentially affect tumour-to-background ratios.
However, simulation studies using emission and CT scans of normal subjects and
simulated lesions in the lungs [Chan, 1997], may be performed to estimate the effect
of thresholding the CT on the final corrected emission image.
Figure 5.10 Transaxial sections through the upper thorax of (a) original CT, and (b) segmented CT
image (background, lung, soft tissue, bone). Honiontal profiles through the (c) original CT, and (d)
segmented CT. Segmentation introduces artificial edges in the attenuation map by disregarding the
gradually varying densities of soft tissues. Misclassification of soft tissues as lung (arrows), and bone
structures as soft tissue (arrowheads) arc illustrated in (b).
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5.2.3 UNIFORM LINEAR SCALING
A simple scaling method to transform an attenuation map from transmission
energies, Et,„ to the relevant attenuation map at the energy, E,, of a complementary
emission scan was suggested and implemented by Tsui et al. [Tsui, 1989]. The
nri201authors used a collimated monoenergetic sheet source ( Etx=75keV) to estimate
an attenuation map for a 99n1Tc SPECT emission scan (E„=140keV). This techniques
was later extended to translate X-ray CT images by means of a single scale factor to
an attenuation map for use in attenuation compensation of SPECT data (2011 and
99mTc scans) [LaCroix, 1994].
The use of a single scale factor for the transformation of the attenuation map may
be motivated by the major role of Compton interactions at CT energies [Phelps,
1975a]. Two assumptions can then be made. First, most biological tissues have
similar attenuation properties over the range of diagnostic energies (fig. 5.11).
Second, a single scale factor should suffice to transform the attenuation information
from CT energies to 511keV or any other energy of radionuclides used.
Figure	 5.11	 Mass
attenuation coefficient
[cm 2g-1] of various soft
tissues relative to the mass
attenuation of water over
the range of diagnostic
photon energies [Hubbell,
1995]. The range of X-ray
photon
	 energies	 is
indicated in the graph.
The cross-section for Compton scatter depends on the electron density and gives
good correlation with the physical density [Phelps, 1975a]. Therefore- a mass
attenuation coefficient m i for a tissue i may be introduced:
m,(E) = II' (E)	 Eqn. 5-11
pi
where p, is the physical density and ,u, is the linear attenuation coefficient, and E is
the diagnostic photon energy for which the attenuation is expressed. The similarity in
physical properties of soft tissues is reflected in similarities of their mass attenuation
coefficients (fig. 5.11). However, at lower photon energies photoelectric effect may
become the dominant factor to the total attenuation. Small variations in tissue
composition, expressed by means of the effective atomic number, Zap may then
translate to more significant variations of the mass attenuation coefficients of soft
tissues. The cross-section of the photoelectric effect is thereby assumed to vary with
Zeffa (3sccs4, [Phelps, 1975a; Rutherford, 1976b]). Figure 5.11 also illustrates that
the mass attenuation coefficients of soft tissues closely resemble the mass attenuation
of water for the range of X-ray photon energies used in CT.
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We assume a linear dependence of the mass attenuation coefficients and the
diagnostic photon energies for photon energies around 100keV and higher. A scale
factor can then be defined to transform mass attenuation coefficient from one photon
energy to another. Since the mass attenuation of most soft tissues is close to the mass
attenuation of water (fig. 5.11) that is well tabulated [Hubbell, 1995] we use the
latter to calculate the appropriate scale factor. The scale factor /Ls is calculated from
the ratio of the mass attenuation coefficients of water, mwa,, at the emission and
transmission energies, Eeri, and E,„ respectively:
Mweter(Eem) 
Inwater(Ea)
This scale factor is then used on an image pixel basis to scale the attenuation
information R(x,y,E,) contained in the transmission images:
,u(x, y, Ee„,)= (x, y, ED • Ls,	 Eqn. 5-13
While the use of transformed attenuation information in SPECT requires an
iterative attenuated projector-backprojector algorithm [Tsui, 1989], the
corresponding attenuation correction in PET is more straightforward as indicated by
eqn. 2-6. As for the suggested approach for application in SPECT, attenuation
coefficients at PET energy of 511keV are calculated by applying a single scale factor
to the CT attenuation map ii(x,y,EcT). The attenuation correction factors (ACFs) for
3D PET emission data are calculated by taking the exponent of the line integrals
(forward-projection) through the 2D attenuation maps ,u(x,y,5 1 1 keV) along all LORs
that were measured in the 3D emission scan (fig. 5.12).
Figure 5.12 Data flow when using the linear scaling method for attenuation correction of the PET
data. Insert this partial flow diagram in fig. 5.2 for complete scheme. The original CT image is scaled
uniformly to obtain a 2D attenuation map at 511keV, which is then froward-projected to calculate 3D
ACFs.
In more detail, the attenuation correction factor for a particular LOR through an
inhomogeneous object can be approximated by:
fLs = Eqn. 5-12
where m/ E) is the mass attenuation coefficient of the i-th material, and Al, is the
mass lengths of material i contributing to the LOR for which the ACF is calculated.
By assuming that the mass attenuation coefficients m i for most biological soft tissues
are similar over the range of diagnostic energies, E, (fig. 5.11) we can rewrite eqn. 5-
14:
(nt(E).
ACFLoR = e	 ' , i ELOR Eqn. 5-15
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During the CT scan transmission information is acquired for the same LORs that
are active in the PET emission scan. The mass length for each LOR may then be
substituted from the CT measurements using eqn. 5-1 and 2-6:
ln
Eqn. 5-16E pi l, = 	 .
I and I„ are the measured intensities in the CT transmission scans, and ln(/// o) is the
line integral through the CT attenuation map li(x,y,E cr). The effective energy of the
X-ray spectrum , ECT, is discussed in sectio n 5.2.4. Inserting eqn. 5-16 in eqn. 5-15,
using eqn. 5-12, the ACF can be expressed as:
(m(51IkeV) In I )	 4.51111.)	 I f Ls.g(x EcT)ds
• —
EcT)
ACFLoR = e	 =e	 ° =e	 Eqn.5-17u)R
In other words, the ACF for the PET emission data may be calculated from the
line integrals of the transformed attenuation map at 511keV that has been obtained
from scaling every pixel in the original CT image with the constant scale factor f.
We have studied the linear scaling method in a series of phantom experiments that
are described in detail in [Beyer, 1995] and [Kinahan, 1998]. In concordance with
the results from LaCroix et al. [LaCroix, 1994] we find that linear scaling was a good
approximation when the major contribution to ii(x,y,Ec r) comes from Compton
interactions. It was, however, a poor approximation when photoelectric contributions
dominated, as they do at the lower CT energies (fig. 5.13).
Figure 5.13 Mass attenuation
coefficients [cm2g-1] of water and
cortical bone [Hubbell, 19951. Uniform
linear scaling of bone with a scale factor
for soft tissue will underestimate the
attenuation of dense tissues such as
cortical bone.
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The error is particularly large for higher Z materials, such as bone [Spiers, 1946]
which contains a high percentage of calcium. For these materials, the mass
attenuation depends strongly on the photon energy in the lower energy range of the
CT spectrum (fig. 5.4, 5.5). Scaling the CT attenuation map with a single scale factor
for soft tissue, for example, would overestimate the bone attenuation coefficient at
511keV by 23%, while scaling with a single factor for compact bone would lead to
an 18% underestimation of the attenuation of soft tissues at 511keV.
The effect of overestimating the attenuation of bone is illustrated in fig. 5.14 as an
extension to the phantom experiment described in fig. 5.8. The same set of 3D
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emission data and CT transmission images was used, however, instead of segmenting
the CT attenuation map to determine the attenuation coefficients itt.(x,y) at 511keV,
the CT attenuation map was scaled with a single scale factor (soft tissue). The scale
factor (0.495) depends mainly on the choice of an effective CT energy, and will be
discussed in section 5.2.4. Figure 5.14a shows a transaxial section through the scaled
attenuation map. All three inserts are discernable from the activated background
(water+ 18F). As discussed in section 4.3.3, the CT attenuation measurement is not
affected by the emission activity present during the CT scan. Note also the original
smoothness of the CT data that is maintained after scaling but not after thresholding
(fig. 5.8). The ACFs were calculated from line integrals through the scaled CT
attenuation map, and applied to the emission sinograms. The corrected emission data
were reconstructed with standard 3DRP. Transaxial images are shown in fig. 5.14b
and c before and after scatter correction. Note that the reconstructed images suggest a
(non-existing) activity distribution in the area of the bone insert. This is due to the
overestimation of the attenuation values of bone after soft tissue scaling, which in
turn leads to an overcorrection for attenuation in the bone insert.
a)	 b)	 c)
Figure 5.14 NEMA phantom with three non-active inserts (air, water, bone). The background was
filled with water and 19MBq Transaxial sections are shown through (c) the scaled CT attenuation
map (soft tissue scale factor), attenuation corrected PET image (b) before, and (c) after dual-energy
scatter correction [Grootoonk, 19921 was applied. The overcorrection effect in the cold bone insert
(b,c) is explained in the text.
While the different materials in the NEMA phantom experiment (air, water,
cortical bone) were clearly separable, human tissues exhibit a wider variety of
attenuation values and the effect of over- and underestimation of the true attenuation
values may be more difficult to evaluate. We have chosen a patient study (recurrent
colon cancer with metastases to the upper lung) from the PET/CT. Combined PET
and CT were acquired over a single bed position over the upper thorax. PET
emission data were corrected for attenuation using the transformed CT attenuation
maps, and reconstructed with FORE+OSEM. The images after different CT
attenuation correction algorithms were compared visually, and standard uptake
value (SUV, section 10.2) in the thoracic metastases were chosen as a semi-
quantitative measures of the effect of using different attenuation maps to correct the
emission data.
The attenuation maps after linear scaling are shown in fig. 5.15 together with a
cross-section of the original CT. Note the overestimation of the attenuation of bone
when scaling with a soft tissue factor (fig. 5.156). Similarly, the attenuation of water
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is underestimated when scaling with a cortical bone factor only (fig. 5.15c). Note that
we assumed the 'true' linear attenuation coefficients of soft tissue and bone to be
0.096cm - ' and 0.179cm
-1 , respectively [Hubbell, 1969],
Original CT	 Soft tissue scaling	 Bone scaling
d)	 e)
Figure 5.15 Patient study (recurrent colon cancer) from the PET/CT. Transaxial sections through the
upper thorax: (a) original CT volume, and attenuation map at 511keV after liner scaling with (b) soft
tissue scale factor, and (c) bone scale factor. The attenuation images in (b) and (c) were normalized to
a maximum of 0.0960cm -1 . Corresponding profiles through the mid-line of the thorax are shown in
(d), (e), and (f). Attenuation values for bone (B), soft tissue (S), and lung (L) are indicated in the
profile in (d). Note the overestimation of bone attenuation in (e) and underestimation of soft tissue
attenuation in (f).
Attenuation correction factors were calculated from the CT attenuation maps
transformed with each scale factor and applied to the emission data. Transaxial
sections through the emission volume are shown in fig. 5.16. Note the lower
background activity in case of bone scaling due to the underestimation of the
attenuation of soft tissue (fig. 5.16b). The corresponding transaxial slice through the
emission image with segmented attenuation correction is shown for comparison.
Despite the artifacts seen in fig. 5.10b from misclassification of selected pixels, no
artifacts were observed in the emission images after segmented attenuation
correction. However, due to the lack of a reference images based on standard
attenuation correction, potential biases in the background activity in the lungs, and
low contrast areas (lung boundaries and trachea) must not be excluded.
In addition to visual comparison (fig. 5.16) small circular ROIs were placed over
the central part of the three metastatic lesions to estimate the SUV of the metastases
(lesion 1-3 in fig. 5.16a, from left to right). The SUV values are summarized in table
5.0 for the two different scaling methods. The difference between the SUVs
estimated from the attenuation corrected emission images after bone or soft tissue
scaling is substantial (about 35%). However, the true activity distribution and the
true SUV are unknown.
It is apparent from previous discussions that scaling the complete CT attenuation
map with a soft tissue scale factor overestimates the attenuation of bone at 511keV,
while applying a bone scale factor leads to underestimation of the attenuation of soft
tissues. We may now estimate how much the calculated SUV values in table 5.0 for
the two scaling methods deviate from the true, yet unknown value, by estimating the
fraction of pixel values that would either over- or underestimated when applying a
soft tissue or bone scale factor.
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Figure 5.16 Selected PET/CT patient study (recurrent colon cancer with metastases to the upper
thorax). Transaxial sections through the attenuation corrected emission images are shown for (a)
linear soft tissue scaling, (b) linear bone scaling, (c) segmentation, and (d) hybrid
segmentation/scaling as discussed below.
Table 5.0 Estimated standard-uptake-values (SUV) for three metastatic lesions in attenuation
corrected emission scan of a patient with colon cancer recurrence. CT attenuation maps were
transformed to R(5111(eV) using linear scaling with soft tissue scale factor and cortical bone scale
factor.
Linear sealing for Lesion 1 Lesion 2 Lesion 3
Soft tissue
Bone
2.9±0.4
1.9±0.3
2.8±0.4
1.9±0.3
2.2±0.4
1.5-±0.3
Based on the pixel value histograms (fig. 5.7 and fig. 5.9) a reasonable threshold
for non-bone and bone pixels may be set at 300HU (section 5.2.5). Pixels with values
below 300HU are considered soft tissue (non-bone), the remaining pixels represent
bone. Of all pixels in the 47 CT images of the above patient study, only about 2%
represented bone. In other CT patient studies we have estimated that up to 5% of all
pixels may represent bone, depending on the anatomical location of the region under
consideration. A representative set of transaxial images through a CT volume is
shown in fig. 5.17 together with the estimated fractions of bone.
Figure 5.17 Estimated bone fractions in transaxial slices of whole-body CT study of (a) normal sized
patient: (b) shoulder region, 4%, (c) mcdiastinum, 3%, (d) diaphragm, 4%, (e) kidneys, 3%, and (f)
pelvis, 5%. Upper row: original CT image, lower row: thresholded CT image, only bone pixels are
shown.
From fig. 5.17 it becomes clear that the attenuation in only a small fraction of
pixels representing bone would be overestimated when scaling the CT attenuation
map with a single soft tissue scale factor. In contrast, when scaling the CT
attenuation maps with a single bone scale factor, the attenuation in up to 98% of all
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pixels would be underestimated. When applying soft tissue sealing the mass
attenuation of bone at 511keV is overestimated by 22% (0.116 cm 2g-1 versus
0.095cm2g 1 ). The attenuation of soft tissues is, however, underestimated by 18%
when applying a single bone scale factor (0.079 etn 2g- 1 versus 0.096cm2g-1 ). The
absolute difference between the over- and underestimated attenuation values from
the 'true' attenuation is therefore very similar. Since the number of incorrectly
transformed pixel values is lower in the case of soft tissue scaling, soft tissue scaling
is assumed to yield the more accurate estimate of the true activity distribution
compared to bone scaling. The 'true' SUV values will therefore be closer to the SUV
values estimated from emission images corrected with the soft tissue scale factor
(table 5.C).
The phantom and clinical study suggest to use two separate scale factors (bone
and soft tissue) instead of a single scale factor to limit over- and underestimations of
scaled attenuation coefficients. A dual sealing method could be facilitated by the
rather simple separation between bone and soft tissues (non-bone) owing to the high
contrast in CT images. However, for accurate definition of the two scale factors two
assumptions must be made: (1) the CT energy spectrum can be approximated by a
single effective CT energy, Eeff, and (2) photon attenuation at CT energies and 511
keV is mostly due to Compton interactions, thus allowing us to apply a linear scaling
algorithm. Both assumptions are discussed in the following section before
introducing our method of choice (hybrid segmentation/scaling) for CT based
attenuation correction in section 5.2.5.
5.2.4 SECOND APPROXIMATION: EFFECTIVE ENERGY AND SCALE FACTORS
Prior to applying a scale factor to the CT attenuation data (eqn. 5-13) all pixel
values in the CT images must be transformed from Hounsfield units (HU) to linear
attenuation coefficients 1.4x,y,Ecr). By rearranging eqn. 1-3 with N
to the measured attenuation of pixel (x,y) at CT energies (in HU):
717(--7-(25L.--V))	 Eqn. 5-18#( x, y, E ') = liwater(x,y,E(7) - 1
\ 
+
1 000 ) .
Equation 5-18 is valid strictly only for tissues with attenuation properties between
those of air and water, i.e. Ncrs0HU. The attenuation value of air and water is
defined as -1000HU and OHU, respectively independent of the applied tube potential
or scanner model (section 1.2.2). Necessary CT calibration scans are performed daily
using a water filled and an air filled cylindrical calibration phantom, which are
scanned at all available X-ray tube potentials. These calibration measurements
ensure a linear relation between the soft tissue density and measured attenuation
values. Measured attenuation values for soft tissues with densities lower than water
are similar when scanned with different tube potentials on the same scanner (table
5.D).
For tissues denser than water, however, the I lounsfield units will change with the
tube potential. For example, the higher the applied tube potential (kVp) the lower the
measured 1-lounsfield units for a given material (table 5.D). By increasing the
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maximum tube voltage the X-ray spectrum is shifted towards higher photon energies
(fig. 1.11), for which the measured attenuation values decrease (fig. 5.4). Calibrated
attenuation values for materials denser than water do not exist because the measured
attenuation of these materials at CT energies is affected by the increased effective
atomic number of these materials (e.g. 14 for bone compared to 7 for water) that
translates into increased contributions of the photoelectric effect to the measured
attenuation. Since the photoelectric effect depends non-linearly on the photon energy
(section 1.2.2) calibration measurements, similar to the calibration to air and water,
may not be performed. The measured attenuation of tissues denser than water
therefore depends on the tube potential (table 5.D).
Table 5.D Measured attenuation [HU] from CT scans acquired at two tube potentials: 110kVp and
130kVp. Data from PET/CT scanner. Materials represent phantom inserts in NEMA phantom [Karp,
1991]. Spongiosa bone comprises the soft bone constituents, such as bone marrow, blood, and fat.
Spongiosa and cortical bone inserts were manufactured by RSD Inc. [RSD]. Their measured
attenuation was higher than human spongiosa or cortical bone.
	
Tube potential	 Air	 Water	 Spongiosa	 Compact bone
	
110 kV,,	 -1002±1	 8±1	 362±1
	
1533±3
	
130 kV„	 -1004±1	 7±1	 344±1	 1450±2
The pixel values in CT images represent the attenuation of the polychromatic X-
ray spectrum by the traversed tissues. The attenuation coefficient, originally in units
of Hounsfield units (HU) thereby represents a weighted average of attenuation
measurements for photons at all energies covered by the incident X-ray spectrum. A
linear attenuation coefficient R(x,y,E cr) is defined for the X-ray spectrum in eqn. 5-
18. Since the Hounsfield unit scale for tissue attenuation between air (-1000HU) and
water (OHU) is independent of the tube energy, the coefficient [t(x,y,Ec r) is also
independent of the operation parameters of the scanner. Due to the lack of an upper
limit for the Hounsfield unit scale, however, the linear attenuation coefficient
[t(x,y,Ecr) does also depend on the photon energy for materials denser than water.
The attenuation values for these materials and tissues would, on the other hand, be
difficult to predict without the knowledge of the X-ray spectrum (X-ray photon
energy histogram).
As mentioned in section 5.1.3 the complex multi-spectral interpretation of
attenuation values at CT energies can be simplified by introducing a single effective
CT energy, Eeir The idea is to find an energy Ear such that the measured attenuation
of a polychromatic X-ray beam for materials not too different from water is similar
to the measured attenuation of a monoenergetic photon beam of energy Eeff
[McCullough, 1974]. The effective energy may thus be regarded as a single value to
describe the distribution of photon energies covered by a CT spectrum and the total
attenuation properties of the spectrum. For example, if such an effective energy, Eeff,
could be found, it may replace Fix in eqn. 5-12, and thus simplify the calculation of
the scale factors for the proposed CT based attenuation correction.
The effective energy depends on the tube potential (kV) and the energy spectrum,
which is affected by the pre-patient filtering of the X-rays leaving the anode. One
can imagine that the thicker and denser the filter that is inserted in the beam path
(fig. 1.2) the more lower energy photons are absorbed, and the distribution of X-ray
124
photon energies is shifted towards higher energies. Therefore a higher effective
energy must be used to describe the polychromatic attenuation properties of the
filtered spectrum. The same observation applies to beam hardening, when the lower
energy portion of the X-ray spectrum is preferentially absorbed by the first layers
after the X-ray beam enters the patient. This absorption gives more weight to photons
with higher energies since they are less likely to be absorbed owing to a lower
photoelectric cross-section.
The value of the effective energy is typically in the range of 50% to 70% of the
kV -level [McCullough, 1974; Rutherford, 1976b; Dubai, 1977], and may be
calculated from the available X-ray spectrum [McCullough, 1974]. A direct
measurement of the effective energy is difficult. The effective energy may, however,
be determined indirectly from calibration measurements [Millner, 1978], assuming
that Compton effect dominates attenuation of X-ray photons in soft tissues. The idea
is then to investigate the linear relationship between the measured CT numbers and
the corresponding attenuation coefficients of a set of calibration materials with
known attenuation properties. A correlation coefficient is introduced to describe the
relation between the known attenuation coefficient of the calibration materials and
the measured attenuation from the CT scan for each energy covered by the X-ray
spectrum (sampled in steps of 0.5keV). The effective energy is the energy for which
the correlation coefficient is maximal.
We have composed a calibration phantom to determine the effective energy for
the two CT spectra available from the Somatom AR.SP. Our phantom was based on
a water filled NEMA phantom with three inserts (air, spongiosa bone, cortical bone).
The inserts were manufactured by RSD Inc. [Hubbell, 1969; RSD]. The attenuation
coefficients of water and the three inserts were fitted from tabulated values [Hubbell,
1969] with an energy sampling of 0.5keV. The phantom was scanned in CT mode on
the PET scanner with two choices of X-ray tube potential: 110kV p and 130kVp (table
5.D). The correlation coefficient r(E) was calculated for each photon energy E
(0EkVp) represented by the two spectra (kV) based on the expression given in
[Millner, 1978]:
NE ti i (E) • HU,— E,u, ( HU). I HU,
r(E) — 	 	 Eqn. 5-19
ii(E) • C HU
where N is the number of calibration materials (N=4), pt(E) is the linear attenuation
coefficient for the i—th material at energy E, HU is the measured attenuation of the
i—th material, 0;4E) is the standard deviation of the calculated attenuation coefficients
1,4E), and a-Hu is the standard deviation of the measured attenuation values for the
three inserts. The effective energy can be determined graphically from the maximum
of the correlation coefficient r„,,,,(E) .
The correlation coefficient r(E) is shown in fig. 5.18 for the two available tube
voltages. The maximum correlation coefficient r„JE) is shown in the zoomed centre
graphs in fig. 5.18a, and b, and corresponds to 68keV and 68.5keV for tube
potentials of 110kV p and 130kV p, respectively. In an independent study [Kinahan,
1.0
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1998] we had previously heuristically estimated an effective energy of 70keV to
approximate a tube spectrum of 140kV p. The major difficulty in estimating Eeff
arises from the uncertainty in u1(E) that may vary for the same material depending on
the literature reference. Throughout this work we have used [Hubbell, 1969] as the
reference of choice.
a)	 b)
Figure 5.18 Correlation coefficient r(E) 1978] for calibration measurements at (a) 110kVp,
and (b) 130kV p with the Somatom AR.SP. The effective energy corresponds to the photon energy for
which the r(E) equals r. Note the similarity of the effective energy for 110kVp and 130kVp (zoomed
centre graphs).
After the determination of the effective energy of the X-ray spectra employed in
standard CT scanning with the PET/CT scanner we may now refine the definition of
the scale factors introduced in section 5.2.3. Owing to the complexity of describing
polychromatic attenuation, the scale factors for bone and non-bone tissues (eqn. 5-
12) represent the ratios of mass attenuation coefficients of bone and water,
respectively, at 511keV and the effective energy E efr for the particular tube voltage
that was applied to obtain the CT attenuation images. Table 5.E lists the
contributions to the mass attenuation coefficient of bone and soft tissue (water) at
70keV and 511keV as determined from fitting measured data [Hubbell, 19691 using
a fourth order polynomial fit similar to the calculations made by White and
Fitzgerald [White, 19771.
Table 5.E Fitted mass attenuation [cm 2g-1 ] for soft tissue and bone for 70keV (effective energy) and
511keV. The scale factor [Is (ratio of totals) is calculated from the ratio at 511keV and 70keV.
Material 70keV 511keV Ratio of totals
Water
Bone
0.1942
0.2327
0.0961
0.0946
0.495
0.407
5.2.5 THE COMPROMISE: HYBRID SEGMENTATION-SCALING METHOD
As discussed in the previous chapter, the scaling method is based on the
observation that, over the photon energy range covering both CT and PET (40keV to
511keV), Compton scattering is the most important physical process for the
interaction of photons with matter such as air, water, and soft tissue (low effective
Z). For these substances, the mass attenuation coefficient is almost the same at each
photon energy (fig. 5.11). Attenuation coefficients at 511keV may then be obtained
[t(x,y,EcT)HU
	 1.•
CT Tx
I! —F+exp-e-
[t(x,y,511keV)
f
son	 0
fbone go.
Patient
HU
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from scaling the CT attenuation map under the assumption that the polychromatic
distribution of the X-ray photons may be represented by a monoenergetic beam with
an effective energy. The scale factor that applies to soft tissues does not, however,
apply to bone because the photoelectric cross-section at lower CT energies is
significantly increased due to the relative abundance of high Z materials, such as
calcium in bone.
It has therefore been suggested [Beyer, 1995] to use two scale factors to account
for the differences in attenuation of low-density and high-density tissues, i.e. soft
tissues and bone at lower CT energies. The differences in attenuation arise from the
different contributions of photoelectric absorption of the low and high density (or
low Z and high Z) to the total attenuation, and may be used to separate (segment) the
two classes of tissues in the original CT images. Since, at 511 keV, the contribution
from the photoelectric effect is essentially negligible, and all photon interactions in
human tissues including bone are dominated by Compton scattering, linear scaling
may be justified for soft tissues and bone. Since the use of two separate scale factors
requires a segmentation step to separate bone from non-bone tissues, we refer to this
modified method of transforming the CT attenuation information to 511keV as the
hybrid segmentation/scaling method [Kinahan, 1998].
The hybrid method transforms the CT attenuation maps from the effective CT
energy (70keV) to 511keV in three steps that are illustrated in fig. 5.19: (1) the CT
image is divided into regions of pixels classified as either non-bone (comprising a
variety of soft tissues, including the lungs) or bone by simple thresholding (section
5.2.2). A threshold of 300 HU gives acceptable results. (2) non-bone classified pixel
values are then scaled with a soft tissue factor of 0.410, and bone classified pixel
values are scaled with a lower scaling factor of 0.499. (3) attenuation correction
factors along oblique LORs are obtained by forward projection through the
segmented and scaled CT images.
Figure 5.19 Data flow for hybrid attenuation correction method: the CT attenuation map is segmented
into bone and non-bone (soft tissue), and two separate scale factors are applied to these two tissue
classes.
An illustrative example of the application of the hybrid method to a NEMA
phantom study is shown in fig. 5.20. The CT image after segmentation and scaling to
511keV is shown in fig. 5.20a The corresponding original image was shown in fig.
5.8b. In contrast to the linear scaling method with a single scale factor (fig. 5.14c)
the hybrid method did account for differences in the attenuation properties of bone
Bone	 1 8 F+Water
Water
	
Air
4
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and non-bone inserts. The activity distribution in the phantom after hybrid
attenuation correction (fig. 5.20c) and after scatter correction was applied represents
the original distribution: the three non-active inserts appeared 'cold' (non-active) on
the reconstructed images while the background activity was uniform.
a)
	
b)	 c)
Figure 5.20 The hybrid segmentation/scaling method applied to a NEMA phantom study. The
phantom contained three non-active inserts (air, water, bone). The background was filled with water
and 19MBq 18F. Transaxial sections are shown through (a) the transformed CT attenuation map,
attenuation corrected PET image (b) before, and (c) after dual-energy scatter correction [Grootoonk,
1992].
In section 5.2.3 we have described the application of the scaling method with a
single scale factor (bone or soft tissue) to a clinical patient study from the PET/CT.
Figure 5.21 b shows the attenuation map at 511keV after hybrid segmentation/scaling
was applied to the CT attenuation data. The bone threshold was set to 300HU. Note
the considerable detail that is preserved at the higher energy after hybrid scaling.
Such detail is generally not visible on PET transmission images owing to the high
level of statistical noise. A transaxia1 section through the corrected and reconstructed
emission data is shown in fig. 5.16d together with image examples after linear
scaling and segmented attenuation correction. Apart from variations in image
intensity due to over- and underestimation of attenuation of bone and water,
respectively, the images appeared similar and no artifacts were seen.
Soft tissue scaling	 Hybrid segmentation/scaling
a)	 - b)
Figure 5.21 PET/CT patient study (recurrent colon cancer with metastases to the upper thorax).
Transaxial sections through CT attenuation map after (b) hybrid segmentation/scaling. For
comparison the same transaxial sections after linear scaling with a soft tissue scale factor is included
(a). The corresponding emission images are shown in fig. 5.16a and d.
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We also estimated the SUV values in the three thoracic lesions seen in fig. 5.16
(table 5.F). As we predicted in section 5.2.3 during the discussion of liner scaling,
the SUV values after hybrid scaling were closer to the SUV values after linear
scaling with soft tissue scale factors (table 5.C). Table 5.F also lists the SUV values
after segmented attenuation correction, which are similar to the SUV after the
proposed hybrid attenuation correction was applied. However, one should keep in
mind that potential artifacts from misclassification during the segmentation of lung
and soft tissue (blood pool., muscle, fat) cannot be ruled out at this stage. Therefore
the hybrid method seems to offer the best compromise between quantitative accuracy
and few artifacts.
Table 5.F Estimated standard uptake values (SUV) for three metastatic lesions in attenuation corrected
emission scan of a patient with colon cancer recurrence. CT attenuation maps were transformed to
11(511keV) using the hybrid segmentation/scaling method.
Bone threshold Lesion 1 Lesion 2 Lesion 3
300HU 2.6±0.4 2.6±0.4 2.0±0.5
500HU 2.7±0.5 2.7±0.4 2.2±0.4
Segmentation 2.5±0.4 2.7±0.4 2.2±0.4
The patient study suggests little difference between the linear scaling and the
hybrid methods (table 5.0 and table 5.F), presumably as there is only a small
contribution of the cortical bone component to the CT images. Any difference in the
transformed attenuation maps after linear and hybrid scaling may indeed be
attributed to the pre-defined bone threshold and the number of pixels representing
bone. This is illustrated in table 5.F: the higher the bone threshold for the
segmentation, the fewer pixels are assigned bone values, and the reconstructed
activity values (or SUV) are closer to the values obtained after scaling with soft
tissue scale factor.
5.3 SUMMARY
The intrinsically aligned functional and anatomical information obtained from the
PET/CT scanner allows PET emission images to be complemented with useful
anatomical background information. In addition, the CT transmission information
can be applied to correct the PET emission data for attenuation (and scatter). The
potential advantages of CT based attenuation correction are: (1) no emission
contamination in post-injection CT transmission scans, (2) lower statistical noise of
the CT data compared to a standard PET transmission scan, and (3) elimination of
the cost of the periodic replacement of transmission sources.
We propose a hybrid segmentation/scaling method to transform the measured
attenuation at CT energies to attenuation maps at 511keV. The method assumes that
the polychromatic CT spectrum can be represented by a single effective energy, and
that Compton interactions constitute most of the interactions of X-ray photons with
tissues at CT energies. The latter assumption allows us to apply a single scale factor
to estimate the attenuation coefficients at higher energies (511keV) from
measurements at CT energies (effective energy is about 70keV). Based on a
threshold value of 300HU that was derived from patient studies, the hybrid method
first segments the CT transmission images into bone and non-bone regions. Pixel
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values in either region are then scaled with a constant scale factor to account for the
energy difference of the transmission and emission measurements. Two scale factors,
for non-bone and bone tissues must be used to account for the different attenuation
properties at CT energies. The 3D attenuation correction factors are calculated by
forward-projecting through the exponent of the transformed attenuation map, along
the LORs that are measured in the PET emission scan.
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6. COMPARISON OF CT AND STANDARD TRANSMISSION
SOURCES
6.1 ATTENUATION CORRECTION
6.1.1 PRE-INJECTION TRANSMISSION SCANNING
The most accurate attenuation correction methods are based on measured
transmission scans [Ostertag, 1989]. The effect of photon attenuation in PET is
typically measured with positron-emitting 'Ge/ 68Ga (rod) sources in coincidence
transmission mode. The term rod source refers to the rod-based shape of the sources
that, in the extended position, cover the total axial FOV at once. State-of-the-art full-
ring PET tomographs, such as the ECAT EXACT [Adam, 1997] are equipped with
three 180MBq rod sources for transmission scanning. The rod sources are installed
inside the gantry, where they remain shielded when not in use, and extend in the
FOV of the scanner upon initiation of a transmission scan. In stationary multi-ring
tomographs, the rod sources rotate inside the detector ring on a separate support for
the duration of the transmission scan, while in the ECAT ART the rods are fixed
with respect to the two partial detector rings [Bailey, 1997b]. In both cases the rod
sources orbit around the centre of the FOV to acquire projections from all directions
around the patient.
Rod source transmission scans are performed in coincidence mode, and are
therefore limited by the dead time in the detector closest to the source. Detector dead
time can be reduced by inserting inter-plane septa into the FOV (between the circle
of source rotation and the detector rings) and acquiring transmission data in 2D. The
septa also help to limit the amount of inter-plane scatter in the attenuation data. In 3D
scanners without septa, such as the ECAT ART, rod source activities are even lower
(about 40MBq per rod source) since detector dead time in the absence of inter-plane
shielding (septa) is higher than in multi-ring tomographs with extended septa.
With the limitations on the transmission scan duration (section 3.1), the use of
weak activity rod sources results in low statistics acquisitions. The corresponding
transmission images are generally noisy and of only moderate quality, particularly at
the axial edge of the FOV. Transmission image quality degrades further for large
patients, when attenuation factors of up to 100 are encountered [Ostertag, 1989].
Longer scan times reduce statistical noise (fig. 6.1), but may not be tolerated by
patients with serious disease.
The use of weak activity rod sources together with insufficient counting statistics
due to short transmission scans or imaging obese patients may seriously degrade the
quality of the measured transmission data. Degradations of the quantitative accuracy
of attenuation measurements [Freedman, 1996], for example, were reported for short
transmission scan times [Ostertag, 1989]. For very short scan times almost no or very
few counts are measured along lines-of-response with maximum attenuation (e.g.
along the arms in large patients).
a) b)
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Figure 6.1 Rod source transmission scans of whole-body phantom (30cm by 20cm, 9,000mL volume
filled with water). Transverse images are shown for (a) lmin, (b) 3min, and (c) 6min scan on the
ECAT HR+ with total rod source activity of 370MBq. Note the reduction in apparent noise with
longer transmission scan times.
Attenuation maps are reconstructed from back-projecting the ratio of the
countrates per LOR in a blank and transmission scan. With no counts acquired in an
LOR during the transmission scan, the ACF for this LOR is undefined. This effect is
corrected for by assigning a constant, non-zero number of counts to the transmission
bin to allow an ACF to be calculated for these 'no-count' lines-of-response. The
attenuation along these lines is therefore underestimated'. The longer the
transmission scan time, however, the more counts are detected and the better the
statistician and image quality of the transmission data. This leads to the interesting
observation of a scan time dependence of the accuracy of attenuation measurements
with rod sources. This dependence is illustrated in fig. 6.2. We have measured the
average attenuation of a plastic cylinder (20cm diameter) and an ellipsoidal phantom
(23cm by 30cm, simulating the abdomen), both filled with water, on the ECAT 951R
for different length of transmission scans. For both phantom scans the attenuation
value of water decreased with the scan time, and is constant only for transmission
scan times of 5min and longer. For scan times shorter than 5min the measured
attenuation in the larger phantom is lower compared to the attenuation by the
cylinder. Fewer transmission counts are detected when scanning the ellipsoidal
phantom, and more lines-of-response must be adjusted to avoid undefined ACFs.
This example illustrates, that for PET tomographs equipped with rod sources,
transmission scan times may not be reduced below a minimum scan time without
jeopardizing the quantitative accuracy of the attenuation measurement.
Insufficient counting statistics further result in streak artifacts along the longest
and most attenuating path lengths. Streak artifacts arise from noise correlations in
low count transmission data that are reconstructed with filtered back-projection. A
measure of this 'streakiness' as a function of transmission scan time has been
described in more detail in our recent reference on attenuation correction in whole-
body PET imaging [Beyer, 19974 Streak artifacts, quantitative inaccuracies and
In contrast to our implementation of the calculation of the ACFs, others have reported over-
estimations of the measured attenuation [Ostertag, 1989; Freedman, 1996]. In both cases the statistical
accuracy of the acquired transmission data determines the amount of over- or underestimation of the
measured attenuation.
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statistical deviations may be limited by filtering the transmission profiles prior to the
calculation of the ACF and prior to reconstruction [Palmer, 1986; Dahlbom, 1987].
Several reconstruction techniques [01linger, 1992; Beyer, 1993; McKee, 1994] and
filtering schemes have been proposed, of which limited axial and radial filtering
[Daube-Witherspoon, 1996] offer the best compromise between noise reduction and
spatial distortion [Stearns, 1994]. A spatially varying blur may be introduced by
angular smoothing, and is greatest for features far away from the centre [Daube-
Witherspoon, 1997]. Alternatively, the use of iterative image reconstruction
techniques has been shown to improve image quality of short transmission scans
[01linger, 1994; Fessler, 1994; Fessler, 1995] without introducing spatial
degradations that translate into quantitative errors [Freedman, 19961.
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Figure 6.2 Measured attenuation coefficient of water as a function of the transmission scan time. Data
from ECAT 951R at the PET Facility at the University of Pittsburgh Medical Center, USA. Two
phantoms were used to simulate little and significant attenuation: cylinder (20cm) and ellipsoidal
phantom (23cm by 30cm).
An alternative approach to rod transmission scans is to use a higher gamma ray
flux for short duration and high count density scans, while eliminating the dead time
limitations of the detector closest to the source. Derenzo and colleagues first
suggested the use of a single photon emitting point source of 133Ba (7.8year half-life,
356keV) in 1975 [Derenzo, 1975]. However, a similar approach was implemented
only in 1994, when deKemp and Nahmias proposed the use of a modified rod source
transmission scanning technique [deKemp, 1994]. The new source was a rod source
of higher activity (70MBq) operated in singles mode, rather than in coincidence
mode, on a full-ring scanner (ECAT 953). The authors showed that by removing the
coincidence requirement for the high activity rod source the transmission countrate
increased by a factor of seven, and only the dead time losses in the detector opposite
to the source were shown to affect the overall countrate. However, when operating
the rod sources in singles mode the axial position of the incident photon beam is
undefined and limited only by the collimator width and depth.
To improve spatial resolution [deKemp, 1994] rod sources operated in singles
mode were soon replaced by 137Cs point sources [Karp, 1995]. In order to employ the
transmission data from a ' 37Cs point source scan for attenuation correction of the PET
emission data, the difference in photon energy from the transmission source and the
radionuclides in PET (511keV) must be accounted for. 'Cs emits beta particles and
a monoenergetic 662keV y-ray [Lide, 19921. In case of pre-injection singles
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transmission scans, the attenuation coefficients at 511keV may also be obtained by
simple scaling of the 662keV values [Yu, 1995]. Alternatively, segmentation may be
used to correct for the energy dependence of the attenuation coefficients, and to
correct for the effect of scatter (section 6.1.3).
Furthermore, singles transmission data acquired with point sources suffer from
high susceptibility to emission contamination (section 6.1.2) and scatter (section
6.1.3), due to the fact that lines-of-response are only defined by two points in space:
the detector location of the event and the source position (fig. 6.3b). While the axial
localization of the point source is improved, scattered photons may not be simple to
reject (fig. 6.3b).
0 rejected LOR
• 
accepted(scatter) LOR
accepted LOR
	
accepted LOR
a) rod source, coincidence mode 	 b) singles source, singles mode
Figure 6.3 Detection principle of standard PET transmission sources: (a) ' 8Ge/68Ga rods, (b) 'Cs
point sources.
A recent design, that has been adapted for the ECAT ART [Townsend, 1999a]
and the singles sources in the PET/CT, uses a collimator to limit both axial and
transverse scatter in the singles transmission scan [Bailey, 1997a; Watson, 1997].
The point sources are kept in lead shielded containers, each of which is attached to
the end of each partial ring, opposite to each other at the side where the partial rings
are closest (fig. 6.4). Each point source consists of a pin-sized capsule with an active
region of less than 3mm in diameter that contains 550MBq of 'Cs. The pins are
chain driven and move over the first crystal ring and along the main axis of the FOV
when the transmission scan is initiated. Each source is covered by a multi-slit
tungsten collimator with 12 slits and an axial pitch of twice the axial crystal ring
pitch. Each slit collimates the emitted 662keV photons into a transaxial fan covering
the opposite detector bank with an axial FWHM of about one detector block width
(5.4cm). The slits of the two collimators are axially interleaved to provide full
sampling of all crystal rings as the two 'Cs sources, offset by one ring, are
simultaneously rastered axially behind the collimators for the duration of the
transmission scan [Watson, 1999]. For a given source position data are acquired for
an integral number of gantry revolutions, before both sources move one or two
crystal rings, when the transmission data are acquired post-injection or pre-injection,
respectively (fig. 6.4).
The high activity level of the cesium sources compared to the germanium rods
results in a significant reduction of statistical noise and thus in an improved SNR in
the singles based transmission images [deKemp, 1994]. For example, when scanning
a 20cm water-filled cylinder in the ECAT ART with rods and singles sources, we
observed countrates of useful events of 27kcps and 521kcps, respectively. This is in
source A
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b) Post-injection
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agreement with countrate estimates for singles given by Smith et al. [Smith, 1997]
who mention a factor of 10 to 20 difference when compared to coincidence
countrates.
detector bank
a) Pre-injection
Figure 6.4 Arrangement of the 137Cs singles sources with multi-slit collimators in the ECAT ART. As
the sources raster along the axial FOV, only one source is exposed at the time: (a) scan start, source A
is behind a collimator, source B is exposed, (b) sources A and B are moved by one crystal ring to
expose source A while source B is behind collimator, (c) last position of the sources over crystal ring
24, source A is exposed and source B is behind collimator.
The SNR also increases (Noise-to-signal decreases) as the proportion of randoms
and scattered events decreases. Because random events do not exist in singles scan
mode SNR of singles based transmission scans is higher than the SNR of attenuation
measurements with rod sources. The noise-to-signal ratio for transmission images of
a 20cm diameter uniform water-filled cylinder, plotted as a function of the axial slice
position is shown in fig. 6.5.
20
Rod source
Point source
	 	 I-
24
	 47
Image plane number
Figure 6.5 Standard deviation [%] for
transmission images of a 20cm water-
filled cylinder scanned with two 30MBq
rod sources, and two 550MBq cesium
point sources for 3min each.
Transmission data were acquired with two standard 30MBq 68Ge/68Ga rod sources,
and two 550MBq 137Cs point sources in singles mode for the same, 3min, scan time
in each case. For each study, a 15cm diameter circular ROI was drawn on the image
of the cylinder in each transaxial slice, and the ratio variance/mean (noise-to-signal
a)	 b)
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ratio) plotted as a function of axial position. The improvement in signal-to-noise,
particularly at the extremities of the axial FOV, with singles scanning compared to
coincidence scanning with the rod sources is clearly demonstrated by the graphs.
The improved noise-to-signal ratio observed in the phantom study carries over
into the visual quality of clinical studies, as shown by the thorax scan of a normal
volunteer in fig. 6.6. Both scans were for 3min per bed position and approximately
10 times more counts were acquired with the point sources compared to the rods. For
comparison a transverse CT image of another patient of similar body posture is
shown in fig. 6.6c. The CT scan was acquired for 40s. Note that a countrate was not
recorded. The strength of the X-ray source was, however, estimated to correspond to
a single photon source that produces a non-attenuated countrate of 2. 1012kcps at a
detector 75cm away from the source. The six order of magnitude higher countrate in
CT carries over into improved transmission image quality (lower noise) compared to
rod and singles based transmission images as seen in fig. 6.6c.
Figure 6.6 Transmission image through the mid-thorax of a healthy volunteer, reconstructed from
transmission measurements with (a) rods, and (b) singles sources on an ECAT ART. Total scan time
was 3min. Images were reconstructed with 2D FBP. For comparison the transverse CT image of a
human thorax (different patient) is shown in (c).
Due to the lower source activity of the rods, longer transmission scan times
greatly improve image quality of the reconstructed transmission image (fig. 6.1).
This effect is less noticeable in case of singles transmission data acquired pre-
injection (fig. 6.7a) and CT (fig. 6.7b). While in standard CT increased scan time
may be simulated by repetitive rotation of the tube/detector-assembly around the
patient for a single slice, longer scan times in CT are achieved for a given slice width
by reducing the table increment, and hence reducing the pitch value. Alternatively,
the anode current and the rotation time may be increased (higher mAs-product), a
technique that is unavailable to either rod or singles sources that both have a fixed
source strength. CT images acquired with three different scan times are shown in fig.
6.7b. Note the generally low noise and high uniformity of the transaxial sections
through the CT transmission images.
The amount of total scan time spent for the transmission scan as part of a whole-
body exam is an issue of great dispute. Frequently, 10min to 20min were argued to
be necessary for sufficient image quality per bed position [see [Beyer, 1997a]].
However, we have shown that less than half of the total scan time available should be
dedicated to the transmission acquisition, in order to minimize noise in the corrected
emission images [Beyer, 1997a]. We have acknowledged the noise contributions
from the attenuation data to the noise in the corrected emission image [Holm, 1996],
and we show that segmentation can help reduce the noise propagation significantly
[Beyer, 1997a]. In our experience with the ECAT ART, transmission scan times as
low as 2min are acceptable for whole-body protocols, if segmentation is applied to a
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reconstructed 2D estimate of the measured attenuation map (fig. 6.8). We use the
adaptive segmentation approach by Xu et al. [Xu, 1996] that reduces noise while
maintaining a certain degree of regional variability of tissue densities (e.g. in the
lungs).
a)
b)
1min	 3min	 6min
1.98	 3.8s	 5.7s
Figure 6.7 Scan time and image quality in transmission imaging with (a) singles sources, and (b) CT.
The singles images (a) were acquired with lmin, 3min, and 6min (from left to right) pre-injection scan
times. A standard CT scan (b) was acquired for 1.9s, 2 . 1.9s, and 3• 1.9s (from left to right) rotation
time per slice.
To study the efficacy of the Xu algorithm applied to rod source transmission
scanning with the ECT ART, we designed a whole-body phantom that consisted of
an ellipsoidal trunk (30cm by 20cm) in which we immersed a 5cm diameter compact
Teflon cylinder and a plastic bottle (500mL) filler with air, both parallel to the main
axis of the phantom (fig. 6.8a). The background was filled with water. In addition
two 500mL bottles were attached to either side to simulate arms, and two 500mL
saline bags were placed on the phantom to simulate attenuation from breasts.
Figure 6.8 Whole-body phantom (a) to study the efficacy of attenuation map segmentation for the
ECAT ART. Transaxial views through the (b) measured, and (c) corresponding segmented attenuation
images show good image quality after segmentation for 2min and 5min scan times. At very short scan
times (lmin) noise streak artifacts in the measured data are falsely identified as soft tissue densities,
and lead to biased segmented attenuation information.
The whole-body phantom was scanned for lmin, 2min, and 5min and the
transmission images reconstructed with 2D FBP. Segmentation suppresses noise and
reduces artifacts for scan times as low as 2min. For very short scan times (lmin)
artifacts from the measured attenuation data carry over to the segmented image and
may bias the quantitative accuracy in particular in image planes close to the axial
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edge of the FOV. In case of whole-body studies and very short transmission scan
times (s2min per bed position) we therefore suggest to assemble a multi-bed
transmission volume before the segmentation to help reduce artifacts.
Other studies have shown, that transmission acquisitions with rod sources as short
as 50s may be able to provide accurate attenuation data [Bilger, 1999]. Frequently,
problems in identifying bone structures in ultra-short transmission scans are reported
[Bilger, 1999; Lewellen, 1999], which lead some investigators to neglect bone
structures completely during the segmentation [Mix, 1999]. This is illustrated in fig.
6.9.
J.
Oka
a)	 b)
Figure 6.9 Segmentation of very short rod based transmission scans: (a) measured lmin transmission
image, (b) segmented image. High dense tissues (Teflon insert) are no longer separable from
background densities (water).
6.1 .2 POST-INJECTION TRANSMISSION SCANNING
Post-injection transmission scans can be performed immediately after the
emission acquisition without moving the patient off the bed, thus limiting the chance
of patient motion and consequent misregistration between the emission data and their
ACFs [Daube-Witherspoon, 1988]. Unlike pre-injection transmission scans the total
scan time for the PET exam is limited to the time for the emission and transmission
scan. The patient must not be re-scheduled for the emission scan and patient
throughput is optimized.
Post-injection transmission scanning has been proposed for singles sources
[Smith, 1997; Smith, 1998] after it was successfully applied to rod sources
[Thompson, 1989]. However, due to the single photon acquisition scheme,
sophisticated correction techniques must be developed to account for both the
contamination from the emission activity in the transmission data, and the energy
difference. Note that the use of energy windows was shown to be unsuccessful due to
the inability to differentiate the energy spectra of ' 37Cs and the PET radionuclide
despite the good energy resolution of NaI(T1) scintillators (9%-10%) [Karp, 1995].
Instead the amount of emission contamination may be estimated from mock scan
measurements during or after the post-injection singles scan, without exposing the
point sources [Smith, 1997]. By subtracting the mock scan emission counts after
some scaling, the post-injection transmission data acquired with /37Cs may be
corrected for the energy difference at the same time [Smith, 1998]. Alternatively, the
use of an interleaved collimator and a reference singles scan was shown to yield
accurate results for post-injection transmission imaging [Watson, 1999].
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Emission contamination, like scatter, leads to underestimation of the measured
attenuation coefficients, due to the artificially increased countrate per LOR from
contributions from the emission activity (table 6.A). In a previous study post-
injection singles attenuation correction using segmentation was demonstrated to be
as accurate as coincidence transmission correction in clinical patient studies [Smith,
19971. The segmentation method offers low noise attenuation correction, but is of
limited flexibility in areas of lung an soft tissue boundaries, head and neck studies
(higher bone fraction), and when extremities are inside the FOV [Smith, 1998].
Table 6.A Attenuation measurements of NEMA phantom with two inserts (air, bone). The phantom
was filled with water (pre-injection), and water+37MBq ' 8F (post-injection). Scan times were: 30min
(rods), 16min (collimated), and 42s (CT). Attenuation values are calculated from the average of
attenuation coefficients in circular ROI (3cm diameter) over the central 25 image planes.
Air
Pre-inj Post-inj
Water
Pre-inj Post-inj
CT 130 [HU] -1001.1±0.9 -1000.9±0.9 0.2±0.3 0.9±0.5
Rods [cm-1] 0.024±0.001 0.018±0.001 0.0973±0.0003 0.0641-0.004
Singles [cm 'I 0.0103±0.0007 0.006±0.001 0.0919±0.0008 0.0931-0.009
Theory [cm-11 —0 0.096
An alternative technique has been suggested for post-injection singles scans,
which estimates the emission contamination from an independent 'mock' scan. The
'mock' scan subtracted transmission image is then scaled to account for scatter and
the lower attenuation at 511keV. This method results in accurate but somewhat
noisier images than the segmentation method [Smith, 19981. This method is,
however, more versatile and applicable to the entire body. Watson et al. have
adopted the 'mock' scan method and combined it with a dual collimated point source
(fig. 6.4). The 'mock' data are acquired for the two sources alternatively for the
source that is behind the collimator while the contaminated transmission data are
acquired for the exposed source, before the acquisition reverses after the two source
were moved by one detector ring [Watson, 1999]. In a series of 25 clinical patients
with thoracic indications, less than 2% difference was found in the pre- and post-
injection estimates of the attenuation maps. The transmission image noise was found
to be 17% higher in the latter case which translated into a 10% higher noise level in
the reconstructed emission images after post-injection attenuation correction
[Watson, 19991. The authors pointed out that good clinical performance was
achieved with post-injection singles transmission scans, that can be further improved
the 'mock' method would be combined with segmentation of the attenuation map
and quantitative iterative reconstruction [Watson, 1999]. Another study, dedicated to
the comparison of clinical performance of post-injection singles and coincidence
attenuation correction, supported the hypothesis that singles transmission corrected
whole-body PET images are superior in image quality [Bedigian, 1997]. Post-
injection emission contamination does not affect the accuracy of CT based
attenuation measurements as discussed in section 4.3.3.
6.1.3 SCATTER IN TRANSMISSION SCANS
While emission contamination contributes to the noise of the transmission scan in
post-injection acquisitions only, scatter and random events are present in both pre-
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and post-injection transmission acquisitions. Electronic windowing can applied in
rod source transmission scans when operated in coincidence mode (section 2.3.1) to
reduce noise contributions from scatter and randoms by accepting only events that
are in line with the location of the rod source. Nevertheless, uncorrected small angle
scatter causes the measured attenuation value of water, for example, to be less than
the tabulated value at 511keV. This is shown in fig. 6.2, where the measured
attenuation for long scan times (R=0.092cm-1) is lower than the theoretical
attenuation coefficient of water at 511keV (tt =0.096cm-1 ). For a head size water-
filled cylinder, for example, the measured attenuation was shown to be 7%-9%
below the theoretical value due to scatter in the transmission scan [Digby, 1989]
affecting the measured attenuation mostly in the centre of the phantom. A simple
multiplicative correction of the measured transmission data to account for scatter is
not applicable to heterogeneous objects, and although segmentation of the
transmission image is sometimes used to create attenuation maps not affected by
scatter, scatter is typically not corrected in clinical rod source transmission data.
When first introduced, uncollimated singles sources were shown to be prone to
increased scatter fractions that result in 30%-40% underestimation of the measured
attenuation coefficient [Bailey 1997a]. For example, reconstruction of uncollimated
data gave values for water in a 20cm cylinder of 0.055cm -1-0.069cm-1 , while the
collimation helped reducing the number of accepted scatter, thus bringing the
measured attenuation values of 0.080cm-1 to 0.085cm-1
 closer to the tabulated values
of 0.087cm-1 for 662keV. The scattering probability and the angle of scattering are
both smaller for 662keV photons than 511keV photons if the photopeak window is
set to ±25% of the peak energy [Yu, 1995]. Dual-energy window scatter correction
[Grootoonk, 1992], initially proposed for emission scanning, has been adapted to
correct singles transmission scans for scatter and to yield attenuation coefficients
close to the theoretical values [Yu, 1995].
Scattered events in CT may not be rejected based on energy discrimination
because a photon flux is measured rather than individual photons. Scatter induces
artifacts in the reconstructed CT images that are very similar compared to beam
hardening [Glover, 1982], and may dominate over latter in regions of high density
(pelvis, shoulders) [Joseph, 1982]. The detected scatter intensity has very little high
spatial frequency content because of the isotropic distribution of the Compton
process. Therefore, in most cases, scatter contributions may be approximated by a
constant [Glover, 1982], while in projections with low primary photon flux residual
scatter artifacts after correction may persist. The artifact propensity was shown to
depend on the scatter-to-primary ratio [Joseph, 1982] and the irradiation geometry or
scanner generation [Kanamori, 1985]. Scatter in CT also introduces a quantitative
bias that is larger in the centre of the object and decreases towards the edge of the
FOV of third generation CT scanners due to the collimation effect of the individual
detector elements [Kanamori, 1985]. For a 30cm, water filled cylinder, for example,
a scatter induced decrease of less than 10HU was measured in the centre of the
cylinder. The magnitude of the decrease is, however, a function of additional objects
in the FOV [Joseph, 1982]. Scatter correction may be performed by adding an
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estimated scatter fraction at each projection to the corresponding logarithmic
attenuation data prior to the reconstruction [Glover, 1982].
Table 6.B summarizes the comparison of standard PEI' transmission sources and
CT for attenuation correction of PET emission data. The table is not comprehensive,
but offers parameters based on which the use of rods, singles, and CT attenuation
measurements can be compared. CT, if available in a combined device, offers
quantitative attenuation information of highest accuracy at the cost of maximum
exposure and the necessity of fairly extensive post-acquisition treatment (chapter 5).
Rod source scanning in coincidence mode will be replaced by singles scanning
because of the shorter scan time and the better SNR characteristics of the latter.
Table 6.B Comparison of standard PET transmission sources and CT for attenuation measurements in
PET.
Rods Singles CT
Source strength Low: 5550MBq High: 51,100MBq Very high:	 -1091v1Bq
Dimensionality 2D 3D, single slice
rebinning
2D
Collimation Electronic windowing Axial, slotted Axial and transverse
Residual scatter 9% in 2D 540% (uncollimated) 510HU
513% (collimated)
Pre-injection
Min scan time [min] 2-3 2-3 <lmin
Accuracy High High High
Noise High Low Very low
Post-injection
Min scan time [min] /-3 4-6 51
Accuracy High High High
Noise High Low Very low
6.1.4 PRELIMINARY SUMMARY
The quality and accuracy of PET transmission scans acquired with rod and singles
sources is strongly affected by the statistical accuracy of the acquired data (e.g.
source strength and scan time). Individual measurement of emission contamination
in post-injection transmission studies [Daube-Witherspoon, 1988] further increase
the noise of the corrected transmission data. Segmentation techniques [Huang, 1981]
and adaptive segmentation algorithms [Xu, 19961 were suggested to limit noise
propagation from measured transmission data. Although originally not intended lot
attenuation correction, CT transmission data offer significant advantages over
standard PET transmission measurements. CT based attenuation data are not affected
by post-injection activity contamination and can be acquired in a fraction of the time
required for standard transmission scans. The same anatomical information that is
used to complement the PET images can therefore be employed for the purpose of
CT-based attenuation correction to yield an emission image quality that is superior to
standard correction techniques.
6.2 CHALLENGES FOR CT BASED ATTENUATION CORRECTION
In order for the CT-based attenuation correction algorithms described in the
previous sections to generate accurate ACFs, a number of assumptions were made:
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• the PET and CT volumes are accurately aligned,
• both CT and PET cover the same transaxial field-of-view,
• CT images represent attenuation maps measured at some mean photon energy.
In practice, however, these assumptions do not always hold for all parts of the
body. The quality of CT images is often degraded by artifacts arising from
involuntary patient motion, such as respiration and cardiovascular motion. These
artifacts represent themselves as double degraded contrast or image blurring, in
particular in transition regions to either low or high attenuation (e.g. lung
boundaries), and may thus introduce a quantitative bias in the CT-based attenuation
correction of the available PET emission data. Other challenges to CT-based
attenuation correction may arise from intrinsic limitations of the CT, such as
truncated field-of-view and beam-hardening. These effects are of particular
importance when scanning large patients and the lower abdomen. The following
sections deal with some limitations of CT imaging that are important when using the
available CT information for attenuation correction of PET emission data in a
combined PET/CT tomograph.
6.2.1 PATIENT MOVEMENT
Despite the generally short scan times in CT the quality of CT images is often
compromised because of involuntary respiratory and cardiac motion that may blur
lung detail [Tarver, 1988] or double images of pulmonary vessels and fissures
[Schoepf, 19991. With the introduction of spiral CT motion artifacts to date are
limited almost exclusively to the lingula and the lower lung segments in close
contact with the left ventricle [Remy-Jardin, 1993]. Other areas are, however, still
affected by involuntary patient motion with disturbing frequency [Ritchie, 1992].
The challenge of motion artifacts for CT-based attenuation correction arises from the
fact that PET emission information, which is acquired over several cardiac and
respiratory cycles, is corrected for attenuation based on CT transmission information
that really represents the tissue distribution only at one point in time of the emission
acquisition (assuming periodic undisturbed motion). Since motion artifacts are
particularly obvious in regions with highly variable tissue attenuation they may
introduce artifacts and biases into attenuation corrected emission data similar to
biases from tissue mis-classification during the segmentation of attenuation maps
(section 5.2.2). A better understanding of the affect on CT image quality and the
accuracy of CT-based attenuation is therefore needed to adapt CT-based attenuation
correction to routine clinical PET/CT imaging. This section illustrates the effect of
CT image artifacts from respiration and cardiovascular motion on reconstructed PET
images using the CT transmission information.
6.2.1.1 RESPIRATORY MOTION
Figure 6.10 shows the transaxial cross-sections through the CT and ungated PET
volume of a thorax of a PET/CT patient. The CT scan was acquired during breath
holding with the lungs inflated, while the PET scan was acquired during respiration
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at rest over a period of 10min. Clinical CT scans are typically acquired during breath
hold with the lungs inflated during the CT acquisition. For example, using a 5mm
slice width and a pitch 1.6, the Somatom AR.SP allows to scan 80mm during a single
breathold (24s). Due to the longer scan times in PET (5-10 min per bed position) the
patient breaths normally and the resulting PET image is an integration over many
respiratory and cardiac cycles. The misalignment of the anterior chest wall between
the PET and CT images is clearly seen (fig. 6.10a and b). When using the CT
transmission images for attenuation correction, this misalignment may lead to an
underestimation of the attenuation along LORs passing through that portion of the
chest wall, with subsequent underestimation of true tracer concentration in this
region. As a result the anterior chest wall 'disappears' in the corrected emission
images (fig. 6.10c).
a)	 b)	 C)
Figure 6.10 Transaxial sections through (a) CT and (b) non-corrected PET volume of the thorax of a
patient undergoing a combined PET/CT scan. The CT scan was acquired during breath holding with
the lungs inflated, which displaced the anterior chest wall seen on CT (a) from its average position
during respiration (b). CT based attenuation correction may thus introduce a bias into the corrected
emission image, seen as a disappearing anterior chest wall on PET after attenuation correction (c).
Interestingly, this artifact is not observed in all patient studies when the CT scan
was acquired with the lungs inflated. We are not able to explain this observation. It
may, however, be affected by variations in the respiration cycle during the PET
acquisition. The average patient age was relatively high (57 years, see section 7.1.1),
and there was a prevalence of older patients (32/70 patients were older than 60
years). In addition most of the patients were in serious conditions, which may have
prevented them from following the breathing instructions of the CT operator. This
was verified on a few occasions after the PET/CT scan. All patient studies performed
since the beginning of 1999 were therefore performed without breathhold during the
CT exam.
Nevertheless, since then we did observe occasional alignment errors within the
thorax independent of the breathing pattern during the CT acquisition. Figure 6.11
illustrates misalignment of thoracic lesions seen on CT and PET in a patient with
emphysema who was scanned on the PET/CT for two contiguous bed positions
covering the entire thorax. Two lesions suspicious of malignancy were found in the
PET images. Although two nodules were seen in the same area in the CT image
volume, these lesions were not brought into alignment by simple image fusion.
While the anterior nodule on CT corresponded to the focal FDG uptake in the PET
image (fig. 6.11a), the lesion close to the chest wall was offset from the
corresponding focal FDG accumulation by about 8mm in the horizontal and 13mm in
11" PETIL00100111
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the vertical direction (fig. 6.11b). The CT lesion close to the chest wall was further
away from the centre of the FOV than the anterior lesion, which was likely less
affected by lung inflation and respiratory motion.
Figure 6.11 Misalignment of lung nodule in the mid-thorax in a patient undergoing a combined
PET CT scan. Transaxial CT, PET, and fused PET/CT images are shown. Image sets show (a) anterior
lesion, and (b) lesion close to the chest wall. PET shows corresponding focal FDG accumulation.
PET CT image fusion aligns FDG uptake and lung nodule for anterior lesion. Misalignment of about
10mm in the transverse direction was noted for the chest wall lesion due to breath holding during CT
scan.
Respiration does introduce thoracic changes, in particular in the lower lung (fig.
6.12). During deep inspiration, the ribs of the anterior chest wall shift upward, due to
contraction of the intercostal muscles, and the central portion of the diaphragm shifts
downward due to contraction of diaphragmatic musculature. The thoracic cavity
increases in volume due to anterior bulging of the anterior chest wall and inferior
shift of the diaphragm [Shirakawa, 1994]. Using MRI studies of healthy volunteers,
an average movement of the diaphragm over 15mm during the course of respiration
was estimated [Fredrickson, 1995].
71"
a) expiration	 b) inspiration
Figure 6.12 Schematic of thoracic changes as introduced by respiratory motion [from Ganong, 1985].
Dunng inspiration the central portion of the diaphragm shifts downward, and the thoracic ca% ity
increases in volume.
While this movement should not affect CT scans that are acquired at breathhold, it
may affect image quality of CT scans acquired during normal respiration. This was
previously illustrated in fig. 1.15. Another patient study in fig. 6.13 illustrates the
magnitude of the movement of the diaphragm and the resulting image artifacts. A 49
year old male suffering from lymphoma was scanned on the PET/CT. A helical CT
was acquired over an area from the upper thorax to the level of the liver. The PET'
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scan was performed over three contiguous bed positions for 7.5min per bed. The
patient was able to keep his arms over his head and outside the FOV for the duration
of the PET/CT scan. Figure 6.13a illustrates the magnitude of the motion of the
diaphragm, which introduces discontinuities in the axial tissue density distribution.
These irregularities may translate into a quantitative bias and reduced image quality
if the CT images were used for attenuation correction of the corresponding PET data
(section 5.2.5). The corresponding PET image, however, did not show any noticeable
artifact that could be related to the artifacts around the diaphragm. Instead, fig. 6.13b
shows that the prominent artifacts arising from the low sensitivity in the regions of
the overlapping bed positions.
CT	 PET
b)
Figure 6.13 The effect of the motion of the diaphragm due to normal respiration. Coronal sections
through (a) the CT image, and (b) PET image after CT based attenuation correction. Artifacts from the
motion of the diaphragm are seen in a number of transaxial locations in the CT (a). No artifacts are
seen on the corrected PET image (b) in these areas. Note, however, the broad bands of increased noise
in areas of overlapping bed positions.
The area of the lower lung fields and upper abdomen is notoriously difficult to
evaluate in PET images due to the high background activity of FDG compared to
upper lung fields. It was shown by Miyauchi and Wahl that normal FDG uptake
follows a craniocaudal gradient, with the highest background activity found in the
lower posterior lung (41% higher than in the upper anterior field [Miyauchi, 1996b]).
The high background activity together with the motion of the diaphragm and upper
lung during respiration were shown to contribute to the phenomenon of occasional
false-negative lesions in this region. When gating the PET acquisitions, the spatial
blurring in the transition zone from the lower lung to the liver was reduced and the
tumour-to-background of lesions in that area increased [Miyauchi, 19964
6.2.1.2 MYOCARDIAL MOTION
In addition to the motion of the chest wall, cardiovascular activity results in a
reduced spatial image resolution. Exact CT and PET alignment of detailed structures
in the anterior of the thorax (mediastinum) is therefore not always possible. Incorrect
ACFs as determined from the available CT images may thus be generated in the
region of the myocardium and mediastinum if the original CT attenuation map is
mis-aligned with the PET tracer distribution. From our experience we observe both
good and imperfect alignment of the myocardium and myocardial FDG accumulation
with similar frequency (fig. 6.14). The PET data are always acquired without gating,
a)	 b)	 C)	 d)
PET, corrected 0
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which leads one to assume that the accuracy of the alignment is affected by the time
the relative cardiac cycle captured in the CT scan.
a)	 b)
Figure 6.14 Examples of (a) good, and (b) imperfect alignment of the myocardium in combined
PET/CT studies.
Although the current PET/CT acquisition protocol is not ideal for myocardium
PET studies, our observations may help to study the affect of myocardial motion on
the detectability of lesions in the mediastinum. Figure 6.15 shows a patient study
where the spatial extent of the myocardium on CT (fig. 6.15a) did not correspond to
the extent of the myocardial FDG accumulation in the uncorrected PET images, as
shown in fig. 6.14b. The CT attenuation map (that was misaligned in the region of
the heart) was used to calculate the ACFs (section 5.2.5) that were applied to the
PET emission data. The FDG uptake in the anterior wall of the left ventricle was
underestimated (fig. 6.15c).
Figure 6.15 Effect of imperfect alignment of CT attenuation maps and PET emission data in the area
of the mediastinum. The FDG accumulation in the heart in the uncorrected PET image (b) was
uniform. After using the available CT transmission information (a) for attenuation correction, the
anterior uptake in left ventricle was underestimated (c). The effect of the misaligned attenuation map
on the tumour-to-background ratio of a lymph node suspicious for malignancy (d) was unknown. The
sections in (c) and (d) were 12mm apart axially (i.e. four image planes).
This illustrates the magnitude of the bias that is generated if the PET emission
activity is corrected for attenuation based on a misaligned attenuation map. The bias
introduced in other areas of the corrected images can not be estimated due to the lack
of a knowledge of the 'true' activity distribution. However, the misalignment of the
attenuation map is likely to affect other areas in the corrected emission image
through the forward-projection step to calculate the ACFs for oblique LORs, with a
bias magnitude that depends on the amount of the over- or underestimation of the
ACFs along LORs intersecting the region of interest (fig. 6.15d).
a)
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6.2.2 BEAM HARDENING
In order to scale the CT attenuation image from X-ray beam energies to 511keV, a
mean value for the energy of the X-ray beam is assumed. The results of Kinahan et
al. [Kinahan, 1998] show that, for the purpose of the hybrid algorithm (section
5.2.5), the polychromatic energy spectrum of a typical X-ray source of 140kV p can
be approximated by an average value of 70keV. However, as discussed in section
1.2.3.4 the X-ray spectrum is modified by the effect of beam hardening, in which
lower energy (soft) X-ray photons are preferentially attenuated, causing the mean
photon energy in the beam to increase (harden) with depth in the patient.
Beam hardening results in a non-linear relationship between attenuation and the
projection data. Such a non-linear relationship is generally solved by an iterative
approach or using correction coefficients obtained from a look-up table. Modern CT
scanners (including the Somatom AR.SP) are equipped with algorithms that perform
excellent beam hardening corrections for elliptical objects up to the size of a patient
torso. Although in many imaging situations, beam hardening is satisfactorily
corrected, for large patients, the effect may still be significant. The presence of arms
in the FOV for CT scans on the PET/CT scanner enhances the effect further, which is
particularly problematic in the abdomen as shown in fig. 6.16, when standard beam
hardening correction procedures are inadequate.
abdomen
Figure 6.16 The effect of beam hardening in CT. Two patients (similar weight, 80kg) were scanned
with CT at 130kV p
 (a) without the arms inside the FOV, and (b) with the arms next to the body. Beam
hardening is present in (a) but properly corrected. The presence of arms enhances the effect of beam
hardening that can no longer be corrected for properly by look-up tables (b). The result is an area of
decreased attenuation along the two arms introducing apparent non-uniform attenuation in organs with
otherwise uniform attenuation: compare liver (L), kidney (K), and spleen (S) in (a) and (b).
In order to estimate the effect of beam hardening in the CT transmission images
on the image quality and quantitative accuracy of the reconstructed and corrected
PET emission data we performed a phantom experiment simulating clinical scan
conditions in an abdomen scan. We used an ellipsoidal phantom that measured 23cm
by 29cm in the transaxial direction and that was 20cm deep (volume 9.4L). The
phantom was filled with 18F activity diluted in water at an activity concentration of
about 40kBq/mL, typical for a whole-body scan of a 70kg patient injected with
360MBq of FDG. Both emission and post-injection CT transmission scans were
acquired. First, emission data were acquired for 8min with the abdomen phantom
centred in the FOV of the PET. A spiral CT scan of the phantom was then acquired
(130kVp, 16OrnAs, 5mm slice width, pitch 1.6) over the same axial extent that was
covered by the PET. To simulate the effect of arms positioned next to the body
bed
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surface, two plastic bottles of 500mL each were filled with the same activity
concentration of 18F as the main torso phantom, and attached to the left and right side
of the ellipsoidal phantom parallel to the main scanner axis. A second emission scan
was acquired for another 8min followed by a second spiral CT scan using the same
scan parameters as before. Transaxial and coronal sections through the CT images of
both phantom arrangements are shown in Figure 6.17. The images are thresholded
(from —124HU to 96HU) to increase the visual perception of the beam hardening
artifact caused by the 'arms' (bottles at the side of the phantom). Beam hardening
artifacts are visible as broad streaks along the 'arms' in the transaxial image (fig.
6.17b) as well as the increased statistical noise in the coronal view of fig. 6.17b.
'arms'
ROI A
	
ROI B
a)	 coronal view	 transaxial view	 b)	 coronal view	 transaxial view
Figure 6.17 Artifacts arising from beam hardening in CT study of a phantom simulating the abdomen
(a) without arms and (b) with 'arms' closely attached. Uncorrected beam hardening reduces measured
transmission values across lines of high attenuation, for example, along the arms in (b).
The effect of beam hardening on the accuracy of the measured transmission
values and the reconstructed activity in the phantom was estimated by using two
circular regions of interest (each 3cm diameter). While one region of interest (ROI A)
was placed in the central area of the transaxial image planes unaffected by beam
hardening, the other region (ROI B) was positioned along the lines connecting the
two arms where maximum disturbance from beam hardening is expected. The
transaxial location of ROI A and B is shown in fig. 6.17b.
The regional variation of the measured attenuation in the CT images in regions A
and B is plotted as a function of the axial CT image plane in fig. 6.18. It can be seen
that when only scanning the abdomen phantom the measured attenuation is uniform
across the phantom (fig. 6.18a). The mean ROI values for both regions A and B for
the central 35 planes is —1.5±0.6 H11. This is well within the given accuracy of the
scanner for estimating the attenuation value of water (table 4.H) unaffected by the
presence of post-injection emission contamination. After placing the arms inside the
FOV, measured attenuation in region B along the 'arms' was reduced to —13±3 HU
while the central region remained unaffected (-1.0±0.8 HU). Beam hardening thus
introduced a maximum 1% bias in the measured attenuation values between the
arms. In addition the pixel standard deviation in region B (beam hardening) doubled
as can be seen from the extended error bars in fig. 6.18b. The purpose of subsequent
data analysis was to estimate the effect of lower attenuation values and increased
noise in the measured CT transmission data on the reconstructed corrected emission
activity in the phantom.
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Figure 6.18 Mean pixel attenuation values [HU] in regions A and B as a function of the axial image
plane in CT volumes of the abdomen phantom acquired (a) without the arms, and (b) with the arms
inside the FOV. Beam hardening in (b) caused the attenuation in the affected region (ROI B) to
decrease while the pixel noise in both regions increased. The attenuation in the central region A was
unaffected by the arms.
The PET emission data were corrected for attenuation using the available CT
transmission information. The emission data were also decay corrected to account for
the delay time between the two emission scans (10min). The corrected emission
sinograms were reconstructed using the 3D filtered back-projection [Kinahan, 1989].
Corresponding images for the two phantom arrangements are shown in fig. 6.19.
Upon visual examination no artifacts were seen in the corrected emission images that
could be immediately related to beam hardening artifacts.
arms
• k
• 4.
a)	 coronal view	 transaxial view	 b) coronal view	 transaxial view
Figure 6.19 Examples of coronal and transaxial PET images of the (a) abdomen phantom, and (b) the
abdomen phantom with arms after CT-based scatter and attenuation correction were applied.
Quantitative analysis on the basis of mean pixel values in regions A and B,
however, revealed some effect on the reconstructed activity distribution in the
corrected PET images (fig. 6.20). The ROIs A and B were placed in the same
position as shown in Figure 6.17b on all 47 transaxial PET images. For the
quantitative analysis it was assumed that the water and 18F activity were distributed
uniformly in the phantom. Therefore, the ratio of the mean ROI values of A and B in
the corrected and reconstructed PET images was expected to be close to unity. When
scanning the abdomen phantom with arms in the FOV, the activity concentration in
ROI B (affected by beam hardening) averaged over the central 35 planes decreased
from 4,772±380 [arb. units] to 4,025±633 [arb. units], while the activity
concentration in the unaffected region A decreased less significantly from 4,730±331
[arb. units] to 4,233±344 [arb. units].
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Figure 6.20 Mean pixel value in regions A and B as a function of the axial image plane in corrected
and reconstructed PET images of the abdomen phantom (a) without the arms, and (b) with the arms
inside the FOV. A slight decrease in reconstructed activity in the phantom was noted when the arms
were present inside the FOV (b).
Figure 6.20 illustrates that beam hardening in the CT images used for CT based
attenuation correction of the PET emission data affects the quantitative accuracy in
the corrected reconstructed emission images. The bias in the CT images that is
initially confined to pixels in areas of high attenuation, for example along the arms
(fig. 6.17b), is propagated through the forward-projecting of the transaxial CT
images when calculating the 3D attenuation correction factors to affect the
quantitative accuracy in regions outside the initially affected region. The magnitude
of the bias depended on the location of the area of interest, and was maximum for
region B, and less significant in region A (fig. 6.18). By applying the CT based ACFs
to the 3D emission sinograms, overall recovered emission activity was lower due the
underestimation of the attenuation values in certain regions of the CT images (fig.
6.17b and fig. 6.18b). It should, however, be pointed out that while the mean pixel
values in regions-of-interest A and B decreased in the presence of the arms the
overall standard deviation in ROI B increased (fig. 6.20b), and the original and
unbiased ROI values of A and B fall therefore within the biased statistical accuracy.
To measure the degree of non-uniformity introduced by localized beam hardening
artifacts in the original CT and corrected in corrected PET images, the ratio of the
mean pixel values in regions A and B was formed. The ratio is plotted in fig. 6.21 for
the original CT transmission images (fig. 6.21a) and the corrected PET images
reconstructed with 3D filtered backprojection (fig. 6.21b) as a function of the axial
image plane number.
It can be seen that by bringing the arms into the FOV a small bias was introduced
into the CT transmission data (fig. 6.21a). Uniformity across axial planes, however,
was undisturbed (small standard deviation of the ratio of the mean pixel values in
regions A and B) as expected from a uniform phantom. The noise in the emission
data of the abdomen phantom (no arms, no beam hardening artifacts) is amplified by
3DRP into noise of the mean pixel values in regions A and B. The presence of noise
correlations (streaks) is common to filtered backprojection and can lead to
fluctuations of the mean pixel values that translate into ratios of the mean pixel
values in A and B which deviate from unity (fig. 6.21b). The ratio of the mean pixel
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values in regions B and A averaged over the central 35 planes (as a measure of the
uniformity across transaxial planes) was 1.00±0.15.
Figure 6.21 The ratio of the mean pixel values in regions A and B as a measure of the degree of non-
uniformity that is introduced by beam hardening in (a) the original CT, (b) the corrected PET images
reconstructed with 3DRP, and (c) the corrected PET images reconstructed with FORE+OSEM.
When introducing the arms in the FOV similar fluctuations in each transaxial
plane and across axial planes were observed for the mean pixel values in regions A
and B. Although the mean pixel values decreased slightly (fig. 6.20b), the ratio was
nearly unity (0.95±0.23). Note that the standard deviation increased compared to the
abdomen study without the arms (15% vs. 24%). This increase in noise can be
attributed to the propagation of bias and noise that were introduced by beam
hardening caused by the arms through 3D attenuation correction of the emission
data.
Figure 6.21c also shows the ratio of mean pixel values in B and A in corrected
emission images reconstructed with FORE+OSEM. The mean ratio over planes 5 to
40 was calculated as 1.05±0.10 and 0.97±0.14 for the abdomen study with and
without the arms, respectively. Although the ratios are similar to the ratios obtained
with 3DRP the uniformity across axial planes is better with FORE+OSEM. In other
words, the effect of noise amplification and introduction of noise correlations as seen
with 3D attenuation correction and 3DRP is suppressed with the FORE+OSEM
algorithm. It remains, however, to be shown in more detailed phantom and clinical
studies how much the introduced bias does affect lesion detectability in the presence
of the intrinsically high levels of noise in the PET emission data.
6.2.3 TRUNCATED FOV
Cl' images are reconstructed from X-ray projections measured from all possible
directions around the object to be imaged. The projections are filtered and
backprojected to obtain a distribution of the attenuation coefficients of the object.
The backprojection technique assumes that a complete set of projections was
acquired that sample the entire object of interest. In clinical scanning, however, the
assumption of complete object coverage by projections from all directions may not
be correct, which may lead to artifacts or quantitative errors in the reconstructed
images if standard reconstruction techniques are used.
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Figure 6.22 illustrates the object coverage in a third generation CT scanner
(section 1.1.1). The X-ray tube/detector assembly rotates around the centre of the
FOV, and describes a circle of diameter D (focus-isocentre). The X-ray beam is
limited to a fan opening angle a that depends on the extent of the curved detector
array opposite to the tube. As the tube/detector assembly rotates fan beams from all
directions will intersect to form a circle of radius r from the centre of rotation. The
area covered by this circle corresponds to the maximum FOV that can be
reconstructed, and is defined by the X-ray fan opening a and diameter D.
Figure 6.22 Object coverage in a
third generation CT scanner. Object
/ is covered by projections from all
directions, while object 2 is outside
the maximum FOV and only
covered by projections from a few
particular directions.
An object (object 1) that is located inside this circle will be intersected from
projections from all directions. For an object located outside this circle (object 2)
projections are measured only for some but not all positions of the tube/detector
assembly. This object is therefore not entirely sampled by the X-ray measurements.
A reconstruction from projection measurements under these circumstances, with
objects inside and outside the maximum FOV, will produce image artifacts [Lehr,
1983]. The magnitude of these artifacts is illustrated in fig. 6.23 that shows two
clinical CT studies from the PET/CT scanner, which offers a maximum CT FOV of
45cm. Frequently, the cross-section of large patients extends beyond 45cm, and
image artifacts at the edge of the FOV in transaxial CT images appear. Since these
image artifacts are created by objects that are located at the edge of the FOV and
outside the maximum FOV of the CT, one may regard the existing CT FOV as too
small to over the entire object, and hence refer to these artifacts as truncated FOV
artifacts, or truncation artifacts. From our experience truncation artifacts vary with
patient size, and the location and density (muscle or bone) of the structures at the
edge of the CT FOV and beyond.
Due to the short total scan times in standard CT scans patients are typically asked
to raise their arms over their head for the duration of the CT scan. Only sedated
patients or patients in critical conditions may be scanned with their arms close to
their body. While truncation artifacts in standard CT are limited to intensive care and
very large patients, the same artifacts are more frequently observed in CT studies
from combined PET/CT scans. For PET/CT studies the patient has to remain in the
same position for the duration of the CT and the PET study. Depending on the axial
coverage and the number of bed positions scanned, this may be up to 60min, a
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duration that would be intolerable to endure with the arms raised over the head.
Therefore patients may keep their arms in a more comfortable position close to their
body, at the expense of frequent image artifacts in the reconstructed CT images.
c)	 d)
Figure 6.23 Truncation artifacts in clinical CT scans of PET/CT patients. The extent (arrows) and
magnitude (profiles) of the artifacts depend on patient size and how much of the cross-section of the
patient is outside the CT FOV. Transaxial section through CT images of (a) the upper thorax of a
normal sized patient, and (b) upper diaphragm of a large patient. Profiles through the midline of the
images (c,d) show increase in attenuation values near the edge of the FOV.
Although these truncation artifacts are often severe they are limited to the edge of
the FOV (fig. 6.23). In addition to the visual disturbance, truncation artifacts may
compromise the quantitative accuracy of the CT as demonstrated by Lehr [Lehr,
1983]. The authors simulated artifactual increase of up to 81-IU in the centre of an
empty FOV (air) with a 2cm disk (912HU) placed at various radii from the centre of
rotation. The magnitude of the artifact was shown to depend linearly on the
attenuation of the objects close to or outside the FOV, and the diameter of the FOV,
and the distance of the exterior densities from the maximum CT FOV [Lehr, 1983].
However, the bias in the presence of an attenuating object in the centre of the FOV is
much smaller than the bias reported by Lehr. In our measurements of the attenuation
in a water-filled 20cm diameter cylinder with a 5cm diameter cylinder made of
spongiosa simulating material placed at various distances from the cylinder (fig.
6.24), we observed only minor deviations of the average attenuation. For example,
with the external object attached to the water cylinder and outside the FOV, we
estimated an average attenuation of (-1.3±7.5)HU and (1.1±7.2)HU, respectively.
The difference is small compared to the bias reported by Lehr and insignificant with
respect to the error of the measurements.
Unlike in uniform phantom studies, the effect of truncation artifacts on human CT
scans is more difficult to estimate. Lehr has measured artifactual increases of up to
500HU in the centre of an abdominal CT study though he simulated an
unrealistically small measured FOV of 18cm [Lehr, 1983]. Nevertheless, noticable
shifts in attenuation values occurred in simulations of CT scans of a lower abdomen
that extended 3cm beyond a more realistic 48cm FOV. These observed shifts in
measured CT attenuation values may strongly bias CT based ACFs. To study the
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effect of CT truncation artifacts on reconstructed PET emission activity distributions
we have performed the following phantom experiment using the PET/CT scanner.
0
a)	 b)	 c)	 d)	 e)
Figure 6.24 Phantom experiment to estimate the bias in the centre of the FOV introduced by a
separate object of slightly higher density (spongiosa bone) placed at various distances from the
cylinder. (a) Ocm, (b) 4cm, (c) 8cm, (d) 10cm, and (e) 13cm (outside the FOV). The mean attenuation
values inside the main cylinder were (a) —1.3HU, (b) —1.1HU, (c) —1.1HU, (d) —0.8HU, and (e) 1.1HU
(standard deviation was 7.5HU).
A plastic cylinder (20cm diameter, 20cm long) with 22MBq 68Ge uniformly
immersed in a resin mixture was positioned in the FOV of the PET/CT scanner. The
cylinder was placed 16cm away from the centre of rotation. Therefore the phantom
was not completely covered by the CT transmission measurement (45cm FOV), and
typical truncation artifacts were observed (fig. 6.25a). The CT scan was followed by
a 15min PET emission scan and a 10min single post-injection transmission scan.
Figure 6.25 Phantom study on CI' based attenuation correction. A 20cm uniform cylinder (22MBq)
was positioned off-centre (in-plane) in the PET/CT scanner. Transverse CT images (a) demonstrate
truncation artifacts. Post-injection singles transmission images (b) were artifact free. PET emission
images after (c) CT-based, and (d) singles-based attenuation correction. The loss in quantitative
accuracy of the images after CT based attenuation correction is demonstrated by the insufficient
recovery of activity distribution as seen in the image (c) and profile.
While part of the cylinder was not covered by all projections measurements
during the CT acquisition, the cylinder was covered entirely by the PET emission
and singles transmission measurements with data acquired over a 60cm FOV (fig.
6.25b). The CT attenuation data were transformed using the hybrid method (section
5.2.5), and the Cl' based ACFs were applied to the emission data. The corrected PET
emission data were reconstructed using the FORE+OSEM algorithm without scatter
correction applied (fig. 6.25c). PET emission images were reconstructed separately
after single-based attenuation correction was applied (fig. 6.25d) instead of CT based
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correction. The two sets of corrected emission images were compared visually and
using profiles through the centre of the object in a central axial image plane.
It is possible to gain further insight into CT-based attenuation correction from
evaluating the results of above phantom study (fig. 6.26). Thereby two observations
deserve further attention: (1) artifacts from truncation at the edge of the CT FOV,
and (2) the effect of missing transmission information in the truncated regions of CT
attenuation maps outside the CT FOV. Both effects occur simultaneously if the
scanned object is covered completely in the PET FOV but only partially in the CT.
CT-based attenuation correction factors are calculated from forward-projection (line
integrals) through the transformed CT attenuation map. These line integrals reflect
the true amount of attenuation along lines-of-response that cross the CT FOV where
the object is entirely covered (fig. 6.26). The ACFs for lines that traverse the CT
FOV will be affected by the artificial increase of attenuation coefficients from
truncation artifacts (B), by missing transmission information (zero attenuation., C),
or by both (D). In the first two cases the ACFs will be too high (B) or too low (C).
Because the effect of artifacts from truncation and truncated transmission
information are non-separable, a prediction for the accuracy of CT-based attenuation
correction along the LORs affected by both factors (fig. 6.26, D) is difficult.
Figure 6.26 CT-based attenuation correction in the presence of truncation artifacts and truncated
attenuation information. Lines-of-response traversing the various regions are affected differently. The
ACFs for LORs (A) will be correct, (B) will be too high due to increased attenuation in edge artifacts,
(C) will be too low or zero due to missing information in the reconstructed attenuation map, and (D)
generally incorrect (difficult to predict).
Nevertheless we designed a simplified torso phantom experiment in an attempt to
quantify potential effects of truncated CT attenuation maps on attenuation-corrected
emission images. A 20cm diameter plastic cylinder (6,000mL volume), resembling
the torso was filled with an activity concentration of 3.7kBq/mL of ' 8F diluted in
water. The cylinder was placed on the bed support and positioned in the centre of the
FOV of the PET/CT scanner. Two water filled plastic bottles (540mL each),
simulating the arms were filled with the same activity concentration of ' 8F in water,
and placed inside the FOV at two different distances from the 'trunk'. To simulate
complete coverage of the object by the CT FOV the arms were first positioned close
to the cylinder trunk. A helical CT scans was acquired over the axial extent of the
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phantom (130kVp, 160mAs per slice, 5mm slice width, pitch 1.6) followed by 10min
emission scan. Then the arms were placed further away from trunk at the edge of the
CT FOV, such that they extended beyond CT FOV (fig. 6.27).
Again a helical CT scan and a 10min PEI' emission scan were acquired. Both sets
of PET emission data were corrected for attenuation using the CT images from the
corresponding CT scans (section 5.2.5), and reconstructed using the FORE+OSEM
algorithm. Corrected emission images were inspected for potential artifacts arising
from truncated attenuation information. A circular region-of-interest (3cm diameter)
was placed over the central 25 image planes to estimate an average value of the
reconstructed activity. The ROI was positioned in the upper part of transaxial section
through the main cylinder, such that it would not be affected by residual beam
hardening artifacts along the line connecting the two arms.
Figure 6.27 Cylindrical phantom v. as filled with 3.7kBq/mL ' 8F in water. Two arms with the same
actn it concentration were placed on the bed support (a) close to the cylinder inside the CT FOV, and
(b) at the edge of the CT FOV but inside the PET FOV. A circular ROI was used for quantitative
ex aluation of the reconstructed emission activities.
Figure 6.28a and b show transaxial sections through the CT attenuation map for
both phantom arrangements. Note that the attenuation images were thresholded to
enhance residual beam hardening after standard beam hardening correction was
applied. The truncation of the CT transmission images is illustrated by the partial
disappearance of the 'arms' when placed at the edge of the CT FOV (fig. 6.28b). The
PET emission images after CT-based attenuation correction are shown in fig. 6.28c
and d. The activity distribution was recovered completely when the arms were inside
the CT FOV. When using the truncated CT attenuation map the emission activity
distribution was not fully recovered (fig. 6.28d). Instead, truncation artifacts in the
arms were noticed and correlated to the missing information in the CT attenuation
maps.
The ROI analysis is summarized in fig. 6.29. The measured CT attenuation in the
main cylinder was (-2.1±0.9)HU and (-0.4±0.9)HU when the arms were inside and
outside the CT FOV, respectively. The position of the arms had therefore only a
marginal effect on the accuracy of the CT attenuation estimate, and was generally
smaller than the effect observed by Lehr [Lehr, 1983], mainly because we measured
the attenuation in a region away from the centre of rotation when the impact of
truncation artifacts is smaller. The attenuation maps at 511keV (ROI values:
(967.0±0.9)10 5cm 1 and (968.7±0.9)10 5cm I , respectively) were obtained after
transforming the CT images using the hybrid method (section 5.2.5). The ROI values
PET+CT d)
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for the corrected and reconstructed emission images are shown in fig. 6.29b. After
the arms were moved away from the cylinder trunk to the edge of the CT FOV the
ROI value inside the cylinder averaged over the central 25 image planes varied from
1.25±0.03 [arb. units] to 1.31±0.05 [arb. units].
a)
Ct.))
b) CT
Figure 6.28 Transaxial sections through the CT attenuation map (a) without, and (b) with truncation
artifacts. The images are enhanced to illustrated residual beam hardening between the arms. The CT
FOV is shown by the red circle. Reconstructed PET' images for the same sections are shown after
attenuation correction with (c) complete CT attenuation maps, and (d) truncated CT attenuation maps.
Artifacts in the emission activity distribution are noticed (arrow in d).
It is interesting to note that while some object information was missing in the CT
transmission images (arms) at least the main object boundary information was
recovered well in the corrected and reconstructed emission images. This may be
understood by the fact that the entire activity distribution of the object was covered
by the projections from all directions in the emission scan, and hence a complete set
of projections was available for reconstruction.
The artifact seen in the intrinsically uniform activity distribution of the left arm
(fig. 6.28d) is caused by the underestimation of attenuation by the left arm for LORs
traversing the left arm outside the CT FOV. During the forward-projection step to
calculate the ACFs (fig. 5.2) this underestimation is likely to affect neighbouring
LORs as well, but this effect was not attempted to measure in this study. This
phantom study seems to suggest that although the emission projections were
complete, CT-based attenuation correction may be considered to have a masking
effect on the emission activity distribution (fig. 6.25c, 6.28d).
The effect, if any, of truncation artifacts in CI' attenuation maps on clinical
PET/CT imaging is even more challenging to estimate. In cases when the patient
extends beyond the CT FOV we occasionally found distinct distortions in the
corrected emission images. Close visual examination often revealed truncations in
the reconstructed emission activity in the areas of the truncation artifacts on the CT.
This is illustrated in the transverse sections of a clinical patient study from the
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PET/CT in fig. 6.30. The tracer uptake seen in the area of the arms in the attenuation
corrected PET images is marginal and mostly confined to those pixels in the CT
attenuation map that have non-zero values, while the non-corrected whole-body
emission clearly shows FDG accumulation in the extremities outside the 45cm FOV
of the CT.
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Figure 6.29 Pixel value average and standard deviation in region-of-interest placed on (a) CT-based
attenuation map, and (b) attenuation corrected emission images of the phantom with the arms inside
(gray) and at the edge of (black) the CT FOV.
Although a thorough review of these observations in a clinical setting is required
we hypothesize that the missing information in the truncated CT attenuation maps
has a larger impact on the CT-based attenuation corrected emission images than the
quantitative bias in the attenuation coefficients as introduced by the truncation
artifacts at the edge of the CT FOV. In other words, clinical PET/CT data indicate
that by using CT-based attenuation maps the corrected emission activity distribution
appears to be masked by the distribution of non-zero attenuation values from the CT
images inside the FOV of the CT (fig. 6.28d and fig. 6.30f). In comparison the bias
introduced by truncation effects in the CT attenuation map into the emission activity
distribution of a uniformly filled phantom was not significant (fig. 6.29).
Figure 6.30 The problem of truncated CT attenuation information for clinical PET/CT studies.
Coronal sections through (a) CT, whole-body PET volume, (b) before, and (c) after CT-based
attenuation correction. Corresponding transaxial views (d-f) at the level of the lower liver illustrate
missing information in attenuation corrected PET (f) in areas not covered by the CT (d). The CT FOV
is indicated by thin in red in all views.
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6.2.4 • CONTRAST MEDIA
In CT imaging, contrast media are introduced either intravenously (i.v.) or orally
to enhance the visualization of structures such as the vascular system or parts of the
digestive system, respectively (section 1.2.4). While contrast media fall into
iodinated and non-iodinated agents [Zwicker, 1991] most contrast agents applied to
date are iodine-based. Typically, up to 150mL of i.v.-contrast agent with iodine
concentrations of 300-380mg/mL are applied [Graf, 1997], which yields an average
iodine concentration of up to 9.5mg iodine per mL blood. The i.v.-contrast media are
distributed in the body exclusively via the blood stream and interstices to enhance
highly vascularized tissues and organs, and are practically not metabolized (fig.
6.31).
a)	 b)
Figure 6.31 Transaxial CT image at the level of the liver (a) before, and (b) after i.v.-administration of
contrast agent. Scans were performed on a GE9800. Circular regions-of-interest were defined to
estimate tissue attenuation coefficients [courtesy Martin Charron, M.D., University of Pittsburgh,
Children's Hospital].
As illustrated by fig. 6.31 the use of these contrast agents increases the attenuation
values of vascular structures to levels above those encountered in non-contrast
images (table 6.C). Depending on the concentration of the contrast agents, increases
in CT attenuation values for soft tissue of up to 200HU are typical. It is interesting to
note that equivomolar concentrations of non-iodinated contrast agents were shown to
lead to a higher peak enhancement of aorta and liver than iodine [Zwicker, 1991] and
to increase image contrast by up to a factor of two [Ruth, 1995].
Table 6.0 Measured attenuation [HU] in abdominal CT images (fig. 6.31) before, immediately after
i.v.-contrast administration, and enhancement [HU] of selected structures in CT image.
Anatomical location Without contrast With contrast Enhancement
Aorta 37±-4 210±7 173
Spleen 39-±5 73±-6 34
Liver 61±5 137±12 76
Similar to the effect of beam hardening, the presence of contrast agents during the
CT scan may bias the apparent tracer concentration in the corresponding regions of
the attenuation-corrected PET image if not corrected for. However, while beam
hardening reduced the apparent attenuation in the affected anatomical regions,
contrast agents increase the attenuation coefficients. The challenges encountered in
using contrast enhanced CT images for attenuation correction include: (1) the
amount of enhancement in the CT image will be time dependent and regionally
variable, (2) iodine does not have a significant photoelectric cross-section at the PET
photon energy of 511keV, and (3) contrast enhanced tissues often have attenuation
a) b)
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values similar to bone structures at CT energies (table 6.D). This implies that the
correct scaling factor for contrast-enhanced regions cannot be known a priori, and
that the segmentation step in the hybrid correction method (section 5.2.5) may mis-
classify contrast-enhanced areas of soft issues as bone.
Table 6.D Measured attenuation [HU] in abdominal CT shortly after oral and i.v.-contrast application.
Note the overlap of attenuation values of bone and contrast enhanced stomach.
Anatomical location With contrast
Aorta 172±19
Liver 125-±17
Spleen 127±221
Stomach 309+71
Rib bone 428±133
Vertebrae 309±23
The misclassification of contrast-enhanced soft tissue regions as cortical bone
leads to incorrect attenuation values that result in incorrect ACFs. This effect is
demonstrated in fig. 6.32 in a patient referred for a PET/CT scan after undergoing
stomach fluoroscopy with barium contrast the previous day. The CT scan in fig.
6.32a shows residual contrast agent in the stomach. The attenuation correction
factors obtained from the CT images were applied to the corresponding PET data,
and the resulting reconstruction is shown in fig. 6.32b. The region of apparently
increased FDG uptake correlates exactly with the distribution of contrast agent and is
due to the use of incorrect ACFs in the PET reconstruction.
The hybrid segmentation/scaling algorithm is based on the segmentation of the
CT image into regions of bone and non-bone, followed by linear scaling with two
independent scale factors. In non-enhanced CT scans, segmentation is
straightforward, and based on a single threshold of 300 HU separating air, lungs and
soft tissue from cortical bone. Two scale factors, for soft tissue and bone, are then
applied to yield translated attenuation maps (fig. 6.33a). In the presence of contrast-
enhanced soft tissues, however, the current implementation of the hybrid method,
faces two challenges: (1) to separate highly enhanced soft tissues from bone, and (2)
to account for the different attenuation of enhanced and non-enhanced soft tissues at
CT energies, while the attenuation is similar at 511keV. A third scale factor for
contrast enhanced soft tissues could therefore be defined an applied to pixels with
measured attenuation between OHU and 3001-1U (fig. 6.33b).
Figure 6.32 (a) The CT scan of patient with residual barium contrast agent in the stomach and bowel
from a fluoroscopic study performed prior to the PET/CT scan. No other contrast was administered
for the CT scan. The corresponding PET image (b) shows a region of apparently-increased FDG
uptake (arrow) correlating exactly with the distribution of high-attenuation contrast agent seen in (a),
misclassified as bone by the CT-based attenuation correction algorithm.
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As mentioned before, the distribution of contrast agents in soft tissues is subject to
temporal variations, which leads to highly variable measured attenuation coefficients
within a single organ and throughout the scanned body region. Therefore, no single
scale factor exists for contrast enhanced soft tissues that transforms the measured
attenuation at CT energies to the attenuation at 511keV, and alternative
transformation techniques must be found.
Figure 6.33 Translation scheme of the hybrid method for (a) non-enhanced CT images, (b) contrast-
enhanced CT images. A third scale factor is introduced in (b) to account for the attenuation properties
of the enhanced soft tissue.
Blankespoor et al. [Blankespoor, 1996] presented a transformation method for
attenuation coefficients acquired at CT energies to corresponding values at various
SPEC!' radionuclide energies. The authors estimated a piecewise linear attenuation
calibration curve from measurements of a set of known materials (various
concentrations of potassium phosphate) that was then used to transform measured
attenuation values of viable tissues to attenuation coefficients at 140kV p. This
calibration method was further developed by Tang et al. [Tang, 1996] to account for
enhanced densities of tissues in the presence of iodinated contrast agents [Tang,
1999]. The calibration method is not only applicable to SPECT energies, but also to
511keV, as shown by Tang [Tang, 1998].
For low density tissues and materials (attenuation values <OHU) the calibration
method is equivalent to our hybrid method proposed in section 5.2.5. In both cases a
piecewise linear relationship between the CT number and the attenuation values at
the radionuclide energy (SPECT or 511keV) is assumed. The attenuation values at
emission energies for tissues denser than water are, however, obtained differently
with the calibration and the hybrid method. Instead of multiplying the measured
attenuation coefficients at CT energies with a linear bone scale factor, a calibrated
look-up table is derived from phantom measurements with the CT/SPECT
tomograph. The calibration procedure thereby correlates measured and calculated
attenuation coefficients of a solution of water and known concentrations of either
potassium phosphate [Blankespoor, 19961 or iodinated contrast agent [Tang, 1996].
A linear transformation function is then derived to estimate the attenuation
coefficients at SPECT energies of tissues measured at CT energies. Note the
calibration must be performed for each emission energy of the SPECT radionuclide,
in addition to every X-ray tube potential that the CT scanner is operated by.
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We have designed a calibration phantom similar to the one suggested by Tang
[Tang, 1998] with 11 chambers (1L each) arranged symmetrically around a 20cm
diameter water-filled cylinder to limit the effect of beam hardening (fig. 6.34). The
external chambers were filled with different concentrations of iodinated contrast
agent (Optiray 320).
Figure 6.34 Calibration phantom for
the PET/CT scanner to derive a
calibrated attenuation map for tissues
and materials denser than water. A
circular 20cm water filled cylinder was
surrounded symmetrically by 11
cylindrical plastic bottles (7.5cm in
diameter) with different concentrations
of iodinated contrast agent: no iodine
• A	 in chamber 11, 8g iodine in chamber 1.
The phantom was scanned with the AR.SP CT scanner at 110kVp and 130kVp
over an axial extent of 16cm (5mm slice width, pitch 1.6). The images were
reconstructed in intervals of 3.4nrun. Circular regions-of-interest were placed over the
11 external chambers, and the average attenuation coefficient at the effective CT
energy was calculated over the central 40 image planes (table 6.E). Note the
increasing attenuation with increasing concentrations of iodinated contrast material,
and the lower attenuation for increasing tube voltage.
Table 6.E Concentration of iodine [mg/mL] in external phantom chambers 1-11, and measured
attenuation [HU] at CT energies.
Chamber Iodine conc.
[mg/mi.]
Attenuation [HU]
at 110kVp
Attenuation [HU]
at 130kVp
1 0 -4.5 -3.4
2 0.06 -1.3 -0.5
3 0.09 -0.7 0.0
4 0.19 0.8 1.1
5 0.38 0.0 0.2
6 0.78 10.7 9.8
7 1.00 22.2 20.4
8 2.00 44.5 39.9
9 3.01 68.0 60.7
10 5.95 134.7 118.9
11 7.83 174.8 154.0
The attenuation coefficient for iodinated water in all chambers at 511keV was also
calculated [Tang, 1998]:
1.1 .(511keV)=-m (511keV)+ k • mwater(511keV)	 Eqn. 6-1
1000 hss"e
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where N is the concentration of iodine in [mg/mL], m is the mass attenuation
coefficient of iodine or water. We estimated the mass attenuation coefficients of
iodine (0.096cm2e) and water (0.096cm2g-1 ) at 511keV from reference values
published by Hubbell [Hubbell, 19691. The factor k is the fractional water content
that was measured to be 1 g of water in 1cm3 of solution. The calculated attenuation
coefficients (eqn. 6-1) were plotted as a function of the average CT attenuation
values (HU) for measurements at 110kV p (fig. 6.35a) and 130kVp
 (fig. 6.35b).
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Figure 6.35 Calculated attenuation coefficient at 511keV versus measured attenuation coefficients at
CT energies for X-ray tube operated at (a) 110kV p, and (b) 130kV p. A linear fit was determined for
both plots to estimate a calibrated bone scale factor.
The linear relation established between the measured and calculated attenuation
data for the calibration materials should be sufficient to estimate the attenuation
coefficients for contrast enhanced tissues scanned at the calibrated CT energies if
their measured attenuation is in the particular range of attenuation values covered by
the calibration. Tang et al. suggested to interpret the attenuation coefficient, tic°",
of these enhanced tissues at some radionuclide energy (e.g. 511keV) as a sum of
attenuation coefficients of water, tot`', and contributions from the contrast material
[Tang, 1998]:
HU
Pcontrast(5 llkeV) = fcentrast 1000 + wale,.(511ke V)	 Eqn. 6-2
where f is a tissue and energy dependent scale factor. This factor may be
obtained from fitting the function in eqn. 6-1 to the measured (HU) and calculated
attenuation coefficients (tt contrasi) of the calibration phantom. From fitting the
calibration data in fig. 6.35 and table 6.E to the linear function in eqn. 6-2, we
determined the following scale factors, Lonfras„ for 110kVp: 4.148. 10 6, and 130kVp:
4.712. 10-6. The similarity of the scale factors is illustrated in the similarity of the
graphs in fig. 6.35a and b.
The CT images of the phantom acquired at 110kV p and 130kVp are shown in fig.
6.36a and b. Note the lack of beam hardening artifacts due to the symmetric
arrangement of the phantom. For comparison the same section from a 6min singles
(fig. 6.36c) and a 20min rod source (fig. 6.36d) transmission scan are shown.
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Figure 6.36 Transverse CT images of the calibration phantom used for the PET/CT scanner at (a)
110kV p , (b) 130kVp. The corresponding transmission images from singles (c) and rod source (d) scan
are shown for comparison. Note the uniform attenuation in standard PET transmission scans.
Figure 6.37 summarizes an interesting result from the comparison of the hybrid
and the calibration method for a tube voltage of 110kV p. While the calibration
method leads to proper attenuation values for all chambers with different iodine
concentrations, as expected from the separate singles and rod source transmission
measurement at 511keV, the hybrid method overestimates the attenuation for iodine
concentrations above 1 mg/mL. This is clear from the principle of the hybrid
segmentation/scaling approach that considers the enhanced chambers as filled with
soft tissue, and neglects the higher photoelectric absorption fraction of iodine.
Similar observations were made from the comparison at 130kVp.
-- Hybrid method
Calibration method
Singles measurement
Figure 6.37 Comparison of attenuation values for the 11 contrast-filled chambers in the calibration
phantom. The calibrated values yield contrast-independent attenuation at 511keV. This is verified by a
separate singles (adjusted for 662keV/511keV difference) and rod source measurements. The hybrid
method overestimates attenuation values for iodine concentrations above lmg/mL.
The hybrid method must therefore be modified when contrast enhanced CT scans
are used for the purpose of CT based attenuation correction. To limit the total
exposure to the patient, additional non-enhanced CT scans solely for the purpose of
unaffected CT based attenuation correction must not be performed. The observation
that contrast enhancement may exceed the threshold of 300HU currently applied to
separate bone, deserves further attention. Since more pixels in an imaged volume
will be affected by contrast agent, the bone threshold might be increased to allow for
proper scaling of the enhanced tissues at the cost of underestimation of a few bone
pixels. However, the bias introduced by the underestimation may be insignificant due
to the low bone fraction in human CT studies (section 5.2). Finally, a similar
calibration procedure may be used to derive an attenuation map for high density
pixel values (bone) based on a calibration phantom filled with various concentrations
of potassium phosphate (K 2HPO4), a salt used to simulate bone [Tang, 1999]. The
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calibration for bone and subsequent comparison with the hybrid method are,
however, deferred to the future.
6.3 SUMMARY
CT data represent low-noise transmission information that can be transformed to
appropriate attenuation information at 511keV. However, limitations of CT imaging
may bias CT based attenuation correction factors used for the PET emission data.
These limitations include: patient motion artifacts, beam hardening, truncation
artifacts, and contrast agents.
Due to the short scan time in CT scanning, patients are typically asked to hold
their breath during the CT acquisition, while they breathe shallowly during the PET
acquisition. Respiratory and cardiovascular motion introduce a three-dimensional
shift between the attenuation map and the emission data, and may thus introduce
artifacts, such as disappearing chest walls in PET images. We also observed
misalignments of anatomical lesions and focal FDG uptake in the lungs.
Misalignments were, however, less frequently observed in the abdomen. For imaging
the thorax, the spatial correlation of the anatomy of the patient and the tracer
distribution could be improved by acquiring the CT scans at expiration, which is the
state of the respiratory cycle that the patient remains in longest. A more complex
approach would be to smooth the CT attenuation map with a spatially-varying
gradient, thus bringing the anatomical features closer to their averaged position in the
PET emission data.
Beam hardening and truncation artifacts are inherent to CT imaging in case of
large patients. These artifacts are amplified by the presence of the arms in the FOV
during the CT studies, because most patients are not able to tolerate their arms over
their heads for the duration of a combined PET/CT scan. Since the morphology of
the patient must not be changed between the CT and PET acquisitions, patients
typically leave their arms close to their body for the PET/CT exam. The effect of
beam hardening on PET emission data corrected for attenuation based on the affected
CT images, was shown to slightly reduce the apparent tracer concentration, but also
increased the noise in the corresponding regions of the attenuation-corrected PET
image. The degradation is more significant in corrected emission data reconstructed
with 3DRP than it is in images reconstructed with FORE+OSEM.
The effect of truncation artifacts is more difficult to evaluate since it may not be
entirely separated from beam hardening. Truncation artifacts are seen as partial rings
or increased attenuation near parts of the body of the patient that are only covered by
CT projections from a few directions. After transforming the original CT images
these artifacts introduced a bias in the attenuation map at 511keV, but were shown to
have only a small effect on the quantitative accuracy of the reconstructed tracer
distribution, presumably because of the mutual compensation of over- and
underestimation of the ACFs along projections from different directions (see fig.
6.26). An additional masking effect in the emission images after CT-based
attenuation correction was observed in patient studies when the body contour
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extended beyond the transaxial FOV of the CT. In the future the truncation artifacts
in the CT transmission images and transformed attenuation maps can be limited by
constrained image reconstruction of the available CT data. The idea is to extrapolate
the truncated X-ray projections from fitting an elliptical model to the body contour
that is obtained from reconstructing the truncated CT data [Herman, 19811. Thereby
the exterior contour of the patient can be estimated from the non-truncated PET
emission projections. By comparing the outline of the body as determined from the
CT and from the PET images reconstructed from emission data not corrected for
attenuation, the missing volume can then be estimated. This volume will be added to
the original CT image and set to the average linear attenuation coefficient for the
arms or any other truncated region.
The analysis of the effects of beam hardening and truncation artifacts is based on
a series of simple phantom studies that deserve further expansion. At this time we are
not able to predict the effect of these CT inherent artifacts on detectability or
quantitation of lesions in attenuation corrected PET images.
Finally, the use of i.v.-contrast agents is planned for most of the CT studies as part
of the PET/CT protocol in the future. The hybrid segmentation/scaling method could
be adjusted to the varying attenuation of i.v.-contrast-enhanced tissues by
introducing a third scale factor for the range of attenuation values between 01-1U and
300HU. The use of oral contrast agent may, however, require a modified scale factor
that is to be determined from future phantom studies with a variety of oral contrast
agents.
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7. PET AND CT ACQUISITION PROTOCOLS
7.1 SCANNING PROTOCOLS
7.1.1 PATIENT POPULATION
Patients undergoing a PET/CT evaluation with the prototype tomograph are
referred by physicians of the University of Pittsburgh Cancer Institute either
clinically or through the Department of Radiology. Typical indications for PET/CT
scans include a variety of different cancers, such as neoplasms in the regions of the
head and neck, lung, esophagus, breast, pancreas, and lymphomas, melanomas, and
colorectal recurrence (section 8.1-8.3). All subjects must sign a consent form
produced by the University of Pittsburgh Biomedical Institutional Review Board and
the Ethics Committee. Only patients who fullfill at least one of the following
inclusion criteria are considered for a PET/CT study:
• Newly-diagnosed primary cancer based on standard clinical evaluation
procedures.
• Recurrence of a previously-treated malignancy.
• Subjects who are at least 18 years of age.
Patients are excluded from a PET/CT study for one of the following reasons:
• Prior enrollment of the patient in a research protocol within the preceding 30
days.
• Female subjects of who have a positive blood pregnancy test within 48h prior to
the study.
• Patients with body weights of 160kg and above.
Of the 70 patients scanned on the PET/CT tomograph between June 1998 and
August 1999 31 (44%) were male and 39 (56%) were female with an average age of
57 years. The age distribution is illustrated in fig. 7.1.
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Figure 7.1 Age distribution of PET/CT patients scanned between June 1998 and August 1999.
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Figure 7.3 Duration of the uptake
period in PET/CT patients after
administration of FDG radiotracer
and before initiation of the PET/CT
protocol.
167
7.1.2 PATIENT PREPARATION AND POSITIONING
The patients, are asked to refrain from eating at least four hours prior to the
PET/CT scan. They may take necessary medication with water before the scan. All
oncology studies are performed with FDG as a tracer for glucose metabolism
(section 2.1.5.). The total activity of FDG injected varies slightly with the weight of
the patient: more activity is injected in heavy patients, while the total activity is
reduced for very thin subjects. Most patients are injected with 260-270MBq of FDG.
This is illustrated in fig. 7.2 together with a tendency to adjust the injected activity to
the patient weight.
Figure 7.2 Patient weight and activity
of FDG injected. There is a trend to
use more activity in heavier patients
and less activity in thinner patients.
Most subjects, however, were
injected with 260-270MBq of FDG, a
range typical for 3D whole-body
PET acquisitions.
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After the radiotracer has been injected patients are asked to remain comfortably in
a relaxed position in a quiet area for the duration of the uptake period (fig. 7.3). In
the studies performed on the PET/CT so far, the time for the uptake period extended
from 30min up to two hours. Typical uptake periods are around 60min.
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Prior to the scan procedure the subjects are asked to void. The patients are
generally positioned in the scanner in the head first supine position. Similar to a
standard PET procedure the subjects keep the arms in a more comfortable position
close to their body for the duration of the combined PET/CT study. Any metal
objects, such as necklaces, bracelets, and belts are removed before the scan.
7.1.3 ACQUISITION PROTOCOLS
Since the patient handling system (PHS) is installed in the front of the gantry (fig.
4.6), i.e. to the front of the CT scanner, it is convenient to perform the CT scans prior
to the PET acquisitions to limit the vertical patient translation inside the gantry. The
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subject is positioned on the patient table and in the centre of the CT FOV by using
the laser positioning system of the CT. A CT topogram, or scout scan is performed to
evaluate the body area of interest and to define the range of the helical CT scans (fig.
7.4). During the scout scan the tube/detector system remains fixed in the AP or
lateral position while the table top with the patient is moved over 128mm, 256mm,
512mm, or 1024mm into the gantry. Using the scout scan, the extent of the body to
be covered by the helical CT scan and subsequent PET acquisition is defined by the
referring physician or the medical personnel on site based on the available patient
history.
IN
Figure 7.4 Acquisition procedure for combined PET/CT study. A CT scout scan is performed (a) to
define the helical Cl' scans (b) that must cover the axial extent of the body to be scanned in CT and
PET mode. After the last helical CT acquisition the patient is moved to the FOV of the PET, such that
the first PET image plane corresponds to the first CT image plane defined on the CT topogram. Since
the bed ov erlap in PET is qpically fixed, the last bed position falls either short of the volume covered
by CT (c) or extends beyond the acquired CT N olume (d). In latter case CT based attenuation
correction can only be performed for bed 1-3.
The helical CT scans are typically defined for a tube voltage of 130kV p and a tube
current of 83mA with a tube rotation time of 1.9s per slice (leading to about 160mAs
per slice). Unlike standard clinical CT procedures, most of PET/CT patient studies
are performed without breath-hold. Using a slice width of 5mm and pitch 1.6, we are
then able to scan an axial length of 160mm in about 40s for each helical scan. The
individual helical scans overlap slightly to account for the incomplete projections at
the axial end position of the acquisition helix (fig. 1.3, 1.5).
Once the final CT scan is acquired the patient table is translated axially to the
FOV of the PET. The first bed position for the whole-body PET scan is determined
from the axial offset of the CT and PET components and the fi rst CT scan position.
This ensures that the first image plane of the CT and PET volume are acquired at the
same axial position of the patient. However, since the axial overlap of consecutive
PET bed positions is fixed the axial extent of the whole-body PET scan is limited to
discrete values. Unless the axial scan length of the helical CT exam (defined on the
topogram) and the axial coverage of the whole-body PET scan (number of bed scans
and amount of bed overlap) are correlated the total axial whole-body length of the
PET scan may either be shorter than the CT volume, or extend beyond the last axial
image plane of the CT (fig. 7.4). In latter case no cr based attenuation correction
may be applied to the last PET bed scan due to insufficient transmission co y erage liii
the emission volume (fig. 7.4d). To avoid mismatches of the axial FOV of the vv hole-
body PET and CT scans in the future one could define a fixed axial scan length, sal)
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40cm, instead of defining a fixed number of PET bed positions to be scanned. The
acquisition software then automatically determines the appropriate helical scan
length and the corresponding number of bed positions of the PET scan. The overlap
between contiguous bed positions can thereby be varied slightly but should be larger
than a threshold value [Cutler, 1996], and less than half the axial FOV (fig. 2.14).
The axial coverage of the patient depends on the clinical conditions of the patient.
If the subject is critically ill and less well, more time is spent on a limited axial FOV
if no metastatic spread is suspected, while in the case of extensive disease short-time
overview scans should be preferred. Since most of the patients referred for a
combined PET/CT scan had known disease and disease extent, the number of bed
positions was limited to around 40cm. Most of the PET scans were therefore
performed over one to three bed positions (fig. 7.5a) while a few extended over as
much as six bed positions in case of metastatic disease (section 8.3). Scan times per
bed position were as short as 5min and as long as 20min for clinical oncology scans
(fig. 7.5b). Generally, we increased the scan time per bed if fewer bed positions were
scanned, in other words, for shorter axial coverage longer scan times were applied to
improve final emission image quality. Of all PET/CT scans 63% were performed in
less than 45min. Although this total scan time is comparable to other scan times
reported for whole-body PET scans [SchOnberger, 1994; Moon, 1998; Pieterman,
1999], the PET/CT scan provides routinely reconstructed and corrected PET
emission images of high quality (chapter 8).
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Figure 7.5 Whole-body PET/CT acquisitions: (a) number of PET scan bed positions, and (b) emission
scan time [min] per bed position. The shorter the axial distance to be scanned (fewer bed positions)
the more time can be spend on the emission acquisition for improved image quality.
7.1.4 SCANNER OPERATION AND SYSTEM CALLS
The PET and CT acquisition components of the combined tomograph are operated
by two separate consoles. Generally, the CT will be performed before the PET
acquisition (section 7.1.3.). The CT data are transferred to the CT imaging system
(IMS, fig. 7.6) where the CT transmission images are reconstructed. The CT images
may be evaluated separately on the standard CT console that is connected to the
IMS.
Since the current prototype scanner utilizes the Siemens CT patient handling
system (PHS), bed position information is stored in the CT file header only. Control
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of the continuous patient table motion is provided by the CT console. During the
PET acquisition, table control is through the local Ethernet connection between the
PET and CT console via remote procedure calls (RPC) to UNIX level commands on
the CT console (fig. 7.6). The PET acquisition of the individual bed positions is
supervised by the acquisition system (ACS, fig. 7.6).
PET console	 CT console
Figure 7.6 PET/CT data acquisition and display.
7.2 IMAGE RECONSTRUCTION, TRANSFER AND DISPLAY
7.2.1 IMAGE PROCESSING PATH
The CT transmission information is reconstructed in the IMS. Standard
reconstruction parameters in the context of combined PET/CT display are: a 450mm
transaxial FOV, and a slice spacing of 3.4mm to match the spacing of the transaxial
PET emission data. Note that these parameters may be optimal for the purpose of
combined PET/CT image display, but are sub-optimal for individual CT scan
evaluation. The lack of small detailed information in a large FOV reconstruction
may, however, be recovered partly by the zoom ability of the display tool described
in section 7.2.2.
PET emission data are transferred to the PET console for further corrections and
image reconstruction. First, the misregistration of the PET and CT data due to the
vertical deflection of the bed (section 4.2.2) as it is translated through the gantry, is
accounted for by adjusting the vertical position information in the header of the
emission data by a general offset value. This value is taken from a look-up table as a
function of the horizontal bed position. The look-up table consists of vertical offsets
for three axial bed extensions: Ocm, 50cm, and 99cm. The corresponding offset
values were determined in phantom experiments as 1.0cm, 1.5cm, and 1.9cm,
respectively. Although, these vertical offsets are close to the estimated vertical
deflection for the least table load (table 4.C), in practice they account for most of our
patient studies. We verified this observation in multiple cases by estimating the
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vertical offset between the CT and PET volumes from retrospective image
alignment. Any vertical deflection for bed positions other than the three axial
extensions, is estimated from linear interpolation between the values in the look-up
table. The only more accurate solution would be to use a support system for the
patient table top that does not interfere with the data acquisition and is stable enough
to support very heavy table loads and maximum table extension (section 4.2.2).
After the CT images are transferred via Ethernet to the PET console, PET
emission data are corrected for attenuation using the available CT images (section
5.2.5). The adjusted and corrected PET data are then reconstructed using the
FORE+OSEM algorithm (section 2.6.3), and displayed together with the
complementary CT images. Image reconstruction is performed on the SPARC 5 PET
console.
7.2.2 IMAGE DISPLAY: THE FUSED IMAGE VIEWER
Ideally, complementary functional and anatomical images should be displayed
side by side or combined as a fused image, whereby latter method has potentially
more diagnostic power. The combined fused PET/CT image display is sometimes
referred to as anato-metabolic imaging, a term introduced by Wahl et al. [Wahl,
1993]. In order to fully account for the intrinsically aligned functional and
anatomical images as provided by the PET/CT system, these images should be
viewed in a single display tool.
We extended the current 3D volume viewer from standard ECAT 7 software as
provided with the recent ECAT PET tomographs to display the PET and CT images
side by side (fig. 7.7). The modified viewing tool' also provides a linked cross-hair
cursors, so that positional correspondence between the PET and CT image sets is
easily established. A second technique of image fusion is also employed, where the
two different image sets are combined into a single image (fig. 7.7, left window).
Although a variety of image fusion techniques exists for displaying functional and
anatomical images of the brain [Wagenknecht, 1999], only few of them are
applicable and useful for the display of complementary information in extra-cerebral
studies. For the purpose of displaying fused PET and CT images the alternating pixel
method as discussed by Rehm et al. [Rehm, 1994] was extended to a 3D display
format. Since the PET images have an isotropic resolution of approximately lOmm
(for whole-body oncology imaging after smoothing and filtering), the PET images
are interpolated into the CT image space without loss of information in the PET
image, thus preserving the resolution of the CT image. The fused image is then
composed of alternating pixel display of the two image volumes. The interleaved
fused image matrix consists of every other pixel from the CT and PET image matrix,
and has the same matrix size as the original CT matrices. As this image fusion
2 The PET/CT viewer has been adapted by Hugo Embert (Ecole Superieure de Chimie, Physique
Electronique de Lyon, France) and Paul Kinahan, PhD (University of Pittsburgh, USA) from the
standard ECAT 7 volume viewer (CTI PET Systems Inc., 810 Innovation Drive, Knoxville, TN
37932, USA).
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method may obscure low-contrast objects [Rehm, 1994], the CT display panel can
also be toggled between CT only and fused PET/CT mode (fig. 7.7).
Figure 7.7 The display and control windows for the PET/CT viewing tool. The attenuation corrected
PET image is displayed in the right window. The display in the left window can be toggled between
the CT and the fused PET/CF image. The cursors in both windows are inter-linked.
The viewing panels have independent color scales and can be switched between
transverse, sagittal, and coronal viewing modes. The available option buttons are
shown in fig. 7.7, top panel. All clinical images included in this thesis (chapter 8)
were generated from the PET/CT viewing tool. The viewing tool includes a number
of useful evaluation features, such as zoom capabilities and an extensive ROI tool
that allows regions of various shapes to be placed on transverse, coronal and sagittal
sections of both the PET and CT images, and mean SUV values read directly from
the PET image on the screen.
7.3 SUMMARY
PET/CT scanning protocols for the combined dual-modality tomograph were
described. Patient preparation is similar to standard PET procedures: the amount of
FDG injected is typically 260MBq and increased slightly for heavier patients. Uptake
periods are of the order of 60min. Most whole-body PET procedures with the dual-
modality modality tomograph involve scanning up to three bed positions for 7min to
15min scan time per bed position. Most whole-body PET/CT studies (63%) are
carried out in less than 45min, and provide accurately aligned CT and PET
information. In addition, the PET data are routinely corrected for attenuation using
the available CT information. Complementary PET and CT images can be viewed in
a versatile display tool that offers linked cursors and toggle option to switch between
displaying CT and PET, or fused PET/CT and PET images.
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The use of CT contrast agents may require a second CT scan, but will not increase
the total scan time significantly. However, additional bed motion may be required
between CT scans and before the PET acquisition, leading to potentially more
complex scan protocols.
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8. PET/CT APPLICATIONS IN CLINICAL ONCOLOGY
This chapter will discuss the efficacy of combined PET/CT imaging for clinical
oncology with the prototype scanner. Selected case studies of thoracic (section 8.1)
and abdominal (section 8.2) malignancies, and metastatic disease (section 8.3) are
reviewed in the context of clinical experience with conventional diagnostic routines
(CT, Ultrasound, MRI) and PET. All patient studies were acquired on the PET/CT
tomograph with the protocol described in chapter 7. No contrast agents were
administered for the CT scans. If not stated otherwise, the following scan parameters
applied:
• PET: 260-270MBq FDG injected, 60min uptake period, 10min scan time per
bed,
• CT:130kVp, 160mAs per slice, 5mm slice width, pitch 1.6.
We have not yet accumulated sufficiently large patient populations for given types
of malignancy to report values for the sensitivity, specificity, and accuracy (chapter
10) of combined PET/CT imaging. Nevertheless we find it useful to report these
numbers from the literature to present our qualitative findings from the PET/CT in
perspective to the accuracy of PET and CT imaging alone as reported by other users.
In addition we estimated standardized uptake values (discussed in section 10.2) for
selected malignancies, despite the controversial discussions over the SUV as a global
measure of malignancy [Keyes, 1995].
8.1 THORAX
8.1.1 HEAD AND NECK CANCER
8.1 .1 .1 INCIDENCE
Carcinomas of the head and neck are among the ten most common cancers in
Europe [DEP, 1999], and in the USA [Landis, 1998], with a prevalence of 12.8, and
22.3 per 100,000 capita, respectively, and contributing 3.2%, and 4.9%, respectively
to all newly diagnosed cancers. Head and neck carcinomas are also among the ten
most lethal cancers with 2.1% and 2.8%, respectively of all cancer deaths.
Of all head and neck malignancies, 90% comprise squamous cell carcinoma
[Biersack, 19971. Head and neck cancer is very often associated with alcohol and
drug abuse, and take their origin in the superior respiratory tracts. There is usually a
high prevalence of distant metastasis associated with the disease [Valk, 1999]. The 5-
year survival rate decreases from 78% (local disease) to 43% (regional lymph node
metastasis) and 20% (distant disease) [Biersack, 1997].
8.1 .1 .2 TREATMENT AND SURVIVAL
Clinical staging requires primarily the morphological evaluation of tumour size
and extent, as well as lymph node and organ involvement. In only 37% of patients
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with head and neck cancer the disease is localized [Biersack, 1997]. Although upon
first detection, head and neck tumours are typically resected, the presence of contra-
lateral disease in patients eliminates surgery as a treatment option. Combined intra-
arterial chemotherapy and radiotherapy have been shown to yield an overall clinical
complete response rate of 86% [Kitagawa, 1999]. Follow-up imaging is required due
to the high incidence of recurrent disease. Proof of recurrence is, however, often
difficult because of post-operative scar tissue and displacement of vessels, lymph
nodes and other anatomical landmarks after surgical intervention.
8.1.1.3 PET IMAGING
The sensitivity for the detection of primary tumours has been reported to be more
than 95%, while the involvement of lymph nodes showed sensitivities between 70%
and 90% [Laubenbacher, 1998]. PET performed generally better than anatomical
imaging [Biersack, 1997], although absolute values for sensitivity, specificity and
accuracy may vary significantly (table 8.A). When monitoring therapy, PET is useful
in predicting treatment response and evaluate post-therapy residual viable cells
[Kitagawa, 1999].
Table 8.A Head and neck cancer. Sensitivity (Sens.), specificity (Spec.) and accuracy (Acc.) of
indiN idual PET and CT imaging. Values for combined PET and CT readings (PET+CT) are based on
independently acquired data sets. All values are given in [%].
PET	 CT	 PET+CT
Reference Sens Spec Ace Sens Spec Ace	 Sens	 Spec	 Ace
Wong, 1996
primary
recurrence
Adams, 1998
N-staging
Lonneux, 1999
recurrence
Lang, 1999
primary
regional N-staging
distant N-staging
90
96
86
80
100
94
69
87
100
98
86
69
88
82
82
85
56
97
88
72
8.1.1.4 CT IMAGING
Definition of residual or recurrent disease after radiotherapy or surgery presents a
challenge for anatomical imaging (CT and MRI). The facial planes can be destroyed
by highly invasive surgery, or distorted by post-surgical scarring and post-irradiation
fibrosis. Both post-treatment effects can make normal anatomical structures
unidentifiable [Rigo, 1996], degrading the accuracy of prediction with CT.
8.1.1.5 COMPLEMENTARY PET AND CT IMAGING
A recent publication clearly demonstrated the benefits of image registration in
localization of PET abnormalities in assessing trismus associated with head and neck
malignancy [Tierney, 1998]. PET/CT image fusion may help identify the size and
extent of the primary tumour in invasively inaccessible areas, such as the oral
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cavities in patients with trismus [Tierney, 19981. The same authors present a case
study where complementary PET and CT image sets helped to decide on the
resectability of the tumour. Another study pointed out that registered FDG-PET
images demonstrated the tumours to be less extensive than was suggested by
anatomical imaging techniques [Wong, 1996]. PET/CT image registration also
proved useful in areas that are clinically particularly inaccessible, such as the
hypopharynx.
8.1.1.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 71-year old female with a known recurrence of head and neck carcinoma after
resection and chemotherapy presented for a PET/CT scan in May 1999. The PET
acquisition comprised three contiguous bed positions scanned for 8min each. The
helical CT was acquired with lOmm slices at 200mAs per slice.
The PET/CT images (fig. 8.1) demonstrated a focal area of markedly elevated
FDG uptake (SUV 28.6±7.7) corresponding to the laryngeal soft tissue mass (fig.
8.1c, d). There were also focal areas of similarly elevated FDG uptake in a soft tissue
mass (fig. 8.1b) in the right neck at the same level and in the left neck (fig. 8.1e)
adjacent to the jugular vein at the level of the circoid cartilage of SUVs 21.4±5.6 and
47.8±4.2, respectively. These findings were consistent with malignant laryngeal
tumour and bilateral malignant adenopathy. Also noted was a small focal area of low
level FDG uptake in the left upper lung (not shown) corresponding a possible ill-
defined opacity on the CT. This finding was somewhat suspicious for malignancy
and further evaluation was recommended.
8.1.1.7 SUMMARY AND CONCLUSION
FDG-PET is a highly valuable tool in the staging and treatment planning of
patients with head and neck malignancies. Anatomical imaging techniques may
suffer from the lack or distortion of normal anatomical landmarks in the evaluation
of nodes or areas suspicious of malignancy, and thus may benefit from
complementary functional information on metabolic activities in these areas. In turn,
PET images pre- and post-treatment can be supported with anatomical information
from registered PET/CT data, or from combined PET/CT acquisitions that become
available with the combined scanner. Since treatment of head and neck cancer almost
always includes highly invasive surgery, combined PET/CT imaging seems most
reasonable in view of accurate diagnosis of anatomically perturbed region. The
delineation of osseous resection margins in pre-operative staging might be a
particularly useful application of combined PET/CT scans.
PET, no attenuation correction Fused PET/CT
cit},
a)
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b)
C)
d)
e)
Figure 8.1 PET/CF study of patient with persistent laryngeal carcinoma. Coronal section (a)
demonstrating four focal areas of increased FDG uptake in the neck (b-e). Transaxial fused PET/CT
images are shown through the centre of each of the four foci seen in (a). At each level the
corresponding transaxial view of the PET images without attenuation correction are shown (left).
PET/CT image fusion accurately localized FDG uptake seen in non-corrected PET images.
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8.1.2 LUNG CANCER
8.1.2.1 INCIDENCE
Although declining over the past two decades lung cancer is still the leading cause
of death in males and third rank in females (after breast and colon cancer). In 1995
195,500 new cases were expected to be diagnosed in Europe [DEP, 1999], compared
to 171,500 new cases in the US in 1998 [Landis, 1998]. Many of these cases will be
found among the 130,000 solitary pulmonary nodules (SPN) detected every year in
the US [ICP, 1994]. Lung carcinomas occur with a prevalence of 52.5, and 63.1 per
100,000 capita in Europe and in the USA, respectively, and contribute 13%, and
14%, respectively to all newly diagnosed cancers. Lung carcinomas are also among
the ten most lethal cancers with 19.5% and 28.3%, respectively of all cancer deaths.
Interestingly, in the US the male/female ratio decreased to 1.6 in 1989 while in
Europe the ratio varies between 11 and 6 [Chiti, 1999]. Generally, the 5-year survival
rate decreases from 50% (no lymph node metastasis) to 8% (positive lymph nodes)
[Biersack, 1997].
8.1.2.2 TREATMENT AND SURVIVAL
Thoracic tumours [Organization, 1982] represent a particular challenge for
oncologists because they are not always readily accessible for invasive tissue
diagnosis. More than 90% of lung cancers are squamous cell carcinomas [Chiti,
1999] and as such tend to spread intrathoracically and beyond. Therefore, non-
invasive diagnostic procedures of high specificity are desired, which would limit the
number of complications during, for example, needle aspiration biopsy [Rigo, 1996].
The presence of extensive mediastinal and contra-lateral lymph node involvement as
well as metastasis preclude curative surgery due to surgical morbidity and poor
prognosis. Therefore, correct staging of lung cancer is crucial to optimize patient
management. Staging involves the determination of tumour size (T), nodal status (N)
and metastasis (M), also referred to as the TNM-classification [Mountain, 1974;
Cymbalista, 1999].
8.1.2.3 PET IMAGING
PET is used to differentiate SPNs, for preoperative staging and for the detection
of recurrences [Rigo, 1996]. Recent data suggest that significant improvement in
patient management can be realized by utilizing PET to maximize thoracotomies for
malignant SPNs and minimize thoracotomies for benign SPNs. On average PET is
96% sensitive and 84% specific in the study of SPNs [Rigo, 1996]. FDG-PET was
also shown to be highly accurate in identifying, localizing, and staging pre-operative
mediastinal lymph node involvement in patients with lung cancer [Gupta, 1998]. In a
review of recent studies an average sensitivity and specificity of 89% and 87% for
mediastinal lymph node staging, and 94% and 92% for extrathoracic metastasis,
respectively were estimated (table 8.B). PET also leads to a high negative predictive
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value that helps to reduce the need for invasive surgical staging of non-small cell
lung cancer (NSCLC) [Vansteenkiste, 1998].
Sensitivity of PET was found to be higher in larger nodules (90% for diameter
3cm) than in smaller nodules (80% for diameter s1.5cm) and may be a result of
partial volume effects [Lowe, 1998]. In addition, an increased rate of false diagnoses
was found to occur in the upper lobes which may be attributed to the varying
physiologic FDG uptake in lung [MiyauchiWahl, 1996b] leading to varying tumour-
to-background ratios throughout the lung.
In a comparison of whole-body FDG PET and chest CT, PET was shown to
change tumour stage in 50% of the selected patients, whereby in 23% of these
patients clinical management was changed according to the PET findings [Changlai,
1999].
Table 8.B Lung cancer: Sensitivity (Sens.), specificity (Spec.) and accuracy (Acc.) of individual PET
and CT imaging. Values for combined PET and CT readings (PET+CT) are based on independently
acquired data sets. All values are given in [%].
Reference Sens
PET
Spec Acc Sens
CT
Spec Acc
PET+CT
Sens	 Spec	 Acc
Wahl, 1994
RIF', 1996
Steinert, 1997
N-staging
N2/N3
Gupta, 1998
Vansteenkiste, 1998
N-staging
N2/N3
Lowe, 1998 #324
82
85
93
89
95
87
92
81
81
99
91
90
81
96
94
91
64
64
79
57
63
59
75
44
68
94
60
63
52
85
61
68
82
93
81
95
81
94
8.1.2.4 CT IMAGING
The diagnostic utility of CT in staging lung cancer and lymph node involvement
is based on size criteria. It was found that by using differing size criteria for nodal
abnormality CT sensitivity decreased as specificity increased [Libshitz, 1984]. For
nodules with diameter  lcm, 1.5cm, and 2cm estimated sensitivity and specificity
were 54%, 23%, 15%, and 68%, 78%, 97%, respectively. Daly and co-workers found
a regional dependence of specificity and accuracy in mediastinal lymph node
evaluation [Daly, 1987]. They showed that CT was less specific and accurate for
central tumours (77% and 79%) compared to peripheral tumours (93% and 90%). A
threshold of lcm diameter is generally accepted for CT imaging in differentiating
benign from malignant lymph nodes [Ferguson, 1986]. The use of helical CT as a
screening technique for lung cancer is limited by the inverse relation of pitch (section
1.1.4) and sensitivity [Kakinuma, 1999].
8.1.2.5 COMPLEMENTARY PET AND CT IMAGING
The advantages of using complementary PET and CT information in tumour
imaging of the thorax was pointed out by Wahl and colleagues in 1993 [Wahl, 1993].
The authors also introduced the term anatometabolic imaging to describe the utility
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of aligned PET and CT information. Although they showed in a preliminary
evaluation from 1994 that fused PET and CT images do not increase the sensitivity
and accuracy of PET imaging alone, image fusion nevertheless '...provides unique
information about the primary lung lesion that in some cases cannot be obtained with
PET alone and may allow development of algorithms that increase the accuracy of
PET and CT. ...' [Wahl, 1994]. In a recent study it was shown that the combined use
of PET and CT information was significantly more accurate in loco-regional lymph
node staging than CT alone [Vansteenkiste, 1998].
8.1.2.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 77-year old male with a family history of cancer (stomach and lung) presented
with recurrent NSCLC. Initial diagnosis in 1997 revealed squamous cell carcinoma
staged at T2, N2 in left upper lung. Patient received radiation therapy in December
1997. Follow-up in April revealed tumour recurrence. A separate CT scan of the
chest (10nun slice widths and 200mAs per slice) demonstrated a lobulated large right
upper lung mass and an enlarged paratracheal lymph node which extended to the
right hilum. In addition, four sub-millimeter pulmonary nodules and several ill-
defined lesions in the liver and renal system were called suspicious for malignancy.
The patient was therefore diagnosed as stage IV lung cancer. Pathology exam
confirmed main tumour in right upper lobe and metastatic moderately-differentiated
squamous cell carcinoma in mediastinal lymph nodes (areas of the hilum, right main
stem bronchus, and pulmonary artery, T2N2).
A PET/CT scan covering the chest from the upper neck to the level of the right
liver (three bed positions with 8min emission scan time per bed) was performed in
July 1998. Combined PET/CT imaging demonstrated increased ring-shaped FDG
accumulation in known lung mass in right upper lobe, indicating active tumour tissue
around a necrotic tumour centre (fig. 8.2a). Note that the mass appeared to have
uniform density. Metabolic activity of the mass, however, was non-uniform as
demonstrated by PET. In addition, the PET/CT scan revealed two nodes suspicious
of metastatic spread of the disease to the right upper lung (paratracheal nodes) as can
be seen in fig. 8.2b and c. Finally, whole-body PET did not demonstrated elevated
FDG accumulation in the region of the liver and renal system, indicating the absence
of metastatic spread to these regions of the body. The patient was therefore down-
staged to stage III lung cancer based on the PET and PET/CT findings.
8.1.3 SUMMARY AND CONCLUSION
Ferguson et al. have shown that up to 95% of benign mediastinal lymph nodes are
lcm or less in greatest diameter [Ferguson, 1986]. Using a size criteria alone to
differentiate benign from malignant lymph node involvement, therefore often leads
to a low specificity of CT. PET is more sensitive and specific than CT for the
detection of small foci of cancer in normal-sized lymph nodes and when
differentiating enlarged benign lymph nodes from enlarged lymph node metastasis in
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Figure 8.2 PET/CT study of lung cancer patient. CT demonstrated uniform large right upper lung
mass (a) that was shown to consist of a necrotic centre surrounded by a hypermetabolic rim on the
corresponding PET study. CT also demonstrated (b) an enlarged paratracheal lymph node in the right
hilum that was hypermetabolic in PET. Whole-body PET demonstrated two additional focal FDG
accumulations in the right upper lung (b, arrowhead) and (c) that were not demonstrated on CT.
PET/CT image fusion located the focal uptakes to right paratracheal lymph nodes.
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the mediastinum [Steinert, 1997]. False results in SPN detection with PET, however,
have been reported for small lesions, lesions at the lung base or with the presence of
scar. Extensive evaluation of combined PET/CT imaging are warranted to determine
if complementary information provided by the PET/CT scanner may facilitate
improved differentiation of benign from malignant node involvement, for example in
case of chronic granulomatous inflammation and small ( 1cm) metastatic lymph
nodes [Gupta, 1999].
It is anticipated that combined PET and CT imaging will be particularly useful in
imaging the aorto-pulmonary region where contrast enhanced CT is insufficient to
accurately assess nodal size in the vicinity of vessels. It was stated by other authors
[Steinert, 19971 that for the exact localization of lymph node metastasis in certain
anatomical areas attenuation corrected PET images are needed. This can be
accomplished with the PET/CT scanner that provides low-noise attenuation corrected
whole-body images in short scan times. The above case study clearly demonstrates
the utility of combined PET and CT imaging with a single scanner.
8.2 ABDOMEN
8.2.1 PANCREAS
8.2.1.1 INCIDENCE
In 1998 29,000 new cases of pancreatic cancer were diagnosed in the US alone,
while for the same year 28,900 people were expected to die from the disease. Over
the past two decades pancreatic incidence rate decreased by almost 2% [Report
1996]. Carcinomas of the pancreas occur with a prevalence of 10.6 per 100,000
capita in Europe and the USA, and contribute 2.7%, and 2.4%, respectively to all
newly diagnosed cancers. Pancreatic carcinomas are also among the ten most lethal
cancers with 4.7% and 5.1%, respectively of all cancer deaths [Landis, 1998; DEP,
1999].
8.2.1.2 TREATMENT AND SURVIVAL
In many patients, the diagnosis of pancreatic cancer is not made until the disease
is well advanced, resulting in a generally poor prognosis. Cure requires the complete
resection of the disease which is confined to the pancreas but can only be attempted
in less than 25% of all patients [Karl, 1993]. For the remaining patients, other
options such as chemo- or radiation therapy do not significantly improve either
prognosis or outcome [Stollful3, 1995], although pre-operative external beam
radiotherapy may offer a means for improving resectability and local control in
patients. Overall, the prognosis of patients with diagnosed pancreatic cancer is one of
the worst among gastro-intestinal cancers, with a 5-year survival of less than 5%.
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8.2.1.3 PET IMAGING
The differential diagnosis of chronic pancreatitis and other benign abnormalities
from pancreatic adenocarcinoma remains a challenge. Pancreatic cancer is often
accompanied by pancreatitis, and the specificity for pancreatic cancer is therefore
somewhat low as compared to the sensitivity that is mostly higher than 90%.
Nevertheless, PET was shown to be of value in the differential diagnosis of
pancreatic cancer and mass-forming pancreatitis [Kato, 1995]. A recent study
[Nakata, 1997] suggested that SUV could be a predictor of prognosis for patients
with pancreatic adenocarcinoma: patients with high SUV (> 3) had a mean survival
of five months, whereas patients with an SUV <3 survived for a mean of 14 months.
In addition to the prognostic value of FDG PET evidence of metastatic disease of
pancreatic carcinoma can be appreciated in PET imaging [Rigo, 1996].
Table 8.0 Pancreatic carcinoma: Sensitivity (Sens.), specificity (Spec.) and accuracy (Ace.) of
individual PET and CT imaging. Values for combined PET and CT readings (PET+CT) are based on
independently acquired data sets. All values are given in tgi.
Reference Sens
PET
Spec Ace Sens
CT
Spec Ace
PET+CT
Sens	 Spec	 Ace
Inokuma, 1995
Rigo, 1996
Biersack, 1997
Wahl, 1997b
Delbeke, 1998
Diederichs, 1998
Zimny, 1998
Diederichs, 1999
94
<95
94
95
85
96
82
90
84
79
91
<90
90
91
87
89
89
80
88
73
74
85
76
83
100
8.2.1.4 CT IMAGING
Although CT has a high sensitivity for detection of pancreatic masses (table 8.C),
it is of limited utility for distinguishing inflammatory or post-operative tissue
changes and viable tumour [Furukawa, 1996]. In addition the accuracy of CT for
measuring tumour size in pancreatic cancer is unclear, and small lymph node
metastasis are frequently missed.
8.2.1.5 COMPLEMENTARY PET AND CT IMAGING
Recently it has been shown [Diederichs, 1998] that combined interpretation of
independently acquired PET and CT data helped to detect pancreatic malignancies
with a sensitivity of 100%. Furthermore, accuracies above 90% were only obtained
with combined PET/CT reading.
8.2.1.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 38-year-old female diagnosed in February 1998 with unresectable pancreatic
carcinoma presented for a PET/CT scan. A stent was placed and during surgery liver
metastasis was noted. Separate CT scanning (10mm slices) revealed a non-specific
hypodense lesion in lower abdomen and minimal decrease in pancreatic mass
compared to previous follow-up scan. Coronal whole-body PET images (70min
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uptake period) demonstrated increased FDG accumulation in the upper mid abdomen
(fig. 8.3a). It is not clear if this uptake is located in the transverse colon or in the
pancreas because of the close proximity of structures. A transaxial CT image shows
the location of a stent in the pancreas (fig. 8.3b). The correct diagnosis was made by
means of the PET/CT image (fig. 8.3c) that showed that this uptake was inside the
pancreas (SUV-5.3), and not in the transverse colon. Transverse sections through the
PET volumes reveal the presence of two metastasis that were localized by means of
PET/CT image fusion to the right posterior chest wall (fig. 8.3d) and the left aorto-
pulmonary window region of the mediastinum, (fig. 8.3e).
8.2.1.7 SUMMARY AND CONCLUSION
Since patients with pancreatic cancer often do poorly after treatment the clinical
benefit of better imaging before therapy is questionable. An improved ability,
however, of better characterizing indeterminate pancreatic masses would be of great
value to patients who present with benign masses and could be spared surgical
intervention [Wahl, 1997131. In the selected cases non-specific FDG uptake was
accurately localized with respect to the anatomy of the patients, a challenge if only
PET images were available. In addition PET also has the ability to detect previously
unknown metastasis [Diederichs, 1999] as demonstrated in the above patient study.
Studies performed on the combined PET/CT scanner, will likely offer increased
diagnostic accuracy because of a more precise localization of faint metabolic activity
in the pancreas. In addition more reliable estimates of SUV is provided due to the
low-noise attenuation correction obtained from the CT scan. In the future combined
PET/CT scans may correlate tumour shrinkage and decreased metabolism to provide
prognostic information from clinical response after a given treatment.
8.2.2 RENAL CELL
8.2.2i INCIDENCE
Between 1974 and 1990, the incidence of renal cancer increased by 38%. In 1992
almost 31,000 new cases of kidney cancer were diagnosed in the USA with a
mortality of 25% [1996]. Renal cell cancer has a prevalence of 11 per 100,000 capita
both in Europe and in the USA, and contributes 2.3%, and 2.4%, respectively to all
newly diagnosed cancers. Renal carcinomas account for 2.3% and 2.1%, respectively
of all cancer deaths. Heavy smoking and overweight increase the risk of renal cell
cancer, which accounts for approximately 3% of all malignancies, and occurs with a
male-to-female ratio of two [Biersack, 1997]. Renal cell cancer patients frequently
present with metastatic disease because of the absence of early warning signs and
early diagnosis.
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a)
PET without attenuation correction
Coronal view
Fused PET/CT
d)
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b)
Fused PET/CT
Figure 8.3 PET/CT study of patient with pancreatic cancer. Coronal view of non-corrected whole-
body PET image shows primary tumour (arrow) in mid-abdomen. Image fusion (c) of transaxial CT
(b) and PET images localizes FDG accumulation to pancreas near the stent. Fused PET/CT images
showed additional focal FDG uptakes in (d) mediastinum and (e) right posterior chest wall, suspicious
of metestasis.
186
8.2.2.2 TREATMENT AND SURVIVAL
Grading is an important prognostic factor in many patients with renal cancer. The
grading of this disease has recently been revised and combined with prognostic
factors [Bostwick, 1998]. In general, the behaviour of metastatic renal cancer in
individual patients can be rather variable, with a spontaneous regression in at least
0.8% of all patients. Surgical resection is performed if the malignant mass is
confined to the kidneys. Therapeutical approaches for metastatic renal cancer include
radio-immunotherapy and biological immunotherapy with interleukin-2, which has
demonstrated response rates of up to 20%. Novel approaches to therapy include gene
and vaccine therapies. The effect of gene therapy may be enhanced when combined
with conventional radio- or chemotherapy. Five-year survival is 58% for all stages
(87% for localized disease and 9% for distant spread [Report 1996]).
8.2.2.3 PET IMAGING
Some series have reported that that renal cell carcinoma has an increased
metabolic rate when imaged by FDG PET. However, these findings have been noted
only in a small number of patients [Wahl, 1991; Goldberg, 1997]. While some
authors find good discrimination between renal cancer and normal tissue, others
observe inconsistencies in the degree of uptake of FDG in renal cell carcinomas, and
show that FDG PET may not predict the cell type or histological grade [Shreve,
1998]. FDG PET is, however, useful in differentiating complex cysts [Goldberg,
1997] although one hour seems to be the optimum delay time for maximum blood
clearance and tumour uptake [Wahl, 1991]. Image contrast in renal cell carcinomas
can be improved by prolonging the delay between injection and start of the scanning
[Rigo, 1996]. Data on overall accuracy of PET imaging on renal masses are sparse
and summarized in table 8.D.
Table 8.D Renal cell carcinoma: Sensitivity (Sens.), specificity (Spec.) and accuracy (Acc.) of
individual PET and CT imaging. Values for combined PET and CT readings (PET+CT) are based on
independently acquired data sets. All values are given in [%].
Reference
Wahl, 1991
Miles, 1991
Jamis-Dow, 1996
5mm
10-15mm
Goldbere, 1997
PET
	 CT	 PET+CT
Sens Spec Acc Sens Spec Acc Sens Spec Acc
100
47
100
90
8.2.2.4 CT IMAGING
CT is the standard imaging technique in the initial evaluation of renal cancer
patients and was shown to be fairly accurate in staging the disease [Miles, 1991]. A
substantial portion of lesions under lcm, however, remains often undetected by CT
[Jamis-Dow, 1996]. CT guided biospies are successfully used to determine the
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histopathology of the renal lesion but have been shown to result in relatively frequent
complications associated with the biopsy intervention [Sateriale, 19911.
8.2.2.5 COMPLEMENTARY PET AND CT IMAGING
We are unaware of any studies on the efficacy of combined PET and CT data sets
for the evaluation of renal cell cancer patients.
8.2.2.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 49-year old male suffering from metastatic renal cell carcinoma of the left
kidney presented for a PET/CT scan in January 1999. The patient was post left
nephrectomy and post treatment with interleukin-2 and interferon in October 1998.
The follow-up CT scan did show no progression of the disease. Multiple spots in the
abdomen were inconsistent with malignancy, and the CT exam was negative for
disease.
The PET images demonstrated a focal area of elevated FDG uptake (SUV
3.6±-0.6) corresponding to the lobulated soft tissue mass in the left renal surgical bed
(fig. 8.4a). Note the uniformity of the mass (b) as it appears on the CT without
contrast. The FDG uptake seen in the PET images was non-uniform and extended
axially over several slices (c). The lateral larger portion of the lesion (b) did not take
up FDG and was centrally hypodense, consistent with necrosis (d).
8.2.3 SUMMARY AND CONCLUSION
In order to decide upon a correct surgical approach accurate pre-operative
knowledge of vascular involvement by the rebal cancer is more important to the
surgeon than the presence of extracapsular spread [Miles, 1991]. Therefor, CT has
been used almost exclusively in the evaluation of solid renal masses due to its
superior anatomic resolution. Combined PET/CT imaging of renal masses would
allow for the first time to complement anatomical detail information with metabolic
information about the mass. Since CT is not specific for staging lymph node
metastases, FDG PET in the context of combined PET/CT may be of particular value
in patients where the disease has spread. Finally, PET/CT imaging may help in the
future in guiding CT biopsies in diffuse renal disease [Sateriale, 1991], and in the
evaluation of response to immunotherapy.
8.2.4 ESOPHAGUS
8.2.4.1 INCIDENCE
Esophageal cancer has a low prevalence in the USA [Landis, 1998] (4.5 per
100,000 capita) and Europe (6.5) [DEP, 1999], and accounts for 2.1% of all deaths in
the USA (ten most common cancer related deaths) and 2.5% in Europe.
C) PET (coronal view), no corrections
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Figure 8.4 PET/CT study of a patient with renal cell carcinoma after resection of the left kidney and
post-therapy with interleukin-2 and interferon. CT scan showed large uniform mass in the surgical bed
(a, b). Whole-body PET scan showed high accumulation of FDG in that area (c). Fused PET/CT
imaging located the FDG uptake to the anterior portion of the lesion (d) whereby the larger lateral part
did not take up FDG, consistent with necrosis. Coronal sections from the level of the kidneys to the
pelvic bones indicate the axial extent of the lesion (e).
Reference
Flanagan, 1997
lymph node involvement
locoregional nodes
Luketich, 1998
Luketich, 1997
locoregional metastasis
distant metestasis
Fukunaga, 1998
Kole, 1998
Macapi nl ac, 1999
8.2.4.4 CT IMAGING
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8.2.4.2 TREATMENT AND SURVIVAL
Patient treatment in esophageal cancer remains unsatisfactory, with up to 50% of
the patients having metastatic spread at presentation. The five-year survival rate is
less than 5%. Surgical resection remains the standard of care at the present time,
affording the best opportunity for cure and prolonged relapse-free survival. Since the
majority of patients present with locally advanced or metastatic disease to regional
lymph nodes, curative resection alone does not translate into long-term survival
[Luketich, 1997]. Preoperative chemotherapy is a logical approach for treating
esophageal cancer because of early widespread dissemination of the disease.
Therefore, effective staging of esophageal cancer, and the identification of micro-
metastatic disease, is critical to patient management.
8.2.4.3 PET IMAGING
Until recently little information was available on the role of FDG PET in the
evaluation of esophageal cancer [Rigo, 1996]. Although FDG PET does not always
accurately identify loco-regional lymph node involvement, sensitivity for the
detection of distant disease is higher than with CT [Flamen, 1999]. In addition to
staging and identification of distant disease, there is growing evidence that FDG PET
is useful in evaluating the status of the primary tumours before and after treatment
and thus could help identify patients who can benefit from multi-drug neo-adjuvant
chemotherapy prior to surgery. A brief literature review on performance of PET in
esophageal cancer is given in table 8.E.
Table 8.E Esophageal cancer. Sensitivity (Sens.), specificity (Spec.) and accuracy (Acc.) of individual
PET and CT imaging. Values for combined PET and CT readings (PET+CT) are based on
independently acquired data sets. All values are given in rot
Sens
PET
Spec Acc Sens
CT
Spec
PET+CT
Acc	 Sens	 Spec Acc
76
72
69
45
88
80
82
100
93
95
76
48
91
97
88
86
45
28
46
68
73
81
45
65
73
92
The effectiveness of CT in determining tumour resectability is around 50%
[Flanagan, 1997] and mostly limited by the difficulty of CT to assess the extent of
local disease and lymph node involvement (table 8.E) in particular at the gastro-
esophageal junction. Another difficulty is to distinguish between esophageal tumour
and vascular structures.
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8.2.4.5 COMPLEMENTARY PET AND CT IMAGING
A study by Kole et al. estimates a diagnostic accuracy of PET and CT together of
92%, which is higher than the accuracy of either modality alone [Kole, 19981. In this
retrospective study of 26 patients PET and CT together would have decreased ill-
advised surgery by 90%.
8.2.4.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 69-year-old man presented with six weeks of dysphagia and odynophagia.
Independent staging revealed a distal esophageal defect just above the hiatal hernia
that was found to represent an adenocarcinoma. PET/CT study was performed in
October 1998. PET emission data were acquired over four contiguous bed positions
for 15min each. CT scans were acquired with 200mAs per slice.
The non-corrected whole-body PET images (fig. 8.5a) demonstrated a long
segment of markedly increased FDG uptake (SUV 8.2±0.9)in the upper abdominal
esophagus extending inferiorly to approximately the level of the gastro-esophageal
junction, consistent with the history of known primary esophageal cancer. Two
additional areas of focally increased FDG uptake are present: in the right para-
tracheal region with an SUV of 4.4±0.6 (fig. 8.5b), and in the gastro-hepatic/celiac
region with an SUV of 4.9±0.6 (fig. 8.5c), consistent with nodal involvement with
tumour.
8.2.4.7 SUMMARY AND CONCLUSION
Fused PET/CT images permitted precise surgical localization of lymph node
involvement that is beneficial for biopsy or node resection. In the future combined
PET/CT imaging could be used to monitor the effects of chemotherapy performed
prior to surgical resection, as part of the recently proposed combined modality
approach to the treatment of esophageal cancer [Luketich, 1998]. Pre- and post-
treatment data sets could then be aligned by means of the available CT volumes thus
accounting for potential morphological alterations after surgery that would unlikely
be considered by the alignment of PET data alone. Fully quantitative information
from the PET data corrected for attenuation based on the CT could also be used to
predict survival based on SUV values as described by [Fukunaga, 1998].
8.2.5 COLORECTAL CARCINOMA
8.2.5.1 INCIDENCE
Colorectal cancer is one of the most frequently occuring malignancies in the
Western world. In 1998 in the USA alone 95,600 patients presented with newly
diagnosed colorectal carcinoma (prevalence 35 per 100,000 capita), 47,700 were
expected to die from the disease the same year (8.4% of all cancer deaths) [Landis,
1998]. Colon cancer has the second highest prevalence of all cancers in Europe and
accounts for 11.9% of all cancer related deaths [DEP, 1999].
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b)
Fused PET/CT
C)
Figure 8.5 PET/CT study of patient with esophageal cancer. Coronal sections of non-corrected whole-
body PET images, each lcm thick show primary tumour (arrowhead) and nodal involvement (arrows).
Transaxial sections through CT, PET, and fused PET/CT images at the apex of the lung (b) and
gastrophelic/celiac region (c) demonstrate nodal tumour involvement.
192
At the time of the diagnosis the disease is localized in 36% of the patients, in
39% and 19% regional and metastasis are present [Biersack, 1997]. The 5-year
survival rate decreases from 91% (no metastasis) to 59% and 6%, respectively. In
one third of all cases with regional lymph node metastasis a solitary liver metastasis
is present, which may be removed surgically. The medium survival is then four to
twelve months.
8.2.5.2 TREATMENT
Surgery is the method of choice to remove the primary tumour. Although 70% of
patients with colorectal carcinoma have resectable tumours, about one third present
with recurrence, commonly within two years [Rigo, 1996]. Recurrent disease is
typically treated with a combination of radiation therapy and regional or global
chemotherapy with fluoroacil (FU) [[Strauss, 1991 #90]]. Although the response to
chemotherapy is variable [Dimitrakopoulou, 1993] chemotherapy outcome can
generally be predicted using I8F-FU PET imaging [Dimitrakopoulou-Strauss, 1998].
A particularly challenging clinical question is if a 're-resection' [Wahl, 1997b] of the
recurrent or metastatic colorectal cancer should be performed in the presence of
recurrence [Sardi, 1988]. So far, off all recurrencies only 25% are curable. Surgical
removal of hepatic metastasis may prolong survival in some patients [Report 1996].
8.2.5.3 PET IMAGING
18F-FU is the most common cytostatic agent used for chemotherapy in colorectal
tumour patients. The radiotracer 'F-FU has been used to measure tumour
metabolism in liver metastasis [Dimitrakopoulou-Strauss, 1998]. It was shown that
the therapeutic response is associated with high 18F-FU uptake, trapping and
metabolism as imaged with ' 8F-FU PET [Dirnitrakopoulou, 1993].
FDG is avidly concentrated in colorectal carcinomas, and current studies indicate
an important role of FDG PET in the evaluation of this cancer. For example, FDG
PET is highly efficient for restaging when recurrence is suspected although the
accuracy may vary with the anatomical side of recurrence. FDG PET is highly
accurate for excluding metastatic disease [Trager, 1999]. However, although FDG
PET may be superior to other imaging techniques in imaging the spread of the
disease to the liver, it appears not as good in detecting disseminated intra-peritoneal
disease [Wahl, 1997b].
8.2.5.4 CT IMAGING
Anatomical imaging with CT is useful for detecting liver metastasis but not nodal
involvement (table 8.F). There is evidence that numerous patients with negative CT
scans have a non-resectable tumour at the time of surgery [Rigo, 19961. CT has been
the conventional imaging modality used to localize recurrence with an accuracy of
25% to 73% [Moss, 1989]. Hepatic metastasis are missed in 7% and involvement of
lobes is underestimated in 33% of all cases. Finally, when identifying a pre-sacral
mass as a locoregional recurrence on CT it is difficult to diagnose its origin.
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Table 8.F Colorectal carcinoma: Sensitivity (Sens.), specificity (Spec.) and accuracy (Ace.) of
individual PET and CT imaging. Values for combined PET and CT readings (PET+CT) are based on
independently acquired data sets. All values are given in [%]. EHM is extra-hepatic metastases.
	
PET	 CT	 PET+CT
Reference	 Sens Spec Ace Sens Spec Ace Sens Spec Acc
Valk, 1994	 83	 56
Schiepers, 1995	 93	 97	 95	 60	 72	 65
Rigo, 1996	 93 67-98
Biersack, 1997	 100	 67
Trager, 1999
	
Recurrence 100
	 96
Hallkar, 1999
	
EHM 88	 100	 67	 100
8.2.5.5 COMPLEMENTARY PET AND CT IMAGING
At the present time we are unaware of studies performed regarding the usefulness
of combined PET and CT imaging for evaluation of colorectal cancer patients.
However, Hallkar et al. [Hallkar, 1999] advocate the use of complementary CT/MR'
and FDG PET information for the pre-operative evaluation of surgical resection of
hepatic metastasis from a primary colorectal carcinoma. While CT and MRI were
shown to provide better segmental localization of hepatic metastasis, FDG PET
showed a superior detection rate for extrahepatic disease.
8.2.5.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 69-year old male with a history of colon cancer was referred for a PET/CT scan
in January 1999. The patient had two surgical procedures performed for rectal cancer
in 1990. The patient developed an abdominal wall recurrence of the malignancy in
1993 which required a massive resection of the abdominal wall and small intestines.
After a successful recovery rising CEA levels in 1998 indicated recurrent metastatic
disease. Previous CT diagnostic evaluation did not reveal the source of the
recurrence. A combined PET/CT study was performed a few months after detecting
recurrent disease.
The emission images (five beds of 6.5min each after 2h uptake period)
demonstrated a long segment of moderately increased FDG uptake in the ascending
colon. Furthermore, moderate FDG uptake was noted in the vicinity of the bladder
indicative of physiologic bowel excretion. Both FDG accumulations can be seen in
the coronal slices of the whole-body PET data (fig. 8.6a) and were considered
normal. However, the combined scan demonstrated evidence of a sigmoid lytic
lesion involving the sacrum with destruction of the right sacral foramina and an
associated soft tissue mass on the CT (fig. 8.6b). The corresponding FDG uptake in
this region was minimal. The appearance of this lesion, however, on the coregistered
PET and CT studies is highly suspicious for recurrent colon cancer, and biopsy may
be indicated.
colon
22 23 24	 25
heart
bladder
PET
Fused PET/CT
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b)
Figure 8.6 PET/CT study of patient with recurrent colon cancer: (a) Contiguous lcm coronal sections
through the whole-body emission image from posterior to anterior, showing normal FDG uptake in
the ascending colon and physiologic bowel excretion. Three contiguous transaxial sections (b) through
CT (top row), attenuation-corrected PET (middle row), and fused PET/CT images (bottom row).
Fused images revealed a lytic lesion involving the sacrum (arrows in CT) that corresponded to mild
FDG uptake in the PET (arrows).
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8.2.5.7 SUMMARY AND CONCLUSION
Combined PET/CT imaging has the potential to affect the pre-operative
evaluation of surgical resection of hepatic metastases [Hallkar, 1999]. There is a
tendency to believe that PET has more of a clinical and economic impact in the
evaluation of post-operative recurrence than in the pre-operative detection and
staging as pointed out by Rigo et al. [Rigo, 1996]. Our clinical example emphasizes
the usefulness of combined imaging in fig. 8.6. The discrimination of physiologic
accumulation of FDG in the lower abdomen is crucial when imaging colorectal
cancer [Miraldi, 1998], and may be supported by combined anatomical and
functional imaging despite the available yet stressful cleansing techniques.
8.2.6 CHOLANGIOCARCINOMA
8.2.6.1 INCIDENCE
Cholangiocarcinomas (CC) can develop from primary sclerosing cholangitis (PSC), a
chronic cholestatic liver disease characterized by inflammation and fibrosis. The
prevalence of this malignant disease in PSC patients was estimated between 7%
[Rosen, 1991] and 9% [Keiding, 1998]. The time delay between the recognition of
CC after diagnosing PSC is up to 25 years. Metastatic disease is common and may be
present in up to 63% of the CC cases diagnosed [Rosen, 1991].
8.2.6.2 TREATMENT AND SURVIVAL
Patients with PSC are typically scheduled for liver transplantion. Due to the
relatively high potential for CC to develop in patients with PSC, liver transplantation
should be considered earlier in the course of the disease as discussed by Rosen et al.
[Rosen, 1991]. The prognosis for patients with PSC and CC is generally poor, with a
median survival around seven months following the diagnosis of CC [Rosen, 1991].
The median survival for liver transplants in the presence of CC is 14 months and 23
months for patients diagnosed with CC before and after the transplantation,
respectively [Abu-Elmagd, 1993].
8.2.6.3 PET IMAGING
Data on the use of PET for the evaluation of CC are limited. A recent study
assessed the usefulness of PET in the detection of CC in 15 PSC patients [Keiding,
1998]. Previously PET was shown to be of high value in the detection of liver
metastases [Rigo, 1996]. FDG PET images also showed accumulation of FDG in CC
lesions. Detection of low- and well-differentiated tumours was challenging owing to
the physiologic uptake in liver. Nevertheless, FDG PET demonstrated CC lesions in
three out of six patients when ultrasound examination had not detected
morphological changes.
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8.2.6.4 CT IMAGING
Hilar CC appears on CT usually as a low density or isodense mass that abruptly
obstructs converging dilated bile ducts. Dynamic and contrast enhanced CT scans are
therefore useful when assessing the amount of tumour infiltration of vascular
structures in the vicinity of the CC and liver [T'akayasu, 1990]. Recently, helical CT
scans with multi-phase contrast enhancement were used to assess the involvement of
anatomic structures in the vicinity of the CC. It was found that helical CT is helpful
in the assessment of parenchymal, bilary intrahepatic, and portal involvement
[Feydy, 1999], but that the exact proximal tumour extent along bile ducts tends to be
underestimated [Tillich, 1998]. Therefore, helical CT is insufficient for determining
resectability. Another study demonstrated insufficient sensitivity of CT to detect
parenchymal and lymph node metastases [Frola, 1994] leading to more controversy
about the effectiveness of CT in management of cholangiocarcinomas.
8.2.6.5 COMPLEMENTARY PET AND CT IMAGING
We are unaware of any studies on the efficacy of combined PET and CT data sets
for the evaluation of cholangiocarcinomas.
8.2.6.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 44-year old female with a history of primary sclerosing cholingitis was scanned
on the PET/CT scanner in November 1998. The aim of the study was to assess initial
diagnosis of PSC. PET data were acquired over two bed positions for 15min each.
The PET/CT study demonstrated focal areas of abnormal moderately elevated FDG
uptake in the region of the porta hepatis and right lobe of the liver (fig. 8.7a-d)
corresponding to the area of presumed tumour on CT and consistent with
malignancy. Curvilinear areas of mildly increased tracer accumulation were noted
along the stent track (post wedge resection of right lobe of liver), which may be due
to associated inflammatory changes.
8.2.6.7 SUMMARY AND CONCLUSION
FDG PET scans may be used to decide whether or not to accept a PSC patient for
liver transplantation. Complementary PET/CT imaging with a single tomograph may
be helpful in assessing the presence and extent of cholangiocarcinomas. For
example, while helical CT was reported to be challenged by bile duct involvement
[Tillich, 1998], PET may benefit from the accumulation of radioactivity in malignent
bile duct cells and rapid turnover of the tracer in surrounding hepatocytes [Keiding,
1998].
a) e)
f)b)
c) g)
d) h)
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Figure 8.7 PET/CT study of a patient with cholangiocarcinoma. Coronal section (a) through whole-
body PET image demonstrated axially extended area of moderate FDG accumulation in the region of
the right liver. Transaxial sections (b-d) show extent of FDG uptake. Fused PET/CT images are shown
for the corresponding coronal view (e) and transaxial sections (f-h). Normal physiologic uptake in
myocardium (e) and left kidney (g,h) was noted. Patient was post wedge-resection of right lobe of
liver and right pelvic kidney.
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8.3 METASTATIC DISEASE
8.3.1 LYMPHOMA
8.3.1.1 INCIDENCE
Non-Hodgkin's lymphoma (NHL) includes about ten different types of disease. In
1996 53,000 new cases were diagnosed with NHL in the USA raising to 64,000 in
1999. 27,000 were expected to die from the disease in this year. Hodgkin's disease
(HD) and NHL account for less than 8% of all malignancies [Hoh, 1997]. Because
lowered immune system function raises susceptibility to this group of diseases,
infectious agents that lower immunity, such as HIV, increase the risk. Recipients of
organ transplants are also at higher risk because of the immuno-suppressive drugs
they must take.
8.3.1.2 IMPORTANCE
NHL is diagnosed by means of biopsy of enlarged lymph nodes. The grading, or
characteristics of the proliferation cells strongly influence the choice of therapy, of
which chemotherapy is the most common method. NHL becomes eventually
resistant to chemotherapy but it remain s responsive to modest doses of external
beam radiation to palliate the disease. For higher-grade tumours chemotherapy is
also often combined with radiation therapy. Relapses may be treated with higher-
dose chemotherapy and bone marrow transplantation. Five-year survival is about
51% [Report 1996]. More recently the use of radiolabeled monoclonal antibodies
(MoAb) has been suggested as a revolutionary treatment (not cure) for NI-IL [Nardo,
1998].
8.3.1.3 PET IMAGING
Although PET may be a useful tool for the initial diagnosis of lymphoma (when it
is comparable to CT imaging), staging and therapy monitoring by PET are more
important [Biersack, 1997]. PM' plays an important role in the evaluation of residual
mass in CT after therapy [Bumann, 1998] but only limited data exist regarding the
role of PET after lymphoma therapy [Wahl, 1997b]. PET is very accurate in
determining extra-lymphatic spread of the disease (table 8.G) and was shown to
provide reliable and fast staging in patients with untreated malignant lymphomas and
HD [SchOnberger, 1994]. Since lymphomas may be multi-focal and widespread,
whole-body FDG PET imaging is an accurate and cost-effective method for staging
HD and NHL by focusing subsequent anatomical imaging procedures only to the
necessary regions [Hoh, 1997].
8.3.1.4 CT IMAGING
Staging and grading with CT is based on size criteria of the lymph nodes.
However, even small nodes may harbor metastasis, while large nodes may be benign.
Reference
Finke, 1999
Bares, 1996
PET
Sens	 Spec	 Acc Sens Spec Ace Sens Spec Ace
78-100 97-100
100	 96
CT PET+CT
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In one study disease was present in up to 70% of normally sized lymph nodes
[Moog, 1997]. In addition, diffuse spread to spleen and liver and extra-nodal disease
are often not detected with CT [Burnam, 1998].
Table 8.0 Non-Hodgkin's lymphoma: Sensitivity (Sens.), specificity (Spec.) and accuracy (Acc.) of
individual PET and CT imaging. Values for combined PET and CT readings (PET+CT) are based on
independently acquired data sets. All values are given in rot Finke et al. was multi-centre study.
8.3.1.5 COMPLEMENTARY PET AND CT IMAGING
We are unaware of any studies on the efficacy of combined PET and CT data sets
for the evaluation of lymphoma.
8.3.1.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 48 year-old woman with a history of NHL was referred for a PET/CT scan.
Spiral CI' data were acquired over a limited axial range that extended from the liver
to the uterus. PET data were acquired over three corresponding bed positions for a
scan duration of 13 min per bed. An area of pronounced FDG uptake (SUV
10.3±1.5), located dorsally at the level of the lower abdomen, was seen on the PET
images (fig. 8.8a) corresponding to a 2cm soft tissue mass in the subcutaneous fat as
seen on the CT images (200mAs per slice). The PET scan also demonstrated FDG
accumulation (SUV 2.0±0.1) in the pelvic region (fig. 8.8b) distinct from normal
bowel activity. The fused PET/CT images localized this focal FDG accumulation to
a known SI bone lesion seen on CT (fig. 8.8b, double arrows). Due to the large cross-
sectional area of the patient (130kg), there was significant beam hardening of the CT,
as is apparent in the dorsal region of fig. 8.8b.
8.3.1.7 SUMMARY AND CONCLUSION
Whole-body PET scans could be used to direct the combined PET/CT imaging
protocol to a particular lesion of interest, such as the SI bone lesion in the patient
study above that would have been difficult to assess with either imaging technique
alone. It can furthermore be conceived that combined PET/CT imaging can assist in
the detection of bone marrow infiltration or the assessment of extra-lymphatic
spread, such as to the spleen or digestive tract, as reported by Rigo et al. [Rigo,
1996]. In addition, the combination of functional PET and anatomical CT imaging
may be useful when fibrosis develops as a result of tumour necrosis, and when
initially enlarged tumours remain enlarged after effective sterilization of the tumour
[Rigo, 1996].
PET
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a)
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b)
Figure 8.8 PET/CT study of patient with NHL: (a) transaxial sections through CT (left), PET (right),
and fused PET/CT (centre) at the level of the pelvis show soft tissue lesion metastasis, (b) coronal
sections through the same image volumes extending from the lower kidneys to the uterus. The arrows
in (b) indicate the extent of the known SU bone lesion that was shown to be metabolically hyperactive
on the fused PET/CT images.
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8.3.2 MELANOMA
8.3.2.1 INCIDENCE
Melanoma is the most aggressive cutaneous malignancy, and accounts for three
quarters of all deaths from skin cancer with a yearly 4% increase in incidence
[Report 1996]. In 1992 38,300 new cases were diagnosed in the USA of which 7,300
died. The incidence is increasing rapidly and may be related to sun exposure.
8.3.2.2 TREATMENT AND SURVIVAL
Correct staging of melanoma is very important in defining most effective
treatment. In 25% of the patients scanned with PEI' surgical intervention was
cancelled owing to the presence of metastatic spread and other treatment forms were
defined instead. At the time of diagnosis, 82% of the patients present with a localized
disease, while 8% and 4% have regional or distant metastases, respectively reducing
the 5-year survival rate from 92% to 52% and 14%, respectively [Biersack, 1997].
8.3.2.3 PET IMAGING
So far, FDG appears to be the preferred PET imaging agent in melanoma PET
[Wahl, 1997b]. Clinical evaluation confirms the high sensitivity of PET (table 8.H)
in detecting melanoma lesions in particular in the abdomen, and lymph nodes and to
a lesser extent for detecting pulmonary lesions [Gritters, 1993]. Due to the high
tumour-to-background ratio in melanoma lesions, PET can detect superficial lymph
nodes or skin lesions of 5mm or less [Rigo, 1996]. PET improves the selection of
surgical candidates and help clarify inconclusive findings from conventional staging
techniques [Damian, 1996]. FDG uptake can be used to assess the effect of
chemotherapy as early as 90min after administration of the therapeutic agents
[Strauf3, 1996b].
Table 8.H Melanoma: Sensitivity (Sens.), specificity (Spec.) and accuracy (Acc.) of individual PET
and CT imaging. Values for combined PET and CT readings (PETA-CT) are based on independently
acquired data sets. All values are given in [%].
Reference Sens
PET
Spec Acc Sens
CT
Spec
PET+CT
Acc	 Sens	 Spec	 Acc
Pounds, 1995 92 75
Rigo, 1996 100
Biersack, 1997 92 75
Macfarlane, 1998 88
Holder, 1998 94 83 55 84
Rinne, 1998
primary 100 94 80
follow-up 92 94 92 58 45 56
8.3.2.4 CT IMAGING
Malignant melanoma is an aggressive neoplasm that can involve every organ
system. Therefore whole-body CT scans (chest and abdomen) are performed for
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evaluation of melanoma patients [Fishman, 1990]. It was shown that during staging
of malignant liver metastases unenhanced CT scans demonstrated 62% of the
measurable lesions [Chomyn, 1992]. While CT is generally less sensitive than PET
in staging malignant melanoma, CT has a higher sensitivity in detecting small
pulmonary lesions [Rinne, 1998].
8.3.2.5 COMPLEMENTARY PET AND CT IMAGING
We are unaware of any studies on the efficacy of combined PET and CT data sets
for the evaluation of melanoma.
8.3.2.6 CASE STUDY FROM THE COMBINED PET/CT TOMOGRAPH
A 49-year old male with metastatic melanoma was scanned on the PET/CT before
and after chemotherapy in November and December 1998. The patient underwent
abdominal ultrasound where a large retroperitoneal adenopathy was seen.
Subsequent CT showed extensive lymphadenopathy in the hilar and periaortic
region. The PET study before treatment demonstrated many areas of focally
abnormal FDG uptake highly suspicious of malignancy (fig. 8.9a) that could be
interpreted in the context of the anatomy of the patient based on available PET/CT
information (fig. 8.9b). A PET study after chemotherapy one month later showed
partial response to therapy (fig. 8.9c) that could be estimated more carefully on the
basis of the lesion size before (fig. 8.9d) and after (fig. 8.9e) therapy. The lesion in
the mediastinum measured 8.5cm by 7.2cm and 6.4cm by 3.2cm before and after
therapy, respectively. The smaller of the peripancreatic nodes disappeared, the larger
was stable at around 1.4cm. High uptake was noted in the pancreatic head prior to
therapy. After therapy uptake was mild, and lesion diameter decreased from 1.8cm to
1.2cm. A periaortic node seen on the pre-treatment images measured lcm and
appeared three times larger on the post-treatment images, suggestive of further
advanced malignancy in that area. A second node was seen with intense FDG uptake,
and measured 2.7cm by 3.9cm.
8.3.2.7 SUMMARY AND CONCLUSION
The detection of recurrences and metastases in treated patients is challenging due
to the wide range of potential hematogenous spread of the tumour. Whole-body PET
may be clinically used in the search for distant metastases [Reske, 1996] albeit with
limited sensitivity for pulmonary lesions. A case study from the PET/CT tomograph
demonstrates the usefulness of combined PET/CT imaging in the staging and follow-
up of metastatic melanoma.
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Abdominal node  MOMPerisplenic nodes Pancreatic head
Figure 8.9 Patient with metastatic melanoma. PET study before chemotherapy (a) revealed multiple
areas of abnormal FDG accumulation in the chest and abdomen. Sagittal view (b) through CT (left)
attenuation-corrected PET (middle) and fused PET/CT image (right) illustrates foci of FDG uptake in
posterior mediastinum and abdomen. A PET study performed one month later after chemotherapy
showed partial clinical response (c, compare to a). A second PET/CT study (e) helped to evaluate the
response to therapy on the basis of measurements of the lesion size (see text for detail).
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8.4 EXPOSURE AND DOSE RELATED RISKS OF COMBINED PET/CT
STUDIES
Participation in a PET/CT study involves exposure to radiation from the PET and
CT scans. The amount of radiation dose that the patient will receive depends on the
physical scan parameters defined for the CT scan, and the activity injected for the
PET study. Each contribution is discussed individually below, and compared to the
radiation safety guidelines that apply to the general public.
The measurement of absorbed dose entails a determination of the energy
deposition by radiation from the X-ray source and the PET radiopharmaceutical. The
energy deposition is typically measured with ion chambers and phantom materials
that closely resemble the physical properties of human tissues. The absorbed dose, D,
is measured in [Gy] (1Gray=1Jkg -1 ). In radiation protection, it is the absorbed dose
averaged over the tissue or organ and weighted for the radiation quality that is of
interest. The radiation weighting factors, wR, are compatible with the values of Q,
that correspond to the biological effectiveness of different types of radiation [ICRP
40]. The biological effectiveness in turn is related to the linear energy transfer (LET,
section 9.1.3). For example, X-rays have a rather low biological impact (Q=1)
compared to protons (8.Qs10) and a-particles (15Q0). The dose equivalent is
measured in [Sv] (1Sievert=llke). The relationship between the probability of
stochastic effects and equivalent dose is found also to depend on the organ or tissue
irradiated. A tissue weighting factor is introduced to describe the contribution of that
tissue to the total detriment due to stochastic effects resulting from uniform
irradiation of the whole-body. According to the Recommendations of the ICRP
[ICRP, 1991] most of the tissue weighting factors are between 0.05 and 0.20, with
the skin and gonads being the least and most sensitive organs, respectively. The
weighted equivalent dose (a doubly weighted absorbed dose) is also called the
effective dose equivalent, Der [Huda, 1990].
Federal and State regulations define the yearly dose allowance from licensed
sources, or effective whole-body dose equivalent for the general public as lmSv per
year. This dose equivalent is less than the annual exposure from natural (2.4mSv)
and civil sources (1.6mSv) [Jung, 19951. In contrast, the annual equivalent dose to a
single organ (skin) must not exceed 50mSv. Individuals not employed in an
environment with exposure to radiation, should not exceed these dose allowances to
limit health hazards from radiation exposure. The allowance values are under
constant observation and are frequently adjusted to account for new insight into
health risk factors arising from exposure to ionizing radiation [ICRP, 1991]. The
yearly effective dose equivalent allowance for research subjects and patients by the
FDA (Federal Food and Drug Administration, USA) is 50mGy. To comply with the
same regulations, patients scanned with the PET/CT scanner prototype should not
receive more than 30mGy whole-body dose from both the PET and the CT scan
procedure together.
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8.4.1 EXPOSURE DURING CT EXAM
We have measured the effective dose from CT scans with the Somatom AR.SP,
and estimated the dose received from FDG PET scans from literature references. The
sum of the two estimates was compared with the maximum allowance. Radiation
measurements were made for the helical CT scanning mode with an MDH 9015
electrometer and a 10cm pencil ionization chamber [Seeram, 1994, Chapter 12].
Acrylic cylindrical phantoms of 15cm and 30cm diameter were used for head (and
extremity) and whole-body measurements, respectively. The Multi-Scan-Average-
Dose (MSAD) at a depth of lcm below the phantom surface was calculated for
typical physical and scan parameters. The MSAD is clinically important because it
represents an average dose delivered to the patient when a series of CT scans is
performed. It depends on the dose distribution per slice (collimation) and the slice
spacing. The MSAD is measured in [Gy], and corresponds to the total dose averaged
over the central region equal in length to the CT scan increment (slice spacing)
[Shope, 1981; Spokas, 1982].
X-ray dose measurements with the Somatom AR.SP are summarized in table 8.1.
Note that the measured MSAD values correspond to the single-organ dose received
by the skin. It can be seen from table 8.1 that the single-organ dose from an
abdominal CT scan performed with the AR.SP is in the range from 21mGy to
29mGy (scout scan not included) which corresponds to surface dose equivalents of
21mSv and 29mSv, respectively (Q=1). This range resembles closely the values
reported in a recent survey [Nishizawa, 1991].
Table 8.1 Multi-scan average dose [mGy] measured for the AR.SP at lcm below skin surface for
helical CT scans. Slice width for head, body (abdomen) and extremity scans were lOmm, 5mm, and
3mm with pitches of 1.0, 1.6, and 1.7, respectively.
Scan Tube voltage [kVp] Flux [mAs] MSAD [mGy]
Head 130 160 41.3
Body 110 200 21.5
Body 130 200 28.8
Extremity 110 160 28.0
The effective dose accounts for the dose distribution among the organs in the
body [Jung, 1995] and variations in their sensitivity towards the incoming radiation
[ICRP, 1991]. Individual organ doses are thereby weighted according to the relative
sensitivity of the organ to radiation-induced somatic or genetic effects [Jung, 1995],
and summed over all organs within the FOV. In contrast, the calculation of single
organ doses can lead to considerable errors due to different topographic relations
between phantoms and patients [Hidajat, 1996]. The calculated effective dose, on the
other hand, is more realistic, and provides a way of expressing a complex dose
distribution by a single quantity.
Typical effective doses to the head, chest, and abdomen/pelvis for a standard adult
patients are listed in table 8.J [Wall, 1997]. The table also includes our estimates
from the Somatom AR.SP. The effective mid-line dose, as an estimator of the dose
equivalent, was determined to be in the range of 12.6mSv to 17.4mSv for abdominal
helical scans. Our estimates of the effective dose are twice as high as effective
whole-body dose equivalents reported from measurements with the Alderson
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phantom and typical non-enhanced CT protocols [Becker, 1999]. Our estimates are
also higher than the effective dose values reported in a recent survey [Wall, 1997]
(table 8.J). The difference may be attributed to the fact that the survey included a
wide variety of CT scanners and CT scan protocols [Wall, 1997] different from the
protocols used for our measurements. We like to point out that up to date all CT
scans within the combined imaging protocols were performed without contrast
enhancement. The use of contrast agents during the CT scanning protocol, typically
requires a second scan, and will thus double the dose estimates from the CT
exposure.
Table 8.J Typical effective doses [mSv] to standard adult patients in CT exams of various regions of
the body with and without CT contrast agent administration [Wall, 1997]. For comparison estimates
of the effective dose [mSv] without contrast agent from helical CT scans with the Somatom AR.SP
(from table 8.1) are given.
Range 5th-95th percentile Somatom AR.SP
Region Without contrast With contrast Without contrast
Head
Chest
Abdomen/pelvis
0.6-2.0
1.8-10.7
2.7-12.0
1.2-4.0
3.2-21.3
5.3-24.0
8.3
14.4
More generally the effective whole-body exposure from a CT scan depends on the
inclusion or exclusion of organs that are particularly sensitive to radiation (for
example, bladder and lungs). In addition exposure is a function of helical scan
parameters: tube voltage and current, pitch [McNitt-Gray, 1999], and to a lesser
extent slice thickness, patient size, and scanner geometry [Wilting, 1999]. Recent
developments in CT imaging aim at reducing the radiation flux [Diederichs, 1996]
and dose (up to a factor of 20) in standard CT scans while maintaining acceptable
image quality [Moore, 1989]. Low-dose CT from constant reduction of the tube
current may, however, be only of limited applicability in diagnostic oncology due to
the degradation in soft tissue contrast [FeIsenberg, 1990] while it may suffice at the
same time requirements for high contrast exams, such as in orthopedics. Recently a
new method of dose reduction by means of a modulated tube current has been
successfully tested and implemented on a helical CT scanner [Gree13, 1999], and may
be applied to PET/CT scanning protocols in the near future to limit the total exposure
of the patient.
8.4.2 EXPOSURE DURING PET EXAM
Radiation exposure and risk factors from nuclear medicine procedures are difficult
to assess due to the variability of patient physiology and metabolic activities that lead
to a great variability of tracer distributions and tracer accumulations inside the body,
thus putting different organs at higher risks than others [Herzog, 1990[Meija, 1991
#645]]. Organ doses are estimated in units of Gy with respect to a unit activity, MBq,
injected [Stabin, 1996]. The contribution of individual organs to the effective dose
equivalent, similar to a whole-body dose, have recently been revised [ICRP, 1991]
and used to recalculate the doses for almost all radiopharmaceuticals [Johansson,
1992; Johansson, 1993]. The organs that are most sensitive to radiation and therefore
contribute most to the effective dose are the gonads, lungs, bone marrow, and colon
(to name a few), while skin and bone surfaces are least sensitive [Johansson, 1992].
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Based on extensive calculations several authors have shown that the bladder wall
receives the highest single-organ dose during FDG PET examinations. Values range
from 0.04mGy to 0.23mGy per MBq injected activity [Dowd, 1991]. These estimates
may increase up to 0.31mGy/MBq depending on bladder volume, urine output,
voiding schedule and other parameters [Debar, 1998]. After injection FDG is mostly
taken up by the brain and heart and rapidly cleared from other organs. The patient-
dependent metabolism and the percentual organ uptake affect the dose distribution
arising from FDG accumulation and metabolism. Effective dose equivalents were
estimated as 0.029mSv/MBq for a phantom resembling an average 70kg person
[Debar, 1998], and 0.024mSv/MBq for European and American adults [Mejia,
1991]. The effective dose is smaller for FDG PET scans of infants than for adults. In
infants a greater proportion of the injected activity is accumulated by the cerebellum
while a smaller fraction is excreted to the urine [Ruotsalainen, 1996]. Note that the
effective dose is given in units of [mSv/MBq] that differ from the absorbed dose
([mGy/MBq]) by the organ-specific weighting factors.
For the range of FDG-activities injected for combined PET/CT studies (about
270MBq, sections 8.1 to 83) we estimate effective dose equivalents of 6.5mSv for
patients undergoing the PET scan from the combined PET/CT protocol. Similarly,
the surface-dose and single-organ dose for the organ at maximum risk (bladder wall)
were estimated as 62mGy and 2.7mGy, respectively.
The dose from a 'Cs point source transmission scan was estimated from
exposure of a 300mL air-filled ionization chamber that was placed inside the FOV of
the PET/CT scanner. The chamber was positioned in the centre of the FOV and
20cm away from the centre. The two single photon sources, of 550MBq each, were
exposed together for a typical pre-injection scan duration of 2min. The accumulated
surface and centre dose were estimated as 0.23mGy and 0.09mGy, respectively. Due
to the limited sensitivity of the specific dose meter these figures represent the
accumulated dose over 2min. Nevertheless, the exposure from a singles transmission
scan is two orders of magnitude lower than the patient exposure from a CT
transmission scan (table 8.1) and from a PET emission study.
8.4.3 TOTAL RADIATION EXPOSURE FROM COMBINED PET/CT EXAM
For a standard helical CT scan over 60cm (5mm slice width, pitch 1.6, 130kVp,
160mAs) without contrast enhancement, we estimate an effective surface dose of
21.5mGy (table 8.1). We assume an effective total-whole-body dose of 0.1mGy from
the CT exam.
For a whole-body FDG scan with 270MBq injected activity we expect an
effective surface dose of 2.7mGy (and 62mGy to the bladder wall), or 6.7mGy
effective total-whole-body dose. The effective surface dose increases slightly if a
singles transmission scan is performed together with the emission study.
The total whole-body radiation exposure is therefore 6.8mGy, which is about 14%
of the annual radiation exposure permitted to radiation workers (50mGy) by Federal
regulations. The total single organ dose (skin), assuming that the bladder was not
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irradiated during the CT scan, is 23.7mGy, which is 16% of the annual radiation
exposure permitted to radiation workers (150mGy). There is no known minimum
level of radiation exposure that is recognized as being totally free of the risk of
causing genetic defects or cancer. Studies on the radiation induced cancer risk in
humans are difficult to conduct. They are mostly based on extrapolations from
observations of the survivors of Hiroshima and Nagasaki. It is now estimated that a
5% somatic cancer-induced risk exists for the exposed person that was exposed to
1Sv over one year. For the dose received by a patient during a combined PET/CT
study this risk factor translates into a somatic risk of 1:3,000, which is similar to the
risk to die from smoking 20 cigarettes per day, or the chance to be involved in a
deadly traffic accident [Jung, 1995]. Therefore, the risk associated with the radiation
dose from a combined PET/CT study without CT contrast agents may be considered
to be comparable to other everyday risks. However, the somatic and genetic risks
from CT exams alone will be approximately two times higher for contrast enhanced
examinations [Faulkner, 1987].
It is important to point out, that while the total dose received by the patient during
a CT exam strongly depends on the axial extent of the CT volume in addition to the
physical scan parameters, the total dose from PET scan depends only on the amount
of activity injected. Therefore, additional volume can be scanned in PET (whole-
body scan) without increasing the exposure to the patient. Similar volumes can be
scanned in CT only at the cost of increased dose, or potential degradations in image
quality [Zoetelief, 1998] due to the choice of a larger pitch or lower tube current.
8.5 SUMMARY
From June 1998 until July 1999 we have performed almost 70 combined PET/CT
studies of patients suffering mostly from thoracic and abdominal malignancies (fig.
8.10). In all cases whole-body PET scans were performed for two to five continuous
bed positions. The same area of the patient was covered by non-enhanced helical CT
scans. PET data were routinely corrected for scatter and attenuation using the
available CT information. The resulting image quality is superior to the image
quality achieved with 3DRP reconstruction based on attenuation-corrected emission
data using measured rod source transmission scans. By using CT-based attenuation
correction the artifactual elongation of naturally spherical lesions can be corrected
without significant noise amplification or introduction of additional streak artifacts
arising from noisy transmission data.
A cross-section of clinical patient studies performed on the PET/CT demonstrates
the versatility of the combined PET/CT tomograph for applications in clinical
oncology. We have summarized comparative PET and PET/CT reading of 32
patients with known or suspected malignancies [Charron, 1999]. Our data suggest
that combined PET/CT imaging typically improves anatomically limited PET scan
interpretation. The availability of accurately aligned functional and anatomical
information from a single scan session can help mainly (a) in pre-operative
assessment and localization of primary lesions (fig. 8.2), (b) in pre-operative
assessment of metastatic lesions (fig. 8.1, fig. 8.9b), (c) to differentiate areas of
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variable physiologic uptake versus contiguous neoplastic lesions [[Charron, 1999
#68411, (d) to help differentiate benign and malignant lesions (pancreatitis versus
pancreatic carcinoma, fig. 8.3), (e) to determine the degree of malignancy enlarged
uniform lesions seen on CT (fig. 8.2, fig. 8.4), (f) to evaluate patients with rising
CEA level of unknown origin (fig. 8.6), (g) in therapy follow-up (fig. 8.9), (h) in the
evaluation of post-operative bed (remaining tumour or recurrence, fig. 8.4).
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Figure 8.10 Number of cancer studies performed with the PET/CT tomograph between June 1998 and
July 1999. Thoracic and abdominal cancers are depicted in gray and black, respectively. Metastatic
disease is represented by white bars. 'Others' refers to studies of the brain (1), parathyroid mass (1),
gallbladder (1), sarcoma (1), and the thymus (1).
Another potential application of PET/CT scanning could be to guide a follow-up
CT to equivocal regions demonstrated by a whole-body PET scan. Since the
radiation dose received by the patient during a PET scan does not depend on the
axial extent scanned (unlike in CT), this 'PET/Partial-CT" protocol would limit the
total radiation exposure significantly, an interesting option when scanning children
or pre-treatment patients.
Combined PET/CT scan procedures are prone to the same pitfalls as either scan
modality alone. These pitfalls include the low-specificity of FDG as a tumour
seeking agent, the limited spatial resolution of the PET tomograph, artifactual uptake
of FDG in stressed muscle groups (critical in head/neck scans), and the low
specificity of CT for small lesions. In addition, involuntary patient motion during the
CT scan may lead to significant misregistration with the available PET data (section
6.2.1). These aspects warrant further studies with larger patient population and
specific to individual diseases, to establish the usefulness of the dual-modality
approach with a single tomograph on a statistical basis.
9. THE FUTURE OF PET/CT IMAGING
9.1 POTENTIAL APPLICATIONS OF THE COMBINED TOMOGRAPH
9.1.1 GUIDING IMAGE RECONSTRUCTION
Significant progress has been made in improving PET image quality through the
use of statistically-based reconstruction algorithms (section 2.6.3). These
improvements are particularly significant for count-limited, whole-body PET
scanning (chapter 3) where statistically-based algorithms offer substantially
improved image quality compared to the standard 3D reprojection method. These
algorithmic developments are also important for the PET/CT scanner, because even
though the low-noise CT images are utilized for attenuation correction, the high
noise level in the low-count emission scan remains a concern. For count-limited PET
imaging protocols, combining the sensitivity of 3D imaging with the noise reduction
and reconstruction speed of 2D iterative image reconstruction methods is an
attractive approach. For example, obvious improvements in reconstructed image
quality have been demonstrated with the FORE+OSEM algorithm [Kinahan, 1997],
which is based on accurate and noiseless rebinning of 3D PET data into a 2D data set
[Defrise, 1997], that is reconstructed by the ordered-subset EM (OSEM) iterative
reconstruction algorithm [Hudson, 19941.
Another promising approach to image reconstruction that has been investigated, is
to use an anatomical modality such as MR or CT to constrain the PET
reconstruction, for example [Leahy, 1991; Yan, 1993]. The idea is to extract
geometrical information, such as anatomical boundaries from the CT image, which is
used in a penalty function to constrain the PET reconstruction. The choice of the
penalty function weighting is crucial to avoid lesions which appear as functional
rather than anatomical deficits being suppressed during the PET reconstruction. The
availability of accurately aligned anatomical and functional data offers the potential
to explore, particularly for whole body oncology imaging, the improvements in
reconstructed image quality that can be achieved by incorporating anatomical
information from the CT.
Although not directly related to this thesis, we studied to reconstruct 2D PET data
derived from Fourier rebinning of a 3D PET data set, by minimizing a penalized
weighted least-squares (PWLS) objective function [Fessler, 1994]. This method is
well suited for reconstructing FORE rebinned data with an appropriate statistical
model [[Comtat, 1998 #768]]. The penalty term of the objective function is a
quadratic roughness penalty based on a 3D pixel neighborhood N3D consisting of 26
adjacent neighbors. The penalty weights are derived from the anatomical CT data
and encourage smoothness inside, but not across, anatomical regions. For simplicity
the penalty weights are kept constant during the reconstruction with FORE+PWLS
[Comtat, 1999]. The representation of the anatomical information is based on voxel
labels. Two quantities are associated with an image voxel: the estimated emission
density and the tissue type. A straightforward use of the labels is to set the penalty
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weight to one if two pixels belong to the same class, and to zero otherwise. This
binary use of labels is one type of generating anatomical prior information. The
image in fig. 9.1b shows the potential advantage of using CT-derived anatomical
priors in the PET image reconstruction: for example, the contrast of a small lesion in
the upper mediastinal region in particular is significantly improved with the use of
anatomical priors.
a)	 b)	 c)
Figure 9.1 A transverse section through the reconstructed image (FORE+PWLS) of a torso phantom
with four hot spheres and three cold spheres of different sizes: (a) no anatomical priors, (b) with
anatomical priors, and (c) with blurred anatomical priors. Note improved lesion contrast in upper
mediastinal lesion (arrow).
As discussed in section 6.2.1 mismatches between anatomical and functional data
due to involuntary patient motion are unavoidable. To account for respiratory and
cardiovascular motion, the voxel labels are 'blurred' to reflect the uncertainty
associated with the anatomical information. Although the use of blurred labels
reduces apparent lesion contrast (fig. 9.1c) compared to the aligned images with un-
blurred anatomical priors (fig. 9.1b), image quality is better than the quality of the
images reconstructed without anatomical priors (fig. 9.1a).
9.1.2 ASSISTANCE IN CT GUIDED BIOPSIES
Any mass or lesion which is identified by diagnostic imaging techniques can be
caused by a number of pathological processes, including infection, benign tumours,
which may not require any therapy, benign tumours which become progressively
more aggressive, or cancer. While the diagnosis of a suspicious mass may be based
on imaging studies such as CT or PET, accurate histological typing and grading
require a pathological examination of tissue samples from the mass. CT guided
percutaneous needle biopsies, for example, have gained widespread acceptance in the
clinical management of cancer and are now routinely performed to obtain tissue
samples for cytological, pathological or bacterial analysis [Dunnick, 1989]. Needle
biopsies are generally preferred to open surgical biopsies since they are less invasive
and the patient can be released from the hospital shortly after the biopsy.
The reliability of the diagnosis from the histological samples thereby depends on
the experience of the pathologist, the sampling of the biopsied mass and the sample
size of the extracted specimen. Misdiagnosis can be caused by biopsies taken from
an area of the lesion that is not representative of the entire tumour (e.g. necrosis).
Although fine needle biopsies are minimally invasive compared to open biopsies,
they are associated with significant sampling errors [Adler, 1993]. In particular in
cases of breast cancer with difficult to palpate lesions and difficult to interpret
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mammograms, in patients with multiple small lesions and cysts, and in patients with
large uniform masses fine needle biopsies could benefit from complementary
functional PET information embedded in a coregistered anatomical background
information. While in the head, this has been demonstrated to be fairly successful,
the role of PET in assisting CT-guided biopsies outside the brain have not yet been
studied systematically.
Although the current prototype PET/CT scanner is not ready for use in clinical
CT-guided biopsies (due to the disabled tilt option), a case study from the PET/CT
patient database illustrates the advantages of complementary PET/CT information
for image-guided biopsies of a tumour (fig. 9.2). A 72 year-old woman with primary
squamous cell lung cancer was imaged on the PET/CT scanner. The PEI' emission
scan was acquired for eight minutes. The images shown in fig. 9.2 demonstrate a
large lesion in the upper quadrant of the right lung. Although the lesion appears as a
uniformly-attenuating, isodense mass on CT, PET reveals heterogeneous uptake
consistent with a necrotic center and a rim of intense uptake representing high
metabolic activity. Without the complementary functional information from the PET
exam an insufficient number of samples of the lesion could have been taken, and the
metabolically active rim of the tumour could not have been sampled sufficiently. A
false negative biopsy could have resulted from sampling the necrotic centre of the
lesion. This example clearly illustrates that additional knowledge of the metabolic
functionality of suspect lesions might assist CT guided biopsies when tissue samples
of single or multiple lesions are taken to confirm or exclude malignancies.
Figure 9.2 A case of primary lung cancer demonstrating a large uniform lesion in the posterior part of
the right lung on the CT image (left). The corresponding PET image (right) demonstrates a
hypermetabolic rim around a necrotic lesion centre. Involvement or a paratracheal lymph node
(arrow), also seen on CT, was confirmed.
9.1 .3 IMPROVING RADIATION THERAPY PLANNING
Therapeutic effect of cancer treatment depends on the successful control of local
disease. Surgical, radiotherapeutical and pharmaceutical treatments, or combinations
thereof are now being applied, depending on the location and type of tumour to be
treated (fig. 9.3). While 45% of the cancer patients can be treated successfully by
either surgery (22%), radiotherapy (12%), chemotherapy (5%), or a combination of
surgery and radiotherapy (6%), for one third of the patients (37%) only palliative
treatment can be offered [Tubiana, 1992]. Every sixth patient (18%) dies from failure
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of tumour control, even though the primary tumour is localized. In Europe, this
corresponds to 280,000 deaths per year.
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Figure 9.3 Present situation in cancer treatment. Of all patients 45% are successfully treated with
surgery (22%), radiotherapy (12%), combination (6%), and chemotherapy (5%). Every sixth cancer
patient dies from failure of local disease control.
Small tumours in the subclinical range can be eradicated by radiotherapy, while
reducing morbidity and limiting side effects to normal surrounding tissues. With
increasing tumour size, radiotherapy, however, becomes less effective. Surgical
resection is then often applied, in particular when the lesion can be accessed and
removed with the least risk to the patient. In the case where the lesion is adjacent to
highly sensitive organs such as the brainstem, intensity modulated tumour conformal
radiotherapy [Grant, 1998], or combinations of radiotherapy and chemotherapy can
be used to either substitute or complement surgical intervention. Chemotherapy often
leads to shrinkage of the tumour, e.g. in Hodgkin's disease, that is then irradiated
with a reduced dose deposited in a smaller volume, thus sparing other organs and
reducing complications.
Chemotherapy affects different phases of the cell cycle, and is topographically
non-specific. In other words, the same toxic agent can be used to treat localized
disease or general disease that is not limited to a single organ or anatomical area (e.g.
leukemia). Therefore chemotherapy planning depends on the stage of the disease
(Chapter 8) and the level of tolerance of the patient to toxic pharmaceuticals. Surgery
and radiotherapy treatment planning, on the other hand, depend strongly on the
ability to localize the disease. For surgical resection, viable tumour tissue has to be
defined and removed while sparing healthy tissue surrounding the lesion. The
advantages of combined functional and anatomical information for treatment
planning and pathological examination, have been discussed in chapter 8 and section
9.1.1, respectively.
Radiation therapy in general aims to eradicate cancer cells in malignant masses
and is based on the lethal effects of radiation on cells exposed to radiation. The goal
of radiation therapy is to deliver an effective dose as large as possible to a given
target volume, while limiting exposure to healthy tissue around the lesion, as well as
to the skin in the entrance and exit channels. The target volume is typically defined
by anatomical imaging techniques, such as CT or MRI. The standard radiotherapy
treatment includes conventional irradiation by high-energy photons. Conventional
carbon: SOBP
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radiotherapy is, however, limited by its non-favourable depth dose profile which,
after a maximum dose close to the entrance surface, falls off exponentially with
depth, and by the restriction to passive field shaping devices.
Therapeutic charged particle beams are used instead since they offer several
advantages over photon radiation that can be exploited for the development of
improved treatment techniques. For example, magnetic fields can be used to focus
the charged particle beam to a pencil shaped beam with adjustable spot size
(diameter between 4mm and lOmm) and to steer it over the therapy area. By
variation of the beam intensity and scanning speed together with a variation of the
beam energy, any desired dose distribution within the target volume can be generated
[Haberer, 1993]. Radiotherapy using charged particles is therefore ideal for 3D
conformal tumour irradiation.
In contrast to conventional radiation, charged particles, and ions in particular
exhibit an inverse dose profile. Most of the initial particle energy is delivered in a
narrow region close to the end of the particle tracks — the Bragg peak (fig. 9.4), while
the entrance channel — the plateau region receives a lower fraction of the dose. The
position in depth of the Bragg peak can be controlled by the energy of the incoming
beam. Hence the maximum energy deposited can be accurately adjusted to the
tumour position with a precision of up to 1 mm. Typically the target volume is
separated into voxels of less than 1crn 3 that are irradiated with a pre-defined dose
(dynamic voxel scanning). Transaxially extended tumours are irradiated by
superposition of several Bragg maxima corresponding to particles with different
energies (fig. 9.4). The efficacy of heavy ion therapy is further enhanced by a high
biological effectiveness of the ions, which is shown to be an important advantage for
the treatment of radiation resistant tumours [Amaldi, 1998].
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Figure 9.4 Depth dose profiles of photons, protons and carbon ions. The high physical selectivity
combined with high biological effectiveness make ion beams superior to other radiation's, especially
for deep-seated tumours. In those cases dose is delivered to the target volume by superpositioning
multiple Bragg peaks (Spread Out Bragg Peak, SBOP) with transaxial decrements of 2-4mm.
To exploit the capabilities of radiation treatment with ions exact knowledge of the
location and the extent of the tumour is required. The standard imaging technique in
treatment planning is CT, sometimes replaced by MRI. PET imaging was shown to
represent the metabolic activity of cancer and to estimate viable tumour and spread
of the primary disease (chapter 8). Complementary functional PET and anatomical
a) b)
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CT information is essential when the tumour has started to spread beyond its
morphological boundaries and morphological alterations are not yet seen. The
benefits of combined PET/CT imaging for conventional treatment planning were
described in chapter 8 and could be applicable to more efficient radiotherapy
planning in the near future.
An example where available PET/CT information may be helpful in heavy ion
radiation therapy treatment planning is shown in fig. 9.5. A mass that appears
uniform on CT but non-uniform glucose metabolism was shown by the PET exam.
Utilizing the functional information of the tumour mass for planning radiation
treatment, the dose that is delivered to the tumour can be directed to the
metabolically viable areas of the mass while minimizing the exposure of the
surrounding organs and areas of the mass. The availability of accurately aligned Pet
information could therefore help rendering the active tumour volume to be irradiated,
and to define the dose delivered to individual voxels.
Figure 9.5 Non-uniform glucose metabolism in an abdominal mass of a patient with metastatic
melanoma. The mass appears uniform on CT (a). PETCT image fusion (b) reveal non-uniform partial-
rim FDG accumulations in the large mass at the level of the kidneys (arrowheads). This non-uniform
FDG uptake indicated areas of hypermetabolism surrounding necrotic tissue.
In summary, radiotherapy treatment planning depends on the type of tumour, total
dose, expected side effects, patient tolerance, and fractioning scheme. Based on these
parameters, a 2D and 3D dose distribution is calculated that is then translated into a
beam delivery program. The values for the healthy tissue tolerance and the total dose
that yields maximum clinical response are based on experience and experimental
data from the literature. The biological variability of the tumour and the clinical
response of the individual patient are often referred to as the fourth dimension in
radiotherapy planning (fig. 9.6).
A functional imaging technique can help to define and monitor certain aspects of
cancer biology. In particular, the ability to monitor metabolic response to therapy can
be used to adjust fractional dose delivery for repetitive treatments. Combined
PET/CT data sets, if used during radiotherapy planning, would offer information
both on metabolic and morphological response of the irradiated region, which could
be used to adjust the ongoing treatment protocol. Since radiation therapy with
charged particles is more efficient in most cases and leads to better clinical response
than high-energy photon therapy, the integration of PET/CT imaging in the therapy
planning process may offer better local tumour control and eventually higher relative
survival rates.
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Finally, the work by the GSI/FZ Rossendorf/DKFZ-collaboration to introduce
PET for dose monitoring in heavy ion therapy should be acknowledged. When the
ion beam penetrates the tissues to the target volume, positron-emitting isotopes are
generated by nuclear fragmentation of the primary ions. The stopping points of these
secondary positron emitters can be identified with the aid of PET during or after the
irradiation [Pawelke, 1997]. Using a stationary partial ring PET system, dose
localization can be monitored in-situ and the correctness of the therapy planning can
be verified. This is the first time since the introduction of radiation therapy at the end
of the 19th century that the radiotherapist can see the location of the dose delivered
during treatment [Amaldi, 19981. While the ideas discussed above have not been
implemented yet in practice, the GSI project is in operation since December 1997,
and more than 40 patients have been successfully treated.
Figure 9.6 `4D'-planning of radiation therapy. Based on tumour extent and location 3D target volumes
are defined (left). Dose delivery (middle, red=maximum, yellow=minimum) is planned by choosing
particle type and energy. Biologic activity is estimated from functional imaging or biopsy and added
as a fourth dimension to the therapy plan, affecting the choice of energy, dose-fractioning and the
amount of total dose delivered to the lesion.
9.2 SUMMARY
In this chapter some of the most promising applications of dual-modality PET/CT
imaging, and in particular of the combined prototype scanner have been illustrated in
descending order of importance. Future developments of combined PET/CT systems
may benefit from recent progress in hardware developments of both CT and PET
technology, such as multi-slice helical CT and LSO based PET detector blocks, to
name only two developments.
Multi-slice helical CT refers to a helical CT system equipped with a multiple-row
detector system to allow X-ray transmission data collection at multiple axial
locations simultaneously [Hu, 1999]. Compared to standard single-slice helical CT
larger longitudinal volumes may be scanned more rapidly with high axial resolution.
Due to the larger volume coverage speed with multi-slice helical CT artifacts arising
from patient motion are more limited or suppressed entirely. However, since it is
currently not fully understood how much periodic patient motion (e.g. respiration,
cardiovascular movement) contributes to artifacts in the combined PET/CT images
of the prototype scanner, benefits from a potential replacement of the single-slice
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helical CT with a multi-slice helical CT in a combined tomograph remain to be
shown.
The introduction of the recently discovered scintillation material LSO (section
2.5.2) would improve the performance of the PET components of the dual-modality
tomograph. The overall performance of the combined tomograph in clinical trials
(e.g. sensitivity and specificity of disease staging) is likely to be positively affected.
While the physical properties of LSO and the standard PET detector material BGO
are similar, LSO offers a significantly shorter scintillation decay time and five times
more light output per absorbed annihilation photon. Therefore better countrate
performance can be achieved with LSO based PET detector blocks compared to
BGO [Moisan, 1997; Casey, 1997], due to the shorter detector dead time and slightly
improved energy resolution of the LSO. Furthermore, LSO based detector blocks
may be cut into smaller crystals than current BGO crystals to allow better spatial
resolution.
With its simple concept, the prototype PET/CT scanner offers a good compromise
between integration of dual-modality imaging components within a single gantry and
service accessibility. However, certain modifications are needed to facilitate easier
access to all system components for cleaning and tune up. Standard requirements in
future dual-modality designs should be to reduce the dust migration inside the
combined gantry from the CT graphite brushes, easy access to CT and PET slip rings
for cleaning, and accurate balance and counterbalance of the combined system. The
choice of the X-ray tube and PET detector material are further concerns but are
limited theoretically by budget constraints only.
10. APPENDIX
10.1 QUANTIFYING THE PERFORMANCE OF DIAGNOSTIC IMAGING
For a given disease the performance of imaging techniques is typically compared
on the basis of the three parameters: sensitivity, specificity, and accuracy, each of
which describes an aspect of the quality of a diagnostic test with a particular imaging
technique. For the evaluation of diagnostic decisions we assume that a 'true' answer
exists to the question whether an abnormality is present. This answer is typically
found in biopsies or from post mortem examinations. A statistical decision matrix
shown in table 10.A can be constructed to cover all four possible situations in
diagnostic imaging.
Table 10.A Statistical decision matrix showing all four possible situations for diagnostic decision
making.
Diagnostic assessment of 	 The disease is 'truly' present
presence	 yes	 no
yes	 True positive (TP)	 False positive (FP)
no	 False negative (FN)	 True negative (TN)
Comparing the actual answer given by the imaging procedure to the 'true' answer
leads to the definition of sensitivity:
TPSensitivity =
TP + FN'
as the ability of the imaging technique to detect patients with disease; the
definition of specificity:
TN 
Specificity —
TN + FP ,
as the ability to rule out disease in normal patients, and the definition of accuracy:
TP +TN 
Accuracy —
TP+ FN +TN + FP ,
as the diagnostic ability to detect true outcomes (positive and negative) among all
test results. All three measures, sensitivity, specificity, and accuracy are typically
given in [%].
10.2 STANDARDIZED UPTAKE VALUES (SUV)
As discussed in section 2.1.5, the increased glucose metabolism of malignant cells
is exploited for PET and the detection of tumours in-vivo. While subjective
interpretation of PET images may be sufficient for tumour detection [Chiro, 1988]
most publications refer to the Standardized Uptake Value (SUV) as a semi-
quantitative measure of tracer accumulation in regions-of-interest. Compared to the
regional tumour-to-background ratio as a regional measure of tracer concentration in
tumours only, the SUV relates the tracer uptake in tissues in a region of interest
(ROI) to the average tracer concentration in the body. The SUV is calculated from
the expression:
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SUV— 
	 ROT counts [MBq / ml] 
{Injected dose [MBq]}/ {Body weight [g]}
Note, this expression assumes that the scanner has been calibrated, and the
emission images have been corrected for attenuation (section 3.1.4) and scatter to
yield tissue concentrations in absolute units of radioactive concentration (MBq/mL).
Most references publish the calculated SUV as a dimensionless number. The SUV
has been used to distinguish significant uptake in malignant tissue from uptake in a
normal or non-malignant process by adopting a threshold value. For example, an
SUV greater than a particular value (e.g. 2.5) is suggestive of a malignant process
[Strauf3, 1991], but must not be used for staging purposes [Crippa, 1998].
Despite its interesting concept the SUV is sometimes referred to as 'Silly Useless
Value' and subject of intense controversy [Keyes, 1995]. A major problem of the
SUV concept is that it is subject to too many sources of variability, such as patient
size and body composition, length of the uptake time of the radiopharmaceutical,
plasma glucose levels, and physical limitations of the tomographs (recovery
coefficient and partial volume effects) [Keyes, 1995]. Although several corrections
have been suggested to account for the strong positive correlation of the SUV with
patient weight [Zasadny, 1993] other sources of variability may lead to significant
differences in SUVs within a patient population and between the results published by
groups using different PET tomographs. It is argued that the SUV is useful only in
therapy follow-up of individual lesions of the same patient, whereby the lesions must
be large enough not to be affected by the physical resolution of the tomograph
[Keyes, 1995].
11. SUMMARY OF THE THESIS WORK
Traditionally, imaging modalities such as CT, MR, SPECT and PET have
contributed separately, but often in complimentary ways, to the overall diagnosis of
pathological conditions. Since the potential of combining functional and anatomical
images is a powerful one, in recent years there has been significant progress in the
development of multi-modality image co-registration and alignment techniques.
However, with the exception of the brain, the re-alignment of images from different
modalities is not straightforward, even when surface markers or reference points are
used. The construction of a prototype dual-modality tomograph capable of providing
both PET and CT images without movement of the patient and without the use of
external reference markers, therefore represents a significant advance, in particular
for oncological applications.
This thesis describes the design and performance of the prototype PET/CT
tomograph [Beyer, 2000]. The PET/CT scanner provides accurately aligned
anatomical (CT) and functional (PET) information over an axial range of up to
100cm sufficient to examine the patient from the chin to the thighs. In this thesis, a
hybrid segmentation/scaling method is proposed, which uses the available CT
transmission images for attenuation correction of the PET emission data. This
method of CT-based attenuation correction is described in detail in chapter 5. The
use of CT-based attenuation correction together with iterative reconstruction of the
corrected emission data provides quantitative whole-body PET emission images of
high image quality. Standard uptake values can be estimated from the corrected PET
emission images in all combined PET/CT studies on a routine basis, and applied to
the differential diagnosis of neoplasms and in estimating response to therapy.
However, care should be taken as the quantitative accuracy of the CT-based
attenuation corrected PET emission data is affected by spatial mismatches between
the PEI' and CT data from involuntary patient motion (respiration and cardiovascular
motion). These mismatches are only partly eliminated by the short CT scan times.
Beam hardening and truncation artifacts from large objects that extend beyond the
field-of-view of the CT do not degrade the quantitative accuracy, but can introduce
minor artifacts in the corrected emission images.
The prototype scanner was constructed with commercially available PET and CT
tomographs. A series of phantom measurements demonstrate that, despite the
proximity of the PET and CT, cross talk between the two systems is limited, and that
the PET and CT components of the combined system perform as well as individual
PET and CT systems. The performance of the combined PET/CT tomograph
benefited from improvements of the countrate performance of the ECAT ART that
were achieved by reduced detector block integration times [Townsend, 1999a;
Townsend, 1999b]. These experiments were also carried out as part of this thesis.
Since its installation in May of 1998 in the PET Center at the University of
Pittsburgh Medical Center, the PET/CT tomograph has been used successfully in the
diagnosis and follow-up of more than 80 oncology patients. A clinical evaluation of
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the first 35 patient studies confirmed that combined PET/CT information improves
the diagnostic accuracy over PET alone and in selected cases leads to a change in
therapy over using PET information alone [Charron, 1999]. In addition to the
immediate impact on clinical diagnosis in oncology, the application of the PET/CT is
likely to assist CT-guided biopsies and radiation therapy planning in the near future.
These developments should form the core of further work.
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